Sentence,class,file
http://www.fda.gov/ohrms/ dockets/ac/06/slides/2006-4208S1-Slide-Index.htm.,Non-OADS,/arxiv_data1/oa_pdf/fb/3b/CG-CGCR170009.PMC5356152.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/a5/3c/CG-CGCR170002.PMC5356153.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/51/7e/CG-CGCR170007.PMC5356167.pdf
"Uroweb, http://uroweb.org/wp-con-tent/uploads/09-Prostate-Cancer_LR.pdf (2015, accessed 19 April 2016).",Non-OADS,/arxiv_data1/oa_pdf/05/d7/10.1177_2051415816654048.PMC5356175.pdf
"Prostate Cancer: Diagnosis and Management Clinical  Guideline: NICE, https://www.nice.org.uk/guidance/cg175 (2014, accessed 20 June 2016).",Non-OADS,/arxiv_data1/oa_pdf/05/d7/10.1177_2051415816654048.PMC5356175.pdf
"Prostate  cancer: Diagnosis and management, https://www.nice.org.uk/guidance/cg175/chapter/1-recommendations  22.",Non-OADS,/arxiv_data1/oa_pdf/e0/ab/10.1177_2051415816685211.PMC5356176.pdf
"V.1.2015, http://www.nccn.org/professionals/physician_gls/pdf/pros- tate.pdf  43.",Non-OADS,/arxiv_data1/oa_pdf/e0/ab/10.1177_2051415816685211.PMC5356176.pdf
"Prostate cancer statistics, http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer (2013, accessed 4  March 2016).",Non-OADS,/arxiv_data1/oa_pdf/d3/8b/10.1177_2051415816656121.PMC5356177.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/38/26/CG-CGCR170004.PMC5356200.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e7/65/CG-CGCR170010.PMC5356201.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/e9/bf/CG-CGCR170008.PMC5356202.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/b3/b9/CG-CGCR170005.PMC5356208.pdf
"1, 89 –96 http://dx.doi.org/10.1080/23328940.2016.1257407",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Compr Physiol 2014;4:1677-713; PMID:25428857; http://dx.doi.org/10.1002/ cphy.c140013 [2] Nakamura, K, Morrison SF.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
Proc Natl Acad Sci US A 2010; 107:8848-53; PMID:20421477; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
Clin Infect Dis2000; 31:S162-7; PMID:111 13019; http://dx.doi.org/ 10.1086/317515 [7] Szekely M. The vagus nerve in thermoregulation and energy metabolism.,OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Auton Neurosci 2000; 85:26-38;PMID:11189024; http://dx.doi.org/10.1016/S1566-0702 (00)00217-4 [8] Blouet C, Schwartz GJ.",OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Hepatic glucokinase modulates obesity predisposi- tion by regulating BAT thermogenesis via neural signals.Cell Metab 2012; 16:825-32; PMID:23217261; http://dx.doi.org/10.1016/j.cmet.2012.11.006 [10] Madden CJ, Morrison SF.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
Am J Physiol Endocrinol Metab2016; 311:E287-92; PMID:27354235; http://dx.doi.org/ 10.1152/ajpendo.00081.2016[11] Berthoud HR.,Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Regul Pept 2008; 149:15-25; PMID:18482776; http://dx.doi.org/10.1016/j.regpep.2007.08.024 [12] Pardo JV, Sheikh SA, Kuskowski MA, Surerus-Johnson C, Hagen MC, Lee JT, Rittberg BR, Adson DE.",OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Nutrition 2015; 31:1416-22; PMID:26429664; http://dx.doi.org/10.1016/j.nut.2015.05.007 [14] Koren MS, Holmes MD.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Epilepsy Behav 2006;8:246-9; PMID:16343997; http://dx.doi.org/10.1016/j.yebeh.2005.10.001 [15] Vijgen GH, Bouvy ND, Leenen L, Rijkers K, Cornips E, Majoie M, Brans B, van Marken Lichtenb elt WD.",OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Am J Physiol Regul IntegrComp Physiol 2009; 296:R831-43; PMID:19129373;http://dx.doi.org/10.1152/ajpregu.91007.2008 [17] Nakamura K, Morrison SF.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Am J Physiol Regul Integr Comp Physiol 2007; 292:R127-36; PMID:16931649;http://dx.doi.org/10.1152/ajpregu.00427.2006 [18] Morrison SF, Sved AF, Passerin AM.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Annu Rev Physiol1994; 56:93-116; PMID:7912060; http://dx.doi.org/10.1146/annurev.ph.56.030194.000521 [21] Cao WH, Madden CJ, Morrison SF.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"Am J Physiol Regul Integr Comp Physiol 2010;299:R277-90; PMID:20410479; http://dx.doi.org/10.1152/ajpregu.00039.2010 [22] Kong D, Tong Q, Ye C, Koda S, Fuller PM, Krashes MJ, Vong L, Ray RS, Olson DP, Lowell BB.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"J Neurosci2013; 33:14512-25; PMID:24005302; http://dx.doi.org/10.1523/JNEUROSCI.1980-13.2013 [24] Ikramuddin S., Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, Fujioka K, Maher JW, Swain J, Que FG, et al.",OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"JAMA 2014;312:915-22; PMID:25182100; http://dx.doi.org/10.1001/jama.2014.10540[25] Mano-Otagiri A, Ohata H, Iwasaki-Sekino A, Nemoto T, Shibasaki T. Ghrelin suppresses noradrenaline release inthe brown adipose tissue of rats.",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"J Endocrinol 2009;201:341-9; PMID:19351665; http://dx.doi.org/10.1677/JOE-08-0374 [26] Habara H, Hayashi Y, Inomata N, Niijima A, Kan- gawa K. Organ-speci ﬁc activation of the gastric branch of the efferent vagus nerve by ghrelin in ure- thane-anesthetized rats.",OADS,/arxiv_data1/oa_pdf/c1/8f/ktmp-04-01-1257407.PMC5356211.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/e7/ktmp-04-01-1220351.PMC5356212.pdf
"1, 18 –20 http://dx.doi.org/10.1080/23328940.2016.1220351",Non-OADS,/arxiv_data1/oa_pdf/66/e7/ktmp-04-01-1220351.PMC5356212.pdf
Mol Metab 2016; 5:271; PMID:27069867; http://dx.doi.org/10.1016/j.molmet.2016.01.008 Figure 1.,OADS,/arxiv_data1/oa_pdf/66/e7/ktmp-04-01-1220351.PMC5356212.pdf
"Physiol Rev 2004; 84:277; PMID:14715917; http://dx.doi.org/10.1152/physrev.00015.2003 [3] Lopez M, Alvarez CV, Nogueiras R, Di /C19eguez C. Energy balance regulation by thyroid hormones at central level.",Non-OADS,/arxiv_data1/oa_pdf/66/e7/ktmp-04-01-1220351.PMC5356212.pdf
"Trends Mol Med 2013; 19:418; PMID:23707189; http://dx.doi.org/10.1016/j.molmed.2013.04.004 [4] Lopez M, Nogueiras R, Tena-Sempere M, Di /C19eguez C. Hypothalamic AMPK: a canonical regulator of whole-body energy balance.",OADS,/arxiv_data1/oa_pdf/66/e7/ktmp-04-01-1220351.PMC5356212.pdf
"Cell Metab 2014; 19:741-56; PMID:24630813; http://dx.doi.org/10.1016/j.cmet.2014.02.007 Ismael Gonz /C19alez-Garc /C19ıa NeurObesity Group, Department of Physiology, CIMUS University of Santiago de Compostela-Instituto de Investigaci /C19on Sanitaria Santiago de Compostela, 15782, Spain & CIBER Fisiopatolog /C19ıa de la Obesidad y Nutrici /C19on (CIBERobn) Santiago de Compostela, 15706, Spain ismael.gonzalez@usc.es Miguel L /C19opez NeurObesity Group, Department of Physiology CIMUS, University of Santiago de Compostela-Instituto de Investigaci /C19on Sanitaria Santiago de Compostela, 15782, Spain & CIBER Fisiopatolog /C19ıa de la Obesidad y Nutrici /C19on (CIBERobn) Santiago de Compostela, 15706, Spain m.lopez@usc.es20 I. GONZ /C19ALEZ-GARC /C19IA AND M. L /C19OPEZ",Non-OADS,/arxiv_data1/oa_pdf/66/e7/ktmp-04-01-1220351.PMC5356212.pdf
"1, 79 –88 http://dx.doi.org/10.1080/23328940.2016.1230171",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"CMAJ 13 2010; 182:1053-60; http://dx.doi.org/10.1503/cmaj.081050 [3] Yu W, Mengersen K, Wang X, Ye X, Guo Y, Pan X, Tong S. Daily average temperature and mortality among theelderly: a meta-analysis and systematic review of epide-miological evidence.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Int J Biometeorol 2012; 56:569-81;PMID:21975970; http://dx.doi.org/10.1007/s00484-011-0497-3 [4] United Nations, World Population Aging; ST/ESA/SER.",OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Sci Rep 2016; 6:28161;PMID:27320724; http://dx.doi.org/10.1038/srep28161 [6] Hajat S, Vardoulakis S, Heaviside C, Eggen B.",OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"J Epidemiol Community Health 2014; 68:641-8; PMID:24493740; http://dx.doi.org/10.1136/jech-2013-202449 [7] Robine JM, Cheung SL, Le Roy S, Van Oyen H, Grif ﬁths C, Michel JP, Herrmann FR.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
C R Biol 2008;331(2):171-8; PMID:18241810; http://dx.doi.org/ 10.1016/j.crvi.2007.12.001[8] Osborn A. Moscow smog and nationwide heat wave claim thousands of lives.,Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
2014; http://www.nature.com/news/russian-sum mer-tops-universal-heatwave-index-1.16250 .,Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Int J Epidemiol 2008; 37:309-17;PMID:18194962; http://dx.doi.org/10.1093/ije/dym253 [14] Boyson C, Taylor S, Page L. The national heatwave plan - a brief evaluation of issues for frontline health staff.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Epidemiology 2015; 26:781-93; PMID:26332052;http://dx.doi.org/10.1097/EDE.0000000000000375 [16] Dufour A, Candas V. Ageing and thermal responses dur- ing passive heat exposure: sweating and sensory aspects.Eur J Appl Physiol 2007; 100:19-26; PMID:17242944;http://dx.doi.org/10.1007/s00421-007-0396-9 [17] Kenney WL, Fowler SR. Methylcholine-activated eccrine sweat gland density and output as a function of age.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Am J Respir Crit Care Med 2009;179:383-9; PMID:19060232; http://dx.doi.org/10.1164/rccm.200802-217OC [21] Linares C, Diaz J.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
Eur J Public Health 2008; 18:317-22; PMID:18045814; http://dx.doi.org/ 10.1093/eurpub/ckm108TEMPERATURE 87,Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"BMC Public Health2007; 7:200; PMID:17688689; http://dx.doi.org/10.1186/1471-2458-7-200 [23] Basu R, Malig B.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Environ HealthPerspect 2001; 109:463-70; PMID:11401757; http://dx.doi.org/10.1289/ehp.01109463 [25] Kohl HW, Blair SN, Paffenbarger RS, Jr., Macera CA, Kronenfeld JJ.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Appl Physiol Nutr Metab 2014;39:292-8; PMID:24552369; http://dx.doi.org/10.1139/apnm-2013-0317 [27] Larose J, Boulay P, Sigal RJ, Wright HE, Kenny GP.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"PloS One 2013; 8:e83148; PMID:24349447; http://dx.doi.org/10.1371/journal.pone.0083148 [28] Kenny GP, Stapleton JM, Yardley JE, Boulay P, Sigal RJ.",OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Med Sci Sports Exerc 2013; 45:1906-14; PMID:23542894; http://dx.doi.org/10.1249/MSS.0b013e 3182940836 [29] Reardon FD, Leppik KE, Wegmann R, Webb P, Ducharme MB, Kenny GP.",OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Med Biol Eng Comput 2006;44:721-8; PMID:16937214; http://dx.doi.org/10.1007/s11517-006-0086-5 [30] Moran DS, Shitzer A, Pandolf KB.",OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
J Appl Physiol (1985) 2015; 118:299-309;PMID:25505030; http://dx.doi.org/10.1152/japplphysiol.,Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Compr Physiol2013; 3:1689-719; PMID:24265242; http://dx.doi.org/10.1002/cphy.c130011 [36] Jay O, Gariepy LM, Reardon FD, Webb P, Ducharme MB, Ramsay T, Kenny GP.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Am J Physiol Regul Integr CompPhysiol 2007; 292:R167-75; PMID:16931653; http://dx.doi.org/10.1152/ajpregu.00338.2006 [37] Sawka MN, Castellani JW.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"J Appl Physiol (1985) 2007; 103:419-20; PMID:17556501;http://dx.doi.org/10.1152/japplphysiol.00592.2007 [38] Minson CT, Wladkowski SL, Cardell AF, Pawelczyk JA, Kenney WL.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Am J Physiol Regul IntegrComp Physiol 2006; 291:R580-8; PMID:16513764; http://dx.doi.org/10.1152/ajpregu.00918.2005 [41] Sagawa S, Shiraki K, Yousef MK, Miki K. Sweating and cardiovascular responses of aged men to heat exposure.",Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
"Am J Prev Med 1999;16:269-77; PMID:10493281; http://dx.doi.org/10.1016/S0749-3797(99)00025-2 [43] Green RS, Basu R, Malig B, Broadwin R, Kim JJ, Ostro B.",OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
I Int J Public Health 2010; 55:113-21; PMID:19771392; http://dx.doi.org/10.1007/s00038-009-0076-088 G. P. KENNY ET AL.,Non-OADS,/arxiv_data1/oa_pdf/a5/78/ktmp-04-01-1230171.PMC5356213.pdf
The TRPM2 channel is a hypothalamic heat sensor that limits fever and can drive hypothermia.Science 2016; 353:1393-1398; http://dx.doi.org/10.1126/science.aaf7537 Detecting and interpreting changes in temperature is essential for our well-being.,Non-OADS,/arxiv_data1/oa_pdf/82/c2/ktmp-04-01-1258445.PMC5356215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.TEMPERATURE 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/82/c2/ktmp-04-01-1258445.PMC5356215.pdf
"1, 21 –23 http://dx.doi.org/10.1080/23328940.2016.1258445",Non-OADS,/arxiv_data1/oa_pdf/82/c2/ktmp-04-01-1258445.PMC5356215.pdf
Auton Neurosci 2016; 196:14-24; PMID:26924538; http://dx.doi.org/10.1016/j.autneu.2016.02.010.,OADS,/arxiv_data1/oa_pdf/82/c2/ktmp-04-01-1258445.PMC5356215.pdf
"Nat Rev Neurosci 2014; 15:573-89; PMID:25053448; http://dx.doi.org/10.1038/nrn3784 [4] Tan CH, McNaughton PA.",Non-OADS,/arxiv_data1/oa_pdf/82/c2/ktmp-04-01-1258445.PMC5356215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"1, 41 –59 http://dx.doi.org/10.1080/23328940.2016.1200203",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Circ Res 1995; 77:1222-8; PMID:7586235; http://dx.doi.org/10.1161 /01.RES.77.6.1222 [2] Hough T, Ballantyne BL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Clin Invest 1932; 11:1019-36.; http://dx.doi.org/10.1172/JCI100456 [5] Grant RT, Holling HE.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 1957; 139:455-65; PMID:13492236; http://dx.doi.org/10.1113/jphysiol.1957.sp005904 [8] Barcroft H, Bonnar WM, Edholm OG.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 1947; 106:271-8; PMID:16991759;http://dx.doi.org/10.1113/jphysiol.1947.sp004210 [9] Barcroft H, Edholm OG.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 1943; 102:5-20; PMID:16991588; http://dx.doi.org/10.1113/jphysiol.1943.sp004009 [10] Cooper KE, Edholm OG, Fletcher JG, Fox RH, Mac- pherson RK.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol1955; 128:258-67; PMID:14392606; http://dx.doi.org/10.1113/jphysiol.1955.sp005304 [13] Edholm OG, Fox RH, Macpherson RK.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
JPhysiol 1956; 134:612-9; PMID:13398947; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 1956; 134:444-50; PMID:13398924; http://dx.doi.org/10.1113/jphysiol.1956.sp005656 [15] Roddie IC, Shepherd JT, Whelan RF.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 1958;142:219-32; PMID:13564431; http://dx.doi.org/10.1113/jphysiol.1958.sp006011 [17] Fox RH, Edholm OG.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Lancet 1973; 2:744.;PMID:4125839; http://dx.doi.org/10.1016/S0140-6736(73)92587-7 [20] Hibino T, Takemura T, Sato K. Human eccrine sweat contains tissue killikrein and kininase II.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Invest Der-matol 1994; 102:214-20; PMID:7508964; http://dx.doi.org/10.1111/1523-1747.ep12371765 [21] Kellogg DL, Liu Y, McAllister K, Friel C, Pergola PE.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2002; 93:125-1221; http://dx.doi.org/10.1152/japplphysiol.01142.2001 [22] Roddie IC, Shepherd JT, Whelan RF.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 1957; 136:489-97; PMID:13429515; http://dx.doi.org/10.1113/jphysiol.1957.sp005775 [23] Grossmann M, Jamieson MJ, Kellogg DL, Jr, Kosiba WA, Pergola PE, Crandall CG, Shepherd AM.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Microvasc Res 1995; 50:444-52; PMID:8583956; http://dx.doi.org/10.1006/mvre.1995.1070 [24] Shastry S, Minson CT, Wilson SA, Dietz NM, Joyner MJ.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 1962; 162:121-8; PMID:14466872; http://dx.doi.org/10.1113/jphysiol.1962.sp006918 [27] Kolka MA, Stephenson LA.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Phys-iol 2002; 93:1947-51; PMID:12391110; http://dx.doi.org/10.1152/japplphysiol.00036.2002 [29] Kamijo YI, Lee K, Mack GW.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
J ApplPhysiol 2005; 98:829-37; PMID:15489258; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
Auton Neurosci 2016; 196:25-36; http://dx.doi.org/10.1016/j.autneu.2016.01.002 [31] Simpson LL.,OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Comp Physiol 2014; 4:33-89; http://dx.doi.org/10.1002/cphy.c130015 [33] Taylor WF, Bishop VS. A role for nitric oxide in active thermoregulatory vasodilation.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol2003; 94:1971-7; PMID:12679350; http://dx.doi.org/10.1152/japplphysiol.00826.2002 [42] Wilkins BW, Holowatz LA, Wong BJ, Minson CT. Nitric oxide is not permissive for cutaneous active vasodilatationin humans.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 2003; 548:963-9; PMID:12651918; http://dx.doi.org/10.111 3/jphysiol.2002.035931 [43] Kellogg D, Zhao J, Wu Y.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J ApplPhysiol 2009; 107:1438-44; PMID:19745188; http://dx.doi.org/10.1152/japplphysiol.00690.2009 [44] Kellogg DL, Jr, Zhao JL, Wu Y. Endothelial nitric oxide synthase control mechanisms in the cutaneous vascula- ture of humans in vivo.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Am J Physiol Heart Circ Physiol 2008; 295:H123-9; PMID:18469149; http://dx.doi.org/10.1152/ajpheart.00082.2008 [45] Kellogg DL, Zhao JL, Wu Y. Neuronal nitric oxide synthase control mechanisms in the cutaneous vas-culature of humans in vivo.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 2008; 586:847-57; PMID:18048451; http://dx.doi.org/10.1113/jphysiol.2007.144642 [46] McNamara TC, Keen JT, Simmons GH, Alexander LM, Wong BJ.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol2014; 592:5317-26; PMID:25260636; http://dx.doi.org/10.1113/jphysiol.2014.272898 [47] Kellogg DL, Zhao JL, Wu Y, Johnson JM.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2011; 110:1406-13; PMID:21292837; http://dx.doi.org/10.1152/japplphysiol.00702.2010 [48] Hartschuh W, Reinecke M, Weihe E, Yanaihara N. VIP- immunoreactivity in the skin of various mammals:immunohistochemical, radioimmunological and experi-mental evidence for a dual localization in cutaneous nerves and merkel cells.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"PMID:6382194; http://dx.doi.org/10.1016/0196-9781 (84)90213-4 [49] H €okfelt T, Johansson O, Ljungdahl A, Lundberg JM, Schultzberg M. Peptidergic neurones.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Nature 1980;284:515-21; PMID:6154244; http://dx.doi.org/10.1038/284515a0 [50] Vaalasti A, Tainio H, Rechardt L. Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in the nerves of human axillary sweat glands.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Invest Dermatol 1985;85:246-8; PMID:4031541; http://dx.doi.org/10.1111/1523-1747.ep12276717 [51] Savage MV, Brengelmann GL, Buchan AM, Freund PR.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Science 1985; 229:1407-8; PMID:4035357; http://dx.doi.org/10.1126/science.4035357 [53] Kellogg DL, Jr, Hodges GJ, Orozco CR, Phillips TM, Zhao JL, Johnson JM.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"JAppl Physiol 2007; 102:2301-6; PMID:17412796; http://dx.doi.org/10.1152/japplphysiol.00013.2007 [55] Bennett LAT, Johnson JM, Stephens DP, Saad AR, Kellogg D L .E v i d e n c ef o raR o l ef o rV a s o a c t i v eI n t e s t i n a lP e p t i d ei n Active Vasodilatation in the Cutaneous Vasculature of Humans.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 2003; 552:223-32; PMID:12847205;http://dx.doi.org/10.1113/jphysiol.2003.042135 [56] Wilkins BW, Wong BJ, Tublitz NJ, McCord GR, Min- son CT. Vasoactive intestinal peptide fragment VIP10-28 and active vasodilation in human skin.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Phys-iol 2005; 99:2294-301; PMID:16109832; http://dx.doi.org/10.1152/japplphysiol.00500.2005 [57] Wilkins BW, Chung LH, Tublitz NJ, Wong BJ, Minson CT. Mechanisms of vasoactive intestinal peptide-medi-ated vasodilation in human skin.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2004;97:1291-8; PMID:15155712; http://dx.doi.org/10.1152/japplphysiol.00366.2004 [58] Johnson JM, Kellogg DL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2010;109:1229-38; PMID:20522732; http://dx.doi.org/10.1152/ japplphysiol.00407.2010 [59] Kellogg DL, Zhao JL, Wu Y, Johnson JM.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Phys-iol 2012; 113:1512-8; PMID:22961270; http://dx.doi.org/10.1152/japplphysiol.00859.2012 [60] Wong BJ, Wilkins BW, Minson CT. H1 but not H2 his- tamine receptor activation contributes to the rise in skin blood ﬂow during whole body heating in humans.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
JPhysiol 2004; 560:941-8; PMID:15375193; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"org/10.1113/jphysiol.2004.071779 [61] McCord GR, Cracowski J-L, Minson CT. Prostanoids contribute to cutaneous active vasodilation in humans.Am J Physiol Regul Integr Comp Physiol 2006; 291:R596-R602; PMID:16484440; http://dx.doi.org/10.1152/ajpregu.00710.2005 [62] Holowatz LA, Kenney WL.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2009; 106:500-5; PMID:19036898; http://dx.doi.org/10.1152/japplphysiol.91215.2008 [63] Wong BJ, Minson CT. Neurokinin-1 receptor desensiti- zation attenuates cutaneous active vasodilatation inhumans.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 2006; 577:1043-51; PMID:17023511; http://dx.doi.org/10.1113/jphysiol.2006.112508 [64] Wong BJ, Tublitz NJ, Minson CT. Neurokinin-1 recep- tor desensitization to consecutive microdialysis infu-sions of substance P in human skin.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 2005;568:1047-56; PMID:16123103; http://dx.doi.org/10.1113/jphysiol.2005.095372 [65] Milner P, Kirkpatrick KA, Ralevic V, Toothill V, Pear- son J, Burnstock G. Endothelial cells cultured from human umbilical vein release ATP, substance P and ace- tylcholine in response to increased ﬂow.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Proc R Soc Lond B Biol Sci 1990; 241:245-8; http://dx.doi.org/10.1098/rspb.1990.0092 [66] Milner P, Ralevic V, Hopwood AM, Feh /C19er E, Lincoln J, Kirkpatrick KA, Burnstock G. Ultrastructural localisa-tion of substance P and choline acetyltransferase inendothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Experi- entia 1989; 45:121-5; PMID:2465912; http://dx.doi.org/10.1007/BF01954843 [67] Charkoudian N, Fromy Brr, Saumet JL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2001; 90:1860-4; PMID:11299278;http://dx.doi.org/10.1063/1.1384853 [68] Wong BJ, Fieger SM.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
J Appl Physiol 2012;112:2037-42; PMID:22518827; http://dx.doi.org/10.1152/japplphysiol.00209.2012 [69] Wong BJ.,Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Am J Physiol Reg Integ Comp Physiol 2013; 304:R651-R6; http://dx.doi.org/10.1152/ajpregu.00464.2012 [70] Fieger SM, Wong BJ.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"ActaPhysiol 2012; 205:403-10; http://dx.doi.org/10.1111/j.1748-1716.2012.02426.x [71] Brunt VE, Minson CT. KCa channels and epoxyeicosatrie- noic acids: major contributors to thermal hyperaemia inhuman skin.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
J Physiol 2012; 590:3523-34; PMID:22674719; http://dx.doi.org/10.111 3/jphysiol.2012.23639856 B. J. WONG AND C. G. HOLLOWED,OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
J ApplPhysiol 2013; 115:1290-6; PMID:23970531; http://dx.doi.org/10.1152/japplphysiol.00358.2013 [73] Johnson JM.,Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Exerc Sport Sci Rev 1992; 20:59-97; PMID:1623893; http://dx.doi.org/10.1249/ 00003677-199200200-00003 [74] Johnson JM, Park MK.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"JAppl Physiol 1982; 53:744-9; PMID:7129999; http://dx.doi.org/10.1063/1.329940 [75] Kellogg DL, Johnson JM, Kosiba WA.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2005; 99:902-8; PMID:15845777; http://dx.doi.org/10.1152/ japplphysiol.00156.2005 [82] Shibasaki M, Aoki K, Morimoto K, Johnson JM, Taka- mata A.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"; http://dx.doi.org/10.1152/ajpregu.00242.2009 [83] Brengelmann GL, Johnson JM, Hermansen L, Rowell LB.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Am Ind Hyg Assoc J 1994; 55:505-14; PMID:8017291; http://dx.doi.org/10.1080/15428119491018772 [87] Blair DA, Glover WE, Roddie IC.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Circ Res 1961; 9:264-74; http://dx.doi.org/10.1161/01.RES.9.2.264 [88] Fujii N, Meade RD, Alexander LM, Akbari P, Foudil- bey I, Louie JC, Boulay P, Kenny GP.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2016;120:318-27; PMID:26586908; http://dx.doi.org/10.1152/ japplphysiol.00714.2015 [89] Stachenfeld NS, Taylor HS.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol (1985)2009; 107:864-72; PMID:19556454; http://dx.doi.org/10.1152/japplphysiol.91211.2008 [90] Charkoudian N, Johnson JM.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Fertil Steril 1950; 1:53-65; http://dx.doi.org/10.1016/S0015-0282(16)30066-8 [95] Prior JC, McKay DW, Vigna YM, Barr SI.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"FertilSteril 1995; 63:1222-6; PMID:7750591; http://dx.doi.org/10.1016/S0015-0282(16)57601-8 [96] Stephenson LA, Kolka MA.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Eur J Appl Physiol 1989;58:890-5; http://dx.doi.org/10.1007/BF02332224 [99] Hirata K, Nagasaka T, Hirashita M, Takahata T, Nurio- mura T. Effects of human menstrual cycle on thermo- regulatory vasodilation during exercise.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Physiol 1986; 54:559-65; http://dx.doi.org/10.1007/ BF00943341 [100] Rogers SM, Baker MA.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Eur JAppl Physiol 1997; 75:34-8; http://dx.doi.org/10.1007/s004210050123 [101] Houghton B, Holowatz L, Minson C. In ﬂuence of pro- gestin bioactivity on cutaneous vascular responses to passive heating.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Med Sci Sports Exerc 2005; 37:45-51;PMID:15632666; http://dx.doi.org/10.1249/01.MSS.0000150075.81511.FE [102] Stachenfeld NS, Silva C, Keefe DL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"European J Applied Physiol Occupational Physiol 1988; 57:120-5; http://dx.doi.org/10.1007/BF00691250 [104] Kenney WL, Morgan AL, Farquhar WB, Brooks EM, Pierzga JM, Derr JA.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Am J Physiol Heart Circ Physiol 2003; 284:H1662-7; PMID:12505876; http://dx.doi.org/10.1152/ajpheart.00871.2002 [109] Holowatz LA, Thompson CS, Kenney WL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol2006; 574:573-81; PMID:16675494; http://dx.doi.org/10.1113/jphysiol.2006.108993 [110] Holowatz LA, Thompson CS, Kenney WL.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Am J Physiol Heart Circ Physiol 2006; 291:H2965-70; PMID:16905599; http://dx.doi.org/10.1152/ajpheart.00648.2006 [111] Stanhewicz AE, Alexander LM, Kenney WL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J ApplPhysiol (1985) 2013; 115:972-8; PMID:23743404; http://dx.doi.org/10.1152/japplphysiol.00481.2013 [112] Stanhewicz AE, Bruning RS, Smith CJ, Kenney WL, Holowatz LA.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"JAppl Physiol (1985) 2012; 112:791-7; PMID:22162527;http://dx.doi.org/10.1152/japplphysiol.01257.2011 [113] Stanhewicz AE, Alexander LM, Kenney WL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"JAppl Physiol 2009; 107:1121-7; PMID:19661446; http://dx.doi.org/10.1152/japplphysiol.00750.2009 [115] Holowatz LA, Jennings JD, Lang JA, Kenney WL.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2010; 108:1575-81; PMID:20360429; http://dx.doi.org/10.1152/japplphysiol.01362.2009 [116] Bruning RS, Dahmus JD, Kenney WL, Alexander LM.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Med Sci Sports Exerc 2013; 45:674-82; PMID:23135368; http://dx.doi.org/ 10.1249/MSS.0b013e31827981dc [117] Heimhalt-El Hamriti M, Schreiver C, Noerenberg A, Schef ﬂer J, Jacoby U, Haffner D, Fischer DC.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Cardiovasc Diabetol 2013; 12:115-;PMID:23937662; http://dx.doi.org/10.1186/1475-2840-12-115 [118] Naylor LH, Yusof NM, Paramalingam N, Jones TW, Davis EA, Green DJ.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Eur J ApplPhysiol 2014; 114:435-41; PMID:24337670; http://dx.doi.org/10.1007/s00421-013-2785-6 [119] Kenny GP, Sigal RJ, McGinn R. Body temperature regu- lation in diabetes.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Temperature 2016; 3:119-45; http://dx.doi.org/10.1080/23328940.2015.1131506 [120] Carter M, McGinn R, Barrera Ramirez J, Sigal R, Kenny G. Impairments in local heat loss in type 1 diabetes dur-ing exercise in the heat.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Med Sci Sports Exerc 2014;46:2224-33; PMID:24784146; http://dx.doi.org/10.1249/MSS.0000000000000350 [121] McGinn R, Carter MR, Barrera-Ramirez J, Sigal RJ, Flouris AD, Kenny GP.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Scandinavian J Med Sci Sports 2015; 25:e504-e14; http://dx.doi.org/10.1111/sms.12344 [122] Stapleton J, Yardley J, Boulay P, Sigal R, Kenny G. Whole-body heat loss during exercise in the heat is notimpaired in type 1 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Med Sci Sports Exerc 2013;45:1656-64; PMID:23475170; http://dx.doi.org/10.1249/MSS.0b013e31829002f3 [123] Sokolnicki LA, Strom NA, Roberts SK, Kingsley-Berg SA, Basu A, Charkoudian N. Skin blood ﬂow and nitric oxide during body heating in type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
JAppl Physiol 2006; 100:637-41; PMID:16210432; http://dx.doi.org/10.1152/japplphysiol.00943.2005 [125] Kenney WL.,Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Eur J Applied Physiol Occu-pational Physiol 1984; 52:196-201; PMID:6538835;http://dx.doi.org/10.1007/BF00433392 [127] Kenney WL, Kamon E, Buskirk ER.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Am JPhysiol Heart Circ Physiol 2007; 293:H1090-H6; PMID:17483240; http://dx.doi.org/10.1152/ajpheart.00 295.2007 [129] Holowatz LA, Kenney WL.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Physiol 2007;581:863-72; PMID:17347269; http://dx.doi.org/10.1113/jphysiol.2007.128959 [130] Bruning RS, Kenney WL, Alexander LM.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"Microvasc Res 2015; 97:81-7; PMID:24418051; http://dx.doi.org/10.1016/j.mvr.2014.01.001 [131] Smith C, Santhanam L, Bruning R, Stanhewicz A, Ber- kowitz D, Holowatz L. Upregulation of inducible nitricoxide synthase contributes to attenuated cutaneousvasodilation in essential hypertensive humans.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
Hyper-tension 2011; 58:935-42; PMID:21931069; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"N Engl J Med 2006;354:942-55; PMID:16510748; http://dx.doi.org/10.1056/NEJMra052130 [133] Davis SL, Wilson TE, White AT, Frohman EM.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol 2010;109:1531-7; PMID:20671034; http://dx.doi.org/10.1152/ japplphysiol.00460.2010 [134] Davis SL, Korkmas MA, Crandall CG, Frohman EM.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Phys- iol 2005; 98:1740-4; PMID:15640392; http://dx.doi.org/ 10.1152/japplphysiol.00860.2004 [136] Crandall CG, Davis SL.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Appl Physiol2010; 109:1524-30; PMID:20558761; http://dx.doi.org/10.1152/japplphysiol.00466.2010 [137] Davis S, Shibasaki M, Low D, Cui J, Keller D, Purdue G, Hunt J, Arnoldo TBD, Kowalske K, Crandall C. Impaired cutaneous vasodilation and sweating in grafted skin during whole-body heating.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Burn CareRes 2007; 28:427-34; PMID:17438492; http://dx.doi.org/10.1097/BCR.0B013E318053D312 [138] Davis SL, Shibasaki M, Low DA, Cui J, Keller DM, Wingo JE, Purdue GF, Hunt JL, Arnoldo BD, KowalskeKJ, et al.",OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"J Burn Care Res 2009; 30: 675-85; PMID:19506504; http://dx.doi.org/10.1097/BCR.0b013e3181abfd43 [139] Marczak ED, Marzec J, Zeldin DC, Kleeberger SR, Brown NJ, Pretorius M, Lee CR.",Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
Pharmacogenet Genomics 2012;22:620-8; PMID:22668754; http://dx.doi.org/10.1097/ FPC.0b013e32835516e5TEMPERATURE 59,Non-OADS,/arxiv_data1/oa_pdf/27/01/ktmp-04-01-1200203.PMC5356216.pdf
"1, 60 –78 http://dx.doi.org/10.1080/23328940.2016.1277003",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
N Engl J Med 2002; 346:1978-88; PMID:12075060; http://dx.doi.org/ 10.1056/NEJMra011089[2] W.J.,OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Sports Med 2009; 39:389-422; PMID:19402743; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Sci Med Sport 2015; 18:333-7; PMID:24930073;http://dx.doi.org/10.1016/j.jsams.2014.04.007 [9] Byrne C, Lee JK, Chew SA, Lim CL, Tan EY.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Med Sci Sports Exerc 2006;38:803-10; PMID:16672830; http://dx.doi.org/10.1249/01.mss.0000218134.74238.6a [10] Muhamed AMC, Atkins K, Stannard SR, M €undel T, Thompson MW.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Temperature 2016; 3:455-64; http://dx.doi.org/10.1080/23328940.2016.1182669 [11] Gonzalez-Alonso J, Teller C, Andersen SL, Jensen FB, Hyldig T, Nielsen B.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Athl Train 2015; 50:986-1000; PMID:26381473; http://dx.doi.org/ 10.4085/1062-6050-50.9.07 [14] Cuddy JS, Hailes WS, Ruby BC.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Therm Biol 2014;43:7-12; PMID:24956952; http://dx.doi.org/10.1016/j.jtherbio.2014.04.002 [15] Kene ﬁck RW, Cheuvront SN, Palombo LJ, Ely BR, Sawka MN.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
(1985) 2010; 109:79-86; http://dx.doi.org/10.1152/ japplphysiol.00135.2010 [16] Buono MJC.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Temperature 2016; 3:512-513; http://dx.doi.org/10.1080/23328940.2016.1194954 [17] Marino FE.,OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Sports Medicine2006; 36:671-82; PMID:16869709; http://dx.doi.org/10.2165/00007256-200636080-00004 [19] Reilly T, Drust B, Gregson W. Thermoregulation in elite athletes.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Curr Opin Clin Nutr Metab Care 2006; 9:666- 71; PMID:17053417; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Pre- cooling with ice slurry ingestion leads to similar runtimes to exhaustion in the heat as cold water immersion.J Sports Sci 2012; 30:155-65; PMID:22132792; http://dx.doi.org/10.1080/02640414.2011.625968 [21] Wegmann M, Faude O, Poppendieck W, Hecksteden A, Frohlich M, Meyer T. Pre-cooling and sports perfor- mance: a meta-analytical review.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Sports Med 2012;42:545-64; PMID:22642829; http://dx.doi.org/10.2165/11630550-000000000-00000 [22] Bongers CC, Thijssen DH, Veltmeijer MT, Hopman MT, Eijsvogels TM.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Br J Sports Med 2015; 49:377- 84; PMID:24747298; http://dx.doi.org/10.1136/bjsports- 2013-092928 [23] Ruddock A, Robbins B, Tew G, Bourke L, Purvis A.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Sports Med 2016; PMID:27480762; http://dx.doi.org/10.1007/s40279-016-0592-z [24] Tyler CJ, Sunderland C, Cheung SS.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Br JSports Med 2015; 49:7-13; PMID:23945034; http://dx.doi.org/10.1136/bjsports-2012-091739 [25] Stevens CJ, Taylor L, Dascombe BJ.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Sports Med 2016; http://dx.doi.org/10.1007/s40279-016-0625-7 [26] Ellis PD.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"BMC Med 2012;10; http://dx.doi.org/10.1186/1741-7015-10-166 [28] Ross M, Abbiss C, Laursen P, Martin D, Burke L. Pre- cooling methods and their effects on athletic perfor- mance a systematic review and practical applications.Sports Medicine 2013; 43:207-25; PMID:23329610; http://dx.doi.org/10.1007/s40279-012-0014-9 [29] Duf ﬁeld R, Green R, Castle P, Maxwell N. Precooling can prevent the reduction of self-paced exercise inten-sity in the heat.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Med Sci Sport Exer 2010; 42:577-84;http://dx.doi.org/10.1249/MSS.0b013e3181b675da [30] Hessemer V, Langusch D, Bruck LK, Bodeker RH, Brei- denbach T. Effect of slightly lowered body temperatures on endurance performance in humans.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J ApplPhysiol (1985) 2004; 96:1867-74; PMID:14698992; http://dx.doi.org/10.1152/japplphysiol.00979.2003 [34] Duf ﬁeld R, Marino FE.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Eur J Appl Physiol 2007; 100:727-35;PMID:17476523; http://dx.doi.org/10.1007/s00421-007-0468-x [35] Castle PC, Macdonald AL, Philp A, Webborn A, Watt PW, Maxwell NS.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Appl Physiol (1985) 2006;100:1377-84; PMID:16339344; http://dx.doi.org/10.1152/japplphysiol.00822.2005 [36] Minett GM, Duf ﬁeld R, Marino FE, Portus M. Volume- dependent response of precooling for intermittent-sprint exercise in the heat.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Med Sci Sports Exerc 2011;43:1760-9; PMID:21311362; http://dx.doi.org/10.1249/ MSS.0b013e318211be3e [37] Byrne C, Owen C, Cosnefroy A, Lee JK.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Scand J Med Sci Sports 2015; 25:190-9; PMID:25943670; http://dx.doi.org/10.1111/sms.12376 [39] Duf ﬁeld R, Steinbacher G, Fairchild TJ.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J StrengthCond Res 2009; 23:2524-32; PMID:19910821; http://dx.doi.org/10.1519/JSC.0b013e3181bf7a4f [40] Cheung S, Robinson A.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Sports Sci 2004; 22:605-12; PMID:15370490; http://dx.doi.org/10.1080/02640410310001655813 [41] Kruk B, Pekkarinen H, Harri M, Manninen K, Hanni- nen O. Thermoregulatory responses to exercise at lowambient-temperature performed after precooling orpreheating procedures.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Eur J Appl Physiol O 1990; 59:416-20; http://dx.doi.org/10.1007/Bf02388622 [42] Girard O, Brocherie F, Bishop DJ.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Scand J Med Sci Sports2015; 25:79-89; PMID:25943658; http://dx.doi.org/10.1111/sms.12437 [43] Bigland-Ritchie B, Thomas CK, Rice CL, Howarth JV, Woods JJ.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Eur J Sport Sci 2011; 11:419-29;http://dx.doi.org/10.1080/17461391.2010.536577 [47] Tyler CJ, Sunderland C. Cooling the neck region during exercise in the heat.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Athl Training 2011; 46:61-8; http://dx.doi.org/10.4085/1062-6050-46.1.61 [48] Tyler CJ, Wild P, Sunderland C. Practical neck cooling and time-trial running performance in a hot environ-ment.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Eur J Appl Physiol 2010; 110:1063-74;PMID:20694731; http://dx.doi.org/10.1007/s00421-010-1567-7 [49] Eijsvogels TM, Bongers CC, Veltmeijer MT, Moen MH, Hopman M. Cooling during exercise in temperate con- ditions: impact on performance and thermoregulation.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Int J Sports Med 2014; 35:840-6; PMID:24771132;http://dx.doi.org/10.1055/s-0034-1368723 [50] Luomala MJ, Oksa J, Salmi JA, Linnamo V, Holmer I, Smolander J, Dugue B.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Therm Biol 2012; 37:47-55; http://dx.doi.org/10.1016/j.jtherbio.2011.10.009 [51] Mundel T, King J, Collacott E, Jones DA.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"ExpPhysiol 2006; 91:925-33; PMID:16777932; http://dx.doi.org/10.1113/expphysiol.2006.034223 [52] Schlader ZJ, Simmons SE, Stannard SR, Mundel T. The independent roles of temperature and thermal percep-tion in the control of human thermoregulatory behavior.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Physiol Behav 2011; 103:217-24; PMID:21315099; http://dx.doi.org/10.1016/j.physbeh.2011.02.002[53] Stevens CJ, Kittel A, Sculley DV, Callister R, Taylor L, Dascombe BJ.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"JSports Sci 2016; 1-8; PMID:27267974; http://dx.doi.org/10.1080/02640414.2016.1192294 [54] Mundel T, Jones DA.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Eur J Appl Physiol 2010; 109:59-65; PMID:19727797; http://dx.doi.org/10.1007/s00421-009-1180-9 [55] Barwood MJ, Corbett J, Thomas K, Twentyman P. Relieving thermal discomfort: Effects of sprayed L-men-thol on perception, performance, and time trial cyclingin the heat.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Scand J Med Sci Sports 2015; 25:211-8;PMID:25943672; http://dx.doi.org/10.1111/sms.12395 [56] Stevens CJ, Thoseby B, Sculley DV, Callister R, Taylor L, Dascombe BJ.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Scand J Med Sci Sports2016; 26:1209-16; PMID:26408395; http://dx.doi.org/10.1111/sms.12555 [57] Ansley L, Marvin G, Sharma A, Kendall MJ, Jones DA, Bridge MW.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Temperature 2016; 3:1-10;http://dx.doi.org/10.1080/23328940.2016.1216257 [59] De Carvalho MV, De Andrade MT, Ramos GP, Maia- Lima A, Pereira ER, Mendes TT, Marins JC, Amorim FT, Silami-Garcia E. The temperature of water ingested ad libitum does not in ﬂuence performance during a 40- km self-paced cycling trial in the heat.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Sports MedPhys Fitness 2015; 55:1473-9; PMID:25286889 [60] Scheadler CM, Saunders NW, Hanson NJ, Devor ST. Palm cooling does not improve running performance.Int J Sports Med 2013; 34:732-5; PMID:23444094;http://dx.doi.org/10.1055/s-0032-1327576 [61] Hsu AR, Hagobian TA, Jacobs KA, Attallah H, Fried- lander AL.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Int J Sports Med 2015; 36:814-21; PMID:26038879; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Strength CondRes 2015; 29:2261-9; PMID:23722108; http://dx.doi.org/10.1519/JSC.0b013e31829cef4e [64] Riera F, Trong TT, Sinnapah S, Hue O.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"e103718; PMID:25084009; http://dx.doi.org/10.1371/ journal.pone.0103718 [65] Tran Trong T, Riera F, Rinaldi K, Briki W, Hue O. Inges- tion of a cold temperature/menthol beverage increasesoutdoor exercise performance in a hot, humid environ-ment.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"PLoS One 2015; 10: e0123815; PMID:25856401;http://dx.doi.org/10.1371/journal.pone.0123815 [66] Hohenauer E, Taeymans J, Baeyens JP, Clarys P, Clijsen R. The effect of post-exercise cryotherapy on recoverycharacteristics: a systematic review and meta-analysis.PLoS One 2015; 10: e0139028; PMID:26413718; http://dx.doi.org/10.1371/journal.pone.0139028 [67] Guilhem G, Hug F, Couturier A, Regnault S, Bournat L, Filliard JR, Dorel S. Effects of air-pulsed cryother-apy on neuromuscular recovery subsequent to exer- cise-induced muscle damage.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Am J Sports Med 2013; 41:1942-51; PMID:23739686; http://dx.doi.org/10.1177/0363546513490648 [68] Pointon M, Duf ﬁeld R, Cannon J, Marino FE.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Eur J Appl Physiol2011; 111:2977-86; PMID:21445604; http://dx.doi.org/10.1007/s00421-011-1924-1 [69] Costello JT, Baker PR, Minett GM, Bieuzen F, Stewart IB, Bleakley C. Whole-body cryotherapy (extreme coldair exposure) for preventing and treating muscle sore-ness after exercise in adults.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Cochrane Database SystRev 2015): CD010789; http://dx.doi.org/10.1002/14651858.CD010789.pub2 [70] Bleakley CM, Bieuzen F, Davison GW, Costello JT.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Open Access J Sports Med 2014; 10:25-36; http://dx.doi.org/10.2147/OAJSM.S41655 [71] Bleakley C, McDonough S, Gardner E, Baxter GD, Hopkins JT, Davison GW.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Cold-water immersion (cryotherapy) forpreventing and treating muscle soreness after exercise.Cochrane Database Syst Rev 2012; 15: CD008262; http://dx.doi.org/10.1002/14651858.CD008262.pub2 [72] Ban ﬁG, Melegati G, Barassi A, Dogliotti G, d ’Eril GM, Dugue B, Corsi MM.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Therm Biol 2009; 34:55-9; http://dx.doi.org/10.1016/j.jtherbio.2008.10.003 [73] Selfe J, Alexander J, Costello JT, May K, Garratt N, Atkins S, Dillon S, Hurst H, Davison M, Przybyla D,et al.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Appl PhysiolNutr Metab 2007; 32:808-17; PMID:17622299; http://dx.doi.org/10.1139/H07-043 [75] Siegel R, Laursen PB.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Sports Med 2012; 42:89-98; PMID:22175533; http://dx.doi.org/ 10.2165/11596870-000000000-00000[76] Nybo L. Hyperthermia and fatigue.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Appl Physiol (1985) 2008; 104:871-8; PMID:17962572; http://dx.doi.org/10.1152/japplphysiol.00910.2007 [77] Nybo L, Rasmussen P, Sawka MN.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Compr Physiol 2014;4:657-89; PMID:24715563; http://dx.doi.org/10.1002/ cphy.c130012 [78] Nybo L, Nielsen B. Hyperthermia and central fatigue during prolonged exercise in humans.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Impaired exercise performance in the heat is associated with ananticipatory reduction in skeletal muscle recruitment.Pﬂug Arch Eur J Phy 2004; 448:422-30; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Appl Physiol (1985) 2010;109:1989-95; PMID:20689090; http://dx.doi.org/10.1152/japplphysiol.00367.2010 [81] Ely BR, Ely MR, Cheuvront SN, Kene ﬁck RW, Degroot DW, Montain SJ.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Appl Physiol (1985) 2009; 107:1519-25; PMID:19713430; http://dx.doi.org/10.1152/japplphysiol.00577.2009 [82] Parkin JM, Carey MF, Zhao S, Febbraio MA.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Physiol 2008; 586:45-53; PMID:17855754; http://dx.doi.org/10.1113/jphysiol.2007.142158 [84] Lorenzo S, Minson CT, Babb TG, Halliwill JR. Lactate threshold predicting time-trial performance: impact ofheat and acclimation.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
J Appl Physiol (1985) 2011;111:221-7; PMID:21527667; http://dx.doi.org/10.1152/japplphysiol.00334.2011 [85] Hargreaves M. Physiological limits to exercise perfor- mance in the heat.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
J Sci Med Sport 2008; 11:66-71;PMID:17720623; http://dx.doi.org/10.1016/j.jsams.2007.07.002 [86] Cheung SS.,OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Scand J Med SciSpor 2010; 20:53-9; http://dx.doi.org/10.1111/j.1600-0838.2010.01209.x [87] Cotter JD, Taylor NA.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
J Physiol2005; 565:335-45; PMID:15760945; http://dx.doi.org/10.1113/jphysiol.2004.081562 [88] Green BG.,OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Food Chem Toxicol 2015; 86:262-73; PMID:26429629; http://dx.doi.org/ 10.1016/j.fct.2015.09.018 [91] Leeder J, Gissane C, van Someren K, Gregson W, Howatson G. Cold water immersion and recovery fromstrenuous exercise: a meta-analysis.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Br J Sports Med2012; 46:233-40; PMID:21947816; http://dx.doi.org/10.1136/bjsports-2011-090061 [92] McHugh MP, Connolly DA, Eston RG, Gleim GW.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Sports Sci 2011; 29:217-25; PMID:21170794; http://dx.doi.org/10.1080/02640414.2010.526132 [96] Vaile J, O ’Hagan C, Stefanovic B, Walker M, Gill N, Askew CD.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Br J Sports Med 2011; 45:825-9; PMID:20233843; http://dx.doi.org/10.1136/bjsm.2009.067272 [97] Eston R, Peters D. Effects of cold water immersion on the symptoms of exercise-induced muscle damage.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"JSports Sci 1999; 17:231-8; PMID:10362390; http://dx.doi.org/10.1080/026404199366136 [98] White GE, Wells GD.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
ExtremPhysiol Med 2013; 2:26; PMID:24004719; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Med Sci Sport Exer 2003; 35:1517-23; http://dx.doi.org/10.1249/01.Mss.0000084418.96898.2e [103] Swenson C, Sward L, Karlsson J. Cryotherapy in sports medicine.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Sports Med 2010; 40:509-17; PMID:20524715; http://dx.doi.org/10.2165/ 11531940-000000000-00000 [107] Roberts LA, Muthalib M, Stanley J, Lichtwark G, Nosaka K, Coombes JS, Peake JM.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Am J Physiol Regul Integr Comp Physiol 2015;309: R389-98; PMID:26062633; http://dx.doi.org/10.1152/ajpregu.00151.2015 [108] Debold EP.,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Front Physiol 2012; 3; PMID:22675303; http://dx.doi.org/10.3389/fphys.2012.00151 [109] Herrera E, Sandoval MC, Camargo DM, Salvini TF.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Br J Sports Med 2007; 41:365-9; discussion 9;PMID:17224445; http://dx.doi.org/10.1136/bjsm.2006.031237 [111] Herrera E, Sandoval MC, Camargo DM, Salvini TF.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Phys Ther 2010; 90:581-91; PMID:20185615; http://dx.doi.org/10.2522/ptj.20090131 [112] Periard JD, Racinais S, Timpka T, Dahlstrom O, Spreco A, Jacobsson J, Bargoria V, Halje K, AlonsoJM.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
Br JSports Med 2016; http://dx.do i.org/10.1136/bjsports- 2016-096579TEMPERATURE 77,Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Sports Sci2013; 31:1271-9; PMID:23506436; http://dx.doi.org/10.1080/02640414.2013.779740 [114] Fonda B, De Nardi M, Sarabon N. Effects of whole-body cryotherapy duration on thermal and cardio-vascular response.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"J Therm Biol 2014; 42:52-5; PMID:24802149; http://dx.doi.org/10.1016/j.jtherbio.2014.04.001 [115] Cuttell SA, Kiri V, Tyler C. A comparison of 2 practical cooling methods on cycling capacity in the heat.",OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
J AthlTrain 2016; 51:525-32; PMID:27571045; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
"Eur J Appl Physiol2013; 113:1705-17; PMID:23385657; http://dx.doi.org/10.1007/s00421-013-2596-9 [117] Tyler CJ, Sunderland C. Neck cooling and running per- formance in the heat: single versus repeated application.Med Sci Sport Exer 2011; 43:2388-95; http://dx.doi.org/10.1249/MSS.0b013e318222ef7278 C. C. W. G. BONGERS ET AL.",Non-OADS,/arxiv_data1/oa_pdf/ae/b8/ktmp-04-01-1277003.PMC5356217.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/dd/main.PMC5356231.pdf
http://dx.doi.org/10.1016/j.jvsc.2015.05.004 201,OADS,/arxiv_data1/oa_pdf/09/dd/main.PMC5356231.pdf
7(1): 32 -35  ISSN: 2226 -4485 (Print)  Short Communication   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.5     ______________________________________________________________________________________________________ __  *Corresponding Author:  Carlos Javier Panei .,Non-OADS,/arxiv_data1/oa_pdf/fd/f2/OpenVetJ-7-32.PMC5356288.pdf
http://www.openveterinaryjournal.com   C.J.,Non-OADS,/arxiv_data1/oa_pdf/fd/f2/OpenVetJ-7-32.PMC5356288.pdf
http://www.openveterinaryjournal.com   C.J.,Non-OADS,/arxiv_data1/oa_pdf/fd/f2/OpenVetJ-7-32.PMC5356288.pdf
http://www.openveterinaryjournal.com   C.J.,Non-OADS,/arxiv_data1/oa_pdf/fd/f2/OpenVetJ-7-32.PMC5356288.pdf
7(1): 36 -49  ISSN: 2226 -4485 (Print)  Review Article   ISSN: 2218 -6050  (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.6     ______________________________________________________________________________________________________ __  *Corresponding Author:  Grace Frankel .,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
"Retrieved from  https://www.banfield.com/Banfield/media/PDF/Do wnloads/CriticallyAppraisedTopics/2010_Winter_ CAT_Evaluation -of-Nutraceuticals.pdf   Adebowale, A., D u, J., Liang, Z., Leslie, J.L.",Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
Retrieved from  https://www.aaha.org/public_documents/professio nal/guidelines/2015_aaha_aafp_pain_management _guidelines_for_dogs_and_cats.pdf   Extend Joint Ca re.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
"Retrieved from  https://www.extendpetcare.com/   Gupta, R.C., Canerdy, T. D., Lindley, J., Konemann ,  M., Minniear, J., Carroll, B.A., Hendrick, C., Goad,  J.T., R ohde, K., Doss, R., Bagchi, M. and Bagchi,  D. 2012 .",Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
Retrieved from http://www.hc - sc.gc.ca/dhp -mps/vet/index -eng.php .,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
Retrieved from  http://liquidhealthpets.com/products/k9 - glucosamine -for-dogs.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
http://www.openveterinaryjournal.com   A. Bhathal  et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
Retrieved from  http://www.cosequin.com/dogs/joint -and- bone/cosequin -professional -line/cosequin -ds- maximum -strength   Nutramax Laboratories Veterinary Sciences In c.  2016b.,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
"Retrieved from  http://www.nutramaxlabs.com/dog/dog -joint-bone - health/dasuquin -for-dogs   Pascoe, P. J.",Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
Retrieved  from  http://www.petnaturals.com/index.php?,Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
"Retrieved from  http://www.1800petmeds.com/ProMotion+For+M edium+Large+Dogs -prod10490.html   Plumb, D.C. 2015 .",Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
"Retrieved from  http://terramaxpro.com/product/hipjoi nt/  Tilley, L.P. and Smith, F.W.K.Jr.",Non-OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
"Retrieved from  http://www.glycoflex3.com/info.html    Walton, M. B., Cowderoy, E., Lascel les, D. and Innes,  J.F.",OADS,/arxiv_data1/oa_pdf/55/e5/OpenVetJ-7-36.PMC5356289.pdf
7(1): 50-56  ISSN: 2226 -4485 (Print)  Short Communication   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.7     ______________________________________________________________________________________________________ __  *Corresponding Author:  Alexander Welker Biondo .,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
http://www.openveterinaryjournal.com   C. Constantino et al.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
http://www.openveterinaryjournal.com   C. Constantino et al.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
http://www.openveterinaryjournal.com   C. Constantino et al.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
http://www.openveterinaryjournal.com   C. Constantino et al.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
Estimativas da População dos  Municípios Brasileiros com Data de Referência em  1º de Julho de 2014  http://www.ibge.gov.br/home/presidencia/noticias/ pdf/analise_estimativas_2014.pdf (Accessed on 05  may 2015).,OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
http://www.openveterinaryjournal.com   C. Constantino et al.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
http://www.openveterinaryjournal.com   C. Constantino et al.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/OpenVetJ-7-50.PMC5356290.pdf
7(1): 57-60  ISSN: 2226 -4485 (Print)  Case Report   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.,Non-OADS,/arxiv_data1/oa_pdf/1e/33/OpenVetJ-7-57.PMC5356291.pdf
http://www.openveterinaryjournal.com   E.P.,Non-OADS,/arxiv_data1/oa_pdf/1e/33/OpenVetJ-7-57.PMC5356291.pdf
http://www.openveterinaryjournal.com   E.P.,Non-OADS,/arxiv_data1/oa_pdf/1e/33/OpenVetJ-7-57.PMC5356291.pdf
http://www.openveterinaryjournal.com   E.P.,Non-OADS,/arxiv_data1/oa_pdf/1e/33/OpenVetJ-7-57.PMC5356291.pdf
7(1): 61-64  ISSN: 2226 -4485 (Print)  Case Report   ISSN: 2218 -6050 (Online)  DOI: http://dx.doi.org/10.4314/ovj.v7i1.,Non-OADS,/arxiv_data1/oa_pdf/d5/b1/OpenVetJ-7-61.PMC5356292.pdf
http://www.openveterinaryjournal.com   A. Pierini  et al.,Non-OADS,/arxiv_data1/oa_pdf/d5/b1/OpenVetJ-7-61.PMC5356292.pdf
http://www.openveterinaryjournal.com   A. Pierini et al.,Non-OADS,/arxiv_data1/oa_pdf/d5/b1/OpenVetJ-7-61.PMC5356292.pdf
http://www.openveterinaryjournal.com   A. Pierini  et al.,Non-OADS,/arxiv_data1/oa_pdf/d5/b1/OpenVetJ-7-61.PMC5356292.pdf
Available from: http://www.share.pdfonline.com/8a4cf69626 fd406fa90bfb18b33302b1/manuscript_blind%20review.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/84/DRJ-14-13.PMC5356383.pdf
Available from:  https://www.helda.helsinki.fi/bitstream/handle/10138/28083/ oralheal.pdf?sequence=1.,Non-OADS,/arxiv_data1/oa_pdf/89/84/DRJ-14-13.PMC5356383.pdf
Available from: http://www.kidneyatlas.org/book5/adk5-06.ccc.,Non-OADS,/arxiv_data1/oa_pdf/89/84/DRJ-14-13.PMC5356383.pdf
Available at: https://www.nccn.org/about/ nhl.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/58/c3/DRJ-14-73.PMC5356393.pdf
Theseﬁndings can be used to facilitate dialogue in Nigeria by engaging stakeholders to discuss how toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssmphSSM -Population Health http://dx.doi.org/10.1016/j.ssmph.2016.07.003 2352-8273/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/06/ff/main.PMC5356417.pdf
"This is an open access article under the CC BY-NC-ND-IGO license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ACASI, audio computer assisted self-interview; COREQ, consolidated criteria for reporting qualitative research; DHS, Demographic and Health Sur vey; FGD, focus group discussion; HRP, World Health Organization Human Reproduction Programme; IDI, in-depth interview; IPV, intimate partner violence; LM IC, low- and middle- income country; RP2, Review Panel on Research Projects; SDG, Sustainable Development Goals; USAID, United States Agency for International Develop ment nCorresponding author at: Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, 615N.",Non-OADS,/arxiv_data1/oa_pdf/06/ff/main.PMC5356417.pdf
This is an open access article under the CC BY-NC-ND-IGO license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/ff/main.PMC5356417.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/56/fdv211.PMC5356472.pdf
6 The English Indices of Multiple Deprivation 2010. http://www.imd.,Non-OADS,/arxiv_data1/oa_pdf/70/56/fdv211.PMC5356472.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"3, 412 –436 http://dx.doi.org/10.1080/23328940.2016.1216255",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
Comprehensive Physiol 2014; 4:325-65; PMID:24692142; http://dx.doi.org/10.1002/cphy.c130022 [3] Edholm OG.,OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Errors in the esti- mation of hydration status from changes in body mass.J Sports Sci 2007; 25:797-804; PMID:17454547; http://dx.doi.org/10.1080/02640410600875143 [5] Pastene J, Germain M, Allevard A, Gharib C, Lacour J.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Water balance during and after marathon running.Eur J Appl Physiol Occupational Physiol 1996; 73:49-55; PMID:8861668; http://dx.doi.org/10.1007/ BF00262802 [6] Buono MJ, Ball KD, Kolkhorst FW.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J ApplPhysiol (1985) 2007; 103:990-4; PMID:17600161; http://dx.doi.org/10.1152/japplphysiol.00015.2007 [7] Fox RH, Goldsmith R, Kidd DJ, Lewis HE.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Physiol 1963; 166:530-47; PMID:13959046; http://dx.doi.org/10.1113/jphysiol.1963.sp007121 [8] Kenney WL, Tankersley CG, Newswanger DL, Hyde DE, Puhl SM, Turner NL.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
J Physiol 1975; 250:475-89; PMID:1177148; http://dx.doi.org/10.1113/jphysiol.1975.sp011066 [10] Sawka MN.,OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci SportsExerc 2012; 44:1949-57; PMID:22543739; http://dx.doi.org/10.1249/MSS.0b013e31825abc7c [17] Starkie RL, Hargreaves M, Lambert DL, Proietto J, Feb- braio MA.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Exp Physiol1999; 84:775-84; PMID:10481233; http://dx.doi.org/10.1111/j.1469-445X.1999.01815.x [18] Hillman AR, Vince RV, Taylor L, McNaughton L, Mitchell N, Siegler J. Exercise-induced dehydration withand without environmental heat stress results in increased oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Appl Physiol Nutr Metab 2011; 36:698-706; PMID:21980993; http://dx.doi.org/10.1139/h11-080 [19] Laitano O, Kalsi KK, Pook M, Oliveira AR, Gonzalez- Alonso J.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur J Appl Physiol 2010;110:953-60; PMID:20658249; http://dx.doi.org/10.1007/ s00421-010-1577-5 [20] Convertino VA, Keil LC, Greenleaf JE.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur J Appl Physiol 2010; 108:987-97; PMID:19967394; http://dx.doi.org/10.1007/s00421-009-1294-0 [22] Francesconi RP, Sawka MN, Pandolf KB.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2016; 120:567-79; PMID:26769955; http://dx.doi.org/10.1152/japplphysiol.00876.2015 [24] Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, Kienhntopf M, Stumvoll M, Kahn CR, Bl €uher M. Antioxidants prevent health-promoting effects of physi- cal exercise in humans.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"[26] Rasmussen P, Stie H, Nielsen B, Nybo L. Enhanced cere- bral CO 2reactivity during strenuous exercise in man.Eur J Appl Physiol 2006; 96:299-304; PMID:16284788; http://dx.doi.org/10.1007/s00421-005-0079-3 [27] Nybo L, Moller K, Volianitis S, Nielsen B, Secher NH.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"JAppl Physiol 2002; 93:58-64; PMID:12070186; http://dx.doi.org/10.1152/japplphysiol.00049.2002 [28] Fujii N, Honda Y, Hayashi K, Kondo N, Nishiyasu T. Effect of hypohydration on hyperthermic hyperpnea andcutaneous vasodilation during exercise in men.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J ApplPhysiol 2008; 105:1509-18; PMID:18787094; http://dx.doi.org/10.1152/japplphysiol.01206.2007 [29] Senay LC, Christensen ML.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol (1985) 2008;105:433-45; PMID:18483173; http://dx.doi.org/10.1152/japplphysiol.00010.2008 [31] Carter R, 3rd, Cheuvront SN, Vernieuw CR, Sawka MN.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
J Appl Physiol (1985) 2006; 101:1744-50; PMID:16916922; http://dx.doi.or g/10.1152/japplphysiol.,Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Am J Physiol Heart Circulatory Physiol 2015; 309:H1598-607; PMID:26371170; http://dx.doi.org/10.1152/ajpheart.00525.2015 [33] Murrell CJ, Cotter JD, George K, Shave R, Wilson L, Thomas K, Williams MJ, Ainslie PN.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Exp Ger-ontol 2011; 46:1-8; PMID:20600780; http://dx.doi.org/ 10.1016/j.exger.2010.06.004 [34] Murrell CJ, Cotter JD, George K, Shave R, Wilson L, Thomas K, Williams MJ, Ainslie PN.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur J Appl Physiol 2011; 111:469-76;PMID:20886226; http://dx.doi.org/10.1007/s00421-010-1671-8 [35] Gratze G, Rudnicki R, Urban W, Mayer H, Schlogl A, Skrabal F. Hemodynamic and autonomic changes induced by Ironman: prediction of competition time byblood pressure variability.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2005; 99:1728-35; PMID:16002770; http://dx.doi.org/10.1152/jappl-physiol.00487.2005 [36] Bosenberg AT, Brock-Utne JG, Gaf ﬁnS L ,W e l l sM T , Blake GT.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Am J Physiol Regul Integr CompPhysiol 2008; 295:R611-23; PMID:18565834; http://dx.doi.org/10.1152/ajpregu.00917.2007 [38] Pals KL, Chang RT, Ryan AJ, Gisol ﬁCV.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol (1985) 2015; 120:692-701;jap 00536 2015; PMID:26359485; http://dx.doi.org/10.1152/japplphysiol.00536.2015 [40] Watson P, Black KE, Clark SC, Maughan RJ.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci Sports Exerc 2006; 38:2118-24;PMID:17146318; http://dx.doi.org/10.1249/01.mss.000-0235356.31932.0a [41] Watson P, Shirreffs SM, Maughan RJ.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Am J Physiol Regul Integr Comp Physiol2005; 288:R1689-94; PMID:15650123; http://dx.doi.org/ 10.1152/ajpregu.00676.2004 [42] Morrison SA, Cheung SS, Hurst RD, Cotter JD.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Thermal Biol 2013; 38:374-83; http://dx.doi.org/10.1016/j.jtherbio.2013.05.002 [43] Cheuvront SN, Chinevere TD, Ely BR, Kene ﬁck RW, Goodman DA, McClung JP, Sawka MN.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci Sports Exerc 2008; 40:1477-82; PMID:18614943; http://dx.doi.org/10.1249/MSS.0b013e3181-6d65a5 [44] Prosser C, Stelwagen K, Cummins R, Guerin P, Gill N, Milne C. Reduction in heat-induced gastrointestinalhyperpermeability in rats by bovine colostrum and goatmilk powders.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2004; 96:650-4; PMID: 14527963; http://dx.doi.org/10.1152/japplp-hysiol.00- 295.2003 [45] Moseley PL, Gapen C, Wallen ES, Walter ME, Peterson MW.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J PhysiolSci 2011; 61:131-40; PMID:21222186; http://dx.doi.org/10.1007/s12576-010-0130-y [48] Yoshihara T, Naito H, Kakigi R, Ichinoseki-Sekine N, Ogura Y, Sugiura T, Katamoto S. Heat stress activatesthe Akt/mTOR signaling pathway in rat skeletal muscle.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
J ApplPhysiol (1985) 2011; 110:451-7; http://dx.doi.org/10.1152/japplphysiol.00849.2010 [50] Schliess F. Cell hydration and mTOR-dependent signal- ling.,OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Sports Med1997; 23:173-210; PMID:9108637; http://dx.doi.org/10.2165/00007256-199723030-00004 [52] Nielsen B, Hales JR, Strange S, Christensen NJ, Warberg J, Saltin B.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Physiol Lond 1993; 460:467-85; PMID:8487204; http://dx.doi.org/10.1113/jphysiol.1993.sp019482 [53] Maher JT, Bass DE, Heistad DD, Angelakos ET, Hartley LH.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci Sports Exerc 1982; 14:46-52; PMID:7070257; http://dx.doi.org/10.1249/00005768-198201000-00009 [57] Sawka MN, Leon LR, Montain SJ, Sonna LA.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci Sport Exer 2010; 42:2164-72; http://dx.doi.org/10.1249/MSS.0b013e3181e303b0 [59] Ruell PA, Hoffman KM, Chow CM, Thompson MW.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Mol Cell Biochem 2004;267:187-94; PMID:15663200; http://dx.doi.org/10.1023/B:MCBI.0000049382.63841.e4 [60] Lorenzo S, Minson CT. Heat acclimation improves cutaneous vascular function and sweating in trainedcyclists.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2010; 109:1736-43; PMID:20864556; http://dx.doi.org/10.1152/japplphysiol.007-25.2010 [61] Nadel ER, Pandolf KB, Roberts MF, Stolwijk JA.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Temperature 2016; 3:286-97; http://dx.doi.org/10.1080/23328940.2016.1156215 [65] Kihara T, Biro S, Ikeda Y, Fukudome T, Shinsato T, Masuda A, Miyata M, Hamasaki S, Otsuji Y, Minagoe S,Akiba S, Tei C. Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"JAm College Cardiol 2002; 39:754-9; PMID:11869837; http://dx.doi.org/10.1016/S0735-1097(01)01824-1 [67] Ohori T, Nozawa T, Ihori H, Shida T, Sobajima M, Mat- suki A, Yasumura S, Inoue H. Effect of repeated saunatreatment on exercise tolerance and endothelial func-tion in patients with chronic heart failure.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Am J Cardiol2012; 109:100-4; PMID:21944673; http://dx.doi.org/10.1016/j.amjcard.2011.08.014 [68] Laukkanen T, Khan H, Zaccardi F, Laukkanen JA.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"JAMA Internal Med2015; 175:542-8; PMID:25705824; http://dx.doi.org/10.1001/jamainternmed.2014.8187 [69] Miyamoto H, Kai H, Nakaura H, Osada K, Mizuta Y, Matsumoto A, Imaizumi T. Safety and ef ﬁcacy of repeated sauna bathing in patients with chronic systolicheart failure: a preliminary report.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
J Card Fail 2005; 11:432-6; PMID:16105634; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Shear stress mediates endothe-lial adaptations to exercise training in humans.Hypertension 2010; 55:312-8; PMID:20048193;http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.146282 [76] Green DJ, Carter HH, Fitzsimons MG, Cable NT, Thijssen DH, Naylor LH.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Physiol 2010; 588:1571-7; PMID:20211982;http://dx.doi.org/10.1113/jphysiol.2010.186965 [77] Schwimmer H, Eli-Berchoer L, Horowitz M. Acclima- tory-phase speci ﬁcity of gene expression during the course of heat acclimation and superimposed hypohy-dration in the rat hypothalamus.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2006; 100:1992-2003; PMID:16469936; http://dx.doi.org/ 10.1152/japplphysiol.00850.2005 [78] Brunt VE, Eymann TM, Francisco MA, Howard MJ, Minson CT.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Semin Nephrol2005; 25:388-91; PMID:16298260; http://dx.doi.org/10.1016/j.semnephrol.2005.05.007 [85] Kay D, Marino FE.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"JSports Sci 2000; 18:71-82; PMID:10718562; http://dx.doi.org/10.1080/026404100365135 [86] McLellan TM, Cheung SS.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Ergo-nomics 2000; 43:2020-30; PMID:11191783; http://dx.doi.org/10.1080/00140130050201454 [87] Heinicke K, Wolfarth B, Winchenbach P, Biermann B, Schmidt A, Huber G, Friedmann B, Schmidt W. BloodTEMPERATURE 431",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Int J Sports Med 2001; 22:504-12;PMID:11590477; http://dx.doi.org/10.1055/s-2001-17613 [88] Hopper MK, Coggan AR, Coyle EF.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J ApplPhysiol (1985) 2010; 109:1140-7; PMID:20724560; http://dx.doi.org/10.1152/japplphysiol.00495.2010 [91] Garrett AT, Creasy R, Rehrer NJ, Patterson MJ, Cotter JD.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur J Appl Physiol 2012;112:1827-37; PMID:21915701; http://dx.doi.org/10.1007/s00421-011-2153-3 [92] Morrison J, Hopkins W, Sleivert G. Little effect of train- ing in the heat on cycling performance at normal tem- perature.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Br J Sports Med2012; 46:810-5; PMID:22797527; http://dx.doi.org/10.1136/bjsports-2012-091227 [94] Patterson MJ, Stocks JM, Taylor NA.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Sci Med Sport2007; 10:259-62; PMID:16877041; http://dx.doi.org/ 10.1016/j.jsams.2006.06.009 [96] Naito H, Powers SK, Demirel HA, Sugiura T, Dodd SL, Aoki J.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur J Appl Physiol 2011; 111:17-27; PMID:20803152; http://dx.doi.org/10.1007/s00421-010- 1617-1 [98] Nosaka K, Muthalib M, Lavender A, Laursen PB.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur JAppl Physiol 2007; 99:183-92; PMID:17089155; http://dx.doi.org/10.1007/s00421-006-0331-5 [99] Frier BC, Locke M. Heat stress inhibits skeletal muscle hypertrophy.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Physiological Genomics 2005; 23:79-88; PMID:16046617; http://dx.doi.org/10.1152/physiolgenomi- cs.00279.2004 [103] Staib JL, Quindry JC, French JP, Criswell DS, Powers SK.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
Am J Physiol Regul IntegrComp Physiol 2007; 292:R432-9; PMID:16990482;http://dx.doi.org/10.1152/ajpregu.00895.2005 [104] Moseley PL.,Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Physiol 1963; 166:548-62; http://dx.doi.org/10.1113/jphysiol.1963.sp007122 [106] Fox RH, Goldsmith R, Kidd DJ, Lewis HE.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Physiol 1963; 166:530-47; http://dx.doi.org/ 10.1113/jphysiol.1963.sp007121 [107] Horowitz M. Heat acclimation, epigenetics, and cyto- protection memory.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Compr Physiol 2014; 4:199-230;PMID:24692139; http://dx.doi.org/10.1002/cphy.c130025 [108] Horowitz M, Kaspler P, Simon E, Gerstberger R. Heat acclimation and hypohydration: involvement of central angiotensin II receptors in thermoregulation.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Mol Brain Res 2004; 130:95-108; http://dx.doi.org/10.1016/j.molbrainres.2004.07.011 [110] Corbett J, Neal RA, Lunt HC, Tipton MJ.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Physiol 2016; 594:245-7; PMID:26667955; http://dx.doi.org/10.1113/JP270880 [113] Minson CT, Cotter JD.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur J Appl Physiol Occupational Physiol1985; 53:294-8; PMID:4039255; http://dx.doi.org/10.1007/BF00422841 [117] Creasy RH, Hopkins WG, Scoon G, Mayhew S, Cotter JD.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Scand J Med Sci Sports 2015; 25(Suppl1):240-9; http://dx.doi.org/10.1111/sms.12449 [121] Karlsen A, Racinais S, Jensen MV, Norgaard SJ, Bonne T, Nybo L. Heat Acclimatization does not improveVO2max or cycling performance in a cool climate intained cyclists.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Scandinavian J Med Sci Sports 2015; 25(Suppl 1):269-76; PMID:25943678; http://dx.doi.org/10.1111/sms.12409 [122] Bradford CD, Lucas SJ, Gerrard DF, Cotter JD.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Scand J Med Sci Spor 2015; 25:277-86; http://dx.doi.org/10.1111/sms.12351 [123] Hue O, Antoine-Jonville S, Sara F. The effect of 8 days of training in tropical environment on performance inneutral climate in swimmers.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Int J Sports Med 2007;28:48-52; PMID:16761217; http://dx.doi.org/10.1055/s-2006-923958 [124] Buchheit M, Voss SC, Nybo L, Mohr M, Racinais S. Physiological and performance adaptations to an in-sea- son soccer camp in the heat: associations with heart rateand heart rate variability.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Br J Sports Med 2013; 47(Suppl 1):i59- i69; PMID:24282209; http://dx.doi.org/10.1136/ bjsports-2013-092559 [126] Chen TI, Tsai PH, Lin JH, Lee NY, Liang MT.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Isothermic and ﬁxed-intensity heat accli- mation methods elicit equal increases in Hsp72 mRNA.Scandinavian J Med Sci Sports 2015; 25(Suppl 1):259-68; PMID:25943677; http://dx.doi.org/10.1111/sms.12-430 [129] Gibson OR, Mee JA, Tuttle JA, Taylor L, Watt PW, Maxwell NS.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J ThermBiol 2015; 49-50:55-65; PMID:25774027; http://dx.doi.org/10.1016/j.jtherbio.2015.02.005 [130] Heled Y, Peled A, Yanovich R, Shargal E, Pilz-Burstein R, Epstein Y, Moran DS.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"The effect of ten days of heat acclimation onexercise performance in acute hypobaric hypoxia (4350 m).Temperature 2015; 3:176-85; http://dx.doi.org/10.1080/23328940.2015.1072659 [132] Daanen HA, Jonkhoff W, Castellani J, editors.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
Temperature 2014;1:107-14; http://dx.doi.org/10.4161/temp.29800 [135] Hopkins WG.,OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Sports Med 2000; 30:1-15; PMID:10907753;http://dx.doi.org/10.2165/00007256-200030010-00001 [136] Garrett AT, Rehrer NJ, Patterson MJ.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"PMID:21846164; http://dx.doi.org/10.2165/11587320- 000000000-00000 [137] Rehrer NJ, Burke LM.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Physiol Behavior 1984; 33:357-63;PMID:6514825; http://dx.doi.org/10.1016/0031-9384(84)90154-9 [140] Adolph EF, editor.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Therm Biol 1991; 16:241-7;http://dx.doi.org/10.1016/0306-4565(91)90032-W [142] Buskirk ER, Iampietro PF, Bass DE.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci Sports Exerc 2007; 39:377-90; PMID:17277604; http://dx.doi.org/10.1249/mss.0b013e31802ca597 [144] Convertino VA, Armstrong LE, Coyle EF, Mack GW, Sawka MN, Senay LC, Jr, Sherman WM.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Scandinavian J MedSci Sports 2015; 25(Suppl 1):20-38; PMID:25943654;http://dx.doi.org/10.1111/sms.12408 [146] Racinais S, Alonso JM, Coutts AJ, Flouris AD, Girard O, Gonzalez-Alonso J, Hausswirth C, Jay O, Lee JK, Mitch- ell N, et al.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Scand J Med Sci Sports2015; 25(Suppl 1):6-19; PMID:25943653; http://dx.doi.org/10.1111/sms.12467 [147] Sawka MN, Young AJ, Latzka WA, Neufer PD, Quigley MD, Pandolf KB.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
Sports Med 2007; 37:463- 6; PMID:17465636; http://dx.doi.org/10.2165/0000-7256-200737040-00050 [149] Noakes TD.,Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Annals Nutri Metab 2010; 57(Suppl 2):9-17; PMID:21346332;http://dx.doi.org/10.1159/000322697 [150] Adams WC, Mack GW, Langhans GW, Nadel ER.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Acta Physiologica Scandinavica2005; 183:241-55; PMID:15743384; http://dx.doi.org/ 10.1111/j.1365-201X.2004.01400.x [152] Dion T, Savoie F, Asselin A, Gariepy C, Goulet EB.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
Br J Sports Med 2012; 47:679-86; PMID:22763119;http://dx.doi.org/10.1136/bjsports-2012-090-958 [154] Goulet ED.,Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Br JSports Med 2011; 45:1149-56; PMID:21454440; http://dx.doi.org/10.1136/bjsm.2010.077966 [155] Wall BA, Watson G, Peiffer JJ, Abbiss CR, Siegel R, Laursen PB.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Int J Sports Med 2014; 35:1216-22; PMID:25144431; http://dx.doi.org/ 10.1055/s-0034-1375635 [157] Fleming J, James LJ.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Acta Physiologica 2010; 198:179- 90; http://dx.doi.org/10.1111/j.1748-1716.2009.02051.x [161] Dewardener HE, Herxheimer A.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci Sports Exerc 2000; 32:332-48; PMID:10694114; http://dx.doi.org/10.1097/00005768- 200002000-00012 [167] Kirsch KA, von Ameln H, Wicke HJ.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Eur J ApplPhysiol Occupational physiol 1981; 47:191-6; PMID:7026232; http://dx.doi.org/ [168] Merry TL, Ainslie PN, Walker R, Cotter JD.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Physiol Behav 2008; 95:348-52; PMID:18644399; http://dx.doi.org/10.1016/j.physbeh.2008.06.015 [169] Mora-Rodriguez R, Hamouti N, Del Coso J, Ortega JF.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Appl Physiol Nutr Metab2012; 38:73-80; PMID:23368831; http://dx.doi.org/ 10.1139/apnm-2012-0174 [170] Greenleaf JE, Brock PJ, Keil LC, Morse JT.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Am J Hum Biol 2014; 26:311-20; PMID:24469986; http://dx.doi.org/10.1002/ajhb.22509 [172] Goto M, Okazaki K, Kamijo Y, Ikegawa S, Masuki S, Miyagawa K, Nose H. Protein and carbohydrate supple-mentation during 5-day aerobic training enhancedplasma volume expansion and thermoregulatory adap-tation in young men.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2010; 109:1247-55;PMID:20689095; http://dx.doi.org/10.1152/japplphy-siol.00577.2010 [173] Okazaki K, Hayase H, Ichinose T, Mitono H, Doi T, Nose H. Protein and carbohydrate supplementationafter exercise increases plasma volume and albumincontent in older and young men.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2009;107:770-9; PMID:19589953; http://dx.doi.org/10.1152/japplphysiol.91264.2008 [174] Okazaki K, Ichinose T, Mitono H, Chen M, Masuki S, Endoh H, Hayase H, Doi T, Nose H. Impact of protein and carbohydrate supplementation on plasma volume expansion and thermoregulatory adaptation by aerobictraining in older men.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Appl Physiol 2009; 107:725-33; PMID:19608927; http://dx.doi.org/10.1152/japplphys-iol.91265.2008 [175] Kenney WL, Chiu P. In ﬂuence of age on thirst and ﬂuid intake.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Med Sci Sports Exerc 2001; 33:1524-32;PMID:11528342; http://dx.doi.org/10.1097/00005768-200109000-00016 [176] Armstrong LE, Ganio MS, Casa DJ, Lee EC, McDermott BP, Klau JF, Jimenez L, Le Bellego L, Chevillotte E, Lie-berman HR.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Nutr 2012; 142:382-8; PMID:22190027; http://dx.doi.org/10.3945/jn.111.142000 [177] Ganio MS, Armstrong LE, Casa DJ, McDermott BP, Lee EC, Yamamoto LM, Marzano S, Lopez RM, Jimenez L,Le Bellego L, et al.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"2011; 106:1535-43; PMID:21736786; http://dx.doi.org/10.1017/S0007114511002005 [178] Gopinathan PM, Pichan G, Sharma VM.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Arch Environ Health 1988; 43:15-7;PMID:3355239; http://dx.doi.org/10.1080/00039896.19-88.9934367 [179] Yang RC, Mack GW, Wolfe RR, Nadel ER.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Physiol Behav 1989;45:639-47; PMID:2756057; http://dx.doi.org/10.1016/0031-9384(89)90085-1 [187] Cheuvront SN, Ely BR, Kene ﬁck RW, Sawka MN.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"PMID:20631205; http://dx.doi.org/10.3945/ajcn.20- 10.29490 [188] Armstrong LE, Maresh CM, Keith NR, Elliott TA, Van- heest JL, Scheett TP, Stoppani J, Judelson DA, De SouzaMJ.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Am J Physiol Endocrinol Metab 2005; 288: E868-75; PMID:15598669; http://dx.doi.org/10.1152/ ajpendo.00434.2004 [189] Mee JA, Gibson OR, Doust J, Maxwell NS.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Mol Cell Cardiol2004; 37:1053-61; PMID:15522282; http://dx.doi.org/10.1016/j.yjmcc.2004.09.006 [192] Merritt EK, Stec MJ, Thalacker-Mercer A, Wind- ham ST, Cross JM, Shelley DP, Craig Tuggle S,Kosek DJ, Kim JS, et al.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Applied Physiol 2013;115:937-48; PMID:23681911; http://dx.doi.org/10.1152/japplphysiol.00019.2013 [193] Selsby JT, Rother S, Tsuda S, Pracash O, Quindry J, Dodd SL.",OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"J Applied Physiol 2007; 102:1702-7; PMID:17110516; http://dx.doi.org/ 10.1152/japplp-hysiol.00722.2006 [194] Luttrell MJ, Halliwill JR. Recovery from exercise: vul- nerable state, window of opportunity, or crystal ball?Front Physiol 2015; 6:204; PMID:26257656; http://dx.doi.org/10.3389/fphys.2015.00204436 A. P. AKERMAN ET AL.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/ktmp-03-03-1216255.PMC5356617.pdf
"Finally, InChIKey for each drug was retrieved to obtain the corresponding Pub- Chem CID information with the python script “PubChemPy”(https://pypi.python.org/pypi/PubChemPy) and mapped to the DrugBank database to link the corresponding drug information.",OADS,/arxiv_data1/oa_pdf/04/74/PSP4-6-177.PMC5356618.pdf
"Statistical analysis and network visualization The statistical analysis was performed using the Python (v. 3.2, https://www.python.org/) and R platforms (v. 3.01, http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/04/74/PSP4-6-177.PMC5356618.pdf
"Network visualization and analy- sis (such as degree calculation) were conducted using Cytoscape (v. 3.2.0, http://www.cytoscape.org/).",OADS,/arxiv_data1/oa_pdf/04/74/PSP4-6-177.PMC5356618.pdf
31Several ongoing or completed clinical trials (http://clinicaltrials.gov/) for Figure 4 The reconstructed networks for four typical natural products.,Non-OADS,/arxiv_data1/oa_pdf/04/74/PSP4-6-177.PMC5356618.pdf
"47–49Finally, integration of drug-induced transcriptome data in cancer cells, such as LINCLOUD(http://www.lincscloud.org/), for natural products, may helpidentify novel anticancer indications of natural products bythe systems pharmacology framework in the future.",Non-OADS,/arxiv_data1/oa_pdf/04/74/PSP4-6-177.PMC5356618.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://psp-journal.com)Systems Pharmacology-Based Cancer Drug Repurposing Fang et al.,Non-OADS,/arxiv_data1/oa_pdf/04/74/PSP4-6-177.PMC5356618.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/81/opth-11-511.PMC5356917.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 511–515Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  511Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13318 8 refraction outcomes after suction loss during  small-incision lenticule extraction (sMile) amr a gab-alla Ophthalmology Department, Faculty  of Medicine, suez Canal University,   ismailia, egyptPurpose:  To evaluate refractive outcomes of two management approaches after suction loss  during the small-incision lenticule extraction (SMILE) technique.",Non-OADS,/arxiv_data1/oa_pdf/df/81/opth-11-511.PMC5356917.pdf
"The pos - terior surface refractive lenticule is first created (using an out-to-in spiral direction of Correspondence: amr a gab-alla Ophthalmology Department, Faculty of  Medicine, suez Canal University,   ring road, ismailia, 41522, egypt Tel +20 12 2283 6261 email amrophth@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Gab-Alla Running head recto: Refraction outcomes after the suction loss DOI: http://dx.doi.org/10.2147/OPTH.S133188",Non-OADS,/arxiv_data1/oa_pdf/df/81/opth-11-511.PMC5356917.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/df/81/opth-11-511.PMC5356917.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/81/opth-11-511.PMC5356917.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2017:10 29–32Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 29 SHORT REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S128247 Legislative activity related to the human  papillomavirus (HPV) vaccine in the United States  (2006–2015): a need for evidence-based policy Jessica Keim-Malpass1,2 Emma M Mitchell1 Pamela B DeGuzman1 Mark H Stoler3 Christine Kennedy1,2 1School of Nursing, 2Department of  Pediatrics, 3Department of Pathology,    School of Medicine, University of  Virginia, Charlottesville, VA, USAAbstract:  State-based policies to mandate HPV vaccination are politically challenging and  have received broad criticisms.",Non-OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
"There is a critical need to understand the updated legislative landscape for policies related to the HPV vaccine so that research initiatives can study the effect of policy on HPV -Correspondence: Jessica Keim-Malpass School of Nursing, University of Virginia, PO Box 800782, Charlottesville, VA 22908, USATel +1 636 346 6855Fax +1 434 924 2787Email jlk2t@virginia.eduJournal name: Risk Management and Healthcare Policy Article Designation: SHORT REPORTY ear: 2017V olume: 10Running head verso: Keim-Malpass et alRunning head recto: US HPV policyDOI: http://dx.doi.org/10.2147/RMHP .S128247",Non-OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
"Risk Management and Healthcare Policy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 32 Keim-Malpass et al declined.,Non-OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
Available from: http://www.healthy-people.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicid= 23.,Non-OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
Available from: http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6c/d7/rmhp-10-029.PMC5356918.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/amep-8-219.PMC5356919.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9c/ec/amep-8-219.PMC5356919.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 219–220Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 219 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S133314 Improving medical students’ proficiency in  ophthalmoscopy Subothini Sara Selvendran Sudeep Kumar Biswas Nikhil Aggarwal Department of Undergraduate  Medicine, Faculty of Medicine,  Imperial College London, London, UK  Dear editor We read with great interest the article by Gilmour and McKivigan, which assessed  medical students’ ability to accurately match fundus pictures with real patients using a hand-held ophthalmoscope.",Non-OADS,/arxiv_data1/oa_pdf/9c/ec/amep-8-219.PMC5356919.pdf
"1  An interesting  addition to these variables would be an approximation of the number of times the Correspondence: Nikhil Aggarwal Department of Undergraduate Medicine, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK Email na2412@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2017V olume: 8Running head verso: Selvendran et alRunning head recto: Short titleDOI: http://dx.doi.org/10.2147/AMEP .S133314",Non-OADS,/arxiv_data1/oa_pdf/9c/ec/amep-8-219.PMC5356919.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/9c/ec/amep-8-219.PMC5356919.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 220 Selvendran et al individual students had practiced ophthalmoscopy prior to  taking part in this study.,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/amep-8-219.PMC5356919.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/98/ndt-13-779.PMC5356920.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 779–784Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  779OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12705 3 Work–family conflict as a mediator between  occupational stress and psychological health  among mental health nurses in Japan Norio sugawara1,2 Kazuma Danjo3 hanako Furukori4 Yasushi sato2,5 T etsu T omita2,6 akira Fujii7 Taku Nakagami2,8 Kazuyo Kitaoka9 Norio Yasui-Furukori2 1Department of clinical epidemiology,   Translational Medical center, National  center of Neurology and Psychiatry,   Kodaira, T okyo, 2Department of  Neuropsychiatry, hirosaki University  school of Medicine, hirosaki,   aomori, 3Mizoguchi Mental hospital,   shizuoka, 4Department of Psychiatry,   Kuroishi-Akebono Hospital,   Kuroishi, 5Department of Psychiatry,   Mutsu general hospital, Mutsu,   6Department of Psychiatry, hirosaki- aiseikai hospital, Kitazono, hirosaki,   7Department of Psychiatry, seihoku- chuoh hospital, goshogawara,   aomori, 8Department of Psychiatry,   Odate Municipal general hospital,   Odate, akita, 9Mental health Nursing,   institute of Medical, Pharmaceutical  and health sciences, Kanazawa  University, Kanazawa, ishikawa, JapanBackground:  Occupational stress among mental health nurses may affect their psychological  health, resulting in reduced performance.",Non-OADS,/arxiv_data1/oa_pdf/ef/98/ndt-13-779.PMC5356920.pdf
"WFC has been defined as “a form of inter-role conflict in which  the role pressures from the work and family domains are mutually incompatible in correspondence: Norio sugawara Department of clinical epidemiology,  Translational Medical center, National  center of Neurology and Psychiatry,  Kodaira 187-8551, Tokyo, Japan Tel +81 42 341 2712 email nsuga3@yahoo.co.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Sugawara et al Running head recto: Work–family conflict as a mediator DOI: http://dx.doi.org/10.2147/NDT.S127053",Non-OADS,/arxiv_data1/oa_pdf/ef/98/ndt-13-779.PMC5356920.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ef/98/ndt-13-779.PMC5356920.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/98/ndt-13-779.PMC5356920.pdf
"Available from: http://www.mhlw.go.jp/ toukei/saikin/hw/k-tyosa/k-tyosa15/ .. Accessed December 18, 2016.",OADS,/arxiv_data1/oa_pdf/ef/98/ndt-13-779.PMC5356920.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/76/jpr-10-591.PMC5356921.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/06/76/jpr-10-591.PMC5356921.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 591–600Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  591 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128300Maternal anxiety and its correlation with pain  experience during chorion villus sampling and  amniocentesis Katharina Klages1,2 Sudip Kundu1 Joachim Erlenwein3 Michael Elsaesser4 Peter Hillemanns1 Alexander Scharf4 Ismini Staboulidou1 1Department of Gynecology and  Obstetrics, Hanover Medical School,   Hanover, 2Department of Gynecology  and Obstetrics, Diakovere Friederikenstift Hanover, Hanover,   3Department of Anesthesiology,   University of Goettingen, Pain Clinic, Goettingen,  4Department  of Gynecology and Obstetrics,  University of Heidelberg, Heidelberg,  GermanyPurpose: Invasive prenatal diagnostic procedures, such as chorion villus sampling (CVS) and  amniocentesis (AC), are routinely performed to exclude or diagnose fetal chromosomal abnor - malities.",Non-OADS,/arxiv_data1/oa_pdf/06/76/jpr-10-591.PMC5356921.pdf
"1, 30625 Hannover, GermanyTel +49 17 6153 23452Fax +49 511 532 6145Email staboulidou.ismini@mh-hannover.de Journal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Klages et alRunning head recto: Anxiety-dependent pain during invasive prenatal proceduresDOI: http://dx.doi.org/10.2147/JPR.S128300",Non-OADS,/arxiv_data1/oa_pdf/06/76/jpr-10-591.PMC5356921.pdf
Statistical analysis was performed using the statistic program R (https://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/06/76/jpr-10-591.PMC5356921.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/06/76/jpr-10-591.PMC5356921.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 600 Klages et al 39.,Non-OADS,/arxiv_data1/oa_pdf/06/76/jpr-10-591.PMC5356921.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/50/1f/jpr-10-575.PMC5356922.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/50/1f/jpr-10-575.PMC5356922.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 575–590Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  575 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S125667Clear differences in cerebrospinal fluid proteome  between women with chronic widespread pain  and healthy women – a multivariate explorative  cross‑sectional study Patrik Olausson Bijar Ghafouri Emmanuel Bäckryd Björn Gerdle Pain and Rehabilitation Centre,   Department of Medical and Health Sciences, Linköping University,  Linköping, SwedenIntroduction: Frequent chronic local pain can develop into chronic widespread pain (CWP).",Non-OADS,/arxiv_data1/oa_pdf/50/1f/jpr-10-575.PMC5356922.pdf
"A continuum of chronic pain conditions has been proposed, 1 and CWP – including fibromyal- gia syndrome (FMS) – is considered the most negative end point associated with Correspondence: Bijar Ghafouri Pain and Rehabilitation Medicine, PAINOMICS Research Laboratory, Division of Community Medicine, Department of Medical and Health Sciences, Linköping University, Linköping SE 581 85, SwedenTel +46 1 0103 2381Email bijar.ghafouri@liu.seJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Olausson et alRunning head recto: CSF profiling by 2-DEDOI: http://dx.doi.org/10.2147/JPR.S125667",Non-OADS,/arxiv_data1/oa_pdf/50/1f/jpr-10-575.PMC5356922.pdf
"The proteins were divided based on UniProt database (http://web.expasy.org ) definition on biological process in different groups  (labeled Type): M, metabolic; S&I, stress and inflammatory; T, transport; R, regulation proteins.Abbreviations:  VIP, variable of importance; CWP, chronic widespread pain; CON, healthy controls; OPLS‑DA, orthogonal partial least squares discriminant analysis; IOD,  integrated optical density; CoeffCS, scaled and centered coefficients.",OADS,/arxiv_data1/oa_pdf/50/1f/jpr-10-575.PMC5356922.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal‑of‑pain‑research‑journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/50/1f/jpr-10-575.PMC5356922.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 590 Olausson et al,Non-OADS,/arxiv_data1/oa_pdf/50/1f/jpr-10-575.PMC5356922.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/b8/ndt-13-775.PMC5356923.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 775–777Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  775Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13251 6 successful treatment for psychomotor agitation  in neuromyelitis optica spectrum disorder with  trazodone–risperidone combination: a case report Zui Narita1 Harumasa Takano1 T omiki sumiyoshi2 1Department of psychiatry, National  Center Hospital, 2Department of  Clinical epidemiology, Translational  Medical Center, National Center  of Neurology and psychiatry,   T okyo, JapanAbstract:  Neuromyelitis optica (NMO) is a relapsing disease that typically affects the spinal  cord and optic nerves.",Non-OADS,/arxiv_data1/oa_pdf/c0/b8/ndt-13-775.PMC5356923.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c0/b8/ndt-13-775.PMC5356923.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/b8/ndt-13-775.PMC5356923.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 519–530Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  519OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12933 3 Assessing physician and patient acceptance of  infliximab biosimilars in rheumatoid arthritis,  ankylosing spondyloarthritis and psoriatic arthritis  across germany John Waller1 emma sullivan1 James Piercy1 christopher M Black2 sumesh Kachroo2 1Adelphi Real World, Manchester, UK;   2Center for Observational and Real- World Evidence (CORE), Merck &  Co., Inc., Kenilworth, NJ, USAObjectives:  We examined rheumatologists’ motivation for prescribing biosimilars, assessed  their treatment preferences in relation to prescribing behavior and explored patient attitudes  to biosimilars.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"For generic drugs, demonstration of identical structure and  bioequivalence to the reference product is required for licensing purposes; however,  biotherapeutic products (biologics) are larger and more complex entities, and this  approach is not considered appropriate for biosimilars.1 A biosimilar must therefore  be developed strictly in accordance with procedures used for the reference product correspondence: sumesh Kachroo Merck & Co., Inc., 126 East Lincoln  Avenue, Rahway, NJ 07065, USA Tel +1 732 594 3847 email sumesh.kachroo@merck.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Waller et al Running head recto: Biosimilars rheumatology DOI: http://dx.doi.org/10.2147/PPA.S129333",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available  from: http://www.who.int/biologicals/areas/biological_therapeutic s.  Accessed July 29, 2016.",OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://www.fda.gov/downloads/Drugs/ Guidance   Compli anceRegulatoryInformation /Guidances/UCM291134.pd f.  Accessed July 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://www.gabionline.net/Reports/ Use-of-biosimilars-in-Europe-differs-across-countrie s. Accessed  July 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://www.gesetze-im-internet.de/ sgb_5/__129.htm l. Accessed March 2, 2017.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://gabionline.net/Reports/UK-biosimilars- uptake-lower-t han-in-some-other-EU-countrie s. Accessed August 12,  2016.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://ec.europa.eu/DocsRoom/ documents/7651/attachments/1/translations/en/renditions/pd f. Accessed  October 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://www.prnewswire.com/ news-releases/german-rheumatologists-and-gastroenterologists- say-they-are-not- under -pressure-to-switch-patients-on-remicade-to- infliximab-biosimilars-300145025.htm l. Accessed March 2, 2017.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Risk-management-plan_summary/ human/004007/WC500196679.pd f. Accessed August 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://www.gabion - line.net/Biosimilars/General/Biosimilars-of-adalimuma b. Accessed  August 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
Available from: http://www.pfenex.com/the-pfenex- difference /.,Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: https://www.novartis.com/news/media- releases/sandoz-biosimilar-rituximab-regulatory-submission-accepted- european-medicine s. Accessed August 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Available from: http://www.ephmra.org/ Code-of-Conduct-Suppor t. Accessed January 19, 2017.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/00/2f/ppa-11-519.PMC5356924.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/50/a3/1348-9585-58-385.PMC5356935.pdf
"JSOH OEL committee: JSOH new proposal of Occupational Exposure Limits (2016-2017)  appear in the September issue of the Journal of Occupa- tional Health (Volume 58, Number 5), and a brief sum-mary of the proposal will be posted at the Society’s web-site(https://www.sanei.or.jp/oel-eng)in September.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/1348-9585-58-385.PMC5356935.pdf
"[On- line] Available from: URL: http://anzeninfo.mhlw.go.jp/user/anzen/kag/pdf/gan/0416_MAIN.pdf(in Japanese) 4)Japan Bioassay Research Center: Carcinogenicity testing re- port 0438: inhalation study of butyl-2,3-epoxypropyl ether in mice.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/1348-9585-58-385.PMC5356935.pdf
"[Online] Available from: URL: http://anzeninfo.mhlw.go.jp/user/anzen/kag/pdf/gan/0438_MAIN.pdf(in Japanese) 5)Buckley LA, Morgan KT, Swenberg JA, James RA, Hamm TE Jr, Barrow CS.",Non-OADS,/arxiv_data1/oa_pdf/50/a3/1348-9585-58-385.PMC5356935.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/ by/4.0/ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/d4/cox010.PMC5356938.pdf
http://CRAN.R-project.org/package =nlme .,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/cox010.PMC5356938.pdf
https://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/8b/d4/cox010.PMC5356938.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/0b/cc/1348-9585-58-323.PMC5356939.pdf
2012 [cited 2015 Sep. 28]; Availablefrom: URL: http://www.teijin.com/csr/report/pdf/csr_12_10.pdf.,OADS,/arxiv_data1/oa_pdf/0b/cc/1348-9585-58-323.PMC5356939.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d5/f1/1348-9585-58-333.PMC5356940.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/24/84/1348-9585-58-340.PMC5356941.pdf
"25]; Available from: URL: http://www.ilo.org/global/statistics-and-databases/statistics-overview-and-topics/working-time/history/lang--en/index.htm 16) Ministry of Health, Labour and Welfare, Japan.",Non-OADS,/arxiv_data1/oa_pdf/24/84/1348-9585-58-340.PMC5356941.pdf
25]; Available from: URL:http://www.japaneselawtranslation.go.jp/law/detail_main?vm=&id=5 17) International Labour Organization.,Non-OADS,/arxiv_data1/oa_pdf/24/84/1348-9585-58-340.PMC5356941.pdf
"25]; Available from: URL: http://www.ilo.org/global/statistics-and-da tabases/statistics-overview-an d-topics/working-time/lang--en/index.htm 18) Kuwahara K, Imai T, Nishihara A, et al.",OADS,/arxiv_data1/oa_pdf/24/84/1348-9585-58-340.PMC5356941.pdf
"25];Available from: URL: https://www.jetro.go.jp/en/invest/setting_up/laws/section4/page5.html 23) Ministry of Health, Labour and Welfare, Japan.",Non-OADS,/arxiv_data1/oa_pdf/24/84/1348-9585-58-340.PMC5356941.pdf
25]; Availablefrom: URL: http://www.mhlw.go.jp/houdou/0104/h0406-6.html,Non-OADS,/arxiv_data1/oa_pdf/24/84/1348-9585-58-340.PMC5356941.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/3c/03/1348-9585-58-347.PMC5356942.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/25/e3/1348-9585-58-354.PMC5356943.pdf
2012 [cited 2015 Dec. 15]; Available from:URL: http://www.mhlw.go.jp/bunya/kenkou/dl/kenkounippon21_02.pdf (in Japanese).,OADS,/arxiv_data1/oa_pdf/25/e3/1348-9585-58-354.PMC5356943.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/2d/d6/1348-9585-58-365.PMC5356944.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9c/b2/1348-9585-58-373.PMC5356945.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7d/78/1348-9585-58-381.PMC5356946.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/54/4a/1348-9585-58-231.PMC5356947.pdf
"17]; Available from: URL: http://www.mhlw.go.jp/toukei/list/h24-46-50.html 12) Wrzesniewski A, Dutton JE.",Non-OADS,/arxiv_data1/oa_pdf/54/4a/1348-9585-58-231.PMC5356947.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8d/73/1348-9585-58-241.PMC5356948.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ae/3b/1348-9585-58-247.PMC5356949.pdf
"Participants were interviewed using the Computer- Assisted Personal Interviewing method using Blaise ⡴,a software system developed by Statistics Netherlands thatwas designed for use in official statistics (http://www.blaise.com/onlinehelp).",Non-OADS,/arxiv_data1/oa_pdf/ae/3b/1348-9585-58-247.PMC5356949.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6d/7c/1348-9585-58-255.PMC5356950.pdf
Availablefrom: URL: http://www.r-project.org.,Non-OADS,/arxiv_data1/oa_pdf/6d/7c/1348-9585-58-255.PMC5356950.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7d/f9/1348-9585-58-269.PMC5356951.pdf
"11]; Available from: URL: https://www.gov.uk/government/uploads/system/uploads /attachment_data/file/333018/Mana gement_of_HIV_infected_Healthcare_Workers_guidance_January_2014.pdf 6) Henderson DK, Dembry L, Fishman NO, et al.",OADS,/arxiv_data1/oa_pdf/7d/f9/1348-9585-58-269.PMC5356951.pdf
"2005[cited 2016 Jan. 11]; Available from:URL: http://www.who.int/occupational_health/activities/2ilowho.pdf 9) Rahmati-Najarkolaei F, Niknami S, Aminshokravi F, et al.",OADS,/arxiv_data1/oa_pdf/7d/f9/1348-9585-58-269.PMC5356951.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
(http://www.gmo-research.jp/).,OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
"2007[cited 2015 Nov.25]; Available from: URL: http://www.ttl.fi/en/publications/Electronic_publications/Docum ents/BOHS3Edition28Sept2007_ 3_.pdf 2) Cashman C, Slovak A.",Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
2014[cited 2015 Nov. 25]; Available from:URL: http://www.uems-occupati onalmedicine.org/node/78 4) Matsuda S. The occupational physician in France.,Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
[cited 2015 Nov. 25]; Available from: URL: http://www.japaneselawtranslation.go.jp /law/detail/?ft=5&re=01&dn= 1&gn=3&sy=47&ht=A&no= 57&x=65&y=14&ia=03&ky=&p age=1 7) Japan Medical Association.,OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
2011[cited 2015 Nov. 25]; Avail-able from: URL: http://jmaqc.jp/sang/dl_files/sangyo_tebiki_H2304.pdf (in Japanese) 8) Japan Society for Occupational Health.,OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
[cited 2015 Nov. 25];Available from: URL: http://ohtc.med.uoeh-u.ac.jp/ENV/new/new_a1.html (in Japanese) 9) Mori K. Current status and issues in development of occupa- tional physicians in Japan.,Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
"[cited 2015 Nov. 25]; Available from:URL : http://www.mhlw.go.jp/english/wp/wp-hw4/dl/working_conditions_labour _relations/2011071911.pdf 17) Moriguchi J, Sakuragi S, Takeda K, et al.",Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
"[cited 2015 Nov. 25]; Available from: URL: http://www.who.int/occupational_health/Declarwh.pdf 21) Diploma in Occupational Medic ine Examination Regulations, Syllabus and Guidance Notes for Candidates & Teaching Cen-tres: Faculty of Occupational Medicine of the Royal Collegeof Physicians.",Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
[cite d 2015 Nov. 25]; Available from: URL : http://www.fom.ac.uk/wp-content/uploads/DOccMedregs2014.pdf 22) CPD Diploma in Occupational Medicine: The University of Manchester.,Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
[cited 2015 Nov. 25]; Available from:URL: http://www.population-health.manchester.ac.uk/epidemiology/COEH/postgraduate/CPD_D iploma_Guide_for_Applica nts.pdf 23) Diploma in Occupational Medicine: University of Birming- ham.,Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
"[cited 2015 Nov. 25]; Available from: URL: http://www.birmingham.ac.uk/postgra duate/courses/cpd/med/occ upational-medicine.aspx#CourseDetailsTab 24) Terada H, Sone T, Takemura S. Study on actual situation of community industrial physicians for small and medium-sizedenterprises and their involvement in community occupationalhealth services.",Non-OADS,/arxiv_data1/oa_pdf/27/24/1348-9585-58-276.PMC5356952.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/cb/b5/1348-9585-58-289.PMC5356953.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ae/04/1348-9585-58-297.PMC5356954.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/68/e3/1348-9585-58-310.PMC5356955.pdf
"20]; Available from : URL :http://www.ginasthma.com/ 11) Colombi R, Forcina A.",Non-OADS,/arxiv_data1/oa_pdf/68/e3/1348-9585-58-310.PMC5356955.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e6/38/1348-9585-58-314.PMC5356956.pdf
[cited 2015 Sep. 14]; Available from :URL :http://www.cosh h-essentials.org.uk/assets/live/cetb.pdf 6) International Labour Organiza tion (ILO).,OADS,/arxiv_data1/oa_pdf/e6/38/1348-9585-58-314.PMC5356956.pdf
"[cited 2015 Sep. 14]; Availablefrom :URL :http://www.ilo.org/english/pr otection/ctrl_bandin g/toolkit/icct.guide.pdf 7) National Institute of Technology and Evaluation, Japan (NITE) GHS Classification Results (DCM, Mineral Oil andTrimethyl benzene).",OADS,/arxiv_data1/oa_pdf/e6/38/1348-9585-58-314.PMC5356956.pdf
"2015 [ cited 2015 Sep. 14 ] ;Available from :URL :http://www.safe.nite.go.jp/english/ghs/0 6-imcg-0140e.html for DCM, -0711e.html for mineral oil, and-0859e.html for trimethyl benzene.",OADS,/arxiv_data1/oa_pdf/e6/38/1348-9585-58-314.PMC5356956.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9b/13/1348-9585-58-320.PMC5356957.pdf
2014[cited 2015 Oct. 13th]; Available from:URL: https://www.nta.go.jp/kohyo /tokei/kokuzeicho/minkan2 014/pdf/001.pdf.,OADS,/arxiv_data1/oa_pdf/9b/13/1348-9585-58-320.PMC5356957.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/3c/63/1348-9585-58-135.PMC5356958.pdf
"2016[cited 2016 Jan. 27]; Available from:URL: http://jica-ri.jica.go.jp/IFIC_and_JBICI-Studies/english/publications/reports/study/t opical/health/pdf/health_09.pdf 3) Aizawa Y, Nomura S, Matsushita T. Origins of occupational health in Japan with special reference to the Japan Society forOccupational Health.",Non-OADS,/arxiv_data1/oa_pdf/3c/63/1348-9585-58-135.PMC5356958.pdf
2016[cited 2016 Jan.27]; Available from: URL: http://www.ilo.org/wcmsp5/groups/public/ʕed_protect/ ʕprotrav/ʕsafework/documents/public ation/wcms_234221.pdf 13) Horie S. Occupational health policies on risk assessment in Ja- pan.,OADS,/arxiv_data1/oa_pdf/3c/63/1348-9585-58-135.PMC5356958.pdf
"2016[cited 2016 Jan. 25]; Avail-able from: URL: https://www.jstage.jst.go.jp/browseDerek R. Smith, et al.",OADS,/arxiv_data1/oa_pdf/3c/63/1348-9585-58-135.PMC5356958.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b1/e0/1348-9585-58-138.PMC5356959.pdf
2000.Available from :URL :http://www.gpo.gov/fdsys/pkg/BILLS- 106hconres387ih/html/BI LLS-106hconres387ih.htm 4) Raulf M. The latex story.,Non-OADS,/arxiv_data1/oa_pdf/b1/e0/1348-9585-58-138.PMC5356959.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/46/2c/1348-9585-58-145.PMC5356960.pdf
"2014[cited 2015 May 27]; Available from:URL: http://www.mhlw.go.jp/bunya/kenkou/eiyou/h24-houkoShigeki Takemura, et al.",OADS,/arxiv_data1/oa_pdf/46/2c/1348-9585-58-145.PMC5356960.pdf
[cited 2015 May 27]; Available from: URL: http://apps.who.int/bmi/index.jsp.,OADS,/arxiv_data1/oa_pdf/46/2c/1348-9585-58-145.PMC5356960.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a7/6c/1348-9585-58-155.PMC5356961.pdf
"Selection of participants Participants were selected from a pool of 1,187,791 people registered with an online research company calledMacromill (http://www.macro mill.com/) who had agreed to participate in oral health-related surveys when theyregistered.",Non-OADS,/arxiv_data1/oa_pdf/a7/6c/1348-9585-58-155.PMC5356961.pdf
"Available from: URL: http://www.biomedcentral.com/1472-6831/14/63 21) Matsuyama Y, Aida J, Takeuchi K, et al.",OADS,/arxiv_data1/oa_pdf/a7/6c/1348-9585-58-155.PMC5356961.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4a/03/1348-9585-58-163.PMC5356962.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/de/b5/1348-9585-58-170.PMC5356963.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/df/da/1348-9585-58-179.PMC5356964.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
30]; Available from: URL: http://www.meti.go.jp/englis h/press/2011/pdf/0826_03b.pdf 4) The Ministry of the Environment.,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
30]; Available from:URL: http://josen.env.go.jp/en/pdf/annex_01.pdf 5) Nuclear Emergency Response Headquarters.,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
"30]; Available from: URL: http://www.meti.go.jp/english/earthquake/nuclea r/roadmap/pdf/20111226_01.pdf 6) Ministry of Health, Labour and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
"30]; Available from:URL : http://www.mhlw.go.jp/english/topics/2011eq/workers/dr/dr/pr_111222_a04.pdf 7) Ministry of Health, Labour and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
"30]; Avail-able from: URL: http://www.mhlw.go.jp/english/topics/2011eq/workers/dr/dr/pr_120615_a03.pdf 8) Wada K, Yoshikawa T, Hayashi T, Aizawa Y.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
2012[cited 2015 Jan. 5]; Available from: URL: http://www.mhlw.go.jp/new-info/kobetu/roudou/gyousei/anzen/dl/120118-04-zentai.pdf (in Japanese) 12) World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
30]; Available from: URL: http://www.mhlw.go.jp/english/topics/2011eq/workers/dr/dr/pr_130724.html 18) Prime Minister of Japan and his Cabinet.,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
30]; Available from: URL: http://law.e-gov.go.jp/htmldata/S32/S32HO166.html (inJapanese) 19) The Ministry of the Environment.,Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
"30];Available from: URL: https://www.env.go.jp/jishin/rmp/attach/josen-const_cs-h26-8.pdf (in Japanese) 20) López-Ruiz M, Artazcoz L, Martínez JM, Rojas M, Benavides FG.",Non-OADS,/arxiv_data1/oa_pdf/4c/8c/1348-9585-58-186.PMC5356965.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ba/26/1348-9585-58-196.PMC5356966.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a7/f6/1348-9585-58-201.PMC5356967.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
"Available from: URL: http://laborsta.ilo.org/informal_economy_E.html 2) Sarker AR, Khan JA, Informal workers in Bangladesh.",Non-OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
Available from: URL: http://linkinghub.elsevier.com/re trieve/pii/S1877042812004806 8) Sutarjo US.,Non-OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
Available from: URL: http://www.ncbi.nlm.nih.gov/pubmed/18572796 9) Loewenson RH.,OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
Available from: URL: https://www.ssa.gov/policy/docs/ssb/v39n2/v39n2p21.pdf 14) Grossman M. Household Production and Consumption.,OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
Available from: URL:http://www.nber.org/chapters/c3962 15) Becker GS.,Non-OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
"Available from: URL: http://www.sciencedirect.com/sci ence/artic le/pii/S0167527310008077 24) Schofield DJ, Callander EJ, Shrestha RN, Percival R, Kelly SJ, Passey ME.",Non-OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
"BMJ open 2012; 2(6): Available from: URL:http://www.pubmedcentral.nih.gov/a rticlerender.fcgi?artid=35 33107&tool=pmcentrez&rendertype=abstract 30) Mattke S, Balakrishnan A, Bergamo G, Newberry SJ.",Non-OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
"SpringerPlus 2014; 3(1): 435.Available from: URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4153877&tool=pmcentrez&rendertype=abstract 32) Aguayo-rico A, Guerra-turrubiates IA, Instituto RMDO.",OADS,/arxiv_data1/oa_pdf/83/16/1348-9585-58-209.PMC5356968.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/4a/1f/1348-9585-58-216.PMC5356969.pdf
"2002[cited 2015 Dec.2]; Available from: URL: http://apps.who.int/iris/bitstream/10665/67174/1/WHO_NMH_NPH_02.1.pdf 8) Kuh D, Ben-Shlomo Y, Lynch J, et al.",OADS,/arxiv_data1/oa_pdf/4a/1f/1348-9585-58-216.PMC5356969.pdf
"2015[cited 2015 Dec.2]; Available from: URL: http://www.who.int/cardiovascular_diseases/en/ 39) Yusuf S, Hawken S, Ounpuu S, et al.",OADS,/arxiv_data1/oa_pdf/4a/1f/1348-9585-58-216.PMC5356969.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/72/95/1348-9585-58-220.PMC5356970.pdf
Lancet 2015; 385: 117-171. http://dx.doi.or g/10.1016/S0140-6 736(14)61682-61682 14) International Ban Asbestos Secretariat.,Non-OADS,/arxiv_data1/oa_pdf/72/95/1348-9585-58-220.PMC5356970.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/72/61/1348-9585-58-224.PMC5356971.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a7/f2/1348-9585-58-228.PMC5356972.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/df/da/1348-9585-58-389.PMC5356973.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f8/c0/1348-9585-58-404.PMC5356974.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1a/2f/1348-9585-58-413.PMC5356975.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b1/a6/1348-9585-58-425.PMC5356976.pdf
"[cited 2016 Jan. 15]; Availablefrom: URL: https://www.destatis.de/DE/ZahlenFakten/GesamtwirtschaftUmwelt/UnternehmenHandwerk/KleineMittlereUnternehmenMittelstand/Aktuell_.html 29) Andersen HH, Mühlbacher A, Nübling M, Schupp J, Wagner GG.",Non-OADS,/arxiv_data1/oa_pdf/b1/a6/1348-9585-58-425.PMC5356976.pdf
"[cited 2016 Jan. 15]; Available from:URL: http://ssrn.com/abstract=2432439 41) Conway N, Briner RB.",OADS,/arxiv_data1/oa_pdf/b1/a6/1348-9585-58-425.PMC5356976.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ae/9f/1348-9585-58-434.PMC5356977.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/25/65/1348-9585-58-444.PMC5356978.pdf
"[cited 2015 Sep. 2]; Available from: URL: http://www.eurofound.europa.eu/ publications/htmlfiles/ef1182.ht m 2) Chu C, Rosenfield M, Portello JK, Benzoni JA, Collier JD.",Non-OADS,/arxiv_data1/oa_pdf/25/65/1348-9585-58-444.PMC5356978.pdf
[cited 2015 Sep. 2]; Availablefrom: URL: http://www.msssi.gob.es/ciudadanos/saludAmbLaboral/docs/datos.pdf.,OADS,/arxiv_data1/oa_pdf/25/65/1348-9585-58-444.PMC5356978.pdf
2]; Available from: URL: http://www.inrs.fr/accueil/dms/inrs/CataloguePapier/ED/TI-ED-924/ed924.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/65/1348-9585-58-444.PMC5356978.pdf
[cited 2015 Sep. 2]; Available from: URL: http://www.hse.gov.uk/pubns/priced/l26.pdf.,OADS,/arxiv_data1/oa_pdf/25/65/1348-9585-58-444.PMC5356978.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e2/f5/1348-9585-58-452.PMC5356979.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/db/a9/1348-9585-58-460.PMC5356980.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/86/2e/1348-9585-58-470.PMC5356981.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a5/5b/1348-9585-58-477.PMC5356982.pdf
[cited 2016 Mar.4]; Available from: URL: http://www.mhlw.go.jp/bunya/roudoukijun/anzeneisei48/dl/anzeneisei48-01.pdf (in Japnese).,OADS,/arxiv_data1/oa_pdf/a5/5b/1348-9585-58-477.PMC5356982.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e0/95/1348-9585-58-482.PMC5356983.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e5/77/1348-9585-58-489.PMC5356984.pdf
"]OEL Skin   absorptionClass of    carcinogenicityClass of sensitizing   potentialReproductive  ToxicantsYear of  proposal ppm mg/m3Airway Skin n-butyl-2,3-epoxy-propyl ether   [2426-08-6]0.25 1.33 2B 2 3 ’16 Dimethylamine [124-40-3] 2 3.7 3 ’16 2-Ethyl-1-hexanol [104-76-7 ］ 1 5.3 pending ’16 Lead and compounds (as Pb except alkyl lead compounds) [7439-92-1]0.03 2B 1 #’16 See JSOH’S web site for brief summary of OEL documentation at http://sanei.or.jp496 J Occup Health, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/1348-9585-58-489.PMC5356984.pdf
"Occupational exposure limits based on biological monitoring SubstanceAssay  mate- rialParameter OEL-B Sampling timeYear of  pro- posal Acetone urine Acetone 40 mg/l Within 2 h prior to end of shift ’01 2-Butoxyethanol and   2-Butoxyethyl acetateurine Butoxyacetic acid 200 mg/g·Cr End of shift ’08 Carbon disulfide urine 2-thiothiazolidine- 4-carboxylic acid†0.5 mg/g·Cr End of shift (Avoid sizable  intake of brasicca vegetables) ’15 Cobalt and inorganic compounds  (except cobalt oxides) blood Cobalt 3 μg/l Within 2 h prior to end of shift  at end of work week’05 urine Cobalt 35 μg/l Within 2 h prior to end of shift  at end of work week’05 Chlorobenzene urine 4-Chlorocatechol  (hydrolysis) 120 mg/g·Cr End of shift ’08 3,3’-Dichloro-4,4’-diaminodiphe - nyl-methane (MBOCA) urine total MBOCA 50 μg/g·Cr End of shift at end of work - week’94 Dichloromethane urine Dichloromethane 0.2 mg/l End of shift ’05 Hexane urine 2,5-Hexanedione 3 mg/g·Cr   (after acid hydrolysis) End of shift at end of work - week’94 urine 2,5-Hexanedione 0.3 mg/g·Cr   (without acid hydrolysis) End of shift at end of work - week Indium and compounds serum Indium 3 μg/l Not critical ’94 Lead and compounds   (except alkyl lead compounds) blood Lead 15 μg/100 ml Not critical ’07 blood Protoporphyrin 200 μg/100 ml·RBC Not critical ’13 80 μg/100 ml·blood (After one month or more  since consecutive exposure) ’94 urine δ-Aminolevulinic acid 5 mg/l Not critical  (After one month or more  since consecutive exposure) ’94 Mercury and compounds   (except alkyl mercury compounds) urine total inorganic   mercury35 μg/g·Cr Not critical ’93 Methanol urine Methanol 20 mg/l End of shift ’10 Methylethylketone urine Methylethylketone 5 mg/l End of shift or A few hours  after high exposure’06 Methyl isobutyl ketone urine Methyl isobutyl  ketone1.7 mg/l End of shift ’07 Phenol urine Phenol 250 mg/g·Cr End of shift ’08 Polychlorobiphenyls (PCBs) blood total PCB 25 μg/l Not critical ’06 Styrene urine Mandelic acid +  Phenylglyoxylic acid430 mg/l End of shift at end of work  week’07 blood Styrene 0.2 mg/l End of shift at end of work  week’07 Tetrahydrofuran urine Tetrahydrofuran 2 mg/l End of shift  (’15) Toluene blood Toluene 0.6 mg/l Within 2 h prior to end of  shift at end of work week’99 urine Toluene 0.06 mg/l ’99 Trichloroethylene urine total trichloro-com - pounds150 mg/l Within 2 h prior to end of  shift at end of work week’99 urine Trichloroethanol 100 mg/l ’99 urine Trichloroacetic acid 50 mg/l Xylene urine total (o-, m-, p-)   methylhippuric acid800 mg/l End of shift at end of work  week’05 †: Provisional See JSOH website for brief summary of OEL documentation at http://sanei.or.jp/oel-eng⎞ ⎬ ⎠ ⎞ ⎟  ⎬ ⎟   ⎠J Occup Health, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/1348-9585-58-489.PMC5356984.pdf
"See JSOH web site for brief summary of OEL documentation at http://sanei.or.jp/oel-engJ Occup Health, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/1348-9585-58-489.PMC5356984.pdf
"To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-sa/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ad/c4/1348-9585-58-e1.PMC5356985.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b3/fc/idr-10-091.PMC5357068.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b3/fc/idr-10-091.PMC5357068.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance 2017:10 91–96Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 91 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S126274Risk factors for multidrug-resistant tuberculosis  among tuberculosis patients: a case-control study Abdulhalik Workicho Wondwosen Kassahun Fessahaye Alemseged Department of Epidemiology, College  of Health Sciences, Jimma University,  Jimma, Ethiopia Background: Multidrug-resistant tuberculosis (MDR-TB) did not receive major attention until  recently in sub-Saharan Africa where the tuberculosis incidence and risk factors are highest.",Non-OADS,/arxiv_data1/oa_pdf/b3/fc/idr-10-091.PMC5357068.pdf
"2,3Correspondence: Abdulhalik Workicho Department of Epidemiology, College of Health Sciences, Jimma University, PO Box 378, Jimma, EthiopiaTel +251 91 340 7305Email abdulhalikw@gmail.comJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Workicho et alRunning head recto: Risk factors for MDR-TBDOI: http://dx.doi.org/10.2147/IDR.S126274",Non-OADS,/arxiv_data1/oa_pdf/b3/fc/idr-10-091.PMC5357068.pdf
"Infection and Drug Resistance 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/b3/fc/idr-10-091.PMC5357068.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 96 Workicho et al Acknowledgements This investigation received financial support from Jimma  University.,Non-OADS,/arxiv_data1/oa_pdf/b3/fc/idr-10-091.PMC5357068.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fd/91/jhc-4-049.PMC5357069.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fd/91/jhc-4-049.PMC5357069.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2017:4 49–58Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 49 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S129063 Irreversible electroporation of hepatocellular  carcinoma: patient selection and perspectives Asha Zimmerman1 David Grand2 Kevin P Charpentier1 1Department of Surgery, 2Department  of Radiology, Rhode Island Hospital,   Brown University, Providence, RI, USAAbstract: Irreversible electroporation (IRE) is a novel form of tissue ablation that uses  high-current electrical pulses to induce pore formation of the cell lipid bilayer, leading to cell  death.",Non-OADS,/arxiv_data1/oa_pdf/fd/91/jhc-4-049.PMC5357069.pdf
"NanoKnife electrodes are housed in a 19-gauge Correspondence: Kevin P Charpentier Department of Surgery, Rhode Island Hospital, Brown University, 2 Dudley Street, Suite 370, Providence, RI 02905, USATel +1 401 228 0560Fax +1 401 228 0636Email kcharpentier@usasurg.orgJournal name: Journal of Hepatocellular Carcinoma Article Designation: REVIEW Y ear: 2017V olume: 4Running head verso: Zimmerman et alRunning head recto: Irreversible electroporation of HCC: patient selection and perspectives DOI: http://dx.doi.org/10.2147/JHC.S129063",Non-OADS,/arxiv_data1/oa_pdf/fd/91/jhc-4-049.PMC5357069.pdf
Available  from: http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014.,Non-OADS,/arxiv_data1/oa_pdf/fd/91/jhc-4-049.PMC5357069.pdf
"Journal of Hepatocellular Carcinoma 2017:4submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/fd/91/jhc-4-049.PMC5357069.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 58 Zimmerman et al 35.,Non-OADS,/arxiv_data1/oa_pdf/fd/91/jhc-4-049.PMC5357069.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 79–87Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 79 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S126763 Long-term management of type 2 diabetes with  glucagon-like peptide-1 receptor agonists Hamish Courtney1 Rahul Nayar2 Chinnadorai Rajeswaran3 Ravi Jandhyala4 1Diabetes Department, Royal Victoria  Hospital, Belfast, 2City Hospitals  Sunderland NHS Foundation Trust,   Sunderland, 3Department of Diabetes  & Endocrinology, Mid Y orkshire NHS Trust, Dewsbury,  4Medical Affairs,   Diabetes, AstraZeneca, Luton, UKAbstract:  Continuously reducing excess blood glucose is a primary goal for the management  of type 2 diabetes (T2D).",Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
"1,2Correspondence: Chinnadorai Rajeswaran Department of Diabetes & Endocrinology, Mid Yorkshire NHS Trust, Dewsbury Hospital Halifax Road, Dewsbury WF13 4HS, UKEmail chinnadorai.rajeswaran@midyorks.nhs.ukJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Courtney et alRunning head recto: Long-term management of type 2 diabetes with GLP-1RAsDOI: http://dx.doi.org/10.2147/DMSO.S126763",Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 87 Long-term management of type 2 diabetes with GLP-1RAs 26.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
Available from: http://www.fda.gov/down-loads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071627.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02465515?term= NCT02465515&r ank=1.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01144338?term= NCT01144338&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01394952.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/dmso-10-079.PMC5357070.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1b/9d/bctt-9-163.PMC5357071.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1b/9d/bctt-9-163.PMC5357071.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 163–169Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 163 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S126124 Knowledge, attitudes and behaviors of primary  health care nurses and midwives in breast cancer  early diagnosis applications Aliye Bulut1  Aziz Bulut2 1Department of Nursing, Higher  School of Health, Bingol University,   2Department of General Surgery,   Bingol State Hospital, Bingol, T urkeyPurpose: The purpose of this research was to analyze the knowledge, attitudes and behaviors  of the nurses and midwives about the early diagnosis of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/1b/9d/bctt-9-163.PMC5357071.pdf
"3,4Correspondence: Aliye Bulut Department of Nursing, Higher School of Health, Bingol University, Selahaddin-i Eyyubi Mah, Aydınlık Cad 1, 12000 Bingol, TurkeyTel +90 505 817 3113Email aliyedemirok@yahoo.comJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Bulut and BulutRunning head recto: Nurses and midwives in the breast cancer early diagnosis applicationsDOI: http://dx.doi.org/10.2147/BCTT.S126124",Non-OADS,/arxiv_data1/oa_pdf/1b/9d/bctt-9-163.PMC5357071.pdf
Available from: http://www.turkcancer.org.php.,Non-OADS,/arxiv_data1/oa_pdf/1b/9d/bctt-9-163.PMC5357071.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/1b/9d/bctt-9-163.PMC5357071.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 169 Nurses and midwives in the breast cancer early diagnosis applications  12.,Non-OADS,/arxiv_data1/oa_pdf/1b/9d/bctt-9-163.PMC5357071.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 141–152Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 141 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S81712 Mastectomy skin flap necrosis: challenges   and solutions Stuart A Robertson1  Johann A Jeevaratnam2  Avi Agrawal2  Ramsey I Cutress3,4 1Department of Surgery, University  Hospital Coventry and Warwickshire  NHS Trust, Coventry, 2Department of  Breast Surgery, Portsmouth Hospitals NHS Trust, Cosham, Portsmouth,   3Department of Breast Surgery,   University Hospital Southampton NHS Foundation Trust, Princess Anne Hospital,  4Somers Cancer Research  UK Centre, Southampton General Hospital Southampton, UKIntroduction: Mastectomy skin flap necrosis (MSFN) has a reported incidence of 5%–30%  in the literature.",Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
"3–10 Numerous factors may contribute to this high rate, Correspondence: Stuart A Robertson   Department of Surgery, University  Hospital Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry CV2 2DX, UK   Email stuart.robertson@uhcw.nhs.ukJournal name: Breast Cancer - Targets and Therapy Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Robertson et alRunning head recto: Mastectomy skin flap necrosisDOI: http://dx.doi.org/10.2147/BCTT.S81712",Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
"More light may be shed upon the possibility of delay to adjuvant therapy following immediate breast reconstruction, when the results from the National UK Immediate Breast Reconstruction and Adjuvant Therapy Audit (iBRA-2) are published (http://ibrastudy.com/iBRA2.php).",Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
"However, there is still rela-tively little high-quality evidence comparing the benefits and complication rates of these new procedures, and so the UK Implant Breast Reconstruction evAluation (iBRA) study is currently prospectively investigating and evaluating these outcomes (http://ibrastudy.com/Home.php).Articles identified from literature search n=329 Included articles n=37Excluded articles (not relevant to aims of review) n=292 Total number of articles included n=106Additional articles (from references or citations known to authors) n=69 Figure 3 A flow diagram showing selection of articles for review.",Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
Available from: http://www.wmciu.nhs.uk/documents/Second ABCR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 152 Robertson et al  79.,Non-OADS,/arxiv_data1/oa_pdf/77/30/bctt-9-141.PMC5357072.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/52/cb/dddt-11-733.PMC5357073.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 733–746Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  733Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12532 3 risk assessment and experimental design in the  development of a prolonged release drug delivery  system with paliperidone sonia iurian luana T urdean ioan T omuta Department of Pharmaceutical  T echnology and Biopharmacy,   University of Medicine and Pharmacy  Iuliu Haţieganu, Cluj-Napoca, RomaniaAbstract:  This study focuses on the development of a drug product based on a risk assessment- based approach, within the quality by design paradigm.",Non-OADS,/arxiv_data1/oa_pdf/52/cb/dddt-11-733.PMC5357073.pdf
"Novel concepts, taken up  by the regulatory agencies, require the “built-in” quality of a drug product, through  a scientifically proven, quality by design approach, which is meant to predict and  control all sources of errors.2–4 From the development stage of a new formulation, a complete quality target product  profile (QTPP) should be established, with the desired characteristics of the product and  the critical quality attributes (CQAs) that have to be monitored in the intermediate and  final stages of the preparation procedure.5 Risk assessment analysis involves one or more  of the following tools: Ishikawa diagrams, failure mode effects analysis (FMEA), and  hazard analysis and critical control points (HACCPs), and it is supposed to identify and  rank the critical process parameters (CPPs).6 Usually, the variables that have an impact  on CQAs are interconnected; therefore, their study using design of experiments (DoEs) correspondence: ioan Tomuta Department of Pharmaceutical  Technology and Biopharmacy,  University of Medicine and Pharmacy  Iuliu Haţieganu, 41 Victor Babes,  400012 Cluj-Napoca, Romania Tel +40 264 595770 Fax +40 264 595770 email tomutaioan@umfcluj.r o Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Iurian et al Running head recto: Development of a prolonged release drug delivery system with paliperidone DOI: http://dx.doi.org/10.2147/DDDT.S125323",Non-OADS,/arxiv_data1/oa_pdf/52/cb/dddt-11-733.PMC5357073.pdf
"Available from: http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/default.ht m.  Accessed October 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/52/cb/dddt-11-733.PMC5357073.pdf
"Available from: http://www.fda.gov/cder/guidance/index.ht m.  Accessed October 8, 2016.",OADS,/arxiv_data1/oa_pdf/52/cb/dddt-11-733.PMC5357073.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/52/cb/dddt-11-733.PMC5357073.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/cb/dddt-11-733.PMC5357073.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/65/copd-12-849.PMC5357074.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 849–857International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  849OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13042 8 Is cardiac autonomic modulation during upper  limb isometric contraction and Valsalva maneuver  impaired in COPD patients?",Non-OADS,/arxiv_data1/oa_pdf/33/65/copd-12-849.PMC5357074.pdf
"Correspondence: andréa lúcia  gonçalves da silva rua Vereador Benno Kist, 1780/15,  Bairro santo Inácio, santa Cruz do  sul, rs, CeP 96820-688, Brazil Tel +55 51 3717 7374 email andreag@unisc.b r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Goulart et al Running head recto: Cardiac autonomic modulation during IC and VM in COPD DOI: http://dx.doi.org/10.2147/COPD.S130428",Non-OADS,/arxiv_data1/oa_pdf/33/65/copd-12-849.PMC5357074.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/33/65/copd-12-849.PMC5357074.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/65/copd-12-849.PMC5357074.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/11/ijn-12-1969.PMC5357075.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1969–1983International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1969OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12757 5 humanized cD7 nanobody-based immunotoxins  exhibit promising anti-T -cell acute lymphoblastic  leukemia potential Yuan Yu1–3 Jialu li1–3 Xuejun Zhu4 Xiaowen Tang2,5 Yangyi Bao6 Xiang sun6 Yuhui huang1,2 Fang Tian4 Xiaomei liu1,2 lin Yang1–3 1The cyrus Tang hematology center,  2collaborative Innovation center  of hematology, soochow University,  3suzhou cancer Immunotherapy and  Diagnosis engineering center, suzhou,  4central laboratory, Department of  hematology, The affiliated hospital  of Nanjing University of chinese  Medicine, Jiangsu Province hospital  of Traditional chinese Medicine,  Nanjing, 5Department of hematology,  The First affiliated hospital of  soochow University, suzhou,  6Department of hematology-Oncology,  The First People’s hospital of hefei,  hefei, People’s republic of chinaBackground:  Nanobodies, named as VHHs (variable domain of heavy chain of HCAb [heavy- chain antibodies]), are derived from heavy-chain-only antibodies that circulate in sera of camelids.",Non-OADS,/arxiv_data1/oa_pdf/90/11/ijn-12-1969.PMC5357075.pdf
"Keywords:  CD7, humanized nanobody, T-cell acute lymphoblastic leukemia, patient-derived  xenograft model, recombinant immunotoxins,  Pseudomonas exotoxin A Introduction T-cell acute lymphoblastic leukemia (T-ALL) is a highly invasive type of blood cancer  that clinically presents primarily as infection, fever, anemia, or abnormal bleeding correspondence: lin Yang The cyrus Tang hematology center,  soochow University, 199 ren’ai road,  sIP, suzhou, Jiangsu 215123, People’s  republic of china Tel +86 512 6588 0877 Fax +86 512 6588 1544 email yanglin@suda.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Yu et al Running head recto: Humanized CD7 nanobody-based immunotoxins for treating T-cell ALL DOI: http://dx.doi.org/10.2147/IJN.S127575",Non-OADS,/arxiv_data1/oa_pdf/90/11/ijn-12-1969.PMC5357075.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/90/11/ijn-12-1969.PMC5357075.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/11/ijn-12-1969.PMC5357075.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f3/68/ov-6-031.PMC5357077.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f3/68/ov-6-031.PMC5357077.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Oncolytic Virotherapy 2017:6 31–38Oncolytic Virotherapy Dovepress submit your manuscript | www.dovepress.com Dovepress  31 Original research open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OV.S127179curative effect of hF10 on liver and peritoneal  metastasis mediated by host antitumor immunity Y oshihiro hotta1 hideki Kasuya2 itzel Bustos2 Y oshinori naoe2 T oru ichinose2 Maki Tanaka3 Yasuhiro Kodera1 1Department of surgery ii, 2cancer  immune Therapy research center,   nagoya University graduate school  of Medicine, nagoya, 3Takara Bio inc.,   Otsu, JapanBackground: HF10 is a highly attenuated type 1 herpes simplex virus (HSV) with proven  effective oncolytic effect.",Non-OADS,/arxiv_data1/oa_pdf/f3/68/ov-6-031.PMC5357077.pdf
"Many studies have investigated correspondence: hideki Kasuya cancer immune Therapy research center, nagoya University graduate school of Medicine, 65 Tsurumai-cho, showa-ku, nagoya 466 8550, JapanTel +81 52 744 2507email kasuya@med.nagoya-u.ac.jpJournal name: Oncolytic Virotherapy Article Designation: Original ResearchY ear: 2017V olume: 6Running head verso: Hotta et alRunning head recto: Curative effect of HF10 on liver and peritoneal metastasisDOI: http://dx.doi.org/10.2147/OV .S127179",Non-OADS,/arxiv_data1/oa_pdf/f3/68/ov-6-031.PMC5357077.pdf
"Oncolytic Virotherapy 2017:6submit your manuscript | www.dovepress.com Dovepress Dovepress Oncolytic Virotherapy Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/oncolytic-virotherapy-journalOncolytic Virotherapy is an international, peer-reviewed, open access online journal  publishing original research, study protocols, reviews, editorials and commentaries   on all aspects of oncolytic virology, namely the application of oncolytic viruses for   the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/f3/68/ov-6-031.PMC5357077.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 38 hotta et al  7.,Non-OADS,/arxiv_data1/oa_pdf/f3/68/ov-6-031.PMC5357077.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/04/ijn-12-1959.PMC5357078.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1959–1968International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1959OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13090 8 Surface-modified gatifloxacin nanoparticles with  potential for treating central nervous system  tuberculosis Patricia Marcianes1 Sofia Negro1,2 luis garcía-garcía3 consuelo Montejo4 emilia Barcia1,2 ana Fernández-carballido1,2 1Department of Pharmaceutics, School  of Pharmacy, University Complutense  of Madrid, Madrid, spain; 2Institute of  Pharmaceutical T echnology, University  complutense of Madrid, Madrid,   spain; 3Multidisciplinary Institute of  Cerebral Cartography, University  complutense of Madrid, Madrid, spain;   4Department of Pharmaceutical and  Health Sciences, School of Pharmacy,   University CEU-San Pablo, SpainAbstract:  A new nanocarrier is developed for the passage of gatifloxacin through the  blood–brain barrier to treat central nervous system tuberculosis.",Non-OADS,/arxiv_data1/oa_pdf/00/04/ijn-12-1959.PMC5357078.pdf
"Therefore, the BBB protects the brain from Correspondence: Sofia Negro Departamento de Farmacia y Tecnología  Farmacéutica, Facultad de Farmacia,  Universidad Complutense de Madrid,  Plaza Ramón y Cajal, Madrid 28040, Spain Tel +34 91 394 1741 Fax +34 91 394 1736 email soneal@ucm.e s Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Marcianes et al Running head recto: Gatifloxacin NPs for CNS tuberculosis DOI: http://dx.doi.org/10.2147/IJN.S130908",Non-OADS,/arxiv_data1/oa_pdf/00/04/ijn-12-1959.PMC5357078.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/00/04/ijn-12-1959.PMC5357078.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/04/ijn-12-1959.PMC5357078.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/83/dddt-11-747.PMC5357079.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 747–757Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  747Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11455 2 Spotlight on blisibimod and its potential in the  treatment of systemic lupus erythematosus:  evidence to date Aleksander Lenert1 Timothy B Niewold2 Petar Lenert3 1Division of Rheumatology,   University of Kentucky, Kentucky  Clinic, Lexington, KY, 2Division of  Rheumatology and Department of  immunology, Mayo Clinic, Rochester,   MN, 3Division of immunology,   Department of internal Medicine, The  University of iowa, iowa City, iA, USAAbstract:  B cells in general and BAFF (B cell activating factor of the tumor necrosis factor  [TNF] family) in particular have been primary targets of recent clinical trials in systemic lupus  erythematosus (SLE).",Non-OADS,/arxiv_data1/oa_pdf/3c/83/dddt-11-747.PMC5357079.pdf
"A similar effect was also  observed in another lupus strain, NZM 2328, where absence of B cells completely  protected mice from development of lupus.3 Subsequently, elegant experiments have  shown that the requirement for B cells goes beyond their role as precursors of antibody- secreting cells and likely reflects their ability to serve as (auto)antigen-presenting cells.4 Correspondence: Aleksander Lenert Division of Rheumatology, University  of Kentucky, Kentucky Clinic, J507,  740 South Limestone St, Lexington,  KY 40536-0284, USA email aleks.lenert@uky.ed uJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Lenert et al Running head recto: Blisibimod for the treatment of SLE DOI: http://dx.doi.org/10.2147/DDDT.S114552",Non-OADS,/arxiv_data1/oa_pdf/3c/83/dddt-11-747.PMC5357079.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3c/83/dddt-11-747.PMC5357079.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/83/dddt-11-747.PMC5357079.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e2/4a/ijn-12-1985.PMC5357082.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1985–1999International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1985OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12552 1 The complex of P aMaM-Oh dendrimer with  angiotensin (1–7) prevented the disuse-induced  skeletal muscle atrophy in mice Valeria Márquez-Miranda1,2,* Johanna abrigo3,4,* Juan carlos rivera3,4 Ingrid araya-Durán1 Javier aravena3,4 Felipe simon3,4 Nicolás Pacheco1 Fernando Danilo   gonzález-Nilo1,2,5 claudio cabello-Verrugio3,4 1center for Bioinformatics and  Integrative Biology ( cBIB), Facultad  de ciencias Biologicas, Universidad  andres Bello, santiago, 2Fundación  Fraunhofer chile research, las  condes, 3Departamento de ciencias  Biologicas, Facultad de ciencias  Biologicas & Facultad de Medicina,   Universidad andres Bello, 4Millennium  Institute on Immunology and  Immunotherapy, santiago, 5centro  Interdisciplinario de Neurociencia  de Valparaíso, Facultad de ciencias,   Universidad de Valparaíso, Valparaíso,   chile *These authors contributed equally  to this workAbstract:  Angiotensin (1–7) (Ang-(1–7)) is a bioactive heptapeptide with a short half-life  and has beneficial effects in several tissues – among them, skeletal muscle – by prevent - ing muscle atrophy.",Non-OADS,/arxiv_data1/oa_pdf/e2/4a/ijn-12-1985.PMC5357082.pdf
"Indeed, different poly(amidoamine) (PAMAM) dendrimer terminal groups are involved, correspondence: Fernando Danilo  gonzález-Nilo Facultad de ciencias Biologicas, center  for Bioinformatics and Integrative  Biology (cBIB), Universidad andres  Bello, avenida republica 239,  santiago 8370146, chile email fernando.gonzalez@unab.c l  claudio cabello-Verrugio Departamento de ciencias Biologicas,  Facultad de ciencias Biologicas,  Universidad andres Bello, avenida  república 239, santiago 8370146, chile email claudio.cabello@unab.c l Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Márquez-Miranda et al Running head recto: Anti-atrophic effect of Ang-(1-7)/PAMAM-OH complex in skeletal muscle DOI: http://dx.doi.org/10.2147/IJN.S125521",Non-OADS,/arxiv_data1/oa_pdf/e2/4a/ijn-12-1985.PMC5357082.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e2/4a/ijn-12-1985.PMC5357082.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/4a/ijn-12-1985.PMC5357082.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.05.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/ba/1f/main.PMC5357086.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 4 e6,Non-OADS,/arxiv_data1/oa_pdf/ba/1f/main.PMC5357086.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.08.001 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/c2/f5/main.PMC5357087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 22 e24,Non-OADS,/arxiv_data1/oa_pdf/c2/f5/main.PMC5357087.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 332 –336 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.07.006 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/03/33/main.PMC5357088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/33/main.PMC5357088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/33/main.PMC5357088.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.09.004 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/99/de/main.PMC5357089.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 25 e28,Non-OADS,/arxiv_data1/oa_pdf/99/de/main.PMC5357089.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 337 –345 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.07.004 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
http://dx.doi.org/10.1016/j.arabjc.2014.07.002 .,OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
http://dx.doi.org/ 10.1016/j.jscs.2015.06.008 .,OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
http://dx.doi.org/10.1016/j.arabjc.2015.,OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
http://dx.doi.org/10.1016/j.arabjc.2015.,OADS,/arxiv_data1/oa_pdf/e0/20/main.PMC5357090.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.11.001 2452-2473/Copyright ©2017 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/11/8f/main.PMC5357091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 29 e31,Non-OADS,/arxiv_data1/oa_pdf/11/8f/main.PMC5357091.pdf
2016;16(2):60 e64.http://dx.doi.org/ 10.1016/j.tjem.2016.04.001 .,OADS,/arxiv_data1/oa_pdf/2b/e1/main.PMC5357092.pdf
http://dx.doi.org/10.1016/j.jor.2015.10.005 .,OADS,/arxiv_data1/oa_pdf/2b/e1/main.PMC5357092.pdf
http://dx.doi.org/10.1177/0363546507304719 .,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/main.PMC5357092.pdf
http://dx.doi.org/10.1007/s00167-015-3980-2 .,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/main.PMC5357092.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM Turkish Journal of Emergency Medicine 17 (2017) 34 http://dx.doi.org/10.1016/j.tjem.2016.11.006 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/main.PMC5357092.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/main.PMC5357092.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/ff/main.PMC5357093.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 370 –375 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.001 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/ff/main.PMC5357093.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/ff/main.PMC5357093.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.09.006 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/d5/5c/main.PMC5357094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 7 e11,Non-OADS,/arxiv_data1/oa_pdf/d5/5c/main.PMC5357094.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 443 –447 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.012 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/10.2135/cropsci2007.09.0519 .,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/10.1111/j.1472-765X.2008.02486.x .,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/10.1007/s13205- 013-0130-8 .,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/10.1166/ jbn.2007.022 .,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
"10, 691–695.http://dx.doi.org/10.1007/s11051-007-9288-5 .Jasim, B., Geethu, P.R., Mathew, J., Radhakrishnan, E.K., 2015.",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
"71, 1– 11.http://dx.doi.org/10.1007/s10725-013-9802-y .",Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/10.3390/molecules161210631 .,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
"150, 5–22.http://dx.doi.org/10.1016/j.envpol.2007.06.006 .",OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/10.1007/s00436-012-2924-8 .,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/10.1007/s12010-012- 9759-8 .,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
http://dx.doi.org/ 10.1016/j.jphotobiol.2015.04.034 .,OADS,/arxiv_data1/oa_pdf/bf/8d/main.PMC5357095.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 413 –418 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.005 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/da/04/main.PMC5357096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/04/main.PMC5357096.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/04/main.PMC5357096.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 381 –386 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.010 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b0/ef/main.PMC5357097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/ef/main.PMC5357097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/ef/main.PMC5357097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/a4/main.PMC5357098.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 376 –380 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.003 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/a4/main.PMC5357098.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/a4/main.PMC5357098.pdf
"International HapMap Consortium 2002–2010, < http://hapmap.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/67/a4/main.PMC5357098.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 387 –396 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.10.008 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bd/cd/main.PMC5357099.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/cd/main.PMC5357099.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/cd/main.PMC5357099.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/e9/main.PMC5357100.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 346 –358 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.07.003 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/21/e9/main.PMC5357100.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/e9/main.PMC5357100.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.06.002 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/57/05/main.PMC5357101.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/57/05/main.PMC5357101.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 299 –305 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.008 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
"The online reporting form is available through this Web site, https://ade.sfda.gov.",OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://who-umc.org/graphics/24355.pdf > (accessed 27/03/2014)’.304 T.M.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
"22–27, September 2014 <http://www.capm.ma/ Doc/Workshop/RAPV/Saudi%20Arabia%20PV%20centre.pdf> (accessed 02/10/2014).",Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://old.sfda.gov.sa/en/about/Pages/ overview.aspx > (accessed 13/03/2015)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://old.sfda.gov.sa/en/about/ Pages/sectors.aspx > (accessed 13/03/2015)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://old.sfda.gov.sa/AR/ DRUG/ABOUT/SECTOR_DEPARTMENTS/NATIONAL_PHARMACOVIGILANCE_CENTER/Pages/default.aspx > (accessed 15/03/2015)’.Saudi Food and Drug Authority ’Reporting Forms.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://www.sfda.gov.sa/ar/drug/resources/ DocLib2/SaudiPharmacovigilanceGuidelineofRegisteredMedici-nes_2011.pdf > (accessed 14/03/2015)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
<http://old.sfda.gov.sa/ar/drug/circulations/Pages/Drug-circulars- 03082010.aspx > (accessed 01/07/2015)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://www.who-umc.org/DynPage.aspx?id= 98082&mn1=7347&mn2=7252&mn3=7322&mn4=7326 > (accessed 05/01/2016)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://www.who.int/medicines/areas/qual- ity_safety/safety_efﬁcacy/pharmvigi/en/ > (accessed 27/03/2014)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
< http://apps.who.int/ medicinedocs/en/d/Js4893e/8.html > (accessed 03/02/2014)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
Intro- duction to the WHOProgrammefor International Drug Monitoring.<http://www.who-umc.org/DynPage.aspx?id=98080&mn1=7347 &mn2=7252&mn3=7322&mn4=7324 > (accessed 5/01/2016)’.,Non-OADS,/arxiv_data1/oa_pdf/20/35/main.PMC5357102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/f8/main.PMC5357103.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 397 –403 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.007 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c0/f8/main.PMC5357103.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/f8/main.PMC5357103.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.09.007 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/49/4d/main.PMC5357104.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 12 e15,Non-OADS,/arxiv_data1/oa_pdf/49/4d/main.PMC5357104.pdf
"Inter-rater agreement was tested by multi-rater, multilevel Kappa test ( http://justus.randolph.name/kappa ).",OADS,/arxiv_data1/oa_pdf/49/4d/main.PMC5357104.pdf
ACGME Competencies: suggested best methods for evaluation ; 2000. http://www.acgme.org/Outcome/assess/ToolTable.pdf .,OADS,/arxiv_data1/oa_pdf/49/4d/main.PMC5357104.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/76/main.PMC5357105.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 440 –442 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.006 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/aa/76/main.PMC5357105.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/76/main.PMC5357105.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/main.PMC5357106.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 306 –318 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.009 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/main.PMC5357106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/main.PMC5357106.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.09.009 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 16 e21,Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/10.1111/acem.12625 .,Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/10.1001/ archinternmed.2011.2243 .,Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/ 10.1016/j.ajem.2009.03.019 .,OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/10.1016/j.ajem.2008.04.031 .,OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/10.1097/ PEC.0b013e31820d64f7 .,Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/10.1016/ j.jemermed.2009.03.026 .,OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/10.1542/peds.2013-0378 .,Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
http://dx.doi.org/10.1111/j.1539-6924.2008.01135.x .,Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
"http://dx.doi.org/10.1016/j.anne- mergmed.2013.12.025 , 136.e1-3 Epub 2014 Feb 13.Treatment/ procedure<1% 1% 2% 5% 10% 15% Fill in blank %Don't understand question8 Head CTJ.",Non-OADS,/arxiv_data1/oa_pdf/16/c3/main.PMC5357107.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 419 –439 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.013 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9a/be/main.PMC5357108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/be/main.PMC5357108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/be/main.PMC5357108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 404 –412 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.011 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/10.1016/j.jdds.2015.04.002 .,OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
"65 (1), 36–48.http://dx.doi.org/10.1016/j.addr.2012.09.037 .",OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/10.1016/S0022-2836(64)80115-7 .,OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
"95 (1), 23– 29.http://dx.doi.org/10.1016/So378-4274(98)00012-5 .",Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/10.2147/IJN.S38043 .,Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/ 10.5772/55290 (Chapter 4).,Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/10.3109/10717544.2012.727500 .,Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
"17, 57. http://dx.doi.org/10.1186/1423-0127-17-57 .",Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/10.1016/j.bcp.2010.01.023 .,OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/10.1602/ neurorx.2.1.99 .,Non-OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
http://dx.doi.org/ 10.3390/molecules16097880 .,OADS,/arxiv_data1/oa_pdf/10/8e/main.PMC5357109.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/b9/main.PMC5357110.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 359 –364 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.002 1319-0164 /C2112016 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/c8/b9/main.PMC5357110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/b9/main.PMC5357110.pdf
"Humana Press Inc.,Totowa, NJ (Accessed 23.07.2016) http://www.worthington-bio- chem.com/pcyp/assay.html .",Non-OADS,/arxiv_data1/oa_pdf/c8/b9/main.PMC5357110.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 319 –331 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.06.008 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6a/d8/main.PMC5357111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/main.PMC5357111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/d8/main.PMC5357111.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/fe/main.PMC5357112.pdf
"Production and hosting by ElsevierSaudi Pharmaceutical Journal (2017) 25, 365 –369 King Saud University Saudi Pharmaceutical Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.jsps.2016.09.004 1319-0164 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/35/fe/main.PMC5357112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/fe/main.PMC5357112.pdf
Contents lists available at ScienceDirect Turkish Journal of Emergency Medicine journal homepage: http://www.elsevier .com/locate/TJEM http://dx.doi.org/10.1016/j.tjem.2016.11.007 2452-2473/Copyright ©2016 The Emergency Medicine Association of Turkey.,Non-OADS,/arxiv_data1/oa_pdf/46/c4/main.PMC5357114.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Turkish Journal of Emergency Medicine 17 (2017) 32 e33,Non-OADS,/arxiv_data1/oa_pdf/46/c4/main.PMC5357114.pdf
"Raw reads were trimmed using SeqPrep (https://github.com/jstjohn/SeqPrep) and Sickle software (Joshi and Fass, 2011).",OADS,/arxiv_data1/oa_pdf/3d/02/apps.1600104.PMC5357120.pdf
Website https://github.com/najoshi/sickle [accessed 18 January 2017].,Non-OADS,/arxiv_data1/oa_pdf/3d/02/apps.1600104.PMC5357120.pdf
"(2015) for training of the ITS2 databases; these were then deposited on Figshare, along with the FASTA file described above (https://dx.doi.org/10.6084/m9.figshare.c.3466311).",OADS,/arxiv_data1/oa_pdf/34/a7/apps.1600110.PMC5357121.pdf
We have called this script ‘classify_reads_subsequent.pl’ and made it available from https://github.com/KarenBell/rbcL-dual-index-metabarcoding.,Non-OADS,/arxiv_data1/oa_pdf/34/a7/apps.1600110.PMC5357121.pdf
"Furthermore, many online data repositories, such as the International Nucleotide Sequences Database Collaboration (http://www.ncbi.nlm.nih.gov/genbank/collab), which incorpo-rates GenBank (Benson et al., 2015), the DNA Data Bank of Japan (DDBJ; Mashima et al., 2015), and the European Molecu-lar Biology Laboratory (EMBL) Nucleotide Sequence Database (Squizzato et al., 2015), do not require researchers submitting sequences to provide links to voucher specimens or raw se-quence data, and may include sequences with incorrect species identification or low-quality sequence data.",Non-OADS,/arxiv_data1/oa_pdf/34/a7/apps.1600110.PMC5357121.pdf
BOLD: The Barcode of  Life Data System (http://www.barcodinglife.org).,Non-OADS,/arxiv_data1/oa_pdf/34/a7/apps.1600110.PMC5357121.pdf
"Gaertn.Michael J. Moore 1789 (OC) Cultivated; purchased from Oasis   Nursery in Stillwater, OKCultivated Bio-Rad Unpublished a Herbaria codes are from Index Herbariorum (http://sweetgum.nybg.org/science/ih/).",Non-OADS,/arxiv_data1/oa_pdf/de/9f/apps.1600128.PMC5357122.pdf
"Based on these unigenes containing SSR loci, we successfully designed 273 pairs of primers using Primer3 (Rozen and Skaletsky, 1999; http://frodo.wi.mit.edu/primer3).",OADS,/arxiv_data1/oa_pdf/25/c2/apps.1600152.PMC5357124.pdf
Website http://dx.doi  .org/10.2305/IUCN.UK.2013-1.RLTS.T32351A2815809.en [accessed   15 January 2017].,Non-OADS,/arxiv_data1/oa_pdf/25/c2/apps.1600152.PMC5357124.pdf
Website https://sites.ualberta.ca/~fyeh/popgene.html [ac-cessed 10 February 2017].,Non-OADS,/arxiv_data1/oa_pdf/25/c2/apps.1600152.PMC5357124.pdf
d The unigenes containing microsatellite loci were searched against the SWISS-PROT database (http://www.expasy.ch/sprot/); — = not found.,OADS,/arxiv_data1/oa_pdf/32/f1/apps.1700001.PMC5357126.pdf
a V oucher and locality information are provided in Appendix 1.Website http://hannonlab.cshl.edu/fastx_toolkit [accessed 1 February  2017].,OADS,/arxiv_data1/oa_pdf/32/f1/apps.1700001.PMC5357126.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602164/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/5f/76/1602164.PMC5357127.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602312/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/5c/57/1602312.PMC5357130.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602093/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/3f/1602093.PMC5357131.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602285/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/7a/91/1602285.PMC5357132.pdf
"W. P. Irwin, “Geologic map of the Klamath Mountains, California and Oregon ” (Miscellaneous Investigations Series Map I-2148, U.S. Geological Survey, 1994); https://ngmdb.usgs.gov/Prodesc/proddesc_10149.htm.",Non-OADS,/arxiv_data1/oa_pdf/7a/91/1602285.PMC5357132.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cb/df/40265_2017_Article_712.PMC5357248.pdf
2013. http://www.worldgastroenterology.org/ assets/export/userﬁles/2013_FINAL_Common%20GI%20Symp toms%20_long.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cb/df/40265_2017_Article_712.PMC5357248.pdf
2011. http://www.fda.gov/Drugs/DrugSafety/ ucm245011.htm .,Non-OADS,/arxiv_data1/oa_pdf/cb/df/40265_2017_Article_712.PMC5357248.pdf
2013. http://www.fda.gov/ Drugs/DrugSafety/ucm290510.htm .,Non-OADS,/arxiv_data1/oa_pdf/cb/df/40265_2017_Article_712.PMC5357248.pdf
2011. http://www.fda.gov/Drugs/InformationOnDrugs/ ApprovedDrugs/ucm284421.htm .,Non-OADS,/arxiv_data1/oa_pdf/cb/df/40265_2017_Article_712.PMC5357248.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bc/76/40265_2017_Article_706.PMC5357258.pdf
2005. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/02177 3s9s11s18s22s25lbl.pdf .,OADS,/arxiv_data1/oa_pdf/bc/76/40265_2017_Article_706.PMC5357258.pdf
2010. https://www.accessdata.fda.gov/ drugsatfda_docs/label/2010/022341lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bc/76/40265_2017_Article_706.PMC5357258.pdf
2014. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/022200Orig1s008.pdf .,OADS,/arxiv_data1/oa_pdf/bc/76/40265_2017_Article_706.PMC5357258.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncom- mercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, pro-vide a link to the Creative Commons license, and indicate if changes weremade.",Non-OADS,/arxiv_data1/oa_pdf/37/6e/520_2017_Article_3635.PMC5357280.pdf
Available at: http://www.yearofcare.co.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/520_2017_Article_3635.PMC5357280.pdf
Available at: https://www.nice.org.uk/guidance/csg4 4.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/520_2017_Article_3635.PMC5357280.pdf
Available at:https://www.gov.uk/government /uploads/system/uploads/ attachment_data/file/228524/0097.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/37/6e/520_2017_Article_3635.PMC5357280.pdf
"Case report A 61-year-old, Caucasian male presented to an outpatient, multi- disciplinary neurological clinic with a diagnosis of ET of at least 9 years.The patient, a high school-educated retired army veteran, lived with his wife and four children in a multi-level home.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/4e/78/tre-07-448-7522-1.PMC5357321.pdf
"Difficulty with cervical and trunk disassociation were noted throughobservation of functional movements Abbreviation: VOR, Vestibulo-ocular Reflex.Ulanowski EA, Danzl MM, Sims KM Physical Therapy for ET and DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/4e/78/tre-07-448-7522-1.PMC5357321.pdf
"His presentation was consistent with characteristics of ET 3,4and prolonged DBS.29In addition, there were similarities of his presentation to those with cerebellar diseases.1,17,18,31–33Table 2.Outcome Measure Results Outcome Measure Pre-intervention 1 Month 2 Month Score Interpretation (MDC and MCID)Cut-off Scores for Risk of Falls Berg Balance Scale 44/56 53/56 56/56 Exceeded the MDC of 5 points for those with Parkinsonism2745/56 for community-dwellingadults with balance deficits 24 Functional GaitAssessment13/30 20/30 25/30 Exceeded the MDC of 6 points for vestibular disorders 2515/30 for those with Parkinson’sdisease 28 Five-Times-Sit-to-Stand18 seconds 18.5 seconds12.9 secondsExceeded the MCID of 2.3 seconds for vestibular disorders 2616 seconds for those withParkinson’s disease 30 10 meter walk test (self-selected)1.13 m/s 1.2 m/s 1.3 m/s Did not exceed the MDC of 0.18 m/s for those with Parkinsonism27N/A 10 meter walk test (fast speed)1.6 m/s Not Tested1.7 m/s Did not exceed the MDC of 0.25 m/s for those with Parkinsonism27N/A Abbreviations: m/s, Meters/Second; MCID, Minimally Clinically Important Difference; MDC, Minimal Detectable Change.Physical Therapy for ET and DBS Ulanowski EA, Danzl MM, Sims KM Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/4e/78/tre-07-448-7522-1.PMC5357321.pdf
"Table 3.Intervention Progression Treatment Session No.Gait Training Functional Training Balance Training Strengthening Miscellaneous 1 With a treadmill with verbal cues to increase heel strike,increase base of support, andfor foot clearanceSit to stand training 1Multidirectional stepping Scapular stabilization exercises in supineVestibulo-ocular reflex exercises (61/62)1 2 With a treadmill with verbal cues to increase base of support, to increase arm swing, to clear the footSit to stand training Multidirectional stepping with verbal cues: for direction change and to colored dots on floorScapular stabilization exercises in supine 3 With a treadmill with verbal cues to increase base ofsupport, to increase arm swing, to clear the footSingle limb stance with VMC (eyes open and eyes closed; onfoam)Discontinued scapular stabilization exercises due tolifting restriction; Four-way bilateral hip strengthening with resistance 1 4 Single limb stance on foam with trunk rotationFour-way bilateral hip strengthening with resistanceUpright stationary bicycle with verbal cues for upright posturein an unsupported position Stepping lunges to raised steps with simultaneous trunk rotation 5 Overground 1with verbal cues for intermittent changes indirection (forward, backward,right, left)Stepping over obstacles with changes of speedsFour-way bilateral hip strengthening with resistance 6 Overground Gait with obstacle training: stepping over and around objects, outdoor training,hills, ramps, and stairs withchanging speedsSingle limb stance with VMC (eyes open and eyes closed; on foam; trunk rotation)Weighted trunk rotation 7 With a treadmill with incline with verbal cues for upright postureSingle limb stance on foam with addition of head turns to integrate visual exercisesSquat training with upper extremity proprioceptive neuromuscular facilitation patterns (D1/D2) includingvisual tracking of the hand 8 With a treadmill with incline with verbal cues for upright postureSingle limb stance on foam with addition of head turns and vestibulo-ocular reflex exercisesSquat training with upper extremity proprioceptive neuromuscular facilitation patterns (D1/D2) includingvisual tracking of the handOutcome measures assessed per outpatient rehabilitation regulations of every 30-day re-assessmentUlanowski EA, Danzl MM, Sims KM Physical Therapy for ET and DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/4e/78/tre-07-448-7522-1.PMC5357321.pdf
"Table 3.Continued Treatment Session No.Gait Training Functional Training Balance Training Strengthening Miscellaneous 9 Overground with resistance bands with verbal cues forupright posture and controlled movementsGait and balance training through obstacle course trainingincorporating single limb stance, cross stepping, reactive stepping, changing speeds, and addingcomplex motor and cognitive tasksUpper extremity proprioceptive neuromuscularfacilitation patterns (D1/D2) including visual tracking of the hand while in quadruped andtall kneelingUpright stationary bicycle with cues for upright posture 10 Overground with resistance bands with verbal cues for upright posture and controlledmovementsStair training with the addition of complex motor tasks; verbal cues for bodyawareness and controlledmovementsGait and balance training through obstacle course training incorporating single limb stance,cross stepping, reactive stepping,changing speeds, and adding complex motor and cognitive tasksStatic balance training that included visual complexity (background changes, headturns, eyes open and eyes closed)Upper extremity proprioceptive neuromuscular facilitation patterns (D1/D2)including visual tracking of thehand while in quadruped and tall kneeling 11 With the treadmill, retro- ambulation with verbal cuesfor ‘‘toe–heel’’ and leaning forwardGait and balance training through obstacle course trainingincorporating single limb stance, cross stepping, reactive stepping, changing speeds, and addingcomplex motor and cognitive tasks Static balance training thatincluded visual complexity(background changes, head turns, eyes open and eyes closed)Upper extremity proprioceptive neuromuscularfacilitation patterns (D1/D2) including visual tracking of the hand while in quadruped andtall kneeling 12 With the treadmill, retro- ambulation with verbal cues for ‘‘toe–heel’’ and leaningforwardGait and balance training through obstacle course training incorporating single limb stance,cross stepping, reactive stepping,changing speeds, and adding complex motor and cognitive tasksStatic balance training that included visual complexity (background changes, headturns, eyes open and eyes closed)Upper extremity proprioceptive neuromuscular facilitation patterns (D1/D2)including visual tracking of thehand while in quadruped and tall kneelingPhysical Therapy for ET and DBS Ulanowski EA, Danzl MM, Sims KM Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/4e/78/tre-07-448-7522-1.PMC5357321.pdf
"Figure 1.Conceptual Model of the Physical Therapy Training .T h ep l a n of care that addressed proximal stabili ty, balance, and functional movements integrated principles of bo dy awareness training and visual motor coordination.Ulanowski EA, Danzl MM, Sims KM Physical Therapy for ET and DBS Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/4e/78/tre-07-448-7522-1.PMC5357321.pdf
"doi: 10.1016/j.apmr.2011.04.008Physical Therapy for ET and DBS Ulanowski EA, Danzl MM, Sims KM Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/4e/78/tre-07-448-7522-1.PMC5357321.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
2015. https://www.nice.org.uk/guidance/TA379/ documents/ﬁnal-appraisal-determination-document .,Non-OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
2013. https://www.nice.org.uk/guidance/ta282/ documents/idiopathic-pulmonary-ﬁbrosis-pirfenidone-ﬁnal-appraisal-determination-document2 .,Non-OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
2015. https://www.scottishmedicines.org.uk/ﬁles/ advice/nintedanib__Ofev__FINAL_September_2015_Amended_ 06.10.15_for_website.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ﬁle/260405/2012-13_national_schedule_of_ reference_costs.xls .,OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
http://www.medicines.org.uk/emc/medicine/30110 .,Non-OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ﬁle/215301/dh_131148.xls .,OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
London: National Insti- tute for Health and Care Excellence; 2013. https://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/bd/28/40273_2016_Article_480.PMC5357477.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/57/59/40273_2016_Article_477.PMC5357482.pdf
"For drug costs, the ofﬁcial prices in the ambulatory settingwere used, as published on the website of the Belgian Federal Institute for Sickness and Invalidity Insurance (http://www.riziv.fgov.be/ ).",Non-OADS,/arxiv_data1/oa_pdf/4d/19/40273_2016_Article_474.PMC5357483.pdf
"[ 36] 2005 study with a chart review of FN hospitalization costs in Belgium and the All Patient Reﬁned Diagnosis-Related Group (APR-DRG) 660 costs obtained from the ofﬁcial source ( http://www.tct.fgov.be ), both actualized to 2014 costs.",Non-OADS,/arxiv_data1/oa_pdf/4d/19/40273_2016_Article_474.PMC5357483.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4d/19/40273_2016_Article_474.PMC5357483.pdf
http://www.cijfersoverkanker.nl/p=57c73326adbaf .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/40273_2016_Article_474.PMC5357483.pdf
http://www.cijfersoverkanker.nl/p=57c87f8ee7324 .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/40273_2016_Article_474.PMC5357483.pdf
http://apps.who.int/gho/data/view.main.LT61950?lang=en .,OADS,/arxiv_data1/oa_pdf/4d/19/40273_2016_Article_474.PMC5357483.pdf
2012. https://kce.fgov.be/publication/report/belgian-guidelines-for- economic-evaluations-and-budget-impact-analyses-second-edi#.VuKmTﬂ97re .,Non-OADS,/arxiv_data1/oa_pdf/4d/19/40273_2016_Article_474.PMC5357483.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)CK2 controls γδthymocyte and T-ALL cell survival ST Ribeiro et al 1610 Leukemia (2017) 1603 –1610",Non-OADS,/arxiv_data1/oa_pdf/00/96/leu2016363a.PMC5357576.pdf
"http://e-jbm.org/   1Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Role of the Cytokine-like Hormone Leptin in Muscle- bone Crosstalk with Aging Mark W. Hamrick Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA The cytokine-like hormone leptin is a classic adipokine that is secreted by adipocytes, in - creases with weight gain, and decreases with weight loss.",Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
"CB2915,  Augusta, GA 30912, USA Tel: +1-706-721-1958 Fax: +1-706-721-6120 E-mail: mhamrick@augusta.edu Received:  December 9, 2016 Accepted:  December 20, 2016 No potential conflict of interest relevant to this  article was reported.Review ArticleJ Bone Metab 2017;24:1-8 https://doi.org/10.11005/jbm.2017.24.1.1 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
Mark W. Hamrick 2  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.1tures.,Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
Leptin in the Aging Muscle-bone Unit https://doi.org/10.11005/jbm.2017.24.1.1  http://e-jbm.org/   3NAs such as miR-31 and miR-223.,Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
"Mark W. Hamrick 4  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.1ceptor impairs bone formation, whereas restoring direct  leptin signaling by transplanting cells expressing the leptin  receptor enhances bone formation.",Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
"Leptin in the Aging Muscle-bone Unit https://doi.org/10.11005/jbm.2017.24.1.1  http://e-jbm.org/   5DISCUSSION  Leptin secretion links food intake and energy reserves  with energy expenditure, growth, and reproduction.",Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
Mark W. Hamrick 6  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.1tions.,Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
Leptin in the Aging Muscle-bone Unit https://doi.org/10.11005/jbm.2017.24.1.1  http://e-jbm.org/   7bone mass by body weight.,Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
Mark W. Hamrick 8  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.1dent dementia.,Non-OADS,/arxiv_data1/oa_pdf/23/60/jbm-24-1.PMC5357607.pdf
"http://e-jbm.org/   15Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Coronary Artery Calcium Score and Bone  Metabolism: A Pilot Study in Postmenopausal  Women Pooneh Salari1, Abbasali Keshtkar2, Shapour Shirani3, Leila Mounesan4 1Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences, Tehran;   2Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran;   3Head of Imaging Center, Tehran Heart Center, Tehran University of Medical Sciences, Tehran;   4 Department of Epidemiology, Center for Academic and Health Policy, and Knowledge Utilization Research Center, Tehran University of  Medical Sciences, Tehran, Iran Background:  Since 1991 many studies evaluated the link between cardiovascular dis - eases and osteoporosis, two age-related conditions, but the main common pathologic  pathway has not been determined yet.",Non-OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
"Although at the first  glance osteoporosis and atherosclerosis seem to be independent, atherosclerotic  plaques and bone tissue have similarities and the process of vascular calcification Corresponding author Pooneh Salari Medical Ethics and History of Medicine  Research Center, Tehran University of Medical  Sciences, 23# 16 Azar Ave, Keshavarz Blvd,  Tehran, Iran Tel: +98-21-6641-9661 Fax: +98-21-6641-9661 E-mail: poonehsalari@gmail.com Received:  December 3, 2016 Revised:  December 25, 2016 Accepted:  December 28, 2016 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2017;24:15-21 https://doi.org/10.11005/jbm.2017.24.1.15 pISSN 2287-6375    eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
16  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.15is mediated by cells and mediators involved in bone for - mation.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
 Coronary Artery Calcium Score and Bone Metabolism https://doi.org/10.11005/jbm.2017.24.1.15  http://e-jbm.org/   17assessed by CRP Human ELISA Kit (ab99995) and Human  RANKL ELISA Kit from DLdevelop respectively.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
18  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.15The mean urine concentration of β cross laps was 0.51 ± 0.36.,OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
" Coronary Artery Calcium Score and Bone Metabolism https://doi.org/10.11005/jbm.2017.24.1.15  http://e-jbm.org/   19mained significant after adjustment for age, weight, BMI  and years since menopause.",Non-OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
20  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.15roles of inflammatory cytokines in osteoporosis and car - diovascular diseases as two common old people problem:  actions toward development of new drugs.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
 Coronary Artery Calcium Score and Bone Metabolism https://doi.org/10.11005/jbm.2017.24.1.15  http://e-jbm.org/   2193:2009-12.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/jbm-24-15.PMC5357608.pdf
"http://e-jbm.org/   23Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Effects of Escherichia Coli -derived Recombinant  Human Bone Morphogenetic Protein-2 Loaded  Porous Hydroxyaptite-based Ceramics on Calvarial  Defect in Rabbits Shin-Young Kim1,*, Youngkyun Lee2,3,*, Seung-Jun Seo4, Jae-Hong Lim5, Yong-Gun Kim1,3 1Department of Periodontology, School of Dentistry, Kyungpook National University, Daegu;   2Department of Biochemistry, School of Dentistry, Kyungpook National University, Daegu;   3Institute for Hard Tissue and Bone Regeneration (IHBR), Kyungpook National University, Daegu;   4Biomedical Engineering and Radiology, School of Medicine, Catholic University of Daegu, School of Medicine, Daegu;   5 Industrial Technology Convergence Center, Pohang Accelerator Laboratory, Pohang University of Science and Technology (POSTECH),  Pohang, Korea Background:  Recombinant human bone morphogenetic proteins (rhBMPs) have been  widely used in regenerative therapies to promote bone formation.",Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
* Shin-Young Kim and Youngkyun Lee contributed  equally to this work and should be considered   co-first authors.Original ArticleJ Bone Metab 2017;24:23-30 https://doi.org/10.11005/jbm.2017.24.1.23 pISSN 2287-6375 eISSN 2287-7029,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
24  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.23consisted of more than 20 proteins of multi-functional growth  factors that belong to transforming growth factor-beta  (TGF-β) superfamily.,OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
"RhBMP-2 Loaded HA Promote Osteogenesis https://doi.org/10.11005/jbm.2017.24.1.23  http://e-jbm.org/   25induced by intramuscular injection of zolazepam (0.2 mL/ kg; Zoletil, Virbac Korea, Seoul, Korea) and xylazine (0.25  mL/kg; Rompun, Bayer Korea Co., Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
26  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.23RESUL TS 1.,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
RhBMP-2 Loaded HA Promote Osteogenesis https://doi.org/10.11005/jbm.2017.24.1.23  http://e-jbm.org/   27ed tomography analysis (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
28  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.23Fig.,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
RhBMP-2 Loaded HA Promote Osteogenesis https://doi.org/10.11005/jbm.2017.24.1.23  http://e-jbm.org/   29is believed that adipogenesis was originated due to the  presence of rhBMP-2.,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
30  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.23150:893-9.,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/jbm-24-23.PMC5357609.pdf
"http://e-jbm.org/   31Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.The Association between Dehydroepiandrosterone  Sulfate (DHEA-S) and Bone Mineral Density in  Korean Men and Women Seung-Gun Park1, Sena Hwang2, Jong-Suk Kim3, Kyung-Chae Park1, Yuri Kwon1, Kyong-Chol Kim3 1Department of Family Medicine, Bundang CHA Medical Center, CHA University School of Medicine, Seoul;   2Department of Endocrinology Internal Medicine, Chaum Life Center, CHA University School of Medicine, Seoul;   3Anti-aging Center, Chaum Life Center, CHA University School of Medicine, Seoul, Korea Background:  The relationship between dehydroepiandrosterone sulfate (DHEA-S) and  bone mineral density (BMD) is controversial.",Non-OADS,/arxiv_data1/oa_pdf/56/cf/jbm-24-31.PMC5357610.pdf
"[3] Osteoporosis is defined on the basis of the assessment of bone mineral density  (BMD), which remains the single best predictor of primary osteoporotic fractures.Corresponding author Kyong-Chol Kim Anti-aging Center, Chaum Life Center, CHA  University School of Medicine, 442 Dosan- daero, Gangnam-gu, Seoul 06062, Korea  Tel: +82-2-3015-5000 Fax: +82-2-3015-5407 E-mail: joyks71@gmail.com Received:  January 12, 2017 Revised:  February 14, 2017 Accepted:  February 16, 2017 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2017;24:31-36 https://doi.org/10.11005/jbm.2017.24.1.31 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/56/cf/jbm-24-31.PMC5357610.pdf
"32  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.31[4] BMD decreases with age, and this age-related decline  has been shown to be associated with factors such as race,  genetics, hormones, lifestyle, and medication.",Non-OADS,/arxiv_data1/oa_pdf/56/cf/jbm-24-31.PMC5357610.pdf
"DHEA-S is Positively Correlated with BMD https://doi.org/10.11005/jbm.2017.24.1.31  http://e-jbm.org/   33Using Pearson’s correlation, we measured the strength of  the correlation between DHEA-S and BMD at the various  skeletal sites.",OADS,/arxiv_data1/oa_pdf/56/cf/jbm-24-31.PMC5357610.pdf
34  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.31chanter even after adjusting for other variables.,Non-OADS,/arxiv_data1/oa_pdf/56/cf/jbm-24-31.PMC5357610.pdf
DHEA-S is Positively Correlated with BMD https://doi.org/10.11005/jbm.2017.24.1.31  http://e-jbm.org/   35promotes alkaline phosphatase activity and collagen I syn - thesis.,OADS,/arxiv_data1/oa_pdf/56/cf/jbm-24-31.PMC5357610.pdf
"36  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.31tures, and primary prevention of fractures in high-risk groups.",Non-OADS,/arxiv_data1/oa_pdf/56/cf/jbm-24-31.PMC5357610.pdf
"http://e-jbm.org/   37Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.The Efficacy of Bisphosphonates for Prevention of  Osteoporotic Fracture: An Update Meta-analysis Ji-Hye Byun1,*, Sunmee Jang1,*, Sumin Lee1, Suyeon Park1, Hyun Koo Yoon2, Byung-Ho Yoon3,**, Yong-Chan Ha4,** 1College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon;   2Department of Internal Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul;  3Department of Orthopaedic Surgery, Inje University College of Medicine, Seoul Paik Hospital, Seoul;   4Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea Background:  The efficacy of bisphosphonates for osteoporotic fracture has been consis - tently reported in recent randomized controlled trials (RCTs) enrolling hundreds of pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
** Byung-Ho Yoon and Yong-Chan Ha contributed  equally to this work and should be considered   co-corresponding authors.Original ArticleJ Bone Metab 2017;24:37-49 https://doi.org/10.11005/jbm.2017.24.1.37 pISSN 2287-6375 eISSN 2287-7029,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
38  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.37porotic fracture prevention.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
Update Review of Bisphosphonate Efficacy https://doi.org/10.11005/jbm.2017.24.1.37  http://e-jbm.org/   39RESUL TS 1.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
40  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.37density-increasing effects in postmenopausal women.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
Update Review of Bisphosphonate Efficacy https://doi.org/10.11005/jbm.2017.24.1.37  http://e-jbm.org/   41Fig.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
42  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.37Fig.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
Update Review of Bisphosphonate Efficacy https://doi.org/10.11005/jbm.2017.24.1.37  http://e-jbm.org/   43the efficacy of bisphosphonate in patients with osteoporo - sis.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
"44  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.37cebo-controlled, double-blind, multicenter study.",Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
Update Review of Bisphosphonate Efficacy https://doi.org/10.11005/jbm.2017.24.1.37  http://e-jbm.org/   45Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
46  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.37Appendix 2.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
Update Review of Bisphosphonate Efficacy https://doi.org/10.11005/jbm.2017.24.1.37  http://e-jbm.org/   47II.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
"48  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.37Queries Search #23 ""Hydroxyethylidene Diphosphonic Acid""[tw] OR ""Diphosphonic Acid, Hydroxyethylidene""[tw] OR ""(1-hydroxyethylene)diphosphonic  acid""[tw] OR ""Didronel""[tw] OR ""Xidifon""[tw] OR ""Xydiphone""[tw] OR ""Xidiphon""[tw] OR ""Etidronate Disodium""[tw] OR ""Phosphonic  acid, (1-hydroxyethylidene)bis-, disodium salt""[tw] OR ""Disodium Etidronate""[tw] OR ""Etidronate, Disodium""[tw] OR ""Disodium  1-Hydroxyethylene Diphosphonate""[tw] OR ""1-Hydroxyethylene Diphosphonate, Disodium""[tw] OR ""Diphosphonate, Disodium  1-Hydroxyethylene""[tw] OR ""Disodium 1 Hydroxyethylene Diphosphonate""[tw] OR ""HEDSPA""[tw] OR ""Sodium Etidronate""[tw]  OR ""Etidronate, Sodium""[tw] OR ""Etidronate, Tetrapotassium Salt""[tw] OR ""Salt Etidronate, Tetrapotassium""[tw] OR ""Tetrapotas - sium Salt Etidronate""[tw] OR ""(1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt""[tw] OR ""Dicalcium Etidronate""[tw] OR  ""Etidronate, Dicalcium""[tw] OR ""Dicalcium EHDP""[tw] OR ""EHDP , Dicalcium""[tw] OR ""Etdronate""[tw] OR ""1-Hydroxyethane-1,1- Diphosphonate""[tw] OR ""1 Hydroxyethane 1,1 Diphosphonate""[tw] OR ""1-Hydroxyethylidene-1,1-Bisphosphonate""[tw] OR ""1  Hydroxyethylidene 1,1 Bisphosphonate""[tw] OR ""Hydroxyethanediphosphonate""[tw] OR ""Ethanehydroxydiphosphonate""[tw] OR  ""Ethanehydroxyphosphate""[tw] OR ""HEDP""[tw] OR ""1,1-hydroxyethylenediphosphonate""[tw] OR ""1,1 hydroxyethylenediphosphonate ""[tw] OR ""EHDP""[tw] 1,074 #24 search (#21 OR #22 OR #23) 3,403 #25 ""minodronate""[tw] 66 #26 ""YM529""[tw] OR ""ONO-5920""[tw] OR ""YM-529""[tw] OR ""Phosphonic acid, (1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis""[tw]  OR ""YH 529""[tw] OR ""YH529""[tw] OR ""YH-529""[tw] OR ""(1-hydroxy-2-(imidazo(1,2-a)-pyridin-3-yl)ethylidene)bisphosphonic acid  monohydrate""[tw] OR ""[tw] OR ""minodronate""[tw] OR ""minodronic acid hydrate""[tw] OR ""1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl) ethane-1,1-bisphosphonic acid monohydrate""[tw]0 #27 minodronate[MeSH] 0  #28 search (#25 OR #26 OR #27) 66 #29 ""pamidronate""[tw] 2,861 #30 pamidronate[MeSH] 0 #31 ""(3-amino-1-hydroxypropylidene)-1,1-bisphosphonate""[tw] OR ""1-hydroxy-3-aminopropane-1,1-diphosphonic acid""[tw] OR  ""APD""[tw] OR ""AHPrBP""[tw] OR ""aminohydroxypropylidene diphosphonate""[tw] OR ""aminopropanehydroxydiphosphonate"" [tw] OR ""amidronate""[tw] OR ""(3-amino-1-hydroxypropylidene)-1,1-biphosphonate""[tw] OR ""amino-1-hydroxypropane-1,1- diphosphonate""[tw] OR ""pamidronate monosodium""[tw] OR ""pamidronate disodium""[tw] OR ""Aredia""[tw] OR ""Novartis brand of  pamidronate disodium salt""[tw] OR ""pamidronate calcium""[tw] 4,508 #32 search (#29 OR #30 OR #31) 6,965 #33 ""tiludronate""[tw] 133 #34 tiludronate[MeSH] 0 #35 ""(4-chlorophenyl)thiomethylene bisphosphonic acid""[tw] OR ""Cl2SMBP""[tw] OR ""tiludronate""[tw] OR ""(chloro-4-phenyl)thiomethylene  biphosphonate""[tw] OR ""(chloro-4-phenyl)thiomethylene bisphosphonate""[tw] OR ""tiludronate disodium""[tw] OR ""Skelid""[tw] 137 #36 search (#33 OR #34 OR #35) 137 #37 osteoporosis[tw] 7,1974 #38 ""osteoporosis""[MeSH] 49,047 #39 ""Osteoporoses""[tw] OR ""Osteoporosis, Post-Traumatic""[tw] OR ""Osteoporosis, Post Traumatic""[tw] OR ""Post-Traumatic  Osteoporoses""[tw] OR ""Post-Traumatic Osteoporosis""[tw] OR ""Osteoporosis, Senile""[tw] OR ""Osteoporoses, Senile""[tw] OR ""Senile  Osteoporoses""[tw] OR ""Senile Osteoporosis""[tw] OR ""Osteoporosis, Involutional""[tw] OR ""Osteoporosis, Age-Related""[tw] OR ""Os - teoporosis, Age Related""[tw] OR ""Bone Loss, Age-Related""[tw] OR ""Age-Related Bone Loss""[tw] OR ""Age-Related Bone Losses""[tw]  OR ""Bone Loss, Age Related""[tw] OR ""Bone Losses, Age-Related""[tw] OR ""Age-Related Osteoporosis""[tw] OR ""Age Related  Osteoporosis""[tw] OR ""Age-Related Osteoporoses""[tw] OR ""Osteoporoses, Age-Related""[tw] 1,220 #40 search (#37 OR #38 OR #39) 72,232 #41 “fracture”[tw] 166,072 #42 fracture[MeSH] 160,391 #43 ""Broken Bones""[tw] OR ""Bone, Broken""[tw] OR ""Bones, Broken""[tw] OR ""Broken Bone""[tw] OR ""Bone Fractures""[tw] OR ""Bone  Fracture""[tw] OR ""Fracture, Bone""[tw] 63,905 #44 search (#41 OR #42 OR #43) 228,415 #45 search (#4 OR #8 OR #12 OR #16 OR #20 OR #24 OR #28 OR #32 OR #36) 12,670 #46 search (#40 AND #44 AND #45) 2,703 #47 Search Filters: Clinical Trial; Full-text; Publication dates From 2014/01/01 to 2016/11/20; English, Korean; 36  (Continued)  PubMed (November 20, 2016)",Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
"Update Review of Bisphosphonate Efficacy https://doi.org/10.11005/jbm.2017.24.1.37  http://e-jbm.org/   49Cochrane Library (November 20, 2016) – 56 articles Queries Search #1 alendronate 1,097 #2 ""Aminohydroxybutane Bisphosphonate"" OR ""Bisphosphonate, Aminohydroxybutane"" OR ""4-Amino-1-Hydroxybutylidene  1,1-Biphosphonate"" OR ""4 Amino 1 Hydroxybutylidene 1,1 biphosphonate"" OR ""Alendronate Sodium"" OR ""Sodium, Alen - dronate"" OR ""Alendronate Monosodium Salt, Trihydrate"" OR ""Fosamax"" OR ""MK-217"" OR ""MK 217"" OR ""MK217""101 #3 search (#1 OR #2) 1,098 #4 risedronate 481 #5 ""Sodium, Risedronate"" OR ""2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate"" OR ""1-Hydroxy-2-(3-pyridyl)ethylidene  diphosphonate"" OR ""2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate"" OR ""Risedronic Acid, Monosodium Salt"" OR  ""Risedronate"" OR ""Bisphosphate Risedronate Sodium"" OR ""Risedronate Sodium, Bisphosphate"" OR ""Sodium, Bisphosphate  Risedronate"" OR ""Risedronic Acid"" OR ""Acid, Risedronic"" OR ""Actonel"" OR ""Atelvia"" 526 #6 search (#4 OR #5) 526 #7 ibandronate 312 #8 ""Bondronat"" OR ""Bonviva"" OR ""ibandronic acid, sodium salt, monohydrate"" OR ""RPR 102289A"" OR ""RPR-102289A"" OR  ""Boniva"" OR ""BM 21.0955"" OR ""BM-21.0955"" OR ""BM-210955"" OR ""BM 210955"" OR ""ibandronate"" OR ""(1-hydroxy- 3-(methylpentylamino)propylidene)bisphosphonate"" OR ""1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate""314 #9 search (#7 OR #8) 314 #10 search (#3 OR #6 OR #9) 1678 #11 MeSH descriptor: [Osteoporosis] explode all trees 3,468 #12 MeSH descriptor: [Bone disease, Metabolic] this term only (SINGLE MESH TERM) 312 #13 MeSH descriptor: [Bone density, Metabolic] this term only 0(BONE DENISTY ,  4306) #14 search (#11 OR #12 OR #13) 5,793 #15 MeSH descriptor: [Colles' Fractures] this term only 86 #16 MeSH descriptor: [Hip Fractures] explode all trees 1,269 #17 MeSH descriptor: [spinal Fractures] this term only 717 #18 MeSH descriptor: [Fractures, Bone] this term only 1,329 #19 MeSH descriptor: [Lumbar Vertebrae] this term only 2,469 #20 search (#15 OR #16 OR #17 OR #18 OR #19) 5,466 #21 search (#10 AND #14 AND #20) Publication year from 2014 to 2016, in Trials 56",Non-OADS,/arxiv_data1/oa_pdf/36/c5/jbm-24-37.PMC5357611.pdf
"http://e-jbm.org/   51Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Association of Serum 25-hydroxy-vitamin D  Concentration and Arterial Stiffness among Korean  Adults in Single Center Jung Hae Lee, Heuy Sun Suh Department of Family Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Korea Background:  There are growing concerns about the role of vitamin D deficiency in car - diovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
"The fourth Korean National Corresponding author Heuy Sun Suh Department of Family Medicine, Gachon  University Gil Hospital, 21 Namdong-daero,  774 beon-gil, Namdong-gu, Incheon 21565,  Korea Tel: +82 32-460-2735 Fax: +82 32-460-3354 E-mail: fmeye@hanmail.net Received:  January 31, 2017 Revised:  February 11, 2017 Accepted:  February 12, 2017 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2017;24:51-58 https://doi.org/10.11005/jbm.2017.24.1.51 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
52  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.51Health and Nutrition Examination Survey (KNHANES V-1  and 2) reported a particularly high prevalence of vitamin D  deficiency (25-hydroxy-vitamin D [25(OH)D] <20 ng/mL)  in up to 60% of Koreans aged ≥10 years (65.9% of males  and 77.7% of females).,Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
25(OH)D and BaPWV https://doi.org/10.11005/jbm.2017.24.1.51  http://e-jbm.org/   53Information about any previous diagnoses of hyperten - sion (HTN) and diabetes mellitus (DM) were obtained throu- gh health interviews.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
54  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.51in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
"25(OH)D and BaPWV https://doi.org/10.11005/jbm.2017.24.1.51  http://e-jbm.org/   55able (F =19.049, P<0.001) and all variance inflation factors  of independent variables were under 10.",OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
"56  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.51decreasing amount of time spent outdoors, the number of  vitamin D deficient people is increasing.",Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
25(OH)D and BaPWV https://doi.org/10.11005/jbm.2017.24.1.51  http://e-jbm.org/   572014;6:1503-11.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
58  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.5142.,Non-OADS,/arxiv_data1/oa_pdf/96/0c/jbm-24-51.PMC5357612.pdf
"http://e-jbm.org/   59Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Characteristics of Patients Diagnosed with  Osteoporosis in South Korea: Results from the  National Claim Registry Hyun Koo Yoon1, Young-Kyun Lee2,*, Yong-Chan Ha3,* 1Department of Internal Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul;  2Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam;   3Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea  Background:  Although osteoporosis is increasing medical issue in the elderly popula - tion, attempts to analyze the characteristics of patients diagnosed with osteoporosis are  rare in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/97/f8/jbm-24-59.PMC5357613.pdf
* Young-Kyun Lee and Yong-Chan Ha contributed  equally to this work and should be considered   co-corresponding authors.Original ArticleJ Bone Metab 2017;24:59-63 https://doi.org/10.11005/jbm.2017.24.1.59 pISSN 2287-6375 eISSN 2287-7029,Non-OADS,/arxiv_data1/oa_pdf/97/f8/jbm-24-59.PMC5357613.pdf
60  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.59pen.,Non-OADS,/arxiv_data1/oa_pdf/97/f8/jbm-24-59.PMC5357613.pdf
Characteristics of Patients with OP in Korea https://doi.org/10.11005/jbm.2017.24.1.59  http://e-jbm.org/   61used type of medical institute and department for 12 months  after the index date.,Non-OADS,/arxiv_data1/oa_pdf/97/f8/jbm-24-59.PMC5357613.pdf
"62  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.592010, the number of real patients with osteoporosis could  be estimated to be around 3,373,758 in Korean population  of 50 years and older, by using the total number of men  and women over the age of 50 in the Korean population.",Non-OADS,/arxiv_data1/oa_pdf/97/f8/jbm-24-59.PMC5357613.pdf
Characteristics of Patients with OP in Korea https://doi.org/10.11005/jbm.2017.24.1.59  http://e-jbm.org/   63time risk of osteoporosis-related fractures in Korea.,Non-OADS,/arxiv_data1/oa_pdf/97/f8/jbm-24-59.PMC5357613.pdf
"http://e-jbm.org/   65Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Current Role and Application of Teriparatide in  Fracture Healing of Osteoporotic Patients:   A Systematic Review Sang-Min Kim1, Kyung-Chung Kang2, Ji Wan Kim3, Seung-Jae Lim4, Myung Hoon Hahn5 1Department of Orthopaedic Surgery, Seoul Medical Center, Seoul;   2Department of Orthopaedic Surgery, Kyung Hee University Hospital, Kyung Hee University, Seoul;   3Department of Orthopedic Surgery, Haeundae Paik Hospital, Inje University College of Medicine, Busan;   4Department of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul;   5 Department of Orthopaedics, Cheil General Hospital and Women’s Healthcare Center, Dankook University College of Medicine, Cheonan,  Korea Background:  The use of osteoanabolic agents to facilitate fracture healing has been of  heightened interest to the field of orthopaedic trauma.",Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
"[2,4-10] Findings from these studies have demonstrated significant in -Corresponding author Myung Hoon Hahn Department of Orthopaedics, Cheil General  Hospital and Women’s Healthcare Center,  Dankook University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu, Seoul 04619,  Korea Tel: +82-2-2000-7278 Fax: +82-2-2000-7896 E-mail: mhhahn@unitel.co.kr  Received:  February 9, 2017 Revised:  February 23, 2017 Accepted:  February 24, 2017 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2017;24:65-73 https://doi.org/10.11005/jbm.2017.24.1.65 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
66  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.65crease of lumbar spine and femoral neck BMD and a lower  risk of vertebral and non-vertebral fractures both in post - menopausal women and men.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
TPTD in Fracture Healing of Osteoporotic Patients https://doi.org/10.11005/jbm.2017.24.1.65  http://e-jbm.org/   67Fig.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
"68  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.65aratide (20 µg) and the placebo groups (7.4 weeks vs. 9.1  weeks, P=0.01), but not different between the teriparatide  (40 µg) and the placebo groups (8.8 weeks vs. 9.1 weeks,  P=0.52).",Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
"TPTD in Fracture Healing of Osteoporotic Patients https://doi.org/10.11005/jbm.2017.24.1.65  http://e-jbm.org/   69tween the groups in fractures of neck of the femur, proxi - mal humerus, and distal radius.",Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
70  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.65and hand (DASH) and grip strength revealed no differenc - es in fractures of proximal humerus and distal radius after  teriparatide injection.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
TPTD in Fracture Healing of Osteoporotic Patients https://doi.org/10.11005/jbm.2017.24.1.65  http://e-jbm.org/   71and 1 retrospective post hoc subgroup analysis.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
72  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.65fracture risk reduction determined by quantitative and  qualitative radiographic assessment.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
Available from: https://www.nice.org.uk/ guidance/CG146 28.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
TPTD in Fracture Healing of Osteoporotic Patients https://doi.org/10.11005/jbm.2017.24.1.65  http://e-jbm.org/   73ing in proximal humerus fractures.,Non-OADS,/arxiv_data1/oa_pdf/b6/3f/jbm-24-65.PMC5357614.pdf
"http://e-jbm.org/   9Copyright © 2017 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.Association between Sarcopenic Obesity and  Metabolic Syndrome in Postmenopausal Women:   A Cross-sectional Study Based on the Korean  National Health and Nutritional Examination  Surveys from 2008 to 2011 Sun-Young Kang, Gyeong Eun Lim, Yang Keun Kim, Hye Won Kim, Kayoung Lee, Tae-Jin Park, Jinseung Kim Department of Family Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea Background:  Menopause contributes to an increase in visceral fat mass and a decrease  in muscle protein synthesis.",Non-OADS,/arxiv_data1/oa_pdf/87/d3/jbm-24-9.PMC5357615.pdf
"[2] Although there are a number of risk factors, such as age, obesity, smok -Corresponding author Jinseung Kim Department of Family Medicine, Busan Paik  Hospital, Inje University College of Medicine,  75 Bokji-ro, Busanjin-gu, Busan 47392, Korea Tel: +82-51-890-6729 Fax: +82-51-894-7554 E-mail:  jinseungkim@inje.ac.kr,   jinseungkim@hanmail.net Received:  November 3, 2016 Revised:  January 18, 2017 Accepted:  January 21, 2017 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2017;24:9-14 https://doi.org/10.11005/jbm.2017.24.1.9 pISSN 2287-6375 eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/87/d3/jbm-24-9.PMC5357615.pdf
"10  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.9ing, dietary habits, and exercise, that affect MS as a predic - tor of cardiovascular disease, low skeletal muscle mass re - lated to a high prevalence of cardiovascular disease emerged  as a spotlighted factor among them.",Non-OADS,/arxiv_data1/oa_pdf/87/d3/jbm-24-9.PMC5357615.pdf
Association between SO and MS https://doi.org/10.11005/jbm.2017.24.1.9  http://e-jbm.org/   11dard error.,OADS,/arxiv_data1/oa_pdf/87/d3/jbm-24-9.PMC5357615.pdf
12  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.9Table 3.,Non-OADS,/arxiv_data1/oa_pdf/87/d3/jbm-24-9.PMC5357615.pdf
Association between SO and MS https://doi.org/10.11005/jbm.2017.24.1.9  http://e-jbm.org/   13CI 4.49-6.90).,Non-OADS,/arxiv_data1/oa_pdf/87/d3/jbm-24-9.PMC5357615.pdf
14  http://e-jbm.org/  https://doi.org/10.11005/jbm.2017.24.1.9tors in postmenopausal women.,Non-OADS,/arxiv_data1/oa_pdf/87/d3/jbm-24-9.PMC5357615.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/ Volume 78  |  N umber 1  |  July 2015       Pediatric ReSeARCH 43",Non-OADS,/arxiv_data1/oa_pdf/6a/0f/pr201557a.PMC5357619.pdf
http://dx.doi.org/10.1016/j.redox.2017.02.025 Received 31 January 2017; Received in revised form 27 February 2017; Accepted 28 February 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/4b/74/main.PMC5357672.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/74/main.PMC5357672.pdf
"The free radicals and the reactive oxygen or nitrogen species (ROS and RNS, respectively), which are produced by mitochondria, but especially in diﬀerent metabolic processes, are necessary for the destruction of http://dx.doi.org/10.1016/j.redox.2017.03.005 Received 22 December 2016; Received in revised form 9 February 2017; Accepted 6 March 2017⁎Correspondence to: Department of Animal Physiology II, Faculty of Biology, Complutense University of Madrid, C/José Antonio Novais, 12, 28040 Madrid, Spain .",Non-OADS,/arxiv_data1/oa_pdf/7d/e1/main.PMC5357673.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7d/e1/main.PMC5357673.pdf
"Measurements of lipofuscin load were made with the open sourceImageJ (National Institute of Health, http://rsb.info.nih.gov/ij ).",OADS,/arxiv_data1/oa_pdf/7d/e1/main.PMC5357673.pdf
2 (2016) 16018. http://dx.doi.org/10.1038/npjamd.2016.18 .,OADS,/arxiv_data1/oa_pdf/7d/e1/main.PMC5357673.pdf
http://dx.doi.org/ 10.1155/2016/8172706 .,Non-OADS,/arxiv_data1/oa_pdf/7d/e1/main.PMC5357673.pdf
(2016) 8675905. http://dx.doi.org/10.1155/2016/8675905 .,Non-OADS,/arxiv_data1/oa_pdf/7d/e1/main.PMC5357673.pdf
http://dx.doi.org/10.18632/aging.101116 .C.,Non-OADS,/arxiv_data1/oa_pdf/7d/e1/main.PMC5357673.pdf
http://dx.doi.org/10.1016/j.redox.2017.02.003 Received 21 December 2016; Received in revised form 1 February 2017; Accepted 5 February 2017⁎Correspondence to: Dept.,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
Available at: 〈http://www.who.int/mediacentre/ factsheets/fs311/en/ 〉.,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
27 (3) (2012) 833– 864. http://dx.doi.org/10.3305/nh.2012.27.3.5680 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.3310/hta13410 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/ 10.1002/14651858.CD003641.pub4 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
824 (2014) 5 –17.http://dx.doi.org/10.1007/978-3-319-07320-0_2 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
3 (1) (2014) 6 –13.http://dx.doi.org/ 10.5409/wjcp.v3.i1.6 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
16 (1) (2014) 378– 400. http://dx.doi.org/10.3390/ijms16010378 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
18 (4) (1997) 232– 243. http://dx.doi.org/10.1002/ (SICI)1098-2744(199704)18:4 < 232::AID-MC7 > 3.0.CO;2-F .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
711 (1 –2) (2011) 13 –27.http://dx.doi.org/10.1016/j.mrfmmm.2011.03.006 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
"[15] Y. Kuchino, F. Mori, H. Kasai, H. Inoue, S. Iwai, K. Miura, et al., Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modi ﬁed base and at adjacent residues, Nature 327 (1987) 77 –79.http://dx.doi.org/10.1038/ 327077a0 .",OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.1038/349431a0 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
32 (2) (2013) 172– 178. http://dx.doi.org/10.1016/j.clnu.2012.08.002 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
771 (2014) 30 –36.http://dx.doi.org/10.1016/j.mrgentox.2014.06.006 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
233 (2006) 28 –35.http://dx.doi.org/10.1016/j.canlet.2005.02.036 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.3390/ijms14023467 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
56 (1) (2013) 47 –57.http://dx.doi.org/10.1503/ cjs.036111 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
A 24 (9) (2014)593– 600. http://dx.doi.org/10.1089/lap.2013.0584 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
161 (1) (2013) 50 –56.http://dx.doi.org/10.1016/ j.trsl.2012.09.002 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/ 10.1111/j.1749-6632.2010.05875.x .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.3390/ ijms12053117.,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
216 (2) (2013) 252– 257. http://dx.doi.org/10.1016/j.jamcoll- surg.2012.10.003 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.1007/s11605-010-1249-0 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
57 (3) (2014) 183– 187. http://dx.doi.org/ 10.1503/cjs.008113 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
21 (6) (2011) 763– 767. http://dx.doi.org/10.1007/s11695-010-0347-0 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
889 (2012) 325– 346. http://dx.doi.org/10.1007/978-1-61779-867-2_21 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
18 (4) (1995) 747– 755. http://dx.doi.org/10.1016/0891- 5849(94)00200-4 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
158 (4) (2011) 628– 633. http://dx.doi.org/10.1016/j.jpeds.2010.09.081 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.1089/ ars.2012.5107 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.1089/ars.2012.4714 .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/ 10.1155/2014/686392.,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
34 (2013) 3293. http://dx.doi.org/10.1007/s13277- 013-1038-y .,Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
http://dx.doi.org/10.1056/NEJMoa1200303 .,OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
"Özer, Reduced antioxidant capacity and increased subclinical in ﬂammation markers in prepubescent obese children and their relationship with nutritional markers and metabolic parameters, Redox Rep.21 (6) (2016) 271– 280. http://dx.doi.org/10.1080/13510002.2015.1133035 .L.",Non-OADS,/arxiv_data1/oa_pdf/17/df/main.PMC5357674.pdf
"Disruption of these http://dx.doi.org/10.1016/j.redox.2017.02.023 Received 25 January 2017; Accepted 27 February 2017⁎Correspondence to: Department of Physiology, University of Tennessee HSC, 71 S. Manassas Street, Memphis, TN 38163, USA.",Non-OADS,/arxiv_data1/oa_pdf/29/15/main.PMC5357675.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/29/15/main.PMC5357675.pdf
"E-mail address: michael.egan@merck.com http://dx.doi.org/10.1016/j.dadm.2017.02.004 2352-8729/ /C2112017 Merck Sharp & Dohme Corp., Luminex Corporation, Philip Scheltens, Charlotte E. Teunissen, James Burke, S. Lance Macaulay, Geir Br/C23athen, Sigrid Botne Sando, Linda R., White, David G. Darby, Stephanie R. Rainey-mith.",Non-OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5357677.pdf
Published by Elsevier Inc. on behalf of Alzheimer’s Associatio n. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5357677.pdf
Published by Elsevier Inc. on behalf of Alzheimer’s Association.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5357677.pdf
"Finally, given the robust performance char-acteristics of this measure, these results support widespreaduse of tau/A b42 in clinical settings, including an ongoing phase III trial of a beta-site APP-cleaving enzyme (BACE)inhibitor in a prodromal AD population ( clinicaltrials.gov https://clinicaltrials.gov/ct2/show/NCT01953601 ).",Non-OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5357677.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2017.02.004 .,OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5357677.pdf
http://dx.doi.org/10.1016/j.redox.2017.03.013 Received 3 February 2017; Received in revised form 6 March 2017; Accepted 9 March 2017⁎Corresponding authors.,OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC5357678.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC5357678.pdf
http://dx.doi.org/10.1016/j.bbacli.2017.03.002 2214-6474/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/29/0b/main.PMC5357680.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/0b/main.PMC5357680.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BALFBiomarkers Mass spectrometry PlasmaProteomicsELISA 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/7a/main.PMC5357681.pdf
http://dx.doi.org/10.1016/j.bbacli.2017.03.001 2214-6474/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/7a/main.PMC5357681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/7a/main.PMC5357681.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Structural MRIBrain injury Cortical thickness RadiotherapySurface-based morphometry 1.,Non-OADS,/arxiv_data1/oa_pdf/10/dd/main.PMC5357686.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.025 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/10/dd/main.PMC5357686.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/dd/main.PMC5357686.pdf
"Data preprocessing Cortical thickness was estimated with FreeSurfer package (version 5.3.0, http://surfer.nmr.mgh.harvard.edu ), a set of automated programs used for cortical surface reconstruction and thickness measurement (Dale, et al., 1999; Fischl, et al., 1999 ).",OADS,/arxiv_data1/oa_pdf/10/dd/main.PMC5357686.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2017.02.007 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
http://dx.doi.org/10.1016/j.ygyno.2014.02.017 .,OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
"http://dx.doi.org/ 10.1016/j.ygyno.2015.02.003 .Ray-Coquard, I., Favier, L., Weber, B., Roemer-Becuwe, C., Bougnoux, P., Fabbro, M., Floquet, A., Joly, F., Plantade, A., Paraiso, D., Pujade-Lauraine, E., 2013.",OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
http://dx.doi.org/10.1038/bjc.,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
http://dx.doi.org/10.18632/oncotarget.1799 .,OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
http://dx.doi.org/ 10.1158/1078-0432.CCR-13-0615 .,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
http://dx.doi.org/10.1038/nbt.2696 .,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
http://dx.doi.org/10.1200/JCO.2011.36.1196 .,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
2. http://dx.doi.org/10.1186/s40661-015- 0013-2 .66 J.A.,Non-OADS,/arxiv_data1/oa_pdf/b5/31/main.PMC5357688.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/d6/main.PMC5357689.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2017.02.009 2352-5789/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/f7/d6/main.PMC5357689.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/d6/main.PMC5357689.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Public health Zika virusZIKVTravel plansPublic perceptions 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/main.PMC5357690.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.0232211-3355/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/main.PMC5357690.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/main.PMC5357690.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/main.PMC5357690.pdf
Downloaded at http://www2.unwto.org/content/why-tourism .170 N.J.O.,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/main.PMC5357690.pdf
http://dx.doi.org/10.1016/j.gore.2017.02.010 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/18/main.PMC5357691.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).endothelial dysfunction.1The combination of these factors is hypothe- sized to lead to disruption of the blood-brain barrier and vasogenic edema.,Non-OADS,/arxiv_data1/oa_pdf/d3/18/main.PMC5357691.pdf
http://dx.doi.org/10.1016/S1474-4422(08)70060-7 .,OADS,/arxiv_data1/oa_pdf/d3/18/main.PMC5357691.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Diffusion tensor imagingStrokeMotor Rehabilitation 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5357692.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.023 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5357692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5357692.pdf
Stroke lesion location The stroke lesion was outlined manually on the T1 structural image in MRIcron ( http://www.mccauslandcenter.sc.edu/mricro/mricon ) using the T2-FLAIR image as a guide in each participant's native space.,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5357692.pdf
"This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Atrophy Behavioral variant frontotemporal dementiaDiagnostic criteriaFrontotemporal lobar degenerationMRIPattern classi ﬁcationNeuroImage: Clinical 14 (2017) 656 –662 Abbreviations: bvFTD, behavioral variant frontotemporal dementia; FTLD, frontotemporal lobar degeneration; FEW, family wise error; GMD, gray matter density; MN I, Montreal Neurological Institute; MPRAGE, magnetization-prepared rapid gradient echo; MRI, magnetic resonance imaging; SVM, support vector machine; VBM, voxel based morphometry.",Non-OADS,/arxiv_data1/oa_pdf/d8/ef/main.PMC5357695.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.001 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/ef/main.PMC5357695.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/ef/main.PMC5357695.pdf
"The data was retrieved from the German FTLD Consortium, a prospective multicenter study on FTLD ( http://www.ftld.de ;Otto et al., 2011 ).",OADS,/arxiv_data1/oa_pdf/d8/ef/main.PMC5357695.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: CerebellumDiffusion tensor imagingFunctional connectivityPsychosis risk Longitudinal Neuroimaging 1.,Non-OADS,/arxiv_data1/oa_pdf/de/fe/main.PMC5357699.pdf
http://dx.doi.org/10.1016/j.nicl.2017.03.001 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/fe/main.PMC5357699.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/fe/main.PMC5357699.pdf
"All fcMRI data were pre-processed using FSL (v.5.0.7; http://fsl.fmrib.ox.ac.uk/fsl ), and analysis was performed in the CONN toolbox version 15.a ( Whit ﬁeld-Gabrieli and Nieto Castañón, 2012 ) implemented with SPM 12 (Wellcome Trust Centre for Neuroimaging).",OADS,/arxiv_data1/oa_pdf/de/fe/main.PMC5357699.pdf
wide excision or vulvectomy with or without reconstruction) and (ii) procedures to Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2017.03.003 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/3b/main.PMC5357701.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/3b/main.PMC5357701.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Antidepressant Bipolar disorder Major depressive disorder (MDD)Near-infrared spectroscopy (NIRS)Schizophrenia 1.,Non-OADS,/arxiv_data1/oa_pdf/18/de/main.PMC5357702.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.008 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/18/de/main.PMC5357702.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/de/main.PMC5357702.pdf
De ﬁned daily dose calculation The Anatomical Therapeutic Chemical (ATC) classi ﬁ cation system and de ﬁned daily dose (DDD) as a measuring unit are recommended by the World Health Organization (WHO) for drug utilization studies (http://www.whocc.no/atc_ddd_index/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/de/main.PMC5357702.pdf
http://www.who.int/ mediacentre/factsheets/fs369/en/ .,Non-OADS,/arxiv_data1/oa_pdf/18/de/main.PMC5357702.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DTINeonatesTemplateTractographyCNR SNR Tensor registrationTensor rotationWrapped ﬁbers Fiber tracking 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1016/j.nicl.2016.12.029 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1002/1522- 2594(200010)44:4 b625::AID-MRM17 N3.0.CO;2-O (URL: http://dx.doi.org/10.1002/ 1522-2594(200010)44:4 b625::AID-MRM17 N3.0.CO;2-O).,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
doi.org/10.1097/01.chi.0000246064.93200.e8 b/doiN(URL: http://dx.doi.org/ 10.1097/01.chi.0000246064.93200.e8 b/urlN).,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1073/pnas.96.18.10422 (arXiv: http://www.,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2106-10.,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1016/j.jpeds.2009.12.030 (URL: http://dx.doi.org/ 10.1016/j.jpeds.2009.12.030 ).,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1109/TMI.2007.899173 .,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
(URL: http://gcgh.grandchallenge s.org/Explorations/Topics/ Pages/BrainDevelopmentandGestationalAge_Round14.aspx ).,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
NeuroImage 33:27 –38.http://dx.doi.org/ 10.1016/j.neuroimage.2006.06.009 (URL: www.elsevier.com/locate/ynimg ).,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1016/j.siny.2006.07.006 .,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1006/nimg.2002.1132 .,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1002/hbm.10102 (URL: http://dx.doi.org/10.1002/hbm.10102 ).,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
neuroimage.2010.02.066 (URL: http://dx.doi.org/10.1016/j.neuroimage.2010.02.066 ).,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1016/j.pscychresns.2010.04.013 (URL: http://www.,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0796-09.2009 (URL: http:// www.jneurosci.org/content/29/48/15089.abstract ,a r X i v : http://www.jneurosci.org/ content/29/48/15089.full.pdf+html ).",Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
(URL: http://www.marchofdimes.com/ peristats/ ).,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1038/nn0310-275 .,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
1016/j.ejrad.2005.11.020 (URL: http://www.sciencedirect.com/science/article/pii/ S0720048X05003852 ).,OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
"http://dx.doi.org/10.3174/ajnr.A1957 (URL: http:// www.ajnr.org/content/31/5/894.abstract ,a r X i v : http://www.ajnr.org/content/31/5/ 894.full.pdf+html ).",Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
"http://dx.doi.org/10.1002/(SICI)1522-2594(199912)42: 6b1123::AID-MRM17 N3.0.CO;2-H (URL: http://dx.doi.org/10.1002/(SICI)1522- 2594(199912)42:6 b1123::AID-MRM17 N3.0.CO;2-H).Yeo, B., Vercauteren, T., Fillard, P., Peyrat, J.M., Pennec, X., Golland, P., Ayache, N., Clatz, O., 2009.",Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
http://dx.doi.org/10.1109/TMI.2007.,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
Imaging:903524 http://dx.doi.org/10.1117/12.2043943 .,Non-OADS,/arxiv_data1/oa_pdf/9d/41/main.PMC5357703.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Anticonvulsants Drug hypersensitivity syndrome PseudolymphomaEosinophilia 1.,Non-OADS,/arxiv_data1/oa_pdf/83/a3/main.PMC5357739.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.12.004 2213-3232/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/83/a3/main.PMC5357739.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/a3/main.PMC5357739.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Laser thermoablationTemporal lobe epilepsyVisual ﬁeld de ﬁcits 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/71/main.PMC5357740.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.12.005 2213-3232/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/71/main.PMC5357740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/71/main.PMC5357740.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HemimegalencephalyPeri-insular functional hemispherotomy Hemispherectomy Postoperative hydrocephalusShunt overdrainage 1.,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC5357741.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.12.003 2213-3232/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC5357741.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC5357741.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Anti-NMDA receptor encephalitis Abnormal movements Video-EEG 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/7a/main.PMC5357742.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.12.002 2213-3232/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/7a/main.PMC5357742.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/7a/main.PMC5357742.pdf
[cited 2016 Oct 7 Available from: http://eeg.sagepub.com/lookup/doi/10.,OADS,/arxiv_data1/oa_pdf/3e/7a/main.PMC5357742.pdf
"185© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Heterotopic Ossification in the Gallbladder Jihyun Ahn · Sunyoung Kim · Kangseung Kim1 · Seogjoon Kim2 Departments of Pathology, 1General Surgery, and 2Radiology, Dongkang Medical Center, Ulsan, KoreaJournal of Pathology and Translational Medicine 2017; 51: 185-186 https://doi.org/10.4132/jptm.2016.03.10▒ BRIEF CASE REPORT ▒ Heterotopic ossification is a common pathologic process in  cases of atherosclerotic plaques, traumatic injury, severe burns,  some carcinomas, and benign neoplasms.1 However, heterotopic  ossification is extremely rare in the gallbladder.",Non-OADS,/arxiv_data1/oa_pdf/c2/fb/jptm-2016-03-10.PMC5357748.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.03.10186     •  Ahn J, et al.",OADS,/arxiv_data1/oa_pdf/c2/fb/jptm-2016-03-10.PMC5357748.pdf
"159© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 A Pyloric Gland-Phenotype Ovarian Mucinous Tumor Resembling   Lobular Endocervical Glandular Hyperplasia   in a Patient with Peutz-Jeghers Syndrome Eun Na Kim · Gu-Hwan Kim1  Jiyoon Kim · In Ah Park  Jin Ho Shin · Yun Chai  Kyu-Rae Kim Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul;  1Department of Medical Genetics, Asan Medical  Center Children’s Hospital, Seoul, KoreaWe describe an ovarian mucinous neoplasm that histologically resembles lobular endocervical  glandular hyperplasia (LEGH) containing pyloric gland type mucin in a patient with Peutz-Jeghers  syndrome (PJS).",Non-OADS,/arxiv_data1/oa_pdf/ee/38/jptm-2016-07-01.PMC5357749.pdf
"Key Words:  Pyloric gland type; Lobular endocervical glandular hyperplasia; Mucinous; Ovary; Peutz- Jeghers syndromeReceived:  April 6, 2016 Revised:  June 27, 2016 Accepted:  July 1, 2016 Corresponding Author Kyu-Rae Kim, MD Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea  Tel: +82-2-3010-4514 Fax: +82-2-472-7898 E-mail: krkim@amc.seoul.kr Journal of Pathology and Translational Medicine 2017; 51: 159-164 https://doi.org/10.4132/jptm.2016.07.01▒ CASE STUDY ▒ Peutz-Jeghers syndrome (PJS) is an autosomal dominant he - reditary disorder characterized by hamartomatous polyposis of  the gastrointestinal tract and mucocutaneous pigmentation  around the lips.",Non-OADS,/arxiv_data1/oa_pdf/ee/38/jptm-2016-07-01.PMC5357749.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.01160     •  Kim EN, et al.",OADS,/arxiv_data1/oa_pdf/ee/38/jptm-2016-07-01.PMC5357749.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.01Pyloric Gland Type Ovarian Mucinous Tumor   •     161 surgery due to intussusception of the small bowel of unknown  cause.,Non-OADS,/arxiv_data1/oa_pdf/ee/38/jptm-2016-07-01.PMC5357749.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.01162     •  Kim EN, et al.",OADS,/arxiv_data1/oa_pdf/ee/38/jptm-2016-07-01.PMC5357749.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.01Pyloric Gland Type Ovarian Mucinous Tumor   •     163 structure with crypts and villi of variable lengths and cystically  dilated glands, which were divided by muscularis mucosa br- anching in various directions (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ee/38/jptm-2016-07-01.PMC5357749.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.01164     •  Kim EN, et al.",OADS,/arxiv_data1/oa_pdf/ee/38/jptm-2016-07-01.PMC5357749.pdf
"187© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Mucosal Schwann Cell Hamartoma in Colorectal Mucosa: A Rare Benign  Lesion That Resembles Gastrointestinal Neuroma Jiheun Han · Yosep Chong · Tae-Jung Kim · Eun Jung Lee · Chang Suk Kang Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, KoreaJournal of Pathology and Translational Medicine 2017; 51: 187-189 https://doi.org/10.4132/jptm.2016.07.02▒ BRIEF CASE REPORT ▒ The term mucosal Schwann cell hamartoma (MSCH) was  first proposed by Gibson and Hornick in 20091 to describe a  group of neuronal polyps purely composed of S-100–positive  Schwann cells, in an attempt to distinguish from true “neuromas”  and “neurofibromas.” To our knowledge, only 10 cases have been  reported in the literature since it was first described (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/ac/25/jptm-2016-07-02.PMC5357750.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.02188     •  Han J, et al.",OADS,/arxiv_data1/oa_pdf/ac/25/jptm-2016-07-02.PMC5357750.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.07.02Mucosal Schwann Cell Hamartoma   •     189 GI schwannomas are composed of bland spindle cells arranged  in vague fascicles.,Non-OADS,/arxiv_data1/oa_pdf/ac/25/jptm-2016-07-02.PMC5357750.pdf
"176pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Mucinous Carcinoma with Extensive Signet Ring Cell Differentiation:   A Case Report Hye Min Kim · Eun Kyung Kim   Ja Seung Koo Department of Pathology, Yonsei University  College of Medicine, Seoul, KoreaBreast cancers that present with mucin include mucinous carcinoma and carcinoma with signet  ring cell differentiation.",Non-OADS,/arxiv_data1/oa_pdf/72/09/jptm-2016-08-17.PMC5357751.pdf
"Key Words:  Breast; Mucinous carcinoma; Signet ring cellReceived:  June 29, 2016 Revised:  August 11, 2016 Accepted:  August 17, 2016 Corresponding Author Ja Seung Koo, MD  Department of Pathology, Severance Hospital,  Yonsei University College of Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea  Tel: +82-2-2228-1772 Fax: +82-2-362-0860 E-mail: kjs1976@yuhs.acJournal of Pathology and Translational Medicine 2017; 51: 176-179 https://doi.org/10.4132/jptm.2016.08.17▒ CASE STUDY ▒ According to the World Health Organization (WHO) classi - fication, breast cancers that could show mucinous differentiation  include mucinous carcinoma and carcinoma with signet ring cell  differentiation.1 Both tumors have a common feature in that they  contain or secrete mucin; however, mucinous carcinoma exhibits  tumor cells floating in the extracellular mucin,2 whereas in carci - noma with signet ring cell differentiation, the tumor nucleus is  pushed into a corner by abundant intracellular mucin.3 Carci - noma with signet ring cell differentiation is reportedly difficult  to define as a distinct entity, since prominent signet ring cell  differentiation can appear in invasive lobular carcinoma, invasive  carcinoma of no special type, and other special types in common.4  Mucinous carcinoma usually shows estrogen receptor (ER) and  progesterone receptor (PR) positivity and human epidermal  growth factor receptor-2 (HER-2) negativity with relatively good  prognosis,5,6 while carcinoma with signet ring cell differentia - tion frequently expresses ER and PR,7 with an uncertain prog - nosis.8 Here, we report a case of breast cancer secreting prominent  extracellular mucin and showing distinct signet ring cell differ - entiation due to abundant intracellular mucin.CASE REPORT A 64-year-old woman presented with nipple discharge from  right breast for 3 months.",Non-OADS,/arxiv_data1/oa_pdf/72/09/jptm-2016-08-17.PMC5357751.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.17Mucinous Cancer with Signet Ring Cell   •     177 ogy.,Non-OADS,/arxiv_data1/oa_pdf/72/09/jptm-2016-08-17.PMC5357751.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.17178     •  Kim HM, et al.",OADS,/arxiv_data1/oa_pdf/72/09/jptm-2016-08-17.PMC5357751.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.17Mucinous Cancer with Signet Ring Cell   •     179 high mitotic index, ER negativity, PR negativity, and HER-2  positivity, which differ from typical mucinous carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/72/09/jptm-2016-08-17.PMC5357751.pdf
"165© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Thymoma and Synchronous Primary Mediastinal Seminomas   with Florid Follicular Lymphoid Hyperplasia in the Anterior Mediastinum:   A Case Report and Review of the Literature Hyang-im Lee1 · In-seok Jang2,3,4  Kyung Nyeo Jeon3,4,5  Gyung Hyuck Ko3,4,6 · Jong Sil Lee3,4,6  Dong Chul Kim3,4,6 · Dae Hyun Song1,3  Jeong-Hee Lee3,4,6 1Department of Pathology, Gyeongsang National University Changwon Hospital, Changwon; 2Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Hospital, Jinju; 3Gyeongsang National University School of Medicine, Jinju; 4Institute of Health  Science, Gyeongsang National University, Jinju;  5Department of Radiology, Gyeongsang National  University Changwon Hospital, Changwon;  6Department of Pathology, Gyeongsang National  University Hospital, Jinju, KoreaThymoma is the most common neoplasm of the anterior mediastinum and has malignant poten - tial.",Non-OADS,/arxiv_data1/oa_pdf/ff/4a/jptm-2016-08-24.PMC5357752.pdf
"Key Words:  Thymoma; Seminoma; Mediastinum; Follicular hyperplasiaReceived:  May 11, 2016 Revised:  August 11, 2016 Accepted:  August 24, 2016 Corresponding Author Jeong-Hee Lee, MD, PhD Department of Pathology, Gyeongsang National  University School of Medicine, 15 Jinju-daero  816beon-gil, Jinju 52727, Korea  Tel: +82-55-772-8062 Fax: +82-55-759-7952 E-mail: jhlee7@gnu.ac.krJournal of Pathology and Translational Medicine 2017; 51: 165-170 https://doi.org/10.4132/jptm.2016.08.24▒ CASE STUDY ▒ In general, thymomas are rare tumors; however, they are the  most common mediastinal tumors in adults, comprising approx - imately 50% of all anterior mediastinal tumors.",Non-OADS,/arxiv_data1/oa_pdf/ff/4a/jptm-2016-08-24.PMC5357752.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.24166     •  Lee HI, et al.",OADS,/arxiv_data1/oa_pdf/ff/4a/jptm-2016-08-24.PMC5357752.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.24Thymoma and Primary Seminoma   •     167 mass was 0.5 cm away (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ff/4a/jptm-2016-08-24.PMC5357752.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.24168     •  Lee HI, et al.",OADS,/arxiv_data1/oa_pdf/ff/4a/jptm-2016-08-24.PMC5357752.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.24Thymoma and Primary Seminoma   •     169 cytokeratin expression in seminoma tumor cells, which reflects  the differential potential or the morphological transformation  of the seminoma into another nonseminomatous GCTs, has  been reported.16 Moreover, a thymic carcinoma or seminoma  may occur in combination with a thymoma within a single tumor.",Non-OADS,/arxiv_data1/oa_pdf/ff/4a/jptm-2016-08-24.PMC5357752.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.24170     •  Lee HI, et al.",OADS,/arxiv_data1/oa_pdf/ff/4a/jptm-2016-08-24.PMC5357752.pdf
"171© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Malignant Solitary Fibrous Tumor with Heterologous   Rhabdomyosarcomatous Differentiation: A Case Report Jeong-Hwa Kwon · Joon Seon Song   Hye Won Jung1 · Jong-Seok Lee2  Kyung-Ja Cho Department of Pathology, 1Department of   Radiology, Research Institute of Radiology,   2Department of Orthopedic Surgery, Asan  Medical Center, University of Ulsan College of  Medicine, Seoul, KoreaMalignant solitary fibrous tumor (MSFT) is a well-described entity, from which heterologous differ - entiation is extremely rare.",Non-OADS,/arxiv_data1/oa_pdf/6e/c7/jptm-2016-08-29.PMC5357753.pdf
"Key Words:  Solitary fibrous tumors; Malignant; RhabdomyosarcomaReceived:  May 19, 2016 Revised:  August 10, 2016 Accepted:  August 29, 2016 Corresponding Author Joon Seon Song, MD, PhD Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine, 88  Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-4548 Fax: +82-2-472-7898 E-mail: songjs@amc.seoul.krJournal of Pathology and Translational Medicine 2017; 51: 171-175 https://doi.org/10.4132/jptm.2016.08.29▒ CASE STUDY ▒ An extrapleural solitary fibrous tumor (SFT) is an uncommon  mesenchymal spindle cell tumor characterized by its unpredict - able behavior.1,2 It can occur in any site of the body.3 Approxi - mately 10% of SFTs are found to be locally aggressive and may  present local or distant recurrence many years after primary treat - ment.4 The distinction between benign and malignant SFT  (MSFT) is difficult and does not have established specific criteria  in the current literature.",Non-OADS,/arxiv_data1/oa_pdf/6e/c7/jptm-2016-08-29.PMC5357753.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.29172     •  Kwon JH, et al.",OADS,/arxiv_data1/oa_pdf/6e/c7/jptm-2016-08-29.PMC5357753.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.29Malignant Solitary Fibrous Tumor   •     173 comatous differentiation with distinct malignant osteoid cells.,Non-OADS,/arxiv_data1/oa_pdf/6e/c7/jptm-2016-08-29.PMC5357753.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.29174     •  Kwon JH, et al.",OADS,/arxiv_data1/oa_pdf/6e/c7/jptm-2016-08-29.PMC5357753.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.29Malignant Solitary Fibrous Tumor   •     175 ment model.,Non-OADS,/arxiv_data1/oa_pdf/6e/c7/jptm-2016-08-29.PMC5357753.pdf
"180pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Mucinous Cystadenoma of the Testis: A Case Report   with Immunohistochemical Findings Gilhyang Kim1 · Dohee Kwon1  Hee Young Na1 · Sehui Kim1  Kyung Chul Moon1,2 1Department of Pathology, 2Kidney Research   Institute, Medical Research Center, Seoul  National University College of Medicine, Seoul,  KoreaMucinous cystadenoma of the testis is a very rare tumor.",Non-OADS,/arxiv_data1/oa_pdf/52/f7/jptm-2016-08-30.PMC5357754.pdf
"Key Words:  Testis; Cystadenoma, mucinous; ImmunohistochemistryReceived:  June 29, 2016 Revised:  August 18, 2016 Accepted:  August 30, 2016 Corresponding Author Kyung Chul Moon, MD Department of Pathology, Kidney Research Institute,  Medical Research Center, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 03080, Korea Tel: +82-2-740-8380 Fax: +82-2-743-5530 E-mail: blue7270@snu.ac.krJournal of Pathology and Translational Medicine 2017; 51: 180-184 https://doi.org/10.4132/jptm.2016.08.30▒ CASE STUDY ▒ Testicular/paratesticular tumors resembling mucinous or  serous ovarian tumors are rare; between the two subtypes, mu - cinous neoplasms are less commonly reported than serous neo - plasms.1-7 To our knowledge, there have been approximately 24  case reports of mucinous neoplasms of the testis or paratestis,  and only four cases of “testicular mucinous cystadenoma” were  found in the English-language literature (Table 1).1,2,8-11 In Korea,  two cases of mucinous cystadenomas of the paratestis or sper - matic cord have been reported.4,7 However, there has been no  published report of testicular mucinous cystadenoma in Korea.",Non-OADS,/arxiv_data1/oa_pdf/52/f7/jptm-2016-08-30.PMC5357754.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.30Mucinous Cystadenoma of the Testis   •     181 nents, were not found.",Non-OADS,/arxiv_data1/oa_pdf/52/f7/jptm-2016-08-30.PMC5357754.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.30182     •  Kim G, et al.",OADS,/arxiv_data1/oa_pdf/52/f7/jptm-2016-08-30.PMC5357754.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.30Mucinous Cystadenoma of the Testis   •     183 nomas lack the atypia of tumor cells.8,15 Testicular mucinous  carcinomas or borderline neoplasms have been reported more  frequently than testicular mucinous cystadenomas.",Non-OADS,/arxiv_data1/oa_pdf/52/f7/jptm-2016-08-30.PMC5357754.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.08.30184     •  Kim G, et al.",OADS,/arxiv_data1/oa_pdf/52/f7/jptm-2016-08-30.PMC5357754.pdf
"148pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea Mostafa Abou El-Ela   Mohamed El-Komy   Rania Abdel Hay · Rehab Hegazy   Amin Sharobim1 · Laila Rashed2  Khalda Amr3 Department of Dermatology, Faculty of Medicine,   Cairo University, Cairo; 1Department of   Dermatology, National Research Center (NRC),  Cairo University, Cairo; 2Department of Clinical  Biochemistry, Faculty of Medicine, Cairo  University, Cairo; 3Department of Molecular  Genetics, National Research Center (NRC),   Cairo University, Cairo, EgyptBackground:  Pityriasis rosea (PR) is a common papulosquamous skin disease in which an infec - tive agent may be implicated.",Non-OADS,/arxiv_data1/oa_pdf/d9/f6/jptm-2016-09-09.PMC5357755.pdf
"Key Words:  Immunity, innate; Toll-like receptors; Reverse transcriptase polymerase chain reaction;  Pityriasis rosea Received:  August 11, 2016 Revised:  September 5, 2016 Accepted:  September 7, 2016 Corresponding Author Rania Abdel Hay, MD Department of Dermatology, Faculty of Medicine,  Cairo University, 13th Abrag Othman, Kournish el  Maadi, Cairo 11431, Egypt Tel: +20-1006084132  Fax: +20-23596724 E-mail: raniamounir@kasralainy.edu.egJournal of Pathology and Translational Medicine 2017; 51: 148-151 https://doi.org/10.4132/jptm.2016.09.09▒ ORIGINAL ARTICLE ▒ Although pityriasis rosea (PR) was identified some time ago,  and much has been done to describe and diagnose the rash, little  is known regarding PR’s etiology.",Non-OADS,/arxiv_data1/oa_pdf/d9/f6/jptm-2016-09-09.PMC5357755.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.09TLRs and PR   •     149 were in the active stage of the disease (having active lesions  appearing within the same week of their visit to the clinic).,Non-OADS,/arxiv_data1/oa_pdf/d9/f6/jptm-2016-09-09.PMC5357755.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.09150     •  El-Ela MA, et al.",OADS,/arxiv_data1/oa_pdf/d9/f6/jptm-2016-09-09.PMC5357755.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.09.09TLRs and PR   •     151 tive immune response through the induction of cytokines and  other pro-inflammatory mediators.,Non-OADS,/arxiv_data1/oa_pdf/d9/f6/jptm-2016-09-09.PMC5357755.pdf
"152pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma:   Correlation with PD-L1 and PD-L2 Expression Young Wha Koh · Jae-Ho Han   Seong Yong Park1 · Dok Hyun Yoon2  Cheolwon Suh2 · Jooryung Huh3 Departments of Pathology and 1Thoracic and  Cardiovascular Surgery, Ajou University School  of Medicine, Suwon; Departments of 2Oncology  and 3Pathology, Asan Medical Center, University  of Ulsan College of Medicine, Seoul, KoreaBackground:  Glucose transporter type 1 (GLUT1) expression is linked to glucose metabolism and  tissue hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
"Key Words:  Hodgkin lymphoma; GLUT1; Programmed death ligand 1; Programmed death ligand 2;  Programmed death-1Received:  August 23, 2016 Revised:  October 17, 2016 Accepted:  November 3, 2016 Corresponding Author Jooryung Huh, MD Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea Tel: +82-2-3010-4553 Fax: +82-2-472-7898 E-mail: jrhuh@amc.seoul.krJournal of Pathology and Translational Medicine 2017; 51: 152-158 https://doi.org/10.4132/jptm.2016.11.03▒ ORIGINAL ARTICLE ▒ Classical Hodgkin lymphoma (cHL) is considered a highly  curable disease with modern therapy; however, at least 20% of  the patients cannot be cured with the standard treatment.1,2 Al- though the International Prognostic Score (IPS) is a powerful  tool for risk stratification, it does not fully reflect the biological  nature of cHL.",Non-OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.03GLUT1 in Hodgkin’s Lymphoma   •     153 HIF pathways.19,22,23 A recent study reported that PD-L1 expres - sion is regulated by GLUT1 in clear cell renal cell carcinoma.24  An anti–PD-1 monoclonal antibody (nivolumab) has exhibited  substantial therapeutic activity and an acceptable safety profile  in relapsed or refractory cHL.25 A GLUT1-specific inhibitor  (STF-31) also suppressed glucose uptake and induced apoptosis  in myeloma cells with high GLUT1 expression.26 However, no  study has examined the relationship between PD-L1 and GLUT1  in patients with cHL.",Non-OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.03154     •  Koh YW, et al.",OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.03GLUT1 in Hodgkin’s Lymphoma   •     155 DISCUSSION In the present study, the expression of GLUT1 was signifi - cantly correlated with PD-L1 and PD-L2 expression, supporting  the hypothesis that GLUT1-related signaling pathways play an  important role in the PD-L1 or PD-L2 pathway.",Non-OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.03156     •  Koh YW, et al.",OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.03GLUT1 in Hodgkin’s Lymphoma   •     157 would be more susceptible to chemotherapy-associated DNA  damage.,Non-OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.03158     •  Koh YW, et al.",OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
https://doi.org/10.1200/JCO.2016.67.3467.,Non-OADS,/arxiv_data1/oa_pdf/b5/7e/jptm-2016-11-03.PMC5357756.pdf
"122pISSN 2383-7837 eISSN 2383-7845 © 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Mesothelin Expression in Gastric Adenocarcinoma and   Its Relation to Clinical Outcomes Song-Hee Han · Mee Joo   Hanseong Kim · Sunhee Chang Department of Pathology, Inje University Ilsan  Paik Hospital, Goyang, KoreaBackground:  Although surgical resection with chemotherapy is considered effective for patients  with advanced gastric cancer, it remains the third leading cause of cancer-related death in South  Korea.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"Key Words:  Mesothelin; Gastric adenocarcinoma; Prognosis Received:  July 15, 2016 Revised:  November 17, 2016 Accepted:  November 17, 2016 Corresponding Author Sunhee Chang, MD, PhD Department of Pathology, Inje University Ilsan Paik  Hospital, 170 Juhwa-ro, Ilsanseo-gu, Goyang  10380, Korea Tel: +82-31-910-7142 Fax: +82-31-910-7139 E-mail: pathate714@gmail.comJournal of Pathology and Translational Medicine 2017; 51: 122-128 https://doi.org/10.4132/jptm.2016.11.18▒ ORIGINAL ARTICLE ▒ Gastric cancer is a major health problem worldwide, causing  approximately one million deaths every year.1 In South Korea,  gastric cancer is the third leading cause of cancer-related death.2  With improved screening methods such as endoscopy and the  development of new techniques such as endoscopic submucosal  dissection, patients can be diagnosed with gastric cancer at an  early stage and are expected to have increased long-term survival  rate and higher quality of life.3 Although surgical resection with  chemotherapy is considered effective for patients with recurrent,  metastatic, or advanced gastric cancer (AGC), the 5-year survival  rate for patients with AGC is only 20%–30%.4 Chemotherapy  increases survival rate, enhances quality of life, and can achieve  symptomatic control; however, it is associated with increased  drug toxicity.5 In recent years, the identification of druggable  oncogenic alterations such as human epidermal growth factor  receptor 2 (HER2) overexpression and the development of drugs  that specifically target HER2 have led to substantial improve - ment in the prognosis of patients with AGC.6 However, onco - genic alterations are detected in only 6.0%–29.5% of gastric  adenocarcinomas.7 Thus, development of novel effective targeted therapy is essential for the management of AGC.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.18Role of Mesothelin in Tumor Progression   •     123 mesothelin expression.11,12 Several studies have examined the  importance of WT1 and calretinin expression in gastric adeno - carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.18124     •  Han SH, et al.",OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.18Role of Mesothelin in Tumor Progression   •     125 RESULTS Mesothelin, calretinin, and WT1 expression in gastric  adenocarcinoma  The pattern of mesothelin expression was characterized by a  diffuse and strong pattern with thick, membranous staining,  especially along the apical cell membrane (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.18126     •  Han SH, et al.",OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.18Role of Mesothelin in Tumor Progression   •     127 Several ongoing clinical trials in patients with these carcinomas  have revealed a beneficial effect.27,28 For example, SS1P is a repre - sentative recombinant antimesothelin immunotoxin, and the  therapy response rate of SS1P combined with chemotherapy  exhibits good response.28 We hypothesized that calretinin and WT1 would show posi - tive reactivity in gastric adenocarcinoma.13-15 No prior studies  have evaluated WT1 expression in gastric adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.11.18128     •  Han SH, et al.",OADS,/arxiv_data1/oa_pdf/c3/75/jptm-2016-11-18.PMC5357757.pdf
"129© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Comparison of the Mismatch Repair System between Primary and   Metastatic Colorectal Cancers Using Immunohistochemistry Jiyoon Jung · Youngjin Kang   Yoo Jin Lee · Eojin Kim   Bokyung Ahn · Eunjung Lee   Joo Young Kim · Jeong Hyeon Lee   Youngseok Lee · Chul Hwan Kim   Yang-Seok Chae Department of Pathology, Korea University Anam  Hospital, Seoul, KoreaBackground:  Colorectal cancer (CRC) is one of the most common malignancies worldwide.",Non-OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
"Key Words:  Colorectal neoplasms; DNA mismatch repair; Microsatellite instability; Immunohisto - chemistryReceived:  September 2, 2016 Revised:  November 24, 2016 Accepted:  December 9, 2016 Corresponding Author Yang-Seok Chae, MD Department of Pathology, Korea University Anam  Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 02841,  Korea  Tel: +82-2-920-5595 Fax: +82-2-920-6576 E-mail: chaeys21@korea.ac.krJournal of Pathology and Translational Medicine 2017; 51: 129-136 https://doi.org/10.4132/jptm.2016.12.09▒ ORIGINAL ARTICLE ▒ Approximately 10%–15% of the colorectal cancer (CRC)  cases have a defective DNA mismatch repair (MMR) gene.1 As  a result of these defects, microsatellites are predicted to accu - mulate during cell division.2 Microsatellite instability (MSI) has  received attention since the discovery of repetitive sequences in  1993.3 Deficient mismatch repair (dMMR) is the molecular  basis for MSI.",Non-OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.09130     •  Jung J, et al.",OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.09MMR System of Colorectal Cancers   •     131 showed deficiencies in both the primary and the paired meta - static lesions.,Non-OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.09132     •  Jung J, et al.",OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.09MMR System of Colorectal Cancers   •     133 of the dMMR cases fit the classification, indicating that the  IHC expression is consistent.",Non-OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.09134     •  Jung J, et al.",OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.09MMR System of Colorectal Cancers   •     135 [5-FU ] and oxaliplatin).,Non-OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.09136     •  Jung J, et al.",OADS,/arxiv_data1/oa_pdf/fe/1c/jptm-2016-12-09.PMC5357758.pdf
"137© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Current Status of Pathologic Examinations in Korea, 2011–2015,   Based on the Health Insurance Review and Assessment Service Dataset Sun-ju Byeon Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine,   Seoul, KoreaBackground:  Pathologic examinations play an important role in medical services.",Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
"Key Words:  Insurance; Pathology, surgical; Cytological pathology; ReimbursementReceived:  July 13, 2016 Revised:  November 28, 2016 Accepted:  December 30, 2016 Corresponding Author Sun-ju Byeon, MD Department of Pathology, Asan Medical Center,  University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea Tel: +82-2-3010-1494 Fax: +82-2-472-7898 E-mail: byeon.sunju@welovedoctor.comJournal of Pathology and Translational Medicine 2017; 51: 137-147 https://doi.org/10.4132/jptm.2016.12.30▒ ORIGINAL ARTICLE ▒ Pathologic examinations play an important role in medical  services.",Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30138     •  Byeon SJ Statistical Software ver.,OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30Current Pathologic Examination Status   •     139 IHC, immunohisto(cyto)chemistry; L-, liquid based; LND, with  lymph node dissection; LNDX, without lymph node dissection;  MaligGro, resected specimen for malignant tumor requiring  gross sectioning; MAPPING, histologic mapping of tumor;  MSI, microsatellite instability; Non-maligGro, resected specimen  requiring gross sectioning; NPB, number of paraffin blocks;  OUTSIDE, outside slide interpretation; SPECIAL, special stain  examinations.",Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
According to HIRA (http://opendata.hira.or.kr/op/opc/olap - MdclRcStatsInfo.do) and the Ministry of the Interior (http://,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30140     •  Byeon SJTable 2.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30Current Pathologic Examination Status   •     141Table 3.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30142     •  Byeon SJTable 4.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30Current Pathologic Examination Status   •     143Table 5.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30144     •  Byeon SJTable 6.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30Current Pathologic Examination Status   •     145Table 7.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30146     •  Byeon SJ rcps.egov.go.kr:8081/jsp/stat/ppl_stat_jf.jsp), there were 53,252  medical institutions and 51,677,054 people in Korea in Decem - ber, 2015 (see Supplementary Table S6).",OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2016.12.30Current Pathologic Examination Status   •     147 considering the period between IR requests and inspection  completions be made after at least 1 year.,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
Electronic Supplementary Material Supplementary materials are available at Journal of Pathology  and Translational Medicine (http://jpatholtm.org).,Non-OADS,/arxiv_data1/oa_pdf/d5/f5/jptm-2016-12-30.PMC5357759.pdf
"103© 2017 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2383-7837 eISSN 2383-7845 Molecular Testing for Gastrointestinal Cancer Hye Seung Lee1,2 · Woo Ho Kim2  Yoonjin Kwak1,2 · Jiwon Koh2  Jeong Mo Bae3 · Kyoung-Mee Kim4  Mee Soo Chang2,3 · Hye Seung Han5  Joon Mee Kim6 · Hwal Woong Kim7  Hee Kyung Chang8 · Young Hee Choi9   Ji Y. Park10 · Mi Jin Gu11  Min Jin Lhee12 · Jung Yeon Kim13  Hee Sung Kim14 · Mee-Yon Cho15  The Gastrointestinal Pathology Study  Group of Korean Society of   Pathologists · The Molecular   Pathology Study Group of Korean  Society of Pathologists Department of Pathology, 1Seoul National   University Bundang Hospital, Seongnam;   2Seoul National University College of Medicine,  Seoul; 3SMG-SNU Boramae Medical Center,  Seoul; 4Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul; 5Konkuk  University School of Medicine, Seoul; 6Inha  University School of Medicine, Incheon;  7Seegene Medical Foundation, Busan; 8Kosin  University Gospel Hospital, Kosin University  College of Medicine, Busan; 9Hallym University  Dongtan Sacred Heart Hospital, Hwaseong;  10Catholic University of Daegu School of  Medicine, Daegu; 11Yeungnam University College  of Medicine, Daegu; 12Seoul Red Cross Hospital,  Seoul; 13Inje University Sanggye Paik Hospital,  Seoul; 14Chung-Ang University College of  Medicine, Seoul; 15Wonju Severance Christian  Hospital, Yonsei University Wonju College of  Medicine, Wonju, KoreaWith recent advances in molecular diagnostic methods and targeted cancer therapies, several  molecular tests have been recommended for gastric cancer (GC) and colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"Key Words:  Gastric neoplasms; Colorectal neoplasms; Molecular diagnosis; Prognosis; Targeted  therapyReceived:  December 1, 2016 Revised:  January 16, 2017 Accepted:  January 24, 2017 Corresponding Author Woo Ho Kim, MD, PhD Department of Pathology, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 03080, Korea  Tel: +82-2-740-8269 Fax: +82-2-765-5600 E-mail: woohokim@snu.ac.krJournal of Pathology and Translational Medicine 2017; 51: 103-121 https://doi.org/10.4132/jptm.2017.01.24▒ REVIEW ▒",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24104     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     105 10% of sporadic GCs and is associated with older age, antral  location, and intestinal type histology.22,23 The independent  prognostic value of MSI status in GC remains controversial;  however, a recent meta-analysis showed that MSI-H is associated  with better overall and disease-specific survival in GC.24 Recent  advances in genome analysis of CRCs and GCs showed that  MSI-H is strongly associated with a distinct subtype character - ized by elevated mutation rates (“hypermutated”).25-27 Cristescu  et al.27 demonstrated that MSI-H GCs have the best overall and  disease-free survival among four molecular subtypes.",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24106     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     107 NRAS  exons 2 to 4, can be more predictable for lack of respon - siveness to EGFR inhibitors than previously proven KRAS  exon  2 testing in first-line chemotherapy for metastatic CRC pa - tients.6,47 Recently, RAS mutation testing is approved as a com - panion diagnosis for EGFR inhibitor treatment in metastatic  CRC patients.",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24108     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     109 Indication Based on confirmative correlation with patient prognosis,  KRAS  mutation testing is recommended in all patients with  newly diagnosed CRC.",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24110     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     111 dation should be analyzed by assessing accuracy, precision, ana - lytical sensitivity and specificity, reportable range, and reference  range.79   Quality assurance Each pathology laboratory should establish internal QA in - structions for using each mutation analysis method and review  all performed mutation analysis in regular QA meetings.",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24112     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     113 is equivocal of any cause, HER2  genetic testing by fluorescence  in situ  hybridization (FISH) or silver in situ  hybridization (SISH)  should be performed.",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24114     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     115 cative infections; (3) EBV DNA amplification to detect viral  DNA in patient tissues; (4) EBV viral load assays to quantitate  EBV DNA in blood or body fluids to monitor disease status  over time; (5) IHC for LMP1, EBNA1, EBNA2, LMP2A (latent  state proteins of EBV), and BZLF1 (lytic state protein; so-called  switch protein from lytic to latent state) to detect EBV-producing  proteins and distinguish latent from replicative infections; (6)  viral culture, which is possible but impractical for clinical use;  (7) electron microscopy, which is also impractical; and (8) serolo - gy using VCA, EBNA, EA, and heterophile antibodies to moni - tor disease-association, -regression or -progression over time.",Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24116     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     117 ducibility has not been shown.,Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24118     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     119 international multicentre study.,Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24120     •  Lee HS, et al.",OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.24Molecular Testing for GI Cancer   •     121 105.,Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
https://doi.org/ 10.1007/s10120-016-0631-3.,Non-OADS,/arxiv_data1/oa_pdf/65/10/jptm-2017-01-24.PMC5357760.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017Wnt signaling in cancer T Zhan et al 1473 Oncogene (2017) 1461 –1473",Non-OADS,/arxiv_data1/oa_pdf/fa/c4/onc2016304a.PMC5357762.pdf
"@ERSpublications Refractory cough is associated with psychological factors, such as low mood, illness beliefs and fatigue http://ow.ly/hbKt30923pb Cite this article as: Hulme K, Deary V, Dogan S, et al .",Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
ERJ Open Res 2017; 3: 00099-2016 [https://doi.org/10.1183/ 23120541.00099-2016].,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
https://doi.org/10.1183/23120541.00099-2016 ERJ Open Res 2017; 3: 00099-2016 ORIGINAL ARTICLE COUGH,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
"Participating patients were also asked to take aquestionnaire bundle for a “non-cough ”friend to complete; this was our healthy, non-cough comparison https://doi.org/10.1183/23120541.00099-2016 2COUGH | K. HULME ET AL.",Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
https://doi.org/10.1183/23120541.00099-2016 3COUGH | K. HULME ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
TABLE 1 Participant demographics Group Refractory cough Explained cough Non-cough Female n 19 24 18 Male n 61 8 4 Age years mean± SD 57.04±13.54 62.49±11.32 54.59±14.46 https://doi.org/10.1183/23120541.00099-2016 4COUGH | K. HULME ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
https://doi.org/10.1183/23120541.00099-2016 5COUGH | K. HULME ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
https://doi.org/10.1183/23120541.00099-2016 6COUGH | K. HULME ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
This collaborative sense-making narrative work has shown promise in other https://doi.org/10.1183/23120541.00099-2016 7COUGH | K. HULME ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
https://doi.org/10.1183/23120541.00099-2016 8COUGH | K. HULME ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
https://doi.org/10.1183/23120541.00099-2016 9COUGH | K. HULME ET AL.,Non-OADS,/arxiv_data1/oa_pdf/2b/4d/00099-2016.PMC5357770.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ Indian Pacing and Electrophysiology Journal 17 (2017) 8 e9 http://dx.doi.org/10.1016/j.ipej.2016.12.006 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/4e/7f/main.PMC5357832.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/dd/main.PMC5357834.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.01.002 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/da/dd/main.PMC5357834.pdf
Ann Noninvasive Electrocardiol 2017;22. http://dx.doi.org/10.1111/ anec.12356 .,Non-OADS,/arxiv_data1/oa_pdf/da/dd/main.PMC5357834.pdf
DOI of original article: http://dx.doi.org/10.1016/j.prnil.2016.04.001 .,OADS,/arxiv_data1/oa_pdf/7a/90/main.PMC5357835.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2016.11.001 p2287-8882 e2287-903X/Copyright ©2016 Asian Paci ﬁc Prostate Society, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/7a/90/main.PMC5357835.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ Indian Pacing and Electrophysiology Journal 17 (2017) 1 e2 http://dx.doi.org/10.1016/j.ipej.2017.01.001 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/85/f2/main.PMC5357853.pdf
2014. https://clinicaltrials.gov/ct2/ show/results/NCT01510652 (Accessed 3 January 2017).,Non-OADS,/arxiv_data1/oa_pdf/85/f2/main.PMC5357853.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/34/main.PMC5357856.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevie r.com/prostate-international http://dx.doi.org/10.1016/j.prnil.2016.12.001 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/9b/34/main.PMC5357856.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.12.003 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/ed/16/main.PMC5357857.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.01.005 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/dc/1d/main.PMC5357858.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/32/main.PMC5357860.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.10.008 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/aa/32/main.PMC5357860.pdf
14 Dec. 2015. https://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/aa/32/main.PMC5357860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/a3/main.PMC5357861.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.10.010 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/79/a3/main.PMC5357861.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/2a/main.PMC5357968.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.001 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/18/2a/main.PMC5357968.pdf
Available from: http://www.ipss.go.jp/pp-newest/e/ppfj02/ppfj02.pdf .,Non-OADS,/arxiv_data1/oa_pdf/18/2a/main.PMC5357968.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/22/main.PMC5357969.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.004 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/c8/22/main.PMC5357969.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/53/main.PMC5357970.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2016.12.003 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/c7/53/main.PMC5357970.pdf
"Available from: https://seer.cancer.gov/statfacts/html/prost.html , www.cancer.gov .",Non-OADS,/arxiv_data1/oa_pdf/c7/53/main.PMC5357970.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/62/main.PMC5357971.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevie r.com/prostate-international http://dx.doi.org/10.1016/j.prnil.2016.12.002 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/1c/62/main.PMC5357971.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/e6/main.PMC5357972.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.003 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/4c/e6/main.PMC5357972.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/1d/main.PMC5357973.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.002 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/8a/1d/main.PMC5357973.pdf
Retrieved from https://uroweb.org/guideline/prostate-cancer/?,Non-OADS,/arxiv_data1/oa_pdf/8a/1d/main.PMC5357973.pdf
Available from: http://www.uroweb.org/guidelines/ .,Non-OADS,/arxiv_data1/oa_pdf/8a/1d/main.PMC5357973.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/42/main.PMC5357994.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2017.01.006 0972-6292/Copyright ©2017, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/40/42/main.PMC5357994.pdf
URL http://2015.obesityweek.com/app/uploads/2015/11/1105-Thurs- day-ObesityWeek-2015-Late-Breaking-TOS-Poster-Abstracts.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/8e/OSP4-3-3.PMC5358074.pdf
URL http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf (accessed July 2016).Obesity Science & Practice Review: liraglutide for weight management A. Mehta et al.,Non-OADS,/arxiv_data1/oa_pdf/9e/8e/OSP4-3-3.PMC5358074.pdf
"Bethesda, MD, HYPERLINK “/archive/csr/ 1975_2007/ ”http://seer.cancer.gov/csr/1975_2007/, based on92 Online weight loss in cancer survivors S. M. Lynch et al.",OADS,/arxiv_data1/oa_pdf/7b/17/OSP4-3-83.PMC5358075.pdf
Available at: http://www.pewinternet.org/files/old-media//Files/Re-ports/2009/PIP_Generations_2009.pdf.27.,Non-OADS,/arxiv_data1/oa_pdf/7b/17/OSP4-3-83.PMC5358075.pdf
"http://www.acrin.org/Portals/0/Administration/ Regulatory/CTCAE_4.02_2009-09-15_QuickReference_5x7.pdf.Washington, D.C. 2009.",OADS,/arxiv_data1/oa_pdf/7b/17/OSP4-3-83.PMC5358075.pdf
Healthy Food Financing Initiative 2016; http://www.acf.hhs.gov/ocs/programs/community-economic-development/healthy-food-financing.,Non-OADS,/arxiv_data1/oa_pdf/3c/cb/OSP4-3-75.PMC5358079.pdf
https://snaped.fns.usda.gov/.,Non-OADS,/arxiv_data1/oa_pdf/3c/cb/OSP4-3-75.PMC5358079.pdf
Available from: http://www.healthcommunities.com/pneumonia/ overview-of-pneumonia.shtml.,Non-OADS,/arxiv_data1/oa_pdf/8a/6f/CMJ-130-647.PMC5358412.pdf
The diagnosis of sensorineural  hearing impairment was made according to the World  Health Organization criteria available at http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/89/61/CMJ-130-703.PMC5358421.pdf
"[8] The paired-end reads generated by sequencing were aligned  to NCBI37/hg19 assembly by the Burrows-Wheeler  Alignment Tool (version 0.7.10, http://bio-bwa.sourceforge.",OADS,/arxiv_data1/oa_pdf/89/61/CMJ-130-703.PMC5358421.pdf
"net/), and variant calling was performed by Genome Analysis  Toolkit (version 3.3-0, https://software.broadinstitute.org/ gatk/index.php).",OADS,/arxiv_data1/oa_pdf/89/61/CMJ-130-703.PMC5358421.pdf
"Moreover, SIFT (http:// sift.jcvi.org/) and PolyPhen2 (http://genetics.bwh.harvard.",OADS,/arxiv_data1/oa_pdf/89/61/CMJ-130-703.PMC5358421.pdf
"A three-dimensional structure of GATA3 was built by Swiss- model (http://swissmodel.expasy.org/workspace/) and then  visualized by Swiss-PdbViewer (version 4.1, http://spdbv.",OADS,/arxiv_data1/oa_pdf/89/61/CMJ-130-703.PMC5358421.pdf
doi: http://doi.org/10.21769/ BioProtoc.1631.,Non-OADS,/arxiv_data1/oa_pdf/65/c9/CMJ-130-717.PMC5358423.pdf
Ann Thorac Surg 1990;49:424-8. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/c9/CMJ-130-717.PMC5358423.pdf
"Among them, five genes including  TGIF1 , LAMA1 , PIEZO2 , AFG3L2 , and MC2R  are listed  in the Developmental Disorders Genotype-Phenotype  Database (DDG2P) (https://decipher.sanger.ac.uk/ ddd#ddgenes).",Non-OADS,/arxiv_data1/oa_pdf/a7/a1/CMJ-130-744.PMC5358428.pdf
"@ERSpublications Investigator-attributed causes of death may lead to unreliable estimates of cause-specific mortality in COPD http://ow.ly/uzt9308TePH Cite this article as: Wise RA, Kowey PR, Austen G, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
ERJ Open Res 2017; 3: 00073-2016 [https://doi.org/10.1183/ 23120541.00073-2016].,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com https://doi.org/10.1183/23120541.00073-2016 ERJ Open Res 2017; 3: 00073-2016 ORIGINAL ARTICLE COPD,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
https://doi.org/10.1183/23120541.00073-2016 2COPD | R.A.,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
https://doi.org/10.1183/23120541.00073-2016 3COPD | R.A.,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
https://doi.org/10.1183/23120541.00073-2016 4COPD | R.A.,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
https://doi.org/10.1183/23120541.00073-2016 5COPD | R.A.,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
Calverley https://doi.org/10.1183/23120541.00073-2016 6COPD | R.A.,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
"World Health Organization, 2016. http://apps.who.int/classifications/icd10/browse/2016/en#/R95-R99 14 McGarvey LP, John M, Anderson JA, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
Respir Res 2015; 16: 65. https://doi.org/10.1183/23120541.00073-2016 7COPD | R.A.,Non-OADS,/arxiv_data1/oa_pdf/f0/a9/00073-2016.PMC5358526.pdf
"@ERSpublications Lipid treatment of macrophages alters gene expression in pathways known to be involved in COPD pathophysiology http://ow.ly/61pu308T8MM Cite this article as: Hayman YA, Sadofsky LR, Williamson JD, et al.",Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
https://doi.org/10.1183/23120541.00026-2016 ERJ Open Res 2017; 3: 00026-2016 ORIGINAL ARTICLE MECHANISMS OF LUNG DISEASE,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
https://doi.org/10.1183/23120541.00026-2016 2MECHANISMS OF LUNG DISEASE | Y.A.,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
For the gene https://doi.org/10.1183/23120541.00026-2016 3MECHANISMS OF LUNG DISEASE | Y.A.,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
https://doi.org/10.1183/23120541.00026-2016 4MECHANISMS OF LUNG DISEASE | Y.A.,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
"TABLE 1 Top 10 up- and downregulated genes following Calogen treatment of PMA/THP-1 cells Fold change Gene symbol Description Direction p-value (corr) 971 IL8 Homo sapiens interleukin 8 (IL8), mRNA [NM_000584] –a neutrophil chemotactic cytokine↑ 3.07×10−10 86 ANGPTL4 Homo sapiens angiopoietin-like 4 (ANGPTL4), transcript variant 1, mRNA [NM_139314] –modulates glucose homeostasis and lipid metabolism↑ 2.80×10−7 63 CXCL3 Homo sapiens chemokine (C-X-C motif) ligand 3 (CXCL3), mRNA [NM_002090] –neutrophil chemoattractant↑ 9.63×10−12 56 FBXW10 Homo sapiens F-box and WD repeat domain containing 10 (FBXW10), mRNA [NM_031456] –a protein ubiquitin ligase↑ 4.39×10−8 46 CCL20 Homo sapiens chemokine (C-C motif) ligand 20 (CCL20), transcript variant 1, mRNA [NM_004591] –involved in inflammation, lymphocyte chemotactic activity↑ 5.13×10−5 45 GPR56 Homo sapiens G protein-coupled receptor 56 (GPR56), transcript variant 3, mRNA [NM_201525]↑ 1.95×10−5 42 ADORA2A Homo sapiens adenosine A2a receptor (ADORA2A), mRNA [NM_000675] –a GPCR with multiple roles, implicated in inflammatory diseases↑ 7.78×10−8 40 CCL4 Homo sapiens chemokine (C-C motif) ligand 4 (CCL4), transcript variant 1, mRNA [NM_002984] –mitogen-inducible monokine with inflammatory functions↑ 5.43×10−7 39 IL8 Interleukin 8 [Source: HGNC Symbol; Acc:6025] [ENST00000401931] –a neutrophil chemotactic cytokine↑ 6.49×10−11 38 CCL4 Homo sapiens chemokine (C-C motif) ligand 4 (CCL4), transcript variant 1, mRNA [NM_002984] –mitogen-inducible monokine with inflammatory functions↑ 5.34×10−7 108.3 XLOC_000604 UI-E-EJ1-ajw-b-14-0-UI.r1 UI-E-EJ1 Homo sapiens cDNA clone UI-E-EJ1-ajw-b-14-0-UI 5 ′, mRNA sequence [BQ188485] – unknown↓ 8.28×10−9 78.5 MS4A6A Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), transcript variant 2, mRNA [NM_022349] – may be involved in signal transduction↓ 2.47×10−7 72.0 GPA33 Homo sapiens glycoprotein A33 (transmembrane) (GPA33), mRNA [NM_005814] –possibly involved in cell –cell recognition↓ 6.52×10−7 71.0 MS4A6A Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), transcript variant 1, mRNA [NM_152852] – may be involved in signal transduction↓ 3.97×10−6 55.2 MRVI1 Homo sapiens murine retrovirus integration site 1 homologue (MRVI1), transcript variant 2, mRNA [NM_130385] –multiple roles including regulation of IP3-induced calcium release↓ 4.06×10−12 42.4 CX3CR1 Homo sapiens chemokine (C-X3-C motif) receptor 1 (CX3CR1), transcript variant 4, mRNA [NM_001337] –CX3C receptor involved in its adhesion and migratory functions↓ 5.43×10−10 40.7 GPR34 Homo sapiens G protein-coupled receptor 34 (GPR34), transcript variant 4, mRNA [NM_001097579] –exact function unknown↓ 9.87×10−12 38.5 ENHO Homo sapiens energy homeostasis associated (ENHO), mRNA [NM_198573] –role in glucose homeostasis and lipid metabolism↓ 2.52×10−6 30.5 LOC100505633 Homo sapiens uncharacterised LOC100505633, non-coding RNA [NR_038849] –unknown function↓ 9.37×10−8 29.8 MNDA Homo sapiens myeloid cell nuclear differentiation antigen (MNDA), mRNA [NM_002432] –may regulate transcription in myeloid cells↓ 8.80×10−8 https://doi.org/10.1183/23120541.00026-2016 5MECHANISMS OF LUNG DISEASE | Y.A.",Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
https://doi.org/10.1183/23120541.00026-2016 6MECHANISMS OF LUNG DISEASE | Y.A.,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
https://doi.org/10.1183/23120541.00026-2016 7MECHANISMS OF LUNG DISEASE | Y.A.,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
https://doi.org/10.1183/23120541.00026-2016 8MECHANISMS OF LUNG DISEASE | Y.A.,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
https://doi.org/10.1183/23120541.00026-2016 9MECHANISMS OF LUNG DISEASE | Y.A.,Non-OADS,/arxiv_data1/oa_pdf/76/8b/00026-2016.PMC5358527.pdf
http://dx.doi.org/10.1016/j.idcr.2017.01.001 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/3c/main.PMC5358528.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  42–44 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/3d/3c/main.PMC5358528.pdf
http://dx.doi.org/10.1016/j.gore.2017.03.010 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
http://dx.doi.org/10.1086/591095 .,OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
http://dx.doi.org/10.1177/ 0956462414542476 .,Non-OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
http://dx.doi.org/10.1158/1055-9965.EPI-06-0997 .,Non-OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
2012: 581712. http://dx.doi.org/10.1155/2012/581712 .,Non-OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
http://dx.doi.org/10.1016/j.bjps.2007.12.009 .,OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
http://dx.doi.org/10.3109/2000656X.2014.,Non-OADS,/arxiv_data1/oa_pdf/3f/56/main.PMC5358529.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/4b/main.PMC5358530.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/4b/main.PMC5358530.pdf
http://dx.doi.org/10.1016/j.shaw.2016.08.003Safety and Health at Work 8 (2017) 72 e76,Non-OADS,/arxiv_data1/oa_pdf/a0/4b/main.PMC5358530.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f1/b8/main.PMC5358531.pdf
E-mail address: peterjo@ohsu.edu http://dx.doi.org/10.1016/j.dadm.2017.02.003 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/b8/main.PMC5358531.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/b8/main.PMC5358531.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diffusion MRIIdiopathic normal pressure hydrocephalusAxon densityAxon undulation 1.,Non-OADS,/arxiv_data1/oa_pdf/56/3f/main.PMC5358533.pdf
http://dx.doi.org/10.1016/j.nicl.2017.03.003 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/56/3f/main.PMC5358533.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/3f/main.PMC5358533.pdf
"Publicly available toolbox was used for processing NODDI ( https://www.nitrc.org/projects/noddi_toolbox ) (Zhang et al., 2012 )a n dW M T I( https://github.com/NYU- DiffusionMRI/Diffusion-Kurtosis-Imaging )(Fieremans et al., 2011; Veraart et al., 2013 ), respectively.",OADS,/arxiv_data1/oa_pdf/56/3f/main.PMC5358533.pdf
"From the b= 0 and b=1 0 0 0s / m m2 volumes, we reconstructed deterministic diffusion tensor tractography of the CST and maps of conventional DTI metrics (FA, MD, AD, and RD), using Diffusion Toolkit ( http://www.trackvis.org/dtk/ ).",OADS,/arxiv_data1/oa_pdf/56/3f/main.PMC5358533.pdf
"Monte-Carlo simulation Virtual diffusion data were generated using a Monte-Carlo random walk simulation implemented in Camino ( http://camino.cs.ucl.ac.uk /) (Hall and Alexander, 2009 ).",OADS,/arxiv_data1/oa_pdf/56/3f/main.PMC5358533.pdf
http://dx.doi.org/10.1002/nbm.3592 .,Non-OADS,/arxiv_data1/oa_pdf/56/3f/main.PMC5358533.pdf
T HIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE ( http://creativecommons.o rg/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.1016/j.jacbts.2016.08.009,Non-OADS,/arxiv_data1/oa_pdf/e0/de/main.PMC5358672.pdf
This is an open access article underthe CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/de/main.PMC5358672.pdf
The GO project has a controlled vocabulary  to show gene functions in any organism (http://www.geneon - tology.org).,Non-OADS,/arxiv_data1/oa_pdf/05/cc/ijmm-39-02-0287.PMC5358693.pdf
"Thus, in this study, we explored  the interaction between KLKs and cholesterol using  the software PyMOL v1.8 (https://www.pymol.org) and  AutoDock  4.2.6  (http://autodock.scripps.edu).",OADS,/arxiv_data1/oa_pdf/05/cc/ijmm-39-02-0287.PMC5358693.pdf
Cancer Research UK: Statistics 2012-2013. http://www.cancer  researchuk.org/health-professional/cancer-statistics/statistics-by- cancer-type/bladder-cancer.,Non-OADS,/arxiv_data1/oa_pdf/21/15/ijo-50-03-0768.PMC5358710.pdf
ATTC (2014) ATCC C ell Lines by G ene Mutation [Online]  Available: http://www.atcc.org.,Non-OADS,/arxiv_data1/oa_pdf/21/ec/ijo-50-03-0773.PMC5358713.pdf
Available: https://dtp.cancer.gov/dtpstandard/subsets/comp.jsp.,Non-OADS,/arxiv_data1/oa_pdf/21/ec/ijo-50-03-0773.PMC5358713.pdf
The sequencing data were uploaded  to the public database the National Center for Biotechnology  Information  (NCBI; http://www.ncbi.nlm.nih.gov/) under  the BioProject  PRJNA256112 with BioSample accession  no.,OADS,/arxiv_data1/oa_pdf/ce/be/ijmm-39-02-0364.PMC5358717.pdf
The clean reads were assembled using  the short oligonucleotide analysis package SOAPdenovo  (version 2.04; http://soap.genomics.org.cn/).,OADS,/arxiv_data1/oa_pdf/ce/be/ijmm-39-02-0364.PMC5358717.pdf
"Furthermore, tRNA and rRNA (5S, 16S, and 23S rRNA) in the  genomic sequence were searched using tRNAscan -SE (http:// lowelab.ucsc.edu/tRNAscan-SE/) (18) and RNAmmer 1.2  (http://www.cbs.dtu.dk/services /RNAmmer/) (19), respec - tively.",OADS,/arxiv_data1/oa_pdf/ce/be/ijmm-39-02-0364.PMC5358717.pdf
"Additionally, tandem repeat sequences and clustered  regularly interspaced short palindromic repeats (CRISPR)  in the genomic sequence were predicted using the Tandem  Repeat Finder (http://tandem.bu.edu/trf/trf.html) and CRISPR  Finder (http://crispr.u-psud.fr/Server/) software, respectively.",OADS,/arxiv_data1/oa_pdf/ce/be/ijmm-39-02-0364.PMC5358717.pdf
"INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE  39:  364-372,  2017 366 Insertion sequences (ISs) were characterized using the  IS Finder database (https://www-is.biotoul.fr//), and the param - eter -e was set as 1e-5, identity set as 35%.",OADS,/arxiv_data1/oa_pdf/ce/be/ijmm-39-02-0364.PMC5358717.pdf
"Besides, protein  domains associated with the genomic sequence were predicted  using the InterPro database  (https://www.ebi.ac.uk/interpro/),  and the parameter was set as -appl PfamA.",OADS,/arxiv_data1/oa_pdf/ce/be/ijmm-39-02-0364.PMC5358717.pdf
"To identify  potential antibiotic resistance genes in the genomic sequence  of MDR-SHH02, sequence alignment of the protein sequences  of antibiotic resistance genes in the Antibiotic Resistance  Genes database (ARDB; http://ardb.cbcb.umd.edu/) (24)  and MDR-SHH02 genomic sequence was conducted using  BLASTP (E-value ≤10-10, identity score ≥90%, and coverage  length  ≥80%).",OADS,/arxiv_data1/oa_pdf/ce/be/ijmm-39-02-0364.PMC5358717.pdf
"Recruitment of macrophages in close pro- ximity to YAP-expressing cells occurred as early as 2 dafter liver transduction, when only scattered cells [Keywords : tumor-initiating cell; macrophage; liver cancer; immunosurveillance; YAP; Hippo pathway]Corresponding authors: gioacchino.natoli@ieo.itArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.296905.117.© 2017 Austenaa and Natoli This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/28/d3/223.PMC5358718.pdf
"After six months, it is available under a Creative CommonsLicense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/28/d3/223.PMC5358718.pdf
"In addition, replicatingplasmids provided a unique opportunity to isolate pro-teins that associate with DNA at specific times during [Keywords : DNA replication; replication termination; p97; CMG; ubiquitin]Corresponding author: mrape@berkeley.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.297184.117.© 2017 Akopian and Rape This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (Attri-bution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/53/34/226.PMC5358719.pdf
"[Keywords :β-cell; maturation; β-cell heterogeneity; pancreatic islets; stem cell differentiation; aging]Corresponding author: mhebrok@diabetes.ucsf.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.294389.116.© 2017 Liu and Hebrok This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (Attri-bution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/01/ea/228.PMC5358720.pdf
"Results and Discussion Cbx3 binds to gene promoters during differentiation To address whether Cbx3 becomes enriched at promoters upon differentiation, we used ITSF medium to convert [Keywords : Cbx3; Med26; embryonic stem cell; neural precursor; preinitiation complex; mesoderm]Corresponding author: mcarey@mednet.ucla.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.292169.",OADS,/arxiv_data1/oa_pdf/6d/c2/241.PMC5358721.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/6d/c2/241.PMC5358721.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.294348.116.© 2017 Guo et al.,OADS,/arxiv_data1/oa_pdf/81/2c/247.PMC5358722.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/81/2c/247.PMC5358722.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/81/2c/247.PMC5358722.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.292516.116.© 2017 Leung et al.,Non-OADS,/arxiv_data1/oa_pdf/f1/13/260.PMC5358723.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f1/13/260.PMC5358723.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/f1/13/260.PMC5358723.pdf
"In addition, analysis of these puta-tive interacting proteins by Search Tool for the Retrievalof Interacting Genes/Proteins (STRING) database analysis(http://string.embl.de) revealed direct protein interactionnetworks for each of the three histone H2A variants ( Sup- plemental Fig.",OADS,/arxiv_data1/oa_pdf/f1/13/260.PMC5358723.pdf
"ZMYM3 binds to dsDNA To evaluate any potential biological activity associated with ZMYM3, we performed a protein domain analysisusing the protein homology/analogy recognition engine(Phyre2; http://www.sbg.bio.ic.ac.uk/phyre2).",OADS,/arxiv_data1/oa_pdf/f1/13/260.PMC5358723.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.291799.116.© 2017 Dewar et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/d3/275.PMC5358724.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/fd/d3/275.PMC5358724.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/fd/d3/275.PMC5358724.pdf
Raw files and MaxQuant output tables are available at ProteomeXchange (http://proteomecentral.proteomexchange.org; ID = PXD004828).,OADS,/arxiv_data1/oa_pdf/fd/d3/275.PMC5358724.pdf
Corresponding author: spbell@mit.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.291336.116.© 2017 Lõoke et al.,Non-OADS,/arxiv_data1/oa_pdf/28/2f/291.PMC5358725.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/28/2f/291.PMC5358725.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/28/2f/291.PMC5358725.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.290957.116.© 2017 Yazinski et al.,Non-OADS,/arxiv_data1/oa_pdf/fd/4c/318.PMC5358727.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (Attri-bution-NonCommercial 4.0 International), as described at http://creative-commons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/fd/4c/318.PMC5358727.pdf
"(2017) firmly vali- dates K-RAS as a therapeutic target for CRC, the fact [Keywords : colorectal cancer; metastasis; Kras; Apc; P53; invasion] Corresponding author: khaigis@bidmc.harvard.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.297630.117.© 2017 Poulin and Haigis This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/a3/02/333.PMC5358753.pdf
"Whether these changes re-semble the in vivo situation in which preimplantationembryos preferentially use mitochondrial OxPhos butshift toward anaerobic glycolysis after implantation into [Keywords : oxidative phosphorylation; metabolomics; stem cell] Corresponding authors: nghh@gis.a-star.edu.sg, ngsc1@gis.a-star.edu.sgArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.293167.116.© 2017 Shyh-Chang and Ng This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/6a/98/336.PMC5358754.pdf
"After six months, it is available under a Creative CommonsLicense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/6a/98/336.PMC5358754.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.293449.116.© 2017 Boutin et al.,Non-OADS,/arxiv_data1/oa_pdf/1f/83/370.PMC5358757.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1f/83/370.PMC5358757.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/1f/83/370.PMC5358757.pdf
Substitutions were annotated using ANNOVAR based on mouse University of California at Santa Cruz known genes.Tumors from the same mouse were compared using Venny 2.1 (http://bioinfogp.cnb.csic.es/tools/venny/index.html).,OADS,/arxiv_data1/oa_pdf/1f/83/370.PMC5358757.pdf
"KRAS al- lelic frequencies were corrected using APC allelic frequencies (TCGA data portal, https://tcga-data.nci.nih.gov).",OADS,/arxiv_data1/oa_pdf/1f/83/370.PMC5358757.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.290379.116.© 2017 Petrenko et al.,Non-OADS,/arxiv_data1/oa_pdf/9d/46/383.PMC5358758.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/9d/46/383.PMC5358758.pdf
"To identify the tran- scripts expressed in a rhythmic manner in αand βcells, separated populations of these two cell types were isolatedfrom triple reporter islets at six time points over 24 h andsubjected to genome-wide transcriptome analysis byRNA-seq (data available at Gene Expression Omnibus[http://www.ncbi.nlm.nih.gov/geo] through accessionnumber GSE95156) (Materials and Methods; Supplemen- tal Figs.",OADS,/arxiv_data1/oa_pdf/9d/46/383.PMC5358758.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.293134.116.© 2017 Curina et al.,Non-OADS,/arxiv_data1/oa_pdf/71/4f/399.PMC5358759.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/71/4f/399.PMC5358759.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/71/4f/399.PMC5358759.pdf
CRISPR/Cas9 genome editing Single-guide sequences specific to the ETS site of Cep55 andFuz corepromoters(listedin SupplementalTableS8 )weredesignedus- ing the CRISPR design tool (http://tools.genome-engineering.org) and cloned into lentiCRISPRv2 (Sanjana et al.,OADS,/arxiv_data1/oa_pdf/71/4f/399.PMC5358759.pdf
"Accession numbers Raw data sets are available in the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo) under ac- cession number GSE88702, which comprises ChIP-seq data (GSE88699), ATAC-seq data (GSE88698), and expression data(GSE88700).",OADS,/arxiv_data1/oa_pdf/71/4f/399.PMC5358759.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.290155.116.© 2017 McJunkin and Ambros This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2f/6d/422.PMC5358761.pdf
"After six months, it is available under a Creative CommonsLicense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/2f/6d/422.PMC5358761.pdf
"The C. elegans Research Community), WormBook , doi: 10.1895/wormbook.1.8.1, http://www.wormbook.org.",Non-OADS,/arxiv_data1/oa_pdf/2f/6d/422.PMC5358761.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d4/f7/10.1177_2325967117694818.PMC5358815.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/main.PMC5358816.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.009 2210-2612/© 2017  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/b7/2c/main.PMC5358816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/f9/main.PMC5358817.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/f9/main.PMC5358817.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.013Urology Case Reports 12 (2017) 49 e50,Non-OADS,/arxiv_data1/oa_pdf/e4/f9/main.PMC5358817.pdf
Outlines.com .http://www.pathologyoutlines.com/topic/ testisgranulosa.html .,Non-OADS,/arxiv_data1/oa_pdf/e4/f9/main.PMC5358817.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/50/main.PMC5358818.pdf
Microscopic  examination  revealed  non- http://dx.doi.org/10.1016/j.ijscr.2017.02.019 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/67/50/main.PMC5358818.pdf
"25  (March–April  (2))  (2016) 113–115, http://dx.doi.org/10.1016/j.carpath.2015.11.004 ,  Epub  2015 December  1.",Non-OADS,/arxiv_data1/oa_pdf/67/50/main.PMC5358818.pdf
"58  (December  (6))  (2011)  981–987, http://dx.doi.org/10.1053/j.ajkd.2011.05.031 ,  Epub  2011  August  26.",Non-OADS,/arxiv_data1/oa_pdf/67/50/main.PMC5358818.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/1d/main.PMC5358819.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.016 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/59/1d/main.PMC5358819.pdf
http://www.nsfc.gov.cn/ .,Non-OADS,/arxiv_data1/oa_pdf/59/1d/main.PMC5358819.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/main.PMC5358820.pdf
Presentation  of  case Many patients have  been  treated  with  this  technique  at  our clinic  since  2005. http://dx.doi.org/10.1016/j.ijscr.2017.02.011 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/b3/main.PMC5358820.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/8e/main.PMC5358900.pdf
"Ten years  after the kidney  transplant,  the  patient  presented  an  episode of  rejection,  and  lost  the  kidney  graft;  for  which  he  received  PD  for http://dx.doi.org/10.1016/j.ijscr.2017.02.048 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/af/8e/main.PMC5358900.pdf
"[Internet]  7  (9) (2011) 528–538 (Nature  Publishing  Group, Available from:  http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/af/8e/main.PMC5358900.pdf
"[Internet]  78  (2010)  611–618  (Nature Publishing  Group, Available  from:  http://www.ncbi.nlm.nih.gov/pubmed/ 20571473 ).",Non-OADS,/arxiv_data1/oa_pdf/af/8e/main.PMC5358900.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7b/63/main.PMC5358901.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.002 143,OADS,/arxiv_data1/oa_pdf/7b/63/main.PMC5358901.pdf
2016; 24(5): http://dx.doi.org/10.1038/ejhg.2015.205 .,Non-OADS,/arxiv_data1/oa_pdf/7b/63/main.PMC5358901.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC5358902.pdf
The  patient  was  haemodinam- http://dx.doi.org/10.1016/j.ijscr.2017.02.052 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC5358902.pdf
"10  (April  (4))  (2016)  QR04–QR08,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC5358902.pdf
"56  (July  (7))  (2015)  e120–e123,  http://dx.doi.org/ 10.11622/smedj.2015115 .",Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC5358902.pdf
"[18]  M.  Peterzan,  T.  Reynolds,  K.  Dulay,  et  al.,  Thoracic  endometriosis  syndrome manifesting  as  atraumatic  haemothorax  causing  difﬁcult  ventilation  under general  anaesthesia,  BMJ  Case  Rep.  2012  (December)  (2012),  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b6/65/main.PMC5358902.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/d9/main.PMC5358903.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.049 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/d9/main.PMC5358903.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/d8/main.PMC5358904.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.024 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/14/d8/main.PMC5358904.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2017.02.024 .",OADS,/arxiv_data1/oa_pdf/14/d8/main.PMC5358904.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/85/main.PMC5358905.pdf
Although  the  foot http://dx.doi.org/10.1016/j.ijscr.2017.02.038 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/62/85/main.PMC5358905.pdf
"93  (May  (10))  (2011)  937–941,  http://dx.doi.org/10.2106/JBJS.",Non-OADS,/arxiv_data1/oa_pdf/62/85/main.PMC5358905.pdf
"Altman,  D.  Moher,  H.  Sox,  D.  Riley,  the  CARE  Group, The CARE  guidelines:  consensus-based  clinical  case  reporting  guideline development,  BMJ  Case  Rep.  7  (2013)  223,  http://dx.doi.org/10.1186/1752- 1947-7-223 .",Non-OADS,/arxiv_data1/oa_pdf/62/85/main.PMC5358905.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/c1/main.PMC5358906.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.050 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/40/c1/main.PMC5358906.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir November2016, Volume: 8, Issue:11, Pages:3193-3197,DOI:http://dx.doi.org/10.19082/3193 Corresponding author: Associate Professor Dr. Akram Kooshki, Department of Nutrition & B iochemistry, Faculty member of Medicine school, Sabzevar University of Me dical Sciences, Sabzevar, Iran.",Non-OADS,/arxiv_data1/oa_pdf/0b/1d/epj-08-3193.PMC5358924.pdf
Trial registration: The trial was registered at TCTR (http://www.clinicaltrials.in.th/) with the ID: TCTR20160125003.,Non-OADS,/arxiv_data1/oa_pdf/0b/1d/epj-08-3193.PMC5358924.pdf
"http://www.ephysician.ir Page3194the latest statistics, 7.8% of the country’s population is made up of elder people; due to population growth, it is predicated that the levels during the next decade will reach to 16% of the total population (1).",Non-OADS,/arxiv_data1/oa_pdf/0b/1d/epj-08-3193.PMC5358924.pdf
http://www.ephysician.ir Page3196is one of four active ingredients in aqueous extracts of Nigella cumin.,Non-OADS,/arxiv_data1/oa_pdf/0b/1d/epj-08-3193.PMC5358924.pdf
"Clinical trial registration: The trial was registered at Thai Clinical Trials Registry (TCTR, URL: http://www.clinicaltria ls.in.th) with the ID: TCTR20160125003.",Non-OADS,/arxiv_data1/oa_pdf/0b/1d/epj-08-3193.PMC5358924.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir November2016, Volume: 8, Issue:11, Pages:3266-3271,DOI:http://dx.doi.org/10.19082/3266 Corresponding author: Hosein Amini_Anabad, Department of Epidemiology, School of Public Health, Iran University of Medical Scien ces, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/20/56/epj-08-3266.PMC5358925.pdf
"http://www.ephysician.ir Page3268efficiency in the input -oriented model, and six research centers were below the average efficiency in output -and hyperbolic -oriented models.",OADS,/arxiv_data1/oa_pdf/20/56/epj-08-3266.PMC5358925.pdf
http://www.ephysician.ir Page3270below full efficiency.,Non-OADS,/arxiv_data1/oa_pdf/20/56/epj-08-3266.PMC5358925.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/2c/main.PMC5358926.pdf
http://dx.doi.org/10.1016/j.tranon.2017.01.012,OADS,/arxiv_data1/oa_pdf/1b/2c/main.PMC5358926.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2017.02.003,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
CA Cancer J Clin .http://dx.doi.org/10.3322/caac.21166 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Int J Cancer .http://dx.doi.org/10.1002/ijc.25516 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1056/NEJMoa1209120 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1016/S0140-6736(99)06093-6 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Radiology .http://dx.doi.org/10.1148/radiol.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1056/NEJMoa1102873 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1378/chest.07-1352 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Eur J Radiol .http://dx.doi.org/10.1016/S0720-048X(02)00297-8 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Int J Cancer .http://dx.doi.org/10.1002/ijc.21183 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1111/crj.12142 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Am J Physiol Lung Cell Mol Physiol .http://dx.doi.org/10.1152/ajplung.00281.2012 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Cancer Sci .http://dx.doi.org/10.1111/j.1349-7006.2008.00889.x .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1016/j.media.2013.07.002 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
PLoS One .http://dx.doi.org/10.1371/journal.pone.0083806 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1371/journal.pone.0088129 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Am J Pathol .http://dx.doi.org/10.1016/S0002-9440(10)61184-4 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1593/neo.81036 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
JT h o r a cD i s .http://dx.doi.org/10.3978/- j.issn.2072-1439.2014.04.05 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1016/S0002-9440(10)64717-7 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.1016/j.crad.2004.02.018 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Chin J Radiol .http://dx.doi.org/10.3321/j.issn:1005-1201.2008.06.008 .,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
Clin Imaging .http://dx.doi.org/10.1016/j.clinimag.2008.06.028 .,OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
http://dx.doi.org/10.3321/j.issn:1000-467X.2008.12.012 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/9f/d8/main.PMC5358927.pdf
This is an open access articleunder the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/03/main.PMC5358928.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.021 140,OADS,/arxiv_data1/oa_pdf/6c/03/main.PMC5358928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/18/main.PMC5358929.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2017.02.006,OADS,/arxiv_data1/oa_pdf/25/18/main.PMC5358929.pdf
http://dx.doi.org/10.1007/s00330-015-4103-7 .,Non-OADS,/arxiv_data1/oa_pdf/25/18/main.PMC5358929.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/51/main.PMC5358930.pdf
http://dx.doi.org/10.1016/j.tranon.2017.01.016,OADS,/arxiv_data1/oa_pdf/2c/51/main.PMC5358930.pdf
Available online 27 January 2017; http://dx.doi.org/10.1016/j.simyco.2017.01.001 .,OADS,/arxiv_data1/oa_pdf/e5/c3/main.PMC5358931.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).available online at www.studiesinmycology.org STUDIES IN MYCOLOGY 86: 1 –28 (2017).,Non-OADS,/arxiv_data1/oa_pdf/e5/c3/main.PMC5358931.pdf
2004 ) and Repeat Modeler ( http://www.repeatmasker.org/RepeatModeler.html ).,OADS,/arxiv_data1/oa_pdf/e5/c3/main.PMC5358931.pdf
"2010 ) pro ﬁle PF00067 (downloaded from the PFAM protein families database, http://pfam.xfam.org/ , last accessed September 16, 2014) against all 23 black yeast proteomes.Proteins that achieved the cut-off 1e −03 were submitted to BLASTP searches against the fungal p450 CYPs database(Nelson 2009 )(http://blast.uthsc.edu ).",OADS,/arxiv_data1/oa_pdf/e5/c3/main.PMC5358931.pdf
"Calculation of Area Using ImageJ The affected area was calculated from tiled images of the entire posterior pole or submacular choroid as well as gross images using ImageJ software (http://imagej.nih.gov/ij/; provided inthe public domain by the National Institutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/62/90/i1552-5783-58-3-1352.PMC5358932.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/eb/main.PMC5358934.pdf
http://dx.doi.org/10.1016/j.idcr.2017.03.001 2214-2509/Crown  Copyright  ©  2017  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/80/eb/main.PMC5358934.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).IDCases  8  (2017)  37–41 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/80/eb/main.PMC5358934.pdf
"Hepatology  2016,  doi:http://dx.doi.org/10.1002/hep.28957  [ahead  of  print] .",Non-OADS,/arxiv_data1/oa_pdf/80/eb/main.PMC5358934.pdf
"Hepatology  2016,  doi:http://dx.doi.org/10.1002/hep.28876  [ahead  of  print] .",Non-OADS,/arxiv_data1/oa_pdf/80/eb/main.PMC5358934.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/be/main.PMC5358935.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.012 2214-2509/©  2017  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/02/be/main.PMC5358935.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  34–36 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/02/be/main.PMC5358935.pdf
"Ophthal  Plast  Reconstr  Surg  2015,  doi:http://dx.doi.org/10.1097/ iop.0 000000000000604 .",Non-OADS,/arxiv_data1/oa_pdf/02/be/main.PMC5358935.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.02.002,OADS,/arxiv_data1/oa_pdf/01/00/main.PMC5358938.pdf
"Available from: http://globocan.iarc.fr , accessed on 16/02/2017.",Non-OADS,/arxiv_data1/oa_pdf/01/00/main.PMC5358938.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/f7/main.PMC5358939.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.03.014 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/f7/main.PMC5358939.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/95/main.PMC5358940.pdf
"Discussion Retained  foreign  bodies  in  the  operative  site  are  infrequent  but serious  iatrogenic  complication,  ﬁrst  described  by  Wilson  in  1884. http://dx.doi.org/10.1016/j.ijscr.2017.03.004 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/c9/95/main.PMC5358940.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.002 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 16 e20,Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"18 (7) (1999) 611e626, http://dx.doi.org/10.1016/S1053-2498(99)00114-X .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"25 (2) (2015) 244 e249, http://dx.doi.org/10.1183/09031936.05.00054804 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"McLaughlin, A. Shillington, S. Rich, Survival in primary pulmonary hy- pertension: the impact of epoprostenol therapy, Circulation 106 (12) (2002) 1477e1482, http://dx.doi.org/10.1161/01.CIR.0000029100.82385.58 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"27 (2016) 67 e119, http://dx.doi.org/10.1093/eurheartj/ehv317 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"[6] K. Dimopoulus, R. Inuzuka, S. Golleto, G. Giannakoulas, et al., Improved sur- vival among patients with Eisenmenger syndrome receiving advanced ther- apy for pulmonary arterial hypertension, Circulation 121 (1) (2010) 20 e25, http://dx.doi.org/10.1161/CIRCULATIONAHA.109.883876 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"Celermajer, Survival outcomes in severe congenital versus non-congenital pulmonary hypertension, Heart Asia 8 (1) (2016) 3 e7,http://dx.doi.org/10.1136/heartasia-2015-010702 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"53 (9) (2009) 733 e740, http://dx.doi.org/10.1016/j.jacc.2008.11.025 .",OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"Babu-Nrayan, et al., Exercise intolerance in adult congenital heart disease, Circulation 112 (6) (2005) 828e835, http://dx.doi.org/10.1161/CIRCULATIONAHA.104.529800 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"19 (12) (1998) 1845 e1855, http://dx.doi.org/10.1053/ euhj.1998.1046 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"32 (6) (2007) 926 e931, http://dx.doi.org/10.1016/ j.ejcts.2007.08.024 .",OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
https://www.ncbi.nlm.nih.gov/ pubmed/11789765 .,Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"27 (12) (2006) 1472 e1477, http://dx.doi.org/10.1093/ eurheartj/ehl017 .E.",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"Jing, Oral sildena ﬁl treatment for Eisen- menger syndrome: a prospective, open-label, multicenter study, Heart 97 (2011) 1876 e1881, http://dx.doi.org/10.1136/heartjnl-2011-300344 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"[17] S. Mukhopadhyay, M. Sharma, S. Ramakrishnan, et al., Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study, Cir-culation 114 (7) (2006) 1807 e1810, http://dx.doi.org/10.1161/CIRCULATIONAHA.105.603001 .",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
"56 (2015) 3 e7,http://dx.doi.org/10.1536/ihj.14-347 .E.",Non-OADS,/arxiv_data1/oa_pdf/62/b4/main.PMC5358942.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/bb/main.PMC5358943.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d6/bb/main.PMC5358943.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.007Urology Case Reports 12 (2017) 47 e48,Non-OADS,/arxiv_data1/oa_pdf/d6/bb/main.PMC5358943.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/64/main.PMC5358944.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.007 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/64/main.PMC5358944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 25 e26,Non-OADS,/arxiv_data1/oa_pdf/35/64/main.PMC5358944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/c0/main.PMC5358947.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.c om/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2017.03.002 2211-3207/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/c0/main.PMC5358947.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/c8/main.PMC5358948.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.03.003 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/c8/main.PMC5358948.pdf
http://dx.doi.org/10.1016/ j.pt.2017.01.001 .,OADS,/arxiv_data1/oa_pdf/c5/c8/main.PMC5358948.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.03.002 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"Kanakaris,  Management  of  infected  non-union  of  the  proximal femur:  a  combination  of  therapeutic  techniques,  Injury  45  (2014)  2101–2105, http://dx.doi.org/10.1016/j.injury.2014.08.046 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"41  (2010)  1–4, http://dx.doi.org/10.1016/j.ocl.2009.07.003 .",OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"2014  (2014) 710302, http://dx.doi.org/10.1155/2014/710302 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"40  (2015) 593–598, http://dx.doi.org/10.1016/j.jhsa.2014.12.007 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"34 (2016) 180–186, http://dx.doi.org/10.1016/j.ijsu.2016.08.014 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"Tissue  Eng.,  InTech,  2013,  http://dx.doi.org/10.5772/55987 .",OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"Injury  47  (2016)  291–292,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"Injury  41  (2010)  553–554,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"22 (2013)  1897–1906,  http://dx.doi.org/10.1007/s00586-013-2731-7 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"99  (2013)  837–843,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"Giannoudis, O. Faour,  T.  Goff,  N.  Kanakaris,  R.  Dimitriou,  Masquelet technique for  the  treatment  of  bone  defects:  tips-tricks  and  future  directions, Injury 42 (2011)  591–598, http://dx.doi.org/10.1016/j.injury.2011.03.036 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"41 (2010) 49–56, http://dx.doi.org/10.1016/j.ocl.2009.07.010 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"38 (2014) 1971–1978,  http://dx.doi.org/10.1007/s00264-014-2422-y .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"Einhorn,  D.  Marsh,  Fracture  healing:  the  diamond concept, Injury 38  (2007),  http://dx.doi.org/10.1016/s0020-1383(08)70003-2 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"Case  Rep.  17  (2015) 106–111, http://dx.doi.org/10.1016/j.ijscr.2015.10.040 .",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"4  (2004)  743–765,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
"34  (2013)  747–754,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/72/84/main.PMC5358950.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.03.006 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
"(London,  England) 36  (2016)  319–323,  http://dx.doi.org/10.1016/j.ijsu.2016.10.025 .",Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
"250  (2009)  187–196,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
"http://data.worldbank.org/about/ country-and-lending-groups-High  income ,  2017.",Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
"Inc  35  (2015)  1295–1313, http://dx.doi.org/10.1148/rg.2015140313 .",Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
"103  (2006)  165–170,  http://dx.doi.org/10.1016/j.ygyno.2006.02.016 .",OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
"10  (2005)  177–181,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
"21  (2012)  1614–1617,  http://dx.doi.org/10.1158/1055-9965.",Non-OADS,/arxiv_data1/oa_pdf/13/6c/main.PMC5358951.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/3b/main.PMC5358952.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.001 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/3b/main.PMC5358952.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 12 e15,Non-OADS,/arxiv_data1/oa_pdf/33/3b/main.PMC5358952.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.02.009,OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1093/annonc/mdu050 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1056/NEJM198007243030403 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1378/chest.10-2133 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1002/cncr.20157 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.3109/02688697.2013.791664 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1007/s10495-013-0877-8 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1016/j.bbamcr.2013.03.029 .,OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1186/1471-2407-10-30 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1093/nop/npv010 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.or- g/10.3892/ijo.2014.2382 [Erratum in: Int J Oncol.,OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1074/jbc.C000228200 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1074/jbc.M113.528430 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1126/scitranslmed.aaf6853 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1007/s11060-014-1551-x .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1074/jbc.M116.730168 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1042/BJ20060793 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1177/1087057113480525 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1093/nar/gku1209 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1038/nn.3510 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1093/neuonc/nov328 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1007/s11060-015-1996-6 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-03-3429 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
"BMC Med 11, 81. http://dx.doi.org/10.1186/1741-7015-11-81 .",Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
http://dx.doi.org/10.1074/jbc.M110.176321 .,Non-OADS,/arxiv_data1/oa_pdf/9b/64/main.PMC5358953.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.02.008,OADS,/arxiv_data1/oa_pdf/dc/55/main.PMC5358954.pdf
"H460, H1299, H358, H2009, and H596 cells wereobtained from the Korean Cell Line Bank in 2012 ( https://cellbank.snu.",Non-OADS,/arxiv_data1/oa_pdf/dc/55/main.PMC5358954.pdf
"Total RNA was extracted using TRI reagent (Ambion, Austin, TX, USA).Quantitative RT-PCR analysis was performed using TaqMan GeneExpression assay reagents and the StepOnePlus Real-Time PCRsystem (Applied Biosystems, Carlsbad, CA, USA) using aninventoried primer-probe set ( http://bioinfo.appliedbiosystems.com/ genome-database/gene-expression.html ).",OADS,/arxiv_data1/oa_pdf/dc/55/main.PMC5358954.pdf
"Mouse Imaging LSL K-ras G12D mice were obtained from the NCI mouse repository ( http://mouse.ncifcrf.gov /), bred, and genotyped according to the supplier's guidelines.",Non-OADS,/arxiv_data1/oa_pdf/dc/55/main.PMC5358954.pdf
*A549 cells do not express BCL-2 ( http://www.proteinatlas.org/ENSG00000171791-BCL2/cell/CAB000003 ).,Non-OADS,/arxiv_data1/oa_pdf/dc/55/main.PMC5358954.pdf
*A549 cells do not express BCL-2 ( http://www.proteinatlas.org/ENSG00000171791-BCL2/cell/CAB000003 ).Neoplasia Vol.,Non-OADS,/arxiv_data1/oa_pdf/dc/55/main.PMC5358954.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/d8/main.PMC5358955.pdf
On  the  14th  post-operative  day  the http://dx.doi.org/10.1016/j.ijscr.2017.02.054 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/bb/d8/main.PMC5358955.pdf
"1)  (2016)  80–84,  http://dx.doi.org/10.1590/0102- 6720201600S10020 .",Non-OADS,/arxiv_data1/oa_pdf/bb/d8/main.PMC5358955.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/06/main.PMC5358956.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.03.005 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/23/06/main.PMC5358956.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2017:13 91–99Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  91 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S125966Aerobic fitness is associated with low  cardiovascular disease risk: the impact of lifestyle  on early risk factors for atherosclerosis in  young healthy Swedish individuals – the Lifestyle, Biomarker, and Atherosclerosis study Maria Fernström1,*  Ulrika Fernberg2,*  Gabriella Eliason1  Anita Hurtig-Wennlöf1 1Department of Medical Diagnostics,   Medical Faculty, School of Health  Sciences, 2Medical Faculty, School of  Medical Sciences, Örebro University,  Örebro, Sweden *These authors contributed equally to  this workBackground: The progression of cardiovascular disease (CVD) and atherosclerosis is slow and  develops over decades.",Non-OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
"Keywords: cIMT, cholesterol, insulin resistance, body fat, diet, aerobic fitness Background Cardiovascular disease (CVD) is one of the most common and serious diseases in  modern society.1 The atherosclerotic process is complex and involves inflammation Correspondence: Maria Fernström   Department of Medical Diagnostics,  School of Health Sciences, Örebro University, Fakultetsgatan 1, 701 82 Örebro, Sweden Tel +46 19 30 12 26   Email maria.fernstrom@oru.seJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 13Running head verso: Fernström et alRunning head recto: Risk factors for atherosclerosis in young adultsDOI: http://dx.doi.org/10.2147/VHRM.S125966",Non-OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
Available from: https://www.livsmedelsverket.se/matvanor-halsa--miljo/kostrad-och-matvanor/matvanekollen/.,Non-OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
Available from: http://apps.who.int/bmi/index.jsp.,OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
Available from: http://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/diagnosis-treatment/diagnosis/dxc-20181913.,Non-OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
Available from: http://www.statistikdatabasen.scb.se.,OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
"Vascular Health and Risk Management  2017:13submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 99 Risk factors for atherosclerosis in young adults 28.,Non-OADS,/arxiv_data1/oa_pdf/08/6f/vhrm-13-091.PMC5358957.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/22/cia-12-515.PMC5358958.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 515–521Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  515OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13263 7 Oral conditions and dysphagia in Japanese,  community-dwelling middle- and older- aged  adults, independent in daily living Akinari Inui1 Ippei Takahashi2 sizuka Kurauchi2 Yuki soma2 T oshiaki Oyama1 Y oshihiro Tamura1 Takao noguchi1 Kouichi Murashita3 shigeyuki nakaji2 Wataru Kobayashi1 1Department of Oral and Maxillofacial  surgery, 2Department of social  Medicine, 3COI research Initiatives  Organization, hirosaki University  graduate school of Medicine,   hirosaki, Aomori Prefecture, JapanPurpose:  Prevention, early detection and effective rehabilitation of dysphagia are important  issues to be considered in an aging society.",Non-OADS,/arxiv_data1/oa_pdf/3d/22/cia-12-515.PMC5358958.pdf
"Previously, Serra-Prat  et al reported that the signs of dysphagia were prevalent in 27.2% of subjects aged 70  and older.3 Additionally, previous studies have shown conflicting findings regarding Correspondence: Akinari Inui Department of Oral and Maxillofacial  surgery, hirosaki University graduate  school of Medicine, 5 Zaifutyo, hirosaki  036-8562, Aomori Prefecture, Japan Tel +81 172 39 5127 Fax +81 172 39 5128 email h14gm308@hirosaki-u.ac.j p Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Inui et al Running head recto: Oral conditions and dysphagia DOI: http://dx.doi.org/10.2147/CIA.S132637",Non-OADS,/arxiv_data1/oa_pdf/3d/22/cia-12-515.PMC5358958.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3d/22/cia-12-515.PMC5358958.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3d/22/cia-12-515.PMC5358958.pdf
"Available from: http://www.mhlw.go.j p. Accessed  January 15, 2017.",Non-OADS,/arxiv_data1/oa_pdf/3d/22/cia-12-515.PMC5358958.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fd/89/bctt-9-171.PMC5358959.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fd/89/bctt-9-171.PMC5358959.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 171–175Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 171 Original researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S120005 Preexposure of MCF-7 breast cancer cell line  to dexamethasone alters the cytotoxic effect  of paclitaxel but not 5-fluorouracil   or epirubicin chemotherapy Frederic Buxant1,*  nadège Kindt2,*  Jean-Christophe noël3  guy laurent4,†  sven saussez2 1Department of gynaecology, iris  south hospital, Brussels, 2Department  of anatomy, laboratory of anatomy  and Cell Biology, Faculty of Medicine  and Pharmacy, University of Mons,  Mons,  3Department of Pathology,   erasme hospital, Free University of  Brussels (UlB), Brussels, 4Department  of histology, laboratory of histology,   Faculty of Medicine and Pharmacy,  University of Mons, Mons, Belgium *These authors contributed equally to  this work †Dr guy laurent passed away on  august 9, 2016Purpose: Glucocorticoids (GCs) are often administered prior to any chemotherapeutics to  prevent the secondary effects of anticancer agents.",Non-OADS,/arxiv_data1/oa_pdf/fd/89/bctt-9-171.PMC5358959.pdf
"Use of taxanes was initially Correspondence: Frederic Buxant Department of gynaecology, his-ixelles hospital, rue Jean Paquot 63, 1050 Brussels, BelgiumTel +32 2 641 4134Fax +32 2 639 8909email fbuxant@his-izz.beJournal name: Breast Cancer - Targets and Therapy Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Buxant et alRunning head recto: Dexamethasone pretreatment before chemotherapy in MCF-7 cellsDOI: http://dx.doi.org/10.2147/BCTT.S120005",Non-OADS,/arxiv_data1/oa_pdf/fd/89/bctt-9-171.PMC5358959.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/fd/89/bctt-9-171.PMC5358959.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 175 Dexamethasone pretreatment before chemotherapy in MCF-7 cells 13.,Non-OADS,/arxiv_data1/oa_pdf/fd/89/bctt-9-171.PMC5358959.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Core Evidence 2017:12 1–10Core Evidence Dovepress submit your manuscript | www.dovepress.com Dovepress 1 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S109654 Canagliflozin in the treatment of type 2 diabetes:  an evidence-based review of its place in therapy Thomas Karagiannis1 Eleni Bekiari1 Apostolos Tsapas1,2 1Clinical Research and Evidence-Based  Medicine Unit, Second Medical  Department, Aristotle University of Thessaloniki, Thessaloniki, Greece;   2Harris Manchester College,   University of Oxford, Oxford,  United  KingdomIntroduction: Deciding on an optimal medication choice for type 2 diabetes is often challeng- ing, due to the increasing number of treatment options.",Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
"Keywords: canagliflozin, type 2 diabetes mellitus, evidence-based review, efficacy, safety,  cost-effectiveness, tolerability, cardiovascular outcomes Core evidence clinical impact summary for canagliflozin Outcome measure Evidence Implications Disease-oriented evidence Glycemic efficacy versus placebo Clear (pair-wise  meta-analyses of randomized controlled trials [RCTs])Canagliflozin 100 and 300 mg once daily reduce HbA1c by 0.6%–0.8%, respectively (Continued )Correspondence: Thomas Karagiannis Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642 Thessaloniki, GreeceTel +30 231 089 2738Fax +30 231 099 2794Email tkaragian@auth.grJournal name: Core Evidence Article Designation: REVIEWY ear: 2017V olume: 12Running head verso: Karagiannis et alRunning head recto: Canagliflozin for type 2 diabetesDOI: http://dx.doi.org/10.2147/CE.S109654",Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htm.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Avail- able from: http://www.ema.europa.eu/ema/index.jsp?curl= pages/ medicines/human/medicines/002649/human_med_001707.jsp&mid=WC0b01ac058001d124.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.nlm.nih.gov/bsd/pubmed_subsets/sysre-views_strategy.html.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: http://work.cochrane.org/pubmed.,OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.cadth.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available  from: https://www.nice.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.cadth.ca/.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.icanimagine.com/sites/www.ican-imagine.com/files/prescribing-information-invokana.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.medicines.org.uk/emc/medicine/28400#POSOLOGY .,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.nice.org.uk/guidance/ta390.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.ispor.org/research_pdfs/46/pdffiles/PDB72.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
"Core Evidence 2017:12submit your manuscript | www.dovepress.com Dovepress Dovepress Core Evidence Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/core-evidence-journalCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to post launch.",Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 10 Karagiannis et al  56.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.ispor.org/research_pdfs/49/pdffiles/PDB55.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.ispor.org/research_pdfs/46/pdffiles/PDB60.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.nice.org.uk/guidance/ta315.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.ispor.org/research_pdfs/46/pdffiles/PDB62.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: https://www.ispor.org/research_pdfs/49/pdffiles/PDB50.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce-ments/ucm531517.htm.,Non-OADS,/arxiv_data1/oa_pdf/43/36/ce-12-001.PMC5358960.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ce/2f/ccide-9-013.PMC5358961.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ce/2f/ccide-9-013.PMC5358961.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dentistry 2017:9 13–18Clinical, Cosmetic and Investigational Dentistry Dovepress submit your manuscript | www.dovepress.com Dovepress 13 OrIg Inal researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCIDE.S130856 Marginal fit of all-ceramic crowns fabricated using  two extraoral C aD/C aM systems in comparison  with the conventional technique Fawaz alqahtani1,2 1Department  of Prosthodontics,   2Higher Education and Scientific  Research, School of Dentistry, Prince  Sattam Bin Abdul-Aziz University,  Al-kharj, Saudi ArabiaObjective: The purpose of this study was to determine the effect of two extraoral computer- aided design (CAD) and computer-aided manufacturing (CAM) systems, in comparison with  conventional techniques, on the marginal fit of monolithic CAD/CAM lithium disilicate ceramic  crowns.",Non-OADS,/arxiv_data1/oa_pdf/ce/2f/ccide-9-013.PMC5358961.pdf
"Marginal fit is a key factor in assuring the longevity of full-veneer restorations; 5 a poor fit leads to cement  dissolution and Correspondence: Fawaz alqahtani Department of Prosthodontics, School of Dentistry, Prince Sattam Bin Abdul-Aziz University, PO Box 153, Al-kharj 11942, Saudi ArabiaTel +966 54 063 3399Fax +966 11 588 6201email implantologist@yahoo.comJournal name: Clinical, Cosmetic and Investigational Dentistry Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: AlqahtaniRunning head recto: Marginal fit of all-ceramic crowns using CAD/CAMDOI: http://dx.doi.org/10.2147/CCIDE.S130856",Non-OADS,/arxiv_data1/oa_pdf/ce/2f/ccide-9-013.PMC5358961.pdf
"Clinical, Cosmetic and Investigational Dentistry 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journalClinical, Cosmetic and Investigational Dentistry is an international,   peer-reviewed, open access, online journal focusing on the latest clini- cal and experimental research in dentistry with specific emphasis on cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/ce/2f/ccide-9-013.PMC5358961.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ce/2f/ccide-9-013.PMC5358961.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/2e/ceor-9-189.PMC5358962.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e2/2e/ceor-9-189.PMC5358962.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 189–199ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  189 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S129696Survey on attitudes of Italian pediatricians   toward cough Alessandro Zanasi1  Luigi Morcaldi2  Salvatore Cazzato3  Massimiliano Mazzolini4  Marzia Lecchi5  Antonio Maria Morselli- Labate6  Marianna Mastroroberto6  Roberto W Dal Negro7 1Italian Association for Cough Study,   Bologna, 2National Observatory  of Health in Childhood and  Adolescence (PAIDOSS: Osservatorio Nazionale sulla Salute dell’Infanzia e dell’Adolescenza), Rome,  3Department  of Pediatrics, Salesi Children’s Hospital, Ancona,  4Department  of Specialist, Diagnostic and Experimental Medicine, Respiratory and Critical Care Unit, S.Orsola-Malpighi Hospital, University of Bologna, Bologna,  5Department of  Biotechnology and Biosciences,  University of Milan Bicocca,  Milan,  6Department of Medical  and Surgical Sciences, Alma Mater Studiorum, University of Bologna,  Bologna,  7National Centre for  Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, ItalyContext: Children’ s cough is a daily concern for most pediatricians.",Non-OADS,/arxiv_data1/oa_pdf/e2/2e/ceor-9-189.PMC5358962.pdf
"Several studies have described Correspondence: Roberto W Dal Negro   National Centre for Respiratory  Pharmacoeconomics and Pharmacoepidemiology, Via Gabriele Rossetti, 4, 37124 Verona, Italy   Tel +39 348 316 8888   Email robertodalnegro@gmail.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Zanasi et alRunning head recto: Attitudes of Italian pediatricians toward coughDOI: http://dx.doi.org/10.2147/CEOR.S129696",Non-OADS,/arxiv_data1/oa_pdf/e2/2e/ceor-9-189.PMC5358962.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/e2/2e/ceor-9-189.PMC5358962.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 199 Attitudes of Italian pediatricians toward cough  □ Mucoactives  □ Cough suppressants  □ Antibiotics  □ Homeopathic drugs  □ Herbal remedies  □ Other (please, specify) ……………………………………………….",Non-OADS,/arxiv_data1/oa_pdf/e2/2e/ceor-9-189.PMC5358962.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 505–513Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  505OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12723 3 The effectiveness of a basic exercise intervention  to improve strength and balance in women with  osteoporosis Montserrat Otero1 Izaro esain2 Ángel M gonzález-suarez1 susana M gil2 1Department of Physical education  and sport, Faculty of education and  sport sciences, University of the  Basque Country (UPV/ ehU), Vitoria- gasteiz, 2Department of Physiology,   Faculty of Medicine and nursing,   University of the Basque Country  (UPV/ ehU), leioa, Bizkaia, spainObjective:  To determine the effects of a simple exercise program on the balance and strength  of postmenopausal women with osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
"It is estimated that this figure will reach  33.9 million women by the year 2025.1 One in three women worldwide is at risk of  suffering an osteoporotic fracture, which is precisely the most serious consequence  of this disease.2 The principal cause of these fractures is falls, which in elderly people  are related to, among other factors, a deteriorated sense of balance3 and low levels of  muscular strength.4 Such is their importance that, in elderly people, having high levels  of strength in the lower limbs and having good balance are important requisites for being  independent and being able to carry out daily activities.5–7 For this reason, increasing the  levels of strength and balance achieved by practicing physical exercise,3,8,9 constitutes Correspondence: susana M gil Department of Physiology, Faculty of  Medicine and nursing, University of the  Basque Country (UPV/ehU), Barrio  sarriena s/n, 48940 leioa, Bizkaia, spain Tel +34 946 012 958 email susana.gil@ehu.eu s Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Otero et al Running head recto: Exercise for osteoporotic women DOI: http://dx.doi.org/10.2147/CIA.S127233",Non-OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
"Available from:  http://www.iofbonehealth.or g. Accessed November 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
Available from: http://www.who.int /.,Non-OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/39142/1/WHO_TRS_843_eng.,OADS,/arxiv_data1/oa_pdf/7a/a5/cia-12-505.PMC5358963.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/f5/cia-12-523.PMC5358964.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 523–529Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  523OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11032 9 Correlation between thoracolumbar curvatures  and respiratory function in older adults nor najwatul Akmal Ab  rahman1 Devinder Kaur Ajit singh1 raymond lee2 1Physiotherapy Programme, school  of rehabilitation sciences, Faculty  of health sciences, Universiti  Kebangsaan Malaysia, Jalan raja Muda  Abdul Aziz, Kuala lumpur, Malaysia;   2school of Applied sciences, london  south Bank University, london, UKAbstract:  Aging is associated with alterations in thoracolumbar curvatures and respiratory  function.",Non-OADS,/arxiv_data1/oa_pdf/11/f5/cia-12-523.PMC5358964.pdf
"In 2008, the census for Malaysia showed that  7% of its population were aged 60 years and above,1 and by 2020, it will increase to  9.5% of the country’s population.2 The growth of an aging population will exhaust  the health care system as there will be an increase in the health care financial and  clinical resources.3 It is well documented that physiological changes take place in multiple organs with  aging that include respiratory system4–7 and thoracolumbar curvatures.8–11 The correla - tion between respiratory function and thoracolumbar curvatures has been discussed in  the literature.12–15 A significant correlation between only lumbar curvature angle with  forced vital capacity (FVC; r=−0.65), %FVC ( r=−0.63) and forced expiratory volume Correspondence: Devinder Kaur Ajit  singh Physiotherapy Programme, school of  rehabilitation sciences, Faculty of health  sciences, Universiti Kebangsaan Malaysia,  Jalan raja Muda Abdul Aziz, 50300 Kuala  lumpur, Malaysia Tel +60 3 2687 8003 Fax +60 3 2687 8199 email devinder@ukm.edu.m y Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Rahman et al Running head recto: Correlation between thoracolumbar curvature and respiratory function DOI: http://dx.doi.org/10.2147/CIA.S110329",Non-OADS,/arxiv_data1/oa_pdf/11/f5/cia-12-523.PMC5358964.pdf
"Available  from: http://www.who.int/gho/publications/world_health_statistics/ EN_WHS10_Full.pd f. Accessed November 25, 2010.",Non-OADS,/arxiv_data1/oa_pdf/11/f5/cia-12-523.PMC5358964.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical­interventions­in­aging­journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/11/f5/cia-12-523.PMC5358964.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/11/f5/cia-12-523.PMC5358964.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/34/main.PMC5358969.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.008 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/34/main.PMC5358969.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 7 e11,Non-OADS,/arxiv_data1/oa_pdf/ed/34/main.PMC5358969.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/6a/main.PMC5358970.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.009 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/6a/main.PMC5358970.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 21 e24,Non-OADS,/arxiv_data1/oa_pdf/b1/6a/main.PMC5358970.pdf
"Four different weathering combinations were tested: 10 mg of oilmixed in 150 ml artificial seawater (OAS) or natural (i.e., GoM) seawater (ON) and 10 mg of oil with dispersant mixed with 150 ml of artificial seawater (OASD)Received: 14 June 2016 Revised: 26 January 2017 Accepted: 13 March 2017 Heliyon 3 (2017) e00269 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"These actions, in turn, increase crude oil bioavailability and thus stimulate the biodegradation and Article No~e00269 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
4) Can certain hydrocarbon ratios be used throughout the Article No~e00269 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Test # Weight of dispersed oil (g) Weight of oil (g) 1 0.0102 0.0107 2 0.0104 0.01103 0.0099 0.0106 4 0.0101 0.0101 5 0.0101 0.0102 6 0.0100 0.0109 7 0.0095 0.01018 0.0104 0.0099 9 0.0098 0.0106 10 0.0102 0.0103 Average 0.0101 0.0104 Article No~e00269 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"Ref Microbial Influence Source of Seawater Temp °C Oil (ppm) Half-Life (days) Analytes Measured Siron et al., 1995 Natural St Lawrence Estuary 4 67 2.1 Soluble Phenanthrenes Brakstad and Faksness, 2000 Natural Trondheim Fjord 13 1000 2.6 nC5-nC9Alkanes and Aromatics Venosa and Holder, 2007 Addition from Prince William Sound, AK Artificial 20 70 6 nC10-nC35 3 51 0 4 Prince et al., 2007 Natural New Jersey 21 70 5 Hydrocarbons greater than nC12 Hazen et al., 2010 Natural Gulf of Mexico 5 N/A 3 nC13-nC26 Campo et al., 2013 Addition from Macondo Wellhead Artificial 25 700 2 nC10-nC35 0.4 51 2 2.8 Prince et al., 2013 Natural New Jersey 8 2.5 2.5 nC18 13 and Total Hydrocarbons 2.2 nC18 11 and Total Hydrocarbons Prince and Butler, 2014 Natural New Jersey 21 2.5 8 Total Hydrocarbons 260 Wang et al., 2016 Natural Gulf of Mexico (deep-water) 5 2 2-16 after a several day lagSaturated and Aromatic Hydrocarbons Zhuang et al., 2016 Addition from Macondo Wellhead Artificial 25 830 3 Total Alkanes 5 52 5 11 Article No~e00269 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Weathering Process Oil Nutrient Aqueous phase OAS 10 mg Lab Weathered Oil Yes 150 ml Artificial sea water OASD 10 mg Dispersed Lab Weathered Oil Yes 150 ml Artificial sea waterON 10 mg Lab Weathered Oil Yes 150 ml Natural sea water OND 10 mg Dispersed Lab Weathered Oil Yes 150 ml Natural sea water Article No~e00269 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"These ratios, however, can be rapidly degraded to Article No~e00269 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"Quantitative biomarker ratios from GC/MS analyses of the oil in various microcosm samples were then compared to the average (n = 15 in our study, Article No~e00269 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"Name m/z Ret Time Name m/z Ret Time (TC28R) Tricyclic Triterpane (22R) 191 45.32 (C27dbS) 13beta,17alpha-diacholestane (20S) 217 43.87 (TC28S) Tricyclic Triterpane (22S) 191 45.52 (C27dbR) 13beta,17alpha-diacholestane (20R) 217 44.37 (TC29R) Tricyclic Triterpane (22R) 191 46.14 (C27aaS) 5alpha,14alpha,17alpha-cholestane (20S) 217 46.16(TC29S) Tricyclic Triterpane (22S) 191 46.38 (C29DbaS) 13beta,17alpha-diaethylcholestane (20S) 217 46.27 (C27Ts) 18alpha(H)-22,29,30-trisnorhopane 191 47.16 (C27aaR) 5alpha,14alpha,17alpha-cholestane (20R) 217 46.73 (C27Tm) 17alpha(H)-22,29,30-trisnorhopane 191 47.72 (C29DbaR) 13beta,17alpha-diaethylcholestane (20R) 217 46.82 (C28ab) 17alpha(H), 21beta(H)-28,30-bisnorhopane 191 48.69 (C28aaS) 5alpha,14alpha,17alpha,24-methylcholestane (20S) 217 47.57 (C25norC29ab) 17alpha(H),21beta(H)-25-norhopane 191 49.06 (C28bbS) 5alpha,14beta,17beta,24-methylcholestane (20S) 217 47.70(C29ab) 17alpha(H)21beta(H)-30-norhopane 191 49.77 (C28bbR) 5alpha,14beta,17beta,24-methylcholestane (20R) 217 47.81 (C29Ts) 18alpha(H)-30-norneohopane 191 49.87 (C28aaR) 5alpha,14alpha,17alpha,24-methylcholestane (20R) 217 48.27 (C30d) 15alpha-methyl-17alpha(H)-27-norhopane (diahopane) 191 50.10 (C29aaS) 5alpha,14alpha,17alpha,24-ethylcholestane (20S) 217 48.69 (C29ba) 17beta(H),21alpha(H)-normoretane 191 50.58 (C29bbR) 5alpha,14beta,17beta,24-ethylcholestane (20R-m/z 217) 217 48.94 (C30 O) 18alpha(H) and 18beta(H) oleanane 191 N/A (C29bbS) 5alpha,14beta,17beta,24-ethylcholestane (20S-m/z 217) 217 49.02 (C30ab) 17alpha(H),21beta(H)-hopane 191 51.18 (C29aaR) 5alpha,14alpha,17alpha,24-ethylcholestane (20R) 217 49.65 (C30ba) 17beta(H),21alpha(H)-moretane 191 51.87 (C27bbR) 5alpha,14beta,17beta-cholestane (20R) 218 46.27 (C31abS) 22S-17alpha(H),21beta(H)-30-homohopane 191 52.99 (C27bbS) 5alpha,14beta,17beta-cholestane (20S) 218 46.39 (C31abR) 22R-17alpha(H),21beta(H)-30-homohopane 191 53.23 (C28bbR) 5alpha,14beta,17beta,24-methylcholestane (20R) 218 47.70 (C30G) Gammacerane 191 N/A (C28bbS) 5alpha,14beta,17beta,24-methylcholestane (20S) 218 47.81 (C32abS) 22S-17alpha(H),21beta(H)-30-bishomohopane 191 54.55 (C29bbR) 5alpha,14beta,17beta,24-ethylcholestane (20R-m/z 218) 218 48.95 (C32abR) 22R-17alpha(H),21beta(H)-30-bishomohopane 191 54.90 (C29bbS) 5alpha,14beta,17beta,24-ethylcholestane (20S-m/z 218) 218 49.04 (C33abS) 22S-17alpha(H),21beta(H)-30-trihomohopane 191 56.50 (C20TA) C20-Triaromatic Steroids 231 40.65 (C33abR) 22R-17alpha(H),21beta(H)-30-trihomohopane 191 57.03 (C21TA) C21-Triaromatic Steroids 231 42.13 (C34abS) 22S-17alpha(H),21beta(H)-30-tetrahomohopane 191 58.76 (SC26TA) C26,20S-Triaromatic Steroids 231 47.63(C34abR) 22R-17alpha(H),21beta(H)-30-tetrahomohopane 191 59.45 (RC26TA + SC27TA) C2620R + C27,20S-Triaromatic Steroids 231 48.67 (Continued ) Article No~e00269 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"(Continued ) Name m/z Ret Time Name m/z Ret Time (C35abS) 22S-17alpha(H),21beta(H)-30-pentahomohopane 191 61.17 (SC28TA) C28,20S-Triaromatic Steroids 231 49.61 (C35abR) 22R-17alpha(H),21beta(H)-30-pentahomohopane 191 62.14 (RC27TA) C27,20R-Triaromatic Steroids 231 50.12 (RC28TA) C28,20R-Triaromatic Steroids 231 51.40 Article No~e00269 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Class Diagnostic Ratio Tri- and Pentacyclic Triterpanes (Hopanes) (m/z 191) C27Ts/C27Tm C29αβ/C29Ts C29αβ/C30αβ C31 ab(S + R)/C32 ab(S + R) + C33 ab(S + R) C32 ab(S + R)/C31 ab(S + R) + C33 ab(S + R) C33 ab(S + R)/C31 aB(S + R) + C32 ab(S + R) Rearranged and Regular 14 α(H)- and 14 β(H)-Steranes (m/z 217 and 218) C27D Ba-S/C27D Ba-R C29D Ba-S/C29D Ba-R C28 aaa-R/C29 aaa-R C29 aa-S/C29 aa-R C29 BB-R/C29 BB-SC29ααS/C29 αα(S + R) C29ββ(R + S)/C29 αα(S + R) C27 BB-R/C27 BB-S C28 BB-R/C28 BB-S C29 BB-R/C29 BB-S C27ββ(R + S)/[C28 ββ(R + S) + C29 ββ(R + S)] C28ββ(R + S)/[C27 ββ(R + S) + C29 ββ(R + S)] C29ββ(R + S)/[C27 ββ(R + S) + C28 ββ(R + S)] Triaromatic Steroids (m/z 231) C20 TA/C21 TA SC26TA/SC28TA RC27TA/RC28TA Inter-Ion Biomarker Ratios (m/z 218/191) C27 ββ(R + S)/C30 αβ C29ββ(R + S)/C30 αβ Article No~e00269 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"3 , with the majority of the alkane Article No~e00269 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 23 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 24 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 25 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 26 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 27 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 28 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"The D2/P2 and D3/P3 ratios remainedconstant in OAS and OASD treatments, however, they increased over the course of Article No~e00269 29 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
"4) Various forensic diagnostic biomarker ratios (i.e., compounds within the m/z 191, 217, 218, and 231 EICs) provided data for forensic identification of MC252 Article No~e00269 30 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 31 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Data are publicly available through the Gulf of Mexico Research Initiative Information & Data Cooperative (GRIIDC) at https://data.gulfresearchinitiative.,OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 32 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 33 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
[Accessed 24 October 2016] https://www.gpo.gov/fdsys/pkg/CFR-2011-title40-vol28/pdf/CFR-2011-ti- tle40-vol28-part300-appC.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 34 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
https://www.epa.gov/hw-sw846/sw-846-compendium .,OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
Article No~e00269 35 http://dx.doi.org/10.1016/j.heliyon.2017.e00269 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/bc/main.PMC5358971.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance 2017:10 97–101Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 97 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S126209Antimicrobial susceptibility profile, treatment  outcome and serotype distribution of clinical  isolates of Salmonella enterica subspecies enterica:  a 2-year study from Kerala, South India Deepa Harichandran Kavitha Radhakrishnan  Dinesh Department of Microbiology, Amrita  School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham University, Kochi, Kerala, IndiaBackground/purpose: Typhoid and paratyphoid fever continue to be important causes of  illness and death in parts of Asia, being associated with poor sanitation and consumption of  unsafe food and water.",Non-OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
"Recovery rate was 97%.Keywords: Salmonella enterica, susceptibility profile, clinical isolatesCorrespondence: Kavitha Radhakrishnan  DineshDepartment of Microbiology, Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham University, AIMS-Ponekkara Post, Kochi, Kerala, IndiaTel +91 484 285 8010Fax +91 484 280 2020Email kavitharadhakrishnan@aims.amrita.eduJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Harichandran and DineshRunning head recto: Clinical isolates of Salmonella enterica subspecies from KeralaDOI: http://dx.doi.org/10.2147/IDR.S126209",Non-OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
Available from: http://www.uptodate.com.,Non-OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs139/en/.,Non-OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
"Infection and Drug Resistance 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 101 Clinical isolates of Salmonella enterica subspecies from Kerala,Non-OADS,/arxiv_data1/oa_pdf/89/a1/idr-10-097.PMC5358982.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 315–323Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  315Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S11110 7 Role of iL-17 in plaque psoriasis: therapeutic  potential of ixekizumab T essa L Hanley1 Zenas ZN Yiu2,3 1Fairfield General Hospital, Bury,   2Centre for Dermatology, 3Centre  for Pharmacoepidemiology and Drug  Safety, Manchester Academic Health  Science Centre, Manchester, UKAbstract:  Developments in the understanding of the immunopathogenesis of psoriasis have  identified interleukin (IL)-17 as the key proinflammatory cytokine in the pathogenesis of plaque  psoriasis, with the consequent development of drugs that target this cytokine or associated  receptors.",Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
"Current licensed biologics include the tumor necrosis  factor (TNF)- α inhibitors etanercept, infliximab and adalimumab; interleukin(IL)-12/ IL-23 antagonist ustekinumab and the IL-17 antagonist secukinumab.6 The increased Correspondence: Zenas ZN Yiu Dermatology Centre, Salford Royal  NHS Foundation Trust, The University  of Manchester, Manchester Academic  Health Science Centre, Manchester, UK Tel +44 161 306 0620 email zenas.yiu@manchester.ac.u k Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Hanley and Yiu Running head recto: Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab DOI: http://dx.doi.org/10.2147/TCRM.S111107",Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/003943/ WC500205804.pd f. Accessed 26/10/2016.,Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
Available from https://clinicaltrials.gov/ct2/show/NCT02561806?ter m=ixekizumab&rank =12.,Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
"October 4, 2016. https://www.youtube.com/watch?v =pTasylB3yA U,  2016.",Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/84/tcrm-13-315.PMC5358983.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/cf/ijn-12-2045.PMC5358984.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2045–2059International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2045OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12529 3 Octanoyl galactose ester-modified microemulsion  system self-assembled by coix seed components  to enhance tumor targeting and hepatoma therapy Ding Qu1,2 Mingjian liu1 Mengmeng huang1,2 lixiang Wang1 Yan chen1,2 congyan liu1,2 Yuping liu1,2 1research center for  Multicomponent Traditional  Medicine and Microecology,   affiliated hospital of Integrated  Traditional chinese and Western  Medicine, Nanjing University of  chinese Medicine, 2research center  for Multicomponent Traditional  Medicine and Microecology, Jiangsu  Provincial academy of Traditional  chinese Medicine, Nanjing, People’s  republic of chinaAbstract:  A nanosized drug delivery platform with a combination of rational components and  tumor targeting is significant for enhancement of anticancer therapy and reduction of side effects.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/ijn-12-2045.PMC5358984.pdf
"For example, there are several clinically applied nanomedi - cines for cancer therapy, such as Doxil® (PEGylated liposomal doxorubicin [DOX],  Johnson & Johnson, NJ, USA), micellular paclitaxel (PTX/NK-105) and Lipusu®  (liposomal paclitaxel [PTX], Luye Pharma, Shandong, China).5,6 Until now, however, correspondence: Yan chen research center for Multicomponent  Traditional Medicine and Microecology,  Jiangsu Provincial academy of chinese  Medicine, 100 shizi road, Nanjing, Jiangsu  210028, People’s republic of china Tel +86 25 8560 8672 Fax +86 25 8563 7809 email ychen202@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Qu et al Running head recto: Gal(oct)-C-MEs in hepatoma therapy DOI: http://dx.doi.org/10.2147/IJN.S125293",Non-OADS,/arxiv_data1/oa_pdf/28/cf/ijn-12-2045.PMC5358984.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/ijn-12-2045.PMC5358984.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/ijn-12-2045.PMC5358984.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cc/13/ijn-12-2033.PMC5358985.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2033–2044International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2033OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12852 5 lipid-coated iron oxide nanoparticles for  dual-modal imaging of hepatocellular carcinoma Jinying liang1–3 Xinxin Zhang2 Yunqiu Miao2 Juan li1 Y ong gan2 1Department of Pharmaceutics, china  Pharmaceutical University, Nanjing,   People’s republic of china; 2shanghai  Institute of Materia Medica, chinese  academy of sciences, shanghai,   People’s republic of china; 3school of  Pharmacy, Xinxiang Medical University,   Xinxiang, People’s republic of chinaAbstract:  The development of noninvasive imaging techniques for the accurate diagnosis of  progressive hepatocellular carcinoma (HCC) is of great clinical significance and has always been  desired.",Non-OADS,/arxiv_data1/oa_pdf/cc/13/ijn-12-2033.PMC5358985.pdf
"Compared  with gadolinium-based MRI contrast agents, including Magnevist® (Gd-DTPA; Bayer  Schering Pharma, Berlin, Germany) and Multihance® (Gd-BOPTA; Bracco Diagnostics  Inc., Princeton, NJ, USA),14,15 superparamagnetic iron oxide NPs have been intensively  investigated as promising MRI probes because of their biocompatibility and safety profiles  as well as suitable magnetic properties.16–18 However, limitations such as low sensitivity  have hindered the further application of MRI as the sole methodology in the diagnosis correspondence: Juan li Department of Pharmaceutics,  china Pharmaceutical University,  24 Tongjiaxiang, Nanjing 210009,  People’s republic of china Tel +86 25 8327 1287 Fax +86 25 8327 1766 email lijuancpu@163.co m  Xinxin Zhang shanghai Institute of Materia Medica,  chinese academy of sciences,   501 haike road, shanghai 201203,  People’s republic of china Tel +86 21 2023 1000 ext 1424 Fax +86 21 2023 1000 ext 1425 email xinxinzhang@simm.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liang et al Running head recto: Hepatocellular carcinoma-targeting dual-modal imaging DOI: http://dx.doi.org/10.2147/IJN.S128525",Non-OADS,/arxiv_data1/oa_pdf/cc/13/ijn-12-2033.PMC5358985.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cc/13/ijn-12-2033.PMC5358985.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/13/ijn-12-2033.PMC5358985.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/38/ba/dddt-11-837.PMC5358986.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 837–849Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  837Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S12791 6 Cardioprotection with halogenated gases: how  does it occur?",Non-OADS,/arxiv_data1/oa_pdf/38/ba/dddt-11-837.PMC5358986.pdf
"Correspondence: Jose Luis Guerrero- Orriach; Marta Ramirez Aliaga Department of Cardioanesthesiology,  virgen de la victoria University Hospital,  University Campus Teatinos, Malaga  29010, Spain email guerreroorriach@gmail.co m;  martaram85@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Guerrero-Orriach et al Running head recto: Pre/postconditioning in cardiac surgery: enzymatic mechanisms DOI: http://dx.doi.org/10.2147/DDDT.S127916",Non-OADS,/arxiv_data1/oa_pdf/38/ba/dddt-11-837.PMC5358986.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/38/ba/dddt-11-837.PMC5358986.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/ba/dddt-11-837.PMC5358986.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/56/dddt-11-827.PMC5358987.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 827–836Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  827Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13153 8 Design, synthesis, and antimelanogenic effects of  (2-substituted phenyl-1,3-dithiolan-4-yl)methanol  derivatives Do hyun Kim1 su Jeong Kim1 sultan Ullah1 hwi Y oung Yun1 Pusoon chun2 hyung ryong Moon1 1college of Pharmacy, Pusan national  University, Busan, 2college of  Pharmacy, inje University, gimhae,   south KoreaAbstract:  The authors designed and synthesized 17 (2-substituted phenyl-1,3-dithiolan-4-yl)  methanol (PDTM) derivatives to find a new chemical scaffold, showing excellent tyrosinase- inhibitory activity.",Non-OADS,/arxiv_data1/oa_pdf/75/56/dddt-11-827.PMC5358987.pdf
"Melanin protects human skin from harmful ultraviolet radiation, and also determines correspondence: Pusoon chun college of Pharmacy, inje University,  197 inje-ro, gimhae, gyeongsangnam-do  621-749, south Korea Tel +82 55 320 3886 email pusoon@inje.ac.k r hyung ryong Moon college of Pharmacy, Pusan national  University, 63-2 Busandaehak-ro,  geumjeong-gu, Busan 609-735,  south Korea Tel +82 51 510 2815 email mhr108@pusan.ac.k rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kim et al Running head recto: PDTM derivatives for tyrosinase inhibition  DOI: http://dx.doi.org/10.2147/DDDT.S131538",Non-OADS,/arxiv_data1/oa_pdf/75/56/dddt-11-827.PMC5358987.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/75/56/dddt-11-827.PMC5358987.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/56/dddt-11-827.PMC5358987.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/64/7a/dddt-11-771.PMC5358988.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 771–782Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  771Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12393 9 Development of erythropoietin receptor-targeted  drug delivery system against breast cancer using  tamoxifen-loaded nanostructured lipid carriers chaw Yee Beh1 chee Wun how1,2 Jhi Biau Foo2 Jia ning Foong3 gayathri Thevi selvarajah3 abdullah rasedee1,3 1laboratory of Vaccines and  immunotherapeutics, institute of  Bioscience, Universiti Putra Malaysia,   serdang, 2Faculty of Pharmacy, M ahsa   University, Jenjarom, 3Faculty of  Veterinary Medicine, Universiti Putra  Malaysia, serdang, MalaysiaAbstract:  Tamoxifen (TAM) has been used in the treatment of breast cancers and is  supplemented with erythropoietin (EPO) to alleviate the cancer-related anemia.",Non-OADS,/arxiv_data1/oa_pdf/64/7a/dddt-11-771.PMC5358988.pdf
"Although beneficial to anemic patients correspondence: abdullah rasedee laboratory of Vaccines and  immunotherapeutics, institute of  Bioscience, Universiti Putra Malaysia,  43400 UPM serdang, selangor, Malaysia Tel +60 3 8947 3455 email rasedee@upm.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Beh et al Running head recto: EpoR-targeted drug delivery system against breast cancer DOI: http://dx.doi.org/10.2147/DDDT.S123939",Non-OADS,/arxiv_data1/oa_pdf/64/7a/dddt-11-771.PMC5358988.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/64/7a/dddt-11-771.PMC5358988.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/7a/dddt-11-771.PMC5358988.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/10/ijn-12-2001.PMC5358989.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2001–2019International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2001OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12429 5 The influence of surface charge on serum protein  interaction and cellular uptake: studies with  dendritic polyglycerols and dendritic polyglycerol- coated gold nanoparticles T ony Bewersdorff1 Jonathan Vonnemann2 asiye Kanik1 Rainer Haag2 andrea haase1 1Department of chemical and Product  safety, german Federal Institute  for risk assessment (Bfr), Berlin,   germany; 2Institute of chemistry and  Biochemistry, Freie Universität Berlin,   Berlin, germanyAbstract:  Nanoparticles (NPs) have gained huge interest in the medical field, in particular for  drug delivery purposes.",Non-OADS,/arxiv_data1/oa_pdf/b0/10/ijn-12-2001.PMC5358989.pdf
"Thus, often for nano-formulated drugs, lower  doses can be applied compared to conventional formulations leading to significantly  reduced side effects.2 Some NP drug carrier systems are already approved, mostly correspondence: andrea haase Department of chemical and Product  safety, german Federal Institute for risk  Assessment, Max-Dohrn-Strasse 8–10,  10589 Berlin, Germany Tel +49 30 18412 3423 Fax +49 30 18412 6 3423 email andrea.haase@bfr.bund.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bewersdorff et al Running head recto: Dendritic polyglycerol interactions with serum proteins affect cellular uptake DOI: http://dx.doi.org/10.2147/IJN.S124295",Non-OADS,/arxiv_data1/oa_pdf/b0/10/ijn-12-2001.PMC5358989.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b0/10/ijn-12-2001.PMC5358989.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/10/ijn-12-2001.PMC5358989.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/31/42/copd-12-897.PMC5358990.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 897–905International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  897OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12997 4 Clinical application value of impulse oscillometry  in geriatric patients with COPD Zhonghui liu* lianjun lin* Xinmin liu geriatrics Department, Peking  University First hospital, Beijing,   People’s republic of China *These authors contributed equally  to this workBackground:  The diagnosis and assessment of COPD rely mainly on the use of spirometry,  which is an effort-dependent test and requires good patient cooperation.",Non-OADS,/arxiv_data1/oa_pdf/31/42/copd-12-897.PMC5358990.pdf
"The Global Initiative for  Chronic Obstructive Lung Disease (GOLD) states that the diagnosis of obstructive  lung disease should be made when the postbronchodilator ratio of the forced expiratory  volume in 1 second (FEV1) to forced vital capacity (FVC) is 70%, with the FEV1 Correspondence: Xinmin liu geriatrics Department, Peking  University First hospital, no 8  Xishiku street, Beijing 100034,  People’s republic of China Tel +86 10 8357 2128 email lxm2128@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liu et al Running head recto: Impulse oscillometry in geriatric patients with COPD DOI: http://dx.doi.org/10.2147/COPD.S129974",Non-OADS,/arxiv_data1/oa_pdf/31/42/copd-12-897.PMC5358990.pdf
"Available from: http://goldcopd.or g. Accessed  March 7, 2017.",Non-OADS,/arxiv_data1/oa_pdf/31/42/copd-12-897.PMC5358990.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international­journal­of­chronic­obstructive­pulmonary­disease­journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/31/42/copd-12-897.PMC5358990.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/42/copd-12-897.PMC5358990.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0e/c6/prom-8-033.PMC5358991.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0e/c6/prom-8-033.PMC5358991.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Patient Related Outcome Measures 2017:8 33–42Patient Related Outcome Measures Dovepress submit your manuscript | www.dovepress.com Dovepress 33 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S126919 Patient-rated versus proxy-rated cognitive and  functional measures in older adults Molly Howland1 Kevin C Allan1 Caitlin E Carlton1 Curtis Tatsuoka2–4 Kathleen A Smyth3 Martha Sajatovic1,2,4,5 1Case Western Reserve University  School of Medicine, 2Neurological  and Behavioral Outcomes Center,   University Hospitals Case Medical Center,  3Department of Epidemiology  and Biostatistics, 4Department of  Neurology, 5Department of Psychiatry,   Case Western Reserve University School of Medicine, Cleveland,  OH, USAObjectives:  Patients with cognitive impairment may have difficulty reporting their func- tional and cognitive abilities, which are important clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/prom-8-033.PMC5358991.pdf
"2 Given the importance of functioning in  determining care needs such as social supports and evaluating intervention efficacy, clinicians must be able to measure these functional components as clinical endpoints, Correspondence: Molly Howland Neurological and Behavioral Outcomes Center, University Hospitals Case Medical Center, 10524 Euclid Avenue, Cleveland, OH 44106, USATel +1 216 844 2808Fax +1 216 844 2742Email molly.howland@case.eduJournal name: Patient Related Outcome Measures Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Howland et alRunning head recto: Patient–proxy discrepancy on functional measuresDOI: http://dx.doi.org/10.2147/PROM.S126919",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/prom-8-033.PMC5358991.pdf
Available from: http://www.healthmeasures.net/images/neuro_qol/Neuro-QOL_User_Manual_v2_24Mar2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/c6/prom-8-033.PMC5358991.pdf
"Patient Related Outcome Measures 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/patient-related-outcome-measures-journalPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/prom-8-033.PMC5358991.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/c6/prom-8-033.PMC5358991.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0c/be/clep-9-157.PMC5358992.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0c/be/clep-9-157.PMC5358992.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 157–166Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 157 METHODOLOGY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S129785 Missing data and multiple imputation in   clinical epidemiological research Alma B Pedersen1   Ellen M Mikkelsen1  Deirdre Cronin-Fenton1  Nickolaj R Kristensen1  Tra My Pham2  Lars Pedersen1  Irene Petersen1,2 1Department of Clinical Epidemiology,   Aarhus University Hospital, Aarhus  N, Denmark; 2Department of  Primary Care and Population Health,  University College London,    London, UKAbstract:  Missing data are ubiquitous in clinical epidemiological research.",Non-OADS,/arxiv_data1/oa_pdf/0c/be/clep-9-157.PMC5358992.pdf
"2 Missing data can constitute considerable challenges Correspondence: Alma B Pedersen   Department of Clinical Epidemiology,  Aarhus University Hospital, Olof Palmes Alle 43-45, 8200 Aarhus N, Denmark   Email abp@clin.au.dkJournal name: Clinical Epidemiology Article Designation: METHODOLOGYY ear: 2017V olume: 9Running head verso: Pedersen et alRunning head recto: Multiple imputation methodDOI: http://dx.doi.org/10.2147/CLEP .S129785",Non-OADS,/arxiv_data1/oa_pdf/0c/be/clep-9-157.PMC5358992.pdf
Available from: https://www.stata.com/manuals13/mi.pdf.,OADS,/arxiv_data1/oa_pdf/0c/be/clep-9-157.PMC5358992.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/0c/be/clep-9-157.PMC5358992.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/28/ijn-12-2069.PMC5358993.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2069–2079International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2069OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12456 4 hesperetin-loaded lipid-core nanocapsules in  polyamide: a new textile formulation for topical  drug delivery Paula dos Passos Menezes1 luiza abrahão Frank2 Bruno dos santos lima1 Yasmim Maria Barbosa  gomes de carvalho1 Mairim russo serafini1 lucindo José  Quintans-Júnior3 adriana raffin Pohlmann4 sílvia stanisçuaski  guterres2 adriano antunes de  souza araújo1 1Department of Pharmacy, Federal  University of sergipe, são cristóvão,   sergipe, Brazil; 2college of Pharmacy,   Federal University of rio grande do  sul, Porto alegre, rio grande do sul,   Brazil; 3Department of Physiology,   Federal University of sergipe, são  cristóvão, sergipe, Brazil; 4Institute  of chemistry, Federal University of  rio grande do sul, Porto alegre, rio  grande do sul, BrazilAbstract:  Chronic venous insufficiency is characterized by chronic reflux disorder of blood  from the peripheral to the central vein, with subsequent venous hypertension and resulting  changes in the skin.",Non-OADS,/arxiv_data1/oa_pdf/88/28/ijn-12-2069.PMC5358993.pdf
"Keywords:  lipid-core nanocapsules, polymer, hesperetin, fabrics, impregnation, medical textiles,  polyamide, poly( ε-caprolactone) Introduction Flavonoids are a large group of phenolic compounds that are widely distributed  in plants.1 Hesperetin (Hst), 5,7,3 ′-trihydroxy-4 ′-methoxyflavanone, is a natural  bioflavonoid found abundantly in citrus fruits with promising antioxidant and anti- inflammatory properties.2,3 Several studies have shown that citrus flavonoids can exert  antiatherogenic and vasculoprotective effects by modulating the expression of molecules  related to inflammation, preventing the formation of foam cells, reducing the area of  atherosclerotic plaques, improving the lipid profile, inhibiting the adhesion of monocytes  to the endothelium and modulating cell migration.4 Furthermore, Hst via the inhibition  of L-type voltage-gated Ca2+ channels and the enhancement of voltage-gated K+ channel  currents of the myocytes has a direct vasorelaxant effect.5 In this regard, activation and correspondence: Paula dos  Passos Menezes; adriano antunes  de souza araújo Department of Pharmacy, Federal  University of sergipe, Marechal rondon  avenue, Jardim rosa elze, são cristóvão,  sergipe 49100-000, Brazil Tel +55 79 2105 6841 Fax +55 79 2105 6827 email paula.dp.menezes@gmail.co m;  adriasa2001@yahoo.com.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Menezes et al Running head recto: Polyamide impregnated with hesperetin-loaded nanocapsules DOI: http://dx.doi.org/10.2147/IJN.S124564",Non-OADS,/arxiv_data1/oa_pdf/88/28/ijn-12-2069.PMC5358993.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/88/28/ijn-12-2069.PMC5358993.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/28/ijn-12-2069.PMC5358993.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/3d/dddt-11-797.PMC5358994.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 797–810Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  797Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S13051 4 Proteinopathy, oxidative stress and mitochondrial  dysfunction: cross talk in Alzheimer’s disease and  Parkinson’s disease Gargi Ganguly1 Sasanka Chakrabarti2 Uttara Chatterjee1 Luciano Saso3 1Department of Pathology, institute  of Post Graduate Medical education  and Research, Kolkata, 2Department  of Biochemistry, iCAR e institute of  Medical Sciences and Research, Haldia,   west Bengal, india; 3Department  of Physiology and Pharmacology  “vittorio erspamer”, Sapienza  University of Rome, Rome, italyAbstract:  Alzheimer’s disease and Parkinson’s disease are two common neurodegenerative  diseases of the elderly people that have devastating effects in terms of morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/59/3d/dddt-11-797.PMC5358994.pdf
"However, there are overlapping similarities  in AD and PD in terms of molecular pathogenesis, which we attempt to highlight in  this review.4–6Correspondence: Sasanka Chakrabarti Department of Biochemistry,  iCARe institute of Medical Sciences  and Research, Haldia 721645,  west Bengal, india Tel +91 98 7448 9805 email profschakrabarti95@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Ganguly et al Running head recto: Proteinopathy, oxidative stress and mitochondrial dysfunction in AD and PD DOI: http://dx.doi.org/10.2147/DDDT.S130514",Non-OADS,/arxiv_data1/oa_pdf/59/3d/dddt-11-797.PMC5358994.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/59/3d/dddt-11-797.PMC5358994.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/3d/dddt-11-797.PMC5358994.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/50/ijn-12-2061.PMC5358998.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2061–2067International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2061OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12155 8 Factors influencing transfection efficiency of   pIDU a/nanoemulsion complexes in a  mucopolysaccharidosis type I murine model Michelle Fraga1,2 Talita giacomet de  Carvalho2,3 Juliana Bidone1 Roselena Silvestri Schuh1,2 Ursula Matte2,3 helder Ferreira T eixeira1 1Pharmaceutical Sciences Graduate  Program, Universidade Federal do Rio  grande do sul, 2Gene Therapy Center,   Experimental Research Center,   Hospital de Clínicas de Porto Alegre,   3Genetics and Molecular Biology  Graduate Program, Universidade  Federal do rio grande do sul,   Porto Alegre, BrazilAbstract:  Mucopolysaccharidosis type I (MPS I) is an autosomal disease caused by  alpha- l-iduronidase (IDUA) deficiency.",Non-OADS,/arxiv_data1/oa_pdf/69/50/ijn-12-2061.PMC5358998.pdf
"However, issues  related to safety, risk of insertional mutagenesis, and the strong immune response  generated by these vectors have limited their application.1 Nonviral gene carriers have been extensively investigated as alternatives to viral  vectors for gene delivery since they offer considerable advantages such as safety and  easy production.3,4 Cationic nanoemulsions have been considered as potential nonviral  nucleic acid delivery systems.5 We recently described the design of PEGylated cationic correspondence: helder Ferreira  Teixeira Faculdade de Farmácia, Universidade  Federal do rio grande do sul, avenida  Ipiranga, 2752, 90610-000 Porto  Alegre, Brazil Tel +55 51 3308 5090 Fax +55 51 3308 5437 email helder.teixeira@ufrgs.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Fraga et al Running head recto: Factors influencing transfection efficiency of pIDUA/nanoemulsion complexes DOI: http://dx.doi.org/10.2147/IJN.S121558",Non-OADS,/arxiv_data1/oa_pdf/69/50/ijn-12-2061.PMC5358998.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/50/ijn-12-2061.PMC5358998.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/50/ijn-12-2061.PMC5358998.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/d0/copd-12-873.PMC5358999.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 873–884International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  873OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12737 3 Positive correlation of airway resistance and  serum asymmetric dimethylarginine level in  COPD patients with systemic markers of  low-grade inflammation gabor Tajti1,2 rudolf gesztelyi3 Krisztian Pak3 Csaba Papp1 sandor Keki4 Magdolna emma szilasi2 angela Mikaczo2 andrea Fodor2 Maria szilasi2 Judit Zsuga1 1Department of health systems  Management and Quality Management  for health Care, Faculty of Public  health, 2Department of Pulmonology,   Faculty of Medicine, 3Department of  Pharmacology and Pharmacotherapy,   Faculty of Medicine, 4Department  of applied Chemistry, Faculty of  science and T echnology, University of  Debrecen, Debrecen, hungaryAbstract:  The major feature of COPD is a progressive airflow limitation caused by chronic  airway inflammation and consequent airway remodeling.",Non-OADS,/arxiv_data1/oa_pdf/ab/d0/copd-12-873.PMC5358999.pdf
"The key symptom of COPD is a persistent airflow limitation that progresses over  time paralleled by prolonged and abortive inflammatory response in the airways given  inhaled irritant particles (eg, smoke)3 and low-grade systemic inflammation.4 Chronic Correspondence: Judit Zsuga Department of health systems  Management and Quality Management  for health Care, Faculty of Public health,  University of Debrecen, nagyerdei körút  98, 4032 Debrecen, hungary Tel +36 30 625 0144 Fax +36 52 41 1717 (ext 55187) email zsuga.judit@med.unideb.h u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Tajti et al Running head recto: ADMA and COPD DOI: http://dx.doi.org/10.2147/COPD.S127373",Non-OADS,/arxiv_data1/oa_pdf/ab/d0/copd-12-873.PMC5358999.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ab/d0/copd-12-873.PMC5358999.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/d0/copd-12-873.PMC5358999.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/34/copd-12-885.PMC5359000.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 885–896International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  885OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11596 9 evidence of eosinophil extracellular trap cell  death in COPD: does it represent the trigger that  switches on the disease?",Non-OADS,/arxiv_data1/oa_pdf/68/34/copd-12-885.PMC5359000.pdf
"Neutrophils are Correspondence: loli Uribe echevarría sanatorio allende, avenue hipólito  Yrigoyen 384, X5000JhQ, Córdoba,  argentina Tel/fax +54 351 426 9298  email uribe@cmefcm.uncor.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Uribe Echevarría et al Running head recto: Occurrence of eosinophil extracellular trap cell death in COPD DOI: http://dx.doi.org/10.2147/COPD.S115969 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/68/34/copd-12-885.PMC5359000.pdf
Or use: http://youtu.be/AlvxH_OJ-P sVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/68/34/copd-12-885.PMC5359000.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/68/34/copd-12-885.PMC5359000.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/34/copd-12-885.PMC5359000.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/10/ijn-12-2021.PMC5359002.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2021–2031International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2021OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12431 8 Cellulose nanofiber aerogel as a promising  biomaterial for customized oral drug delivery Jyoti Bhandari1 Harshita Mishra1 Pawan Kumar Mishra2 rupert Wimmer2,3 Farhan J Ahmad1 Sushama Talegaonkar1 1Department of Pharmaceutics,   Jamia Hamdard, New Delhi, India;   2Department of Wood science,   Mendel University in Brno, Brno,   Czech Republic; 3Institute for Natural  Materials Technology, Department  of Agrobiotechnology, IFA-T ulln,   University of Natural Resources and  life sciences, Vienna, austriaAbstract:  Cellulose nanofiber (CNF) aerogels with favorable floatability and mucoadhesive  properties prepared by the freeze-drying method have been introduced as new possible carriers  for oral controlled drug delivery system.",Non-OADS,/arxiv_data1/oa_pdf/80/10/ijn-12-2021.PMC5359002.pdf
"Other advantages of the oral route include patient  compliance, painless delivery, economical advantage and improvement in daily dosage  regime of the patient.2 In order to enhance the gastric residence time of the oral formu - lations, different approaches have been studied, such as altered density formulations,  floating systems, bioadhesive formulations, swelling systems, ion exchange resins,  porous systems, osmoregulated formulations and effervescent formulations.3 Nanofibers (NFs) possess a huge potential in biomedicine as a carrier for con - trolled drug delivery because of their unique attributes, such as high surface area  per unit mass, extensive porosity and strength with flexibility, in addition to being  economical.4 Due to these significant physicochemical properties, NFs are exploited Correspondence: Sushama Talegaonkar Nanoformulation Research Laboratory,  Department of Pharmaceutics,  Faculty of Pharmacy, Jamia Hamdard,  Mehrauli–Badarpur Road, Hamdard  Nagar, New Delhi 110062, India Tel +91 98 1845 3518 email stalegaonkar@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bhandari et al Running head recto: Cellulose nanofiber aerogel for customized oral drug delivery DOI: http://dx.doi.org/10.2147/IJN.S124318",Non-OADS,/arxiv_data1/oa_pdf/80/10/ijn-12-2021.PMC5359002.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/80/10/ijn-12-2021.PMC5359002.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/10/ijn-12-2021.PMC5359002.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/57/a2/copd-12-861.PMC5359003.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 861–872International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  861OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12987 1 Changes in the number of CD31-CD45-sca-1+  cells and shh signaling pathway involvement in  the lungs of mice with emphysema and relevant  effects of acute adenovirus infection Minhua Deng1,2 Jinhua li2 Ye gan3 Yan Chen2 Ping Chen2 1respiratory Medicine Department,   Pla rocket Force general hospital,   Beijing, 2respiratory Medicine  Department, 3rehabilitation  Department, second Xiangya hospital,   Central south University, Changsha,   hunan Province, People’s republic  of ChinaBackground:  COPD is a leading cause of mortality worldwide, and cigarette smoke is a pivotal  risk factor.",Non-OADS,/arxiv_data1/oa_pdf/57/a2/copd-12-861.PMC5359003.pdf
"Patho - logically, COPD mainly includes chronic inflammation, mucosa metaplasia, alveolar  destruction, and parenchyma cell apoptosis, which are associated with chronic and  repetitive injury and aberrant repair of pulmonary epithelial cells.3,4Correspondence: Ping Chen respiratory Medicine Department,  second Xiangya hospital, Central  south University, no 139 renmin  Middle road, Furong District,  Changsha City, hunan Province 410011,  People’s republic of China Tel +86 731 8529 5848 email pingchen0731@csu.edu.c n Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Deng et al Running head recto: BASC numbers and Shh signaling pathway in emphysema lungs DOI: http://dx.doi.org/10.2147/COPD.S129871",Non-OADS,/arxiv_data1/oa_pdf/57/a2/copd-12-861.PMC5359003.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/57/a2/copd-12-861.PMC5359003.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/a2/copd-12-861.PMC5359003.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/49/08/copd-12-859.PMC5359004.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 859International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/49/08/copd-12-859.PMC5359004.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 859COrrIgenDumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S13339 4 Health behaviors and their correlates among participants in the  Continuing to Confront COPD International Patient Survey  [Corrigendum] Müllerová H, Landis SH, Aisanov Z, et al.",Non-OADS,/arxiv_data1/oa_pdf/49/08/copd-12-859.PMC5359004.pdf
"On page 882, right column, last paragraph, the sentence  “Each question is given either a dichotomous or Likert scale- type response resulting in an overall score which ranges  from 1 to 8, with higher scores indicating greater adher - ence.” should have read “Each question is given either as  a dichotomous or Likert scale-type response resulting in an  overall score which ranges from 0 to 8, with higher scores  indicating greater adherence.”Journal name: International Journal of COPD Article Designation: Corrigendum Y ear: 2017 Volume: 12 Running head verso: Müllerová et al Running head recto: Health behaviors and their correlates among participants in the Continuing to Confront COPD DOI: http://dx.doi.org/10.2147/COPD.S133394 On page 889, Acknowledgment section, the acknowledg - ment read “The survey was conducted by Abt SRBI, a global  survey research firm.",Non-OADS,/arxiv_data1/oa_pdf/49/08/copd-12-859.PMC5359004.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/35/dddt-11-759.PMC5359006.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 759–769Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  759Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12112 2 glycophenotype of breast and prostate cancer  stem cells treated with thieno[2,3- b]pyridine  anticancer compound Angela Mastelić1 Vedrana Čikeš Čulić1 Nikolina Režić Mužinić1 Milena Vuica-ross2  David Barker3 euphemia Y leung4,5 Jóhannes reynisson3 Anita Markotić1 1Department of Medical chemistry  and Biochemistry, University of  split school of Medicine, split,   croatia; 2Department of Pathology,   Johns Hopkins School of Medicine,   Baltimore, MD, Usa; 3school of  chemical sciences, The University of  Auckland, 4Auckland Cancer Society  research centre, The University of  Auckland, 5Molecular Medicine and  Pathology Department, The University  of Auckland, Auckland, New ZealandAbstract:  Tumor progression may be driven by a small subpopulation of cancer stem  cells (CSCs characterized by CD44+/CD24− phenotype).",Non-OADS,/arxiv_data1/oa_pdf/ce/35/dddt-11-759.PMC5359006.pdf
"Tumor progression may be driven  by cancer stem cells (CSCs) that have the ability to self-renew and to regenerate the  primary tumor phenotypic heterogeneity.1,2 The CD44+/CD24− phenotype defines the  subpopulation of cancer cells with stem-like qualities.3 It is believed that CD44+/CD24−  CSCs are involved in therapy resistance in various cancers, including triple-negative  breast cancer (breast cancer that does not express the genes for estrogen receptor,  progesterone receptor and the human epidermal growth factor receptor-2) and prostate  cancer.1,2 Treatment of triple-negative breast cancers with cytotoxic chemotherapeutic  such as paclitaxel shows only 21% of pathologic complete response rate in the breast  and axilla.4 Prostate cancer exhibits high intrinsic drug resistance with sensitivity to  few chemotherapeutics once androgen deprivation fails.5Correspondence: Anita Markotić Department of Medical chemistry  and Biochemistry, University of split  School of Medicine, Šoltanska 2,  21000 split, croatia Tel/fax +385 21 557 870 email anita.markotic@mefst.h r  Jóhannes reynisson school of chemical sciences, The  University of Auckland, Private Bag  92019, Auckland 1142, New Zealand Tel +64 9 373 7599 ext 83746 Fax +64 9 373 7422 email j.reynisson@auckland.ac.n z Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Mastelic ´ et al Running head recto: Glycophenotype of CSCs treated with thieno[2,3- b]pyridine anticancer compound DOI: http://dx.doi.org/10.2147/DDDT.S121122",Non-OADS,/arxiv_data1/oa_pdf/ce/35/dddt-11-759.PMC5359006.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ce/35/dddt-11-759.PMC5359006.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/35/dddt-11-759.PMC5359006.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8f/69/hp-5-011.PMC5359007.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8f/69/hp-5-011.PMC5359007.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hypoxia 2017:5 11–20Hypoxia Dovepress submit your manuscript | www.dovepress.com Dovepress 11 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S127042Update on hypoxia-inducible factors and  hydroxylases in oxygen regulatory pathways: from  physiology to therapeutics Peter Ratcliffe1,2 Peppi Koivunen3 Johanna Myllyharju3 Jiannis Ragoussis4 Judith VMG Bovée5 Ines Batinic-Haberle6 Claire Vinatier7 Valérie Trichet8 Florence Robriquet9 Lisa Oliver9 Betty Gardie9,10 1Target Discovery Institute, University  of Oxford, 2The Francis Crick Institute,   London, UK; 3Oulu Center for Cell- Matrix Research, Biocenter Oulu and  Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu,  Finland;  4McGill University and  Genome Quebec Innovation Centre,  McGill University, Montreal, Canada;   5Department of Pathology, Leiden  University Medical Center, Leiden, the Netherlands;  6Department of Radiation  Oncology, Duke University School of Medicine, Durham, NC, USA;  7INSERM  UMR 1229, Regenerative Medicine and Skeleton-RMeS, T eam STEP , University of Nantes, UFR Odontology,  8UMR  1238 INSERM, Université de Nantes,  Faculté de Médecine,  9CRCINA, INSERM,   Université de Nantes, Nantes, 10Ecole  Pratique des Hautes Etudes, PSL Research University, Paris, FranceAbstract:  The “Hypoxia Nantes 2016” organized its second conference dedicated to the field  of hypoxia research.",Non-OADS,/arxiv_data1/oa_pdf/8f/69/hp-5-011.PMC5359007.pdf
"In Correspondence: Betty Gardie EPHE, CRCINA, Université de Nantes, 8 quai Moncousu, BP 70721, 44007 Nantes, Cedex 1, FranceEmail betty.gardie@inserm.frJournal name: Hypoxia Article Designation: REVIEWY ear: 2017V olume: 5Running head verso: Ratcliffe et alRunning head recto: Hypoxia Nantes 2016DOI: http://dx.doi.org/10.2147/HP .S127042",Non-OADS,/arxiv_data1/oa_pdf/8f/69/hp-5-011.PMC5359007.pdf
"Acknowledgments The meeting “Hypoxia Nantes 2106” (https://hypoxia.univ-nantes.fr) was financially supported by Alliance Bio Expertise, Baker Ruskinn, the Région Pays de la Loire, project “ERRATA” and “EryCan”; Laboratory of Excellence GR-Ex, reference ANR-11-LABX-0051; Nantes University; and Dove Press.",Non-OADS,/arxiv_data1/oa_pdf/8f/69/hp-5-011.PMC5359007.pdf
"Hypoxia 2017:5submit your manuscript | www.dovepress.com Dovepress Dovepress Hypoxia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hypoxia-journalHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/8f/69/hp-5-011.PMC5359007.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 20 Ratcliffe et al  72.,Non-OADS,/arxiv_data1/oa_pdf/8f/69/hp-5-011.PMC5359007.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/ec/dddt-11-783.PMC5359008.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 783–795Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  783Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12991 3 hMgB1 sirna can reduce damage to retinal cells  induced by high glucose in vitro and in vivo shuang Jiang Xiaolong chen Department of Ophthalmology,   shengjing hospital of china Medical  University, shenyang, chinaBackground:  Diabetic retinopathy (DR), one of the most common complications of late-phase  diabetes, is associated with many risk factors, among which continuous low-grade inflammation  is one of the principal ones.",Non-OADS,/arxiv_data1/oa_pdf/15/ec/dddt-11-783.PMC5359008.pdf
"Keywords:  diabetic retinopathy, small interfering RNA, human retinal endothelial cells, high- mobility group box 1, inhibitor of nuclear factor κB, nuclear factor κB Background Diabetic retinopathy (DR) is one of the main microvascular complications of  diabetes mellitus (DM) and one of the leading causes of blindness worldwide.1,2 correspondence: Xiaolong chen Department of Ophthalmology, shengjing  hospital of china Medical University,  36 sanhao street, heping Qu, shenyang,  liaoning 110004, china Tel +86 159 4067 7973 email chenxl@sj-hospital.or g Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Jiang and Chen Running head recto: HMGB1 siRNA for retinal damage from glucose DOI: http://dx.doi.org/10.2147/DDDT.S129913",Non-OADS,/arxiv_data1/oa_pdf/15/ec/dddt-11-783.PMC5359008.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/15/ec/dddt-11-783.PMC5359008.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/ec/dddt-11-783.PMC5359008.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/b6/ndt-13-785.PMC5359117.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 785–792Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  785OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12610 0 Attention-deficit hyperactivity disorder in  elementary school students in shantou, china:  prevalence, subtypes, and influencing factors Yanhong Huang1 Shaoxiong Zheng1 Chongtao Xu1 Kun lin2 Kusheng Wu2 Maochun Zheng1 Jie Zhang1 Haiyun Xu1 1Mental health center, 2Department  of Preventive Medicine, Shantou  University Medical College,   shantou, chinaAbstract:  Attention-deficit hyperactivity disorder (ADHD) is a frequent childhood-onset  psychiatric condition and categorized into three subtypes of predominantly inattentive (ADHD-I),  hyperactive impulsive (ADHD-H), and combined (ADHD-C).",Non-OADS,/arxiv_data1/oa_pdf/9d/b6/ndt-13-785.PMC5359117.pdf
"A meta-analysis resulted in  a pooled prevalence of 5.29% (95% confidence interval [CI] 5.01–5.56) and identified  the main factors contributing to the variability of estimates, including diagnostic criteria,  source of information for reporting the symptoms, and requirement of functional impair - ment for the diagnosis.3 However, study location seemed to have no significant effect on  the estimate, as claimed in the study by the Centers for Disease Control and Prevention, Correspondence: Chongtao Xu;   Haiyun Xu Mental health center, shantou University  Medical College, North Taishan  Road, Shantou, Guangdong Province  515065, china email ctxu@vip.sina.co m;   hyxu@stu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Huang et al Running head recto: ADHD in elementary school students in Shantou, China DOI: http://dx.doi.org/10.2147/NDT.S126100",Non-OADS,/arxiv_data1/oa_pdf/9d/b6/ndt-13-785.PMC5359117.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9d/b6/ndt-13-785.PMC5359117.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/b6/ndt-13-785.PMC5359117.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/45/29/jpr-10-601.PMC5359118.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/45/29/jpr-10-601.PMC5359118.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 601–611Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  601 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S130501Osteopathy for primary headache patients: a  systematic review Francesco Cerritelli1–3  Eleonora Lacorte4  Nuria Ruffini1  Nicola Vanacore4 1Clinical-based Human Research  Department, Centre for Osteopathic  Medicine Collaboration, 2Department  of Neuroscience, Imaging and Clinical Sciences,  3ITAB – Institute for  Advanced Biomedical T echnologies,  G. D’Annunzio University of Chieti,  Pescara,  4National Centre for  Epidemiology, Surveillance and Health Promotion, National Institute of Health, Rome,  ItalyObjective: This systematic review aimed to assess the efficacy, effectiveness, safety, and toler - ability of osteopathic manipulative treatment (OMT) in patients with headache.",Non-OADS,/arxiv_data1/oa_pdf/45/29/jpr-10-601.PMC5359118.pdf
"Guidelines recommend treating chronic  headache Correspondence: Francesco Cerritelli Clinical-based Human Research Department, Centre for Osteopathic Medicine Collaboration, Onlus, Via Vespucci, 188, Pescara 65126, Italy   Email francesco.cerritelli@gmail.comJournal name: Journal of Pain Research  Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Cerritelli et alRunning head recto: Osteopathy for primary headacheDOI: http://dx.doi.org/10.2147/JPR.S130501",Non-OADS,/arxiv_data1/oa_pdf/45/29/jpr-10-601.PMC5359118.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/45/29/jpr-10-601.PMC5359118.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 611 Osteopathy for primary headache Supplementary material Search strategy: keywords used (((((((((((((osteopath* AND manipulat* AND (treatment OR therapy))) OR Manipulation, Osteopathic[MeSH]) OR ((osteo- path* AND medicine))) OR ((manual* AND treatment*))) OR ((spinal AND manipulat*))) OR Manipulation, Spinal[MeSH]) OR ((visceral AND manipulat*))) OR (((crani* OR crani* AND sacral OR cranio *sacral) AND osteopat* AND (manipulat* OR manual OR treatment)))) OR (((craniosacral OR cranio-sacral OR cranio sacral)))) OR ((osteopath* AND diagnosis))) OR ((osteopath* AND palpat*))) OR ((osteopath* AND principle* AND practice*)) AND ((headache AND (disease* OR disorder*)))))",Non-OADS,/arxiv_data1/oa_pdf/45/29/jpr-10-601.PMC5359118.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/4a/ott-10-1535.PMC5359119.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1535–1548OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1535Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12922 0 risk of subsequent primary malignancies  among patients with prior colorectal cancer:  a population-based cohort study Jiao Yang1 shuting li1 Meng lv1 Yinying Wu1 Zheling chen1 Yanwei shen1 Biyuan Wang1 ling chen1 Min Yi1,2 Jin Yang1 1Department of Medical Oncology,   First affiliated hospital of Xi’an  Jiao Tong University, Xi’an, People’s  republic of china; 2Department of  Breast surgical Oncology, University  of T exas MD anderson cancer center,   houston, TX, UsaBackground:  The site-distribution pattern and relative risk of subsequent primary malignancies  (SPMs) in colorectal cancer (CRC) patients remains to be determined.",Non-OADS,/arxiv_data1/oa_pdf/50/4a/ott-10-1535.PMC5359119.pdf
"Studies have found that patients previously diagnosed with CRC are at higher  risk of second primary CRCs than the general population.5–7 Synchronous colorectal correspondence: Jin Yang Department of Medical Oncology,  First Affiliated Hospital of Xi’an Jiao  Tong University, 277 Yanta West  road, Xi’an, shaanxi 710061, People’s  republic of china Tel/fax +86 29 8532 3422 email 1473106133@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Y ang et al Running head recto: Subsequent primary malignancy in CRC DOI: http://dx.doi.org/10.2147/OTT.S129220",Non-OADS,/arxiv_data1/oa_pdf/50/4a/ott-10-1535.PMC5359119.pdf
SEER  currently collects cancer-incidence and -survival data from  population-based cancer registries covering approximately  30% of the US population ( http://seer.cancer.go v).,OADS,/arxiv_data1/oa_pdf/50/4a/ott-10-1535.PMC5359119.pdf
More detailed information on both SEER Stat software and  the method the software uses to derive the SIRs is available  on the SEER-registry website ( http://seer.cancer.gov/seer - stat).,OADS,/arxiv_data1/oa_pdf/50/4a/ott-10-1535.PMC5359119.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/50/4a/ott-10-1535.PMC5359119.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/4a/ott-10-1535.PMC5359119.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/78/ppa-11-547.PMC5359120.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 547–559Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  547Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S12727 7 Relationship between depression and medication  adherence in cardiovascular disease: the perfect  challenge for the integrated care team Carly M Goldstein1,2 emily C Gathright1,3 Sarah Garcia4 1Department of Psychiatry  and Human Behavior, warren  Alpert Medical School of Brown  University, 2weight Control and  Diabetes Research Center, The  Miriam Hospital, Providence, Ri,   3Department of Psychological  Sciences, Kent State University, Kent,   OH, 4Neuropsychology Section,   Department of Psychiatry, University  of Michigan, Ann Arbor, M i, USAAbstract:  Many individuals with cardiovascular disease (CVD) experience depression that  is associated with poor health outcomes, which may be because of medication nonadherence.",Non-OADS,/arxiv_data1/oa_pdf/66/78/ppa-11-547.PMC5359120.pdf
"Estimates of  depression in CVD vary depending on the specific disease processes and assessment  method, but ~50% of patients experience major or minor depression at least once in  the course of experiencing CVD.5 In a study that examined individuals hospitalized for  myocardial infarction (MI), ~20% met the criteria for a major depressive episode based  on a structured interview, and 31.1% self-reported significant depressive symptoms.6  Individuals with heart failure (HF) seem to display a slightly increased prevalence –  over one third – particularly when screened through self-report measures.7,8 Mechanisms Correspondence: Carly M Goldstein Department of Psychiatry and Human  Behavior, weight Control and Diabetes  Research Center, warren Alpert Medical  School of Brown University, The Miriam  Hospital, 196 Richmond Street,  Providence, Ri 02903, USA Tel +1 401 793 8960 Fax +1 401 793 8944 email carly_goldstein@brown.ed u Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Goldstein et al Running head recto: Depression and medication adherence in CVD DOI: http://dx.doi.org/10.2147/PPA.S127277",Non-OADS,/arxiv_data1/oa_pdf/66/78/ppa-11-547.PMC5359120.pdf
Available from: http://www.who.int/chp/knowledge/ publications/adherence_report/en /.,Non-OADS,/arxiv_data1/oa_pdf/66/78/ppa-11-547.PMC5359120.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/66/78/ppa-11-547.PMC5359120.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/57/ott-10-1575.PMC5359121.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1575–1583OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1575Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13008 6 SDF1-3′a polymorphism is associated with  increased risk of hematological malignancy: a   meta-analysis Xiaowen Zhang Yang Fan Zhijie li Medical research center, shengjing  hospital of china Medical University,   shenyang, chinaAbstract:  CXCL12  (also named SDF1 ), a member of the chemokine family, has been  demonstrated to play an important role in the progression of multiple types of hematological  malignancy.",Non-OADS,/arxiv_data1/oa_pdf/67/57/ott-10-1575.PMC5359121.pdf
"Keywords:  SDF1, hematological malignancy, polymorphism, meta-analysis Introduction Cancer is considered as a major public health problem and one of the leading causes of  death worldwide.1 Hematological malignancies, including leukemia, lymphoma, and  other types,2 are in the top 10 causes of cancer death.3 According to the report from  the American Cancer Society, leukemia accounted for an estimated 265,500 deaths  and non-Hodgkin’s lymphoma (NHL) accounted for an estimated 199,700 deaths  worldwide in 2012, respectively.3 It is widely accepted that genetic variants, environ - mental factors, and the interaction of genetic and environmental factors are responsible  for the occurrence and progression of hematological malignancy.4,5 Chemokines, a family of small cytokines, usually act as chemoattractants to manage  the migration of leukocytes in the respective anatomical locations in inflammatory and  homeostatic processes.6,7 Chemokine CXCL12, also named SDF-1, is a member of  chemokine family and functions as the ligand for the chemokine CXCR4 to regulate correspondence: Zhijie li Medical research center, shengjing  hospital of china Medical University,  36 sanhao street, heping District,  shenyang 110004, china Tel +86 189 4025 9465  Fax +86 024 96619 13429 email lizhijie68@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhang et al Running head recto: SDF1 -3′A increases risk of hematological malignancy DOI: http://dx.doi.org/10.2147/OTT.S130086",Non-OADS,/arxiv_data1/oa_pdf/67/57/ott-10-1575.PMC5359121.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/67/57/ott-10-1575.PMC5359121.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/57/ott-10-1575.PMC5359121.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/cc/ott-10-1549.PMC5359122.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1549–1559OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1549Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12856 4 Knockdown of iQgaP1 inhibits proliferation  and epithelial–mesenchymal transition by  Wnt/β-catenin pathway in thyroid cancer Dongyue su1,* Yang liu1,* Tao song2 1Department of endocrinology,   huaihe hospital of henan University,   2Department of Orthopaedics,   The People’s liberation army  155 hospital, Kaifeng, People’s  republic of china *These authors contributed equally  to this workBackground:  Thyroid cancer is the most common endocrine malignant disease with a high  incidence rate.",Non-OADS,/arxiv_data1/oa_pdf/5b/cc/ott-10-1549.PMC5359122.pdf
"EMT occurs in pre-metastatic cancer cells and was first confirmed as a feature of  embryogenesis and has also been found in the healing of wound, fibrosis of organ  and the occurrence of metastasis.4 EMT is considered to play a vital role in the initial correspondence: Tao song Department of Orthopaedics, The  People’s liberation army 155 hospital,  no 3 hospital Front street, Kaifeng  475000, People’s republic of china email doysong@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Su et al Running head recto: Knockdown of IQGAP1 inhibits proliferation and EMT in thyroid cancer DOI: http://dx.doi.org/10.2147/OTT.S128564",Non-OADS,/arxiv_data1/oa_pdf/5b/cc/ott-10-1549.PMC5359122.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/cc/ott-10-1549.PMC5359122.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/cc/ott-10-1549.PMC5359122.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/21/ott-10-1585.PMC5359123.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1585–1601OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1585Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10051 3 Retinoic acid and arsenic trioxide in the  treatment of acute promyelocytic leukemia:  current perspectives Derek McCulloch Christina Brown Harry iland institute of Hematology,   Royal Prince Alfred Hospital,   Camperdown, NSw , AustraliaAbstract:  Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia  (AML) with a unique morphological appearance, associated coagulopathy and canonical bal - anced translocation of genetic material between chromosomes 15 and 17.",Non-OADS,/arxiv_data1/oa_pdf/11/21/ott-10-1585.PMC5359123.pdf
"Building  on these published case reports, Dr Hillestad identified the common characteristics of  this new and rapidly fatal disease.1–5 A subsequent more detailed report on 20 patients  treated at the Hôpital St Louis in Paris by Jean Bernard increased early understanding  of this unique disease.6 APL accounts for 3%–13% of acute myeloid leukemia (AML)  based on data from UK and Swedish registries.7,8 It has been reported that the incidence  of APL is higher in populations originating from Central and South America, where  APL may constitute 28% of AML cases.9,10 The characteristic morphology of APL has been described fully; first, the typical or  hypergranular form of APL with characteristically abnormal promyelocytes exhibiting  a densely granulated cytoplasm, Auer rods or Faggot cells (cells with bundles of Auer  rods) and a nuclear membrane that is often reniform or bilobed.11 A microgranular Correspondence: Derek McCulloch institute of Haematology, Royal Prince  Alfred Hospital, Missenden Road,  Camperdown, NSw 2050, Australia email doctordexmcculloch@yahoo.co.u kJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: McCulloch et al Running head recto: Retinoic acid and arsenic trioxide in the treatment of APL DOI: http://dx.doi.org/10.2147/OTT.S100513",Non-OADS,/arxiv_data1/oa_pdf/11/21/ott-10-1585.PMC5359123.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/11/21/ott-10-1585.PMC5359123.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/21/ott-10-1585.PMC5359123.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a2/1d/ott-10-1521.PMC5359124.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1521–1525OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1521Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12647 1 apatinib treatment combined with chemotherapy  for advanced epithelial ovarian cancer:  a case report Linghui Deng Yue Wang Wenbin Lu Qian Liu Jie Wu Jianhua Jin Department of Oncology, Wujin  people’s Hospital, affiliated to Jiangsu  University, Changzhou, people’s  republic of ChinaAbstract:  Apatinib is a novel oral tyrosine kinase inhibitor targeting vascular endothelial  growth factor receptor-2, which has been proved by clinical trials to be effective and safe for  patients with chemotherapy-refractory gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/a2/1d/ott-10-1521.PMC5359124.pdf
"The patient received a Correspondence: Jianhua Jin Department of Oncology, Wujin  People’s Hospital, Affiliated to Jiangsu  University, No 2 Yongning North road,  Changzhou, Jiangsu 213017, people’s  republic of China Tel +86 519 8557 9182 Fax +86 519 8532 5466 email jianhuajin666@sina.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2017 Volume: 10 Running head verso: Deng et al Running head recto: Apatinib treatment for ovarian cancer: a case report DOI: http://dx.doi.org/10.2147/OTT.S126471",Non-OADS,/arxiv_data1/oa_pdf/a2/1d/ott-10-1521.PMC5359124.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/1d/ott-10-1521.PMC5359124.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/1d/ott-10-1521.PMC5359124.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/77/opth-11-517.PMC5359126.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 517–522Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  517Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12450 0 Clinical and allergological analysis of ocular  manifestations of sick building syndrome Yusuke saeki1 Kazuaki Kadonosono2 eiichi Uchio1 1Department of Ophthalmology,   Fukuoka University school of  Medicine, Fukuoka, 2Department  of Ophthalmology, Yokohama  City University Medical Center,   Y okohama, JapanPurpose:  The disease concept of sick building syndrome (SBS) is still unclear.",Non-OADS,/arxiv_data1/oa_pdf/45/77/opth-11-517.PMC5359126.pdf
"The United States3 and Japanese4,5 governments  have introduced environmental indexes for prevention of SBS, and clinical disorders  associated with office buildings, houses, and schools have also been frequently rec - ognized as SBS especially in Japan since around 2000.Correspondence: eiichi Uchio Department of Ophthalmology,  Fukuoka University school of Medicine,  7-45-1 nanakuma, Jonan-ku, Fukuoka  814-0180, Japan Tel +81 92 801 1011 Fax +81 92 865 4445 email euchio@fukuoka-u.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Saeki et al Running head recto: Ocular manifestations of SBS DOI: http://dx.doi.org/10.2147/OPTH.S124500",Non-OADS,/arxiv_data1/oa_pdf/45/77/opth-11-517.PMC5359126.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/45/77/opth-11-517.PMC5359126.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/77/opth-11-517.PMC5359126.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/76/ppa-11-531.PMC5359127.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 531–536Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  531OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12985 6 estimation of health state utilities in breast cancer seon-ha Kim1 Min-Woo Jo2 Minsu Ock2 hyeon-Jeong lee2 Jong-Won lee3,4 1Department of nursing, college  of nursing, Dankook University,   cheonan, 2Department of Preventive  Medicine, University of Ulsan college  of Medicine, seoul, 3Department of  Breast and endocrine surgery, Asan  Medical center, seoul, 4Department of  surgery, University of Ulsan college  of Medicine, seoul, south KoreaPurpose:  The aim of this study is to determine the utility of breast cancer health states using the  standard gamble (SG) and visual analog scale (VAS) methods in the Korean general population.",Non-OADS,/arxiv_data1/oa_pdf/75/76/ppa-11-531.PMC5359127.pdf
"Two approaches have commonly been used to determine the quality weights: direct evalu - ation using the visual analog scale (VAS), standard gamble (SG), and time trade-off (TTO)  techniques or indirect approaches using multi-attribute health state classification systems  (eg, EQ-5D [EuroQol five dimensions questionnaire]) and quality weight tariffs.7correspondence: Min-Woo Jo Department of Preventive Medicine,  University of Ulsan college of Medicine,  88, Olympic-ro 43-gil, songpa-gu,  seoul 05505, south Korea Tel +82 2 3010 4264 Fax +82 2 477 2898 email mdjominwoo@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kim et al Running head recto: Estimation of health state utilities in breast cancer DOI: http://dx.doi.org/10.2147/PPA.S129856",Non-OADS,/arxiv_data1/oa_pdf/75/76/ppa-11-531.PMC5359127.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/75/76/ppa-11-531.PMC5359127.pdf
Available from: http://ncc.re.kr/main.,Non-OADS,/arxiv_data1/oa_pdf/75/76/ppa-11-531.PMC5359127.pdf
Available from: http://www.kbcs.or.kr /.,Non-OADS,/arxiv_data1/oa_pdf/75/76/ppa-11-531.PMC5359127.pdf
Available from: http://www.kbcs.,Non-OADS,/arxiv_data1/oa_pdf/75/76/ppa-11-531.PMC5359127.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/50/31/ott-10-1603.PMC5359128.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1603–1611OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1603Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11815 1 TcF21 functions as a tumor suppressor in  colorectal cancer through inactivation of  Pi3K/aKT signaling Y ouyi Dai1 huaxin Duan2,3 chaojun Duan4 hong Zhu1 rongrong Zhou1 haiping Pei5 liangfang shen1 1Department of Oncology, Xiangya  hospital, central south University,   2Department of Oncology, hunan  Provincial People’s hospital,   3Department of Oncology, The First  affiliated hospital of hunan normal  University, 4institute of Medical  sciences, Xiangya hospital, central  south University, 5Department of  general surgery, Xiangya hospital,   central south University, changsha,   hunan, People’s  republic of chinaAbstract:  Colorectal cancer (CRC) has become a major public health problem, ranking as the  third most common type of cancer.",Non-OADS,/arxiv_data1/oa_pdf/50/31/ott-10-1603.PMC5359128.pdf
"Our results suggest correspondence: liangfang shen Department of Oncology, Xiangya  hospital, central south University,  87 Xiangya road, changsha,  410008 hunan, People’s  republic of china email 3153559525@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Dai et al Running head recto: TCF21 functions as a tumor suppressor in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S118151",Non-OADS,/arxiv_data1/oa_pdf/50/31/ott-10-1603.PMC5359128.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/50/31/ott-10-1603.PMC5359128.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/31/ott-10-1603.PMC5359128.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fd/59/oarrr-9-055.PMC5359129.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fd/59/oarrr-9-055.PMC5359129.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2017:9 55–59Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 55 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S110585 Color duplex ultrasonography findings of  temporal arteries in a case of giant cell arteritis:  role in diagnosis and follow-up Antonella Laria Alfredo Lurati Magda Scarpellini Fornaroli Hospital, Rheumatology  Unit, Magenta, ItalyAbstract: Giant cell arteritis (GCA) is a systemic autoimmune disease that affects medium- and  large-sized arteries.",Non-OADS,/arxiv_data1/oa_pdf/fd/59/oarrr-9-055.PMC5359129.pdf
"Brightness-mode (B-mode)  Correspondence: Alfredo Lurati Fornaroli Hospital, Rheumatology Unit, Via al Donatore di Sangue 50, Magenta 20013, ItalyEmail alfredomaria.lurati@asst-ovestmi.itJournal name: Open Access Rheumatology: Research and Reviews Article Designation: CASE REPORTY ear: 2017V olume: 9Running head verso: Laria et alRunning head recto: CDU findings in a case of TA in a patient with GCADOI: http://dx.doi.org/10.2147/OARRR.S110585",Non-OADS,/arxiv_data1/oa_pdf/fd/59/oarrr-9-055.PMC5359129.pdf
"Open Access Rheumatology: Research and Reviews 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/fd/59/oarrr-9-055.PMC5359129.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 59 CDU findings in a case of TA in a patient with GCA  3.,Non-OADS,/arxiv_data1/oa_pdf/fd/59/oarrr-9-055.PMC5359129.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6c/12/jaa-10-057.PMC5359130.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6c/12/jaa-10-057.PMC5359130.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 57–65Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 57 OriginAl reseArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S123260Development of an allergy management support  system in primary care Bertine MJ  Flokstra  - de Blok1,2 Thys van der Molen1,2 Wianda A christoffers3 Janwillem Wh Kocks1,2 richard l Oei4 Joanne ng Oude elberink2,4 emmy M roerdink5 Marie louise schuttelaar3 Jantina l van der Velde1,2 Thecla M Brakel1,6 Anthony eJ Dubois2,5 1Department of general Practice,   2griA c research institute,   3Department of Dermatology,   4Department of Allergology,   5Department of Pediatric  Pulmonology and Pediatric Allergy,   University of groningen, University  Medical center groningen,   6T eaching Unit, Department of social  Psychology, University of groningen,   groningen, The netherlandsBackground: Management of allergic patients in the population is becoming more difficult  because of increases in both complexity and prevalence.",Non-OADS,/arxiv_data1/oa_pdf/6c/12/jaa-10-057.PMC5359130.pdf
"1correspondence: Bertine MJ Flokstra -  de BlokDepartment of general Practice, University Medical center groningen, internal Postcode FA21, PO Box 196, 9700 AD groningen, The netherlandsTel +31 50 361 6757Fax +31 50 363 2964Email b.m.j.flokstra@umcg.nlJournal name: Journal of Asthma and Allergy Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Flokstra - de Blok et alRunning head recto: Development of allergy management support systemDOI: http://dx.doi.org/10.2147/JAA.S123260",Non-OADS,/arxiv_data1/oa_pdf/6c/12/jaa-10-057.PMC5359130.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/6c/12/jaa-10-057.PMC5359130.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/7c/ndt-13-793.PMC5359131.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 793–801Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  793OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12682 5 Validation and cultural adaptation of the arabic  versions of the Mini–Mental status examination –  2 and Mini-cog test Mohammad albanna1,* arij Yehya2,* abdalla Khairi1 elnour Dafeeah1 abdelsalam elhadi3 lamia rezgui4 shahada al Kahlout4 adil Y ousif5 Basim Uthman6 hassen al-amin2 1Psychiatry Department, hamad  Medical corporation, 2Psychiatry  Department, Weill cornell Medicine –   Qatar, 3Primary health care  corporation, 4geriatrics Department,   rumailah hospital, hamad Medical  corporation, 5Department of  Mathematics, statistics and Physics,   college of arts and sciences, Qatar  University, 6Neurology Department,   Weill cornell Medicine – Qatar,   Doha, Qatar *These authors contributed equally  to this workIntroduction:  The elderly population is increasing around the world, and the prevalence of  dementia increases with age.",Non-OADS,/arxiv_data1/oa_pdf/29/7c/ndt-13-793.PMC5359131.pdf
"Dementia affects each person  differently and also has a significant impact on families and caregivers.2 Early diag - nosis of cognitive impairment may increase the chance of a slower progression of the  disease.3 Early intervention can provide caregivers with early advice and support.4 Dementia screening tools should be brief, easy to use and valid in different  cultures and across elderly with various educational backgrounds.5 The Mini–Mental  Status Examination (MMSE) and the Mini-Cog have been demonstrated in several correspondence: hassen al-amin Psychiatry Department, Weill cornell  Medicine – Qatar, education city, PO  Box 24144, Doha, Qatar Tel +974 4492 8313 Fax +974 4492 8377 email haa2019@qatar-med.cornell.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Albanna et al Running head recto: Arabic MMSE-2 and Mini-Cog DOI: http://dx.doi.org/10.2147/NDT.S126825",Non-OADS,/arxiv_data1/oa_pdf/29/7c/ndt-13-793.PMC5359131.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/29/7c/ndt-13-793.PMC5359131.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/7c/ndt-13-793.PMC5359131.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 43–50Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  43 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S121203Results of a randomized, prospective, double- dummy, double-blind trial to compare efficacy and  safety of a herbal combination containing Tropaeoli  majoris herba and Armoraciae rusticanae radix  with co-trimoxazole in patients with acute and uncomplicated cystitis Rainer Stange1  Berthold Schneider2  Uwe Albrecht3 Valentina Mueller3 Joerg Schnitker4 Andreas Michalsen1 1Internal and Complementary  Medicine, Immanuel Krankenhaus  Berlin-Wannsee, Berlin, 2Institute  for Biostatistics, Medical University,  3Mediconomics GmbH, Hannover,   4Institute for Applied Statistics,   Bielefeld, GermanyObjectives:  To demonstrate non-inferiority of an herbal combination (horseradish root and  nasturtium herb) to an antibiotic (co-trimoxazole) in acute uncomplicated cystitis.",Non-OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
"Keywords: urinary tract infection, herbal medicinal product, cystitis, horseradish, nasturtium  herb, co-trimoxazole, randomized clinical trialCorrespondence: Uwe Albrecht Mediconomics GmbH, Misburger Straße 81B, 30625 Hannover, GermanyTel +49 511 560 9980Fax +49 511 560 99820Email albrecht@mediconomics.comJournal name: Research and Reports in Urology Article Designation: CLINICAL TRIAL REPORTY ear: 2017V olume: 9Running head verso: Stange et alRunning head recto: Herbal medicinal product for treatment of uncomplicated cystitisDOI: http://dx.doi.org/10.2147/RRU.S121203",Non-OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
Available from: http://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/Leitlinien-Entwuerfe/Brennen%20beim%20Wasserlassen/LL-01_Langfassung_mit_KV_ZD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
Available from: http://www.awmf.org/leitlinien/detail/ll/043-044.html.,Non-OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 50 Stange et al 19.,Non-OADS,/arxiv_data1/oa_pdf/d6/8a/rru-9-043.PMC5359132.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/05/opth-11-523.PMC5359133.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 523–528Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  523Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12104 1 Efficacy of two trabecular micro-bypass stents  combined with topical travoprost in open-angle  glaucoma not controlled on two preoperative  medications: 3-year follow-up David F Chang1 eric D Donnenfeld2 l Jay Katz3 lilit Voskanyan4 Iqbal Ike K Ahmed5 Thomas W samuelson6 Jane ellen giamporcaro7 Dana M Hornbeak7 Kerry D solomon8 1altos eye Physicians, los altos,   Ca, 2Ophthalmic Consultants of  long island, rockville Centre, nY,   3Department of Ophthalmology,   Wills eye hospital, Jefferson Medical  College, Philadelphia, P a, Usa;   4s.V.",Non-OADS,/arxiv_data1/oa_pdf/c7/05/opth-11-523.PMC5359133.pdf
"Substantial data with up to 5 years of follow-up have shown  that the implantation of a single trabecular micro-bypass stent (iStent® Trabecular  Micro-Bypass; Glaukos Corporation, San Clemente, CA, USA) during cataract Correspondence: David F Chang altos eye Physicians, 762 altos Oaks  Drive, los altos, Ca 94024, Usa Tel +1 650 948 9123 Fax +1 650 948 0563 email dceye@earthlink.ne t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Chang et al Running head recto: Two trabecular stents & prostaglandin in OAG on 2 meds: 3 year follow-up DOI: http://dx.doi.org/10.2147/OPTH.S121041",Non-OADS,/arxiv_data1/oa_pdf/c7/05/opth-11-523.PMC5359133.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c7/05/opth-11-523.PMC5359133.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/05/opth-11-523.PMC5359133.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/40/c1/jpr-10-613.PMC5359134.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/40/c1/jpr-10-613.PMC5359134.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 613–619Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  613 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128861Tibial nerve stimulation with a miniature, wireless  stimulator in chronic peripheral neuropathic pain Paweł Sokal1 Marek Harat2 Piotr Zieliński3 Sara Kierońska1 1Department of Neurosurgery,   Military Research Hospital,    Bydgoszcz, 2Department of Public  Health, Ludwik Rydygier Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, T oruń,   3Department of Sports Medicine,   University of Physical Education and Sport, Gdansk, PolandAbstract:  Peripheral neuropathic pain (PNP) and complex regional pain syndrome (CRPS)  can be effectively treated with peripheral nerve stimulation.",Non-OADS,/arxiv_data1/oa_pdf/40/c1/jpr-10-613.PMC5359134.pdf
"For its management, varying Correspondence: Paweł Sokal Department of Neurosurgery, The 10th Military Research Hospital, Powstancow Warszawy Street 5, 85-681 Bydgoszcz, PolandTel +48 261 417 093Fax +48 261 417 094Email psokal@wp.plJournal name: Journal of Pain Research  Article Designation: CLINICAL TRIAL REPORTY ear: 2017V olume: 10Running head verso: Sokal et alRunning head recto: Tibial nerve stimulation in peripheral neuropathic painDOI: http://dx.doi.org/10.2147/JPR.S128861",Non-OADS,/arxiv_data1/oa_pdf/40/c1/jpr-10-613.PMC5359134.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/40/c1/jpr-10-613.PMC5359134.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 619 Tibial nerve stimulation in peripheral neuropathic pain  20.,Non-OADS,/arxiv_data1/oa_pdf/40/c1/jpr-10-613.PMC5359134.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/c8/ppa-11-537.PMC5359135.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 537–545Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  537OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12329 4 Prospective study on the overuse of blood   test-guided antibiotics on patients with acute  diarrhea in primary hospitals of china Xinghui liu1,* Xueke T ong2,* liyin Jin3 Minghao ha4 Feng cao5 Fengxia Xu1 Y ongbin chi1 Denghai Zhang1 limin Xu1 1Department of laboratory,   2Department of infectious Diseases,   shanghai gongli hospital, The  second Military Medical University,   3Department of laboratory, Jinyang  community health service center,   Pudong new District, 4Department  of infectious Diseases and hepatology,   The Affiliated seventh People’s  hospital of shanghai University  of Traditional chinese Medicine,   5Department of Preventive care,   shanghai gongli hospital, The second  Military Medical University, shanghai,   People’s republic of china *These authors contributed equally  to this workBackground:  Overuse with antibiotics in the treatment of infectious diseases has become a  central focus of public health over the years.",Non-OADS,/arxiv_data1/oa_pdf/97/c8/ppa-11-537.PMC5359135.pdf
"Moreover, trained technicians and appropriate equipment are required.3 Therefore, in the  primary hospitals in People’s Republic of China, the most common tests used for the quick  diagnosis and treatment guide of acute diarrhea are blood examinations.4,5 The widely  used diagnostic criteria include the number of white blood cells (WBC), the percentage  of neutrophils (Neu%), and C-reactive protein (CRP).6 Normally, the treatments will be  selected directly depending on the results from these blood examinations.7correspondence: limin Xu;   Denghai Zhang Department of clinical laboratory,  shanghai gongli hospital, The second  Military Medical University, 219 Miaopu  rd, Pudong new Area, shanghai 200135,  People’s republic of china Tel +86 21 5885 8730 ext 5236; 5177 Fax +86 21 5821 9029 email winexlm@163.co m;   shanghai_zhang@hotmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Liu et al Running head recto: Antibiotics overuse on patients with acute diarrhea DOI: http://dx.doi.org/10.2147/PPA.S123294",Non-OADS,/arxiv_data1/oa_pdf/97/c8/ppa-11-537.PMC5359135.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/97/c8/ppa-11-537.PMC5359135.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/93/ott-10-1527.PMC5359136.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1527–1533OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1527Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13218 7 Tyrosine kinase domain mutations of EGFR gene  in head and neck squamous cell carcinoma chittibabu Vatte1 ali M al amri2 cyril cyrus1 shahanas chathoth1 sadananda acharya3 Tariq Mohammad hashim4 Zhara al ali2 saleh Tawfeeq alshreadah2 ahmed alsayyah4 amein K al-ali5 1Department of genetic research,   institute for research and Medical  consultation, University of Dammam,   Dammam, 2Department of internal  Medicine, King Fahd hospital of the  University, University of Dammam,   al-Khobar, 3Department of stemcell  research, institute for research and  Medical consultation, 4Department  of Pathology, King Fahd hospital  of the University, University of  Dammam, al-Khobar, 5Department  of Biochemistry, college of Medicine,   University of Dammam, Dammam,   Kingdom of saudi arabiaBackground:  Epidermal growth factor receptor ( EGFR ) is a commonly altered gene that is  identified in various cancers, including head and neck squamous cell carcinoma (HNSCC).",Non-OADS,/arxiv_data1/oa_pdf/6f/93/ott-10-1527.PMC5359136.pdf
"Despite aggressive and diverse therapies, the survival rate of these patients  has not markedly improved because of the frequent development of locoregional  recurrences, distant metastases, and second primary tumors.4 Epidermal growth factor receptor (EGFR) protein overexpression is seen in .80%  of HNSCC cases5 and is associated with a poor prognosis.6 The overexpression of EGFR  may apparently be triggered by numerous mechanisms such as epigenetic changes,  gene amplification, and oncogenic viruses.7 Hypoxic tumor microenvironment increases  the EGFR mRNA translation, thereby inducing EGFR overexpression.8 EGFR is a  founding member of a HER (erbB) family, which consists of four closely related trans - membrane receptors.9 EGFR has a single hydrophobic transmembrane domain, a cyto - plasmic tyrosine kinase (TK)-containing domain, and an extracellular ligand-binding  domain.10 The cascade on binding of a ligand to the latter  domain initiates the EGFR correspondence: chittibabu Vatte Department of genetic research,  institute for research and Medical  consultation, University of Dammam,  al-rakah, PO Box-1982, Dammam  31441, Kingdom of saudi arabia Tel +966 3333 0867  email cbvatte@uod.edu.s a Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Vatte et al Running head recto: EGFR mutations in HNSCC DOI: http://dx.doi.org/10.2147/OTT.S132187",Non-OADS,/arxiv_data1/oa_pdf/6f/93/ott-10-1527.PMC5359136.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6f/93/ott-10-1527.PMC5359136.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/93/ott-10-1527.PMC5359136.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d4/6a/ppa-11-561.PMC5359137.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 561–569Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  561OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11925 6 Determinants of initiation, implementation, and  discontinuation of amoxicillin by adults with acute  cough in primary care David gillespie,1 Daniel  Farewell,2 lucy Brookes- howell,1 christopher c  Butler,3 samuel coenen,4–6  nick A Francis,2 Paul little,7  Beth stuart,7 Theo Verheij,8  Kerenza hood1 On behalf of the grA ce  consortium 1centre for Trials research, college of  Biomedical & life sciences, 2Division  of Population Medicine, school of  Medicine, cardiff University, cardiff,   3nuffield Department of Primary  health care sciences, University of  Oxford, Oxford, UK; 4laboratory  of Medical Microbiology, Vaccine  & infectious Disease institute  (VAXin FecTiO), 5centre for  general Practice, Department of  Primary and interdisciplinary care  (eliZA), 6clinical epidemiology and  Medical statistics, Department of  epidemiology and social Medicine  (esOc), University of Antwerp,   Antwerp, Belgium; 7Aldermoor  health centre, Primary care and  Population sciences, Faculty of  Medicine, University of southampton,   southampton, UK; 8Department of  general Practice, Julius center for  health sciences and Primary care,   University Medical center Utrecht,   Utrecht, the netherlandsAim:  To investigate the determinants of adherence to amoxicillin in patients with acute lower  respiratory tract infection.",Non-OADS,/arxiv_data1/oa_pdf/d4/6a/ppa-11-561.PMC5359137.pdf
"These determinants may operate on multiple levels to impact correspondence: David gillespie centre for Trials research, college  of Biomedical & life sciences, cardiff  University, heath Park, cardiff,  cF14 4Ys, Wales, UK Tel +44 2920 687610 email gillespied1@cardiff.ac.u k Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Gillespie et al Running head recto: Determinants of adherence to amoxicillin in patients with acute cough DOI: http://dx.doi.org/10.2147/PPA.S119256",Non-OADS,/arxiv_data1/oa_pdf/d4/6a/ppa-11-561.PMC5359137.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d4/6a/ppa-11-561.PMC5359137.pdf
"Patient Preference and Adherence 2017:11submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 569Determinants of adherence to amoxicillin in patients with acute cough of Tromso (Norway), Medical University of Bialystok,  Medical University of Lodz (Poland), National University  Research Council (Romania), Osnovno zdravstvo Gorenjske  (Slovenia), l’Institut d’Investigacions Biomèdiques August  Pi i Sunyer (Spain), Swedish Research Council, Karolinska  Institute (Sweden), Medical Research Council, Cardiff  University, University of Oxford, University of Southampton  (United Kingdom), Swiss National Science Foundation (Swit - zerland) through the European Science Foundation (ESF),  in the framework of the Research Networking Programme  TRACE ( http://archives.esf.org/trac e).",Non-OADS,/arxiv_data1/oa_pdf/d4/6a/ppa-11-561.PMC5359137.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/26/ott-10-1561.PMC5359138.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1561–1573OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1561Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12642 4 Mechanism of immune evasion in breast cancer Mozhi wang1,* Changwang Zhang2,* Y ongxi Song2 Zhenning wang2 Yaojia wang1 Fang Luo1 Yujie Xu1 Yi Zhao1 Zhonghua wu2 Yingying Xu1 1Department of Breast Surgery,   2Department of Surgical Oncology  and General Surgery, The First  Affiliated Hospital of China Medical  University, Shenyang, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Breast cancer (BC) is the most common malignant tumor among women, with high  morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/6d/26/ott-10-1561.PMC5359138.pdf
"A summarized net of mechanisms is presented in Figure 1.Correspondence: Yingying Xu Department of Breast Surgery, The  First Affiliated Hospital of China Medical  University, 155 North Nanjing Street,  Shenyang 110001, Liaoning, People’s  Republic of China Tel +86 24 8328 2741 Fax +86 24 2270 3578 email xuyingying@cmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Wang et al Running head recto: Mechanism of immune evasion in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S126424",Non-OADS,/arxiv_data1/oa_pdf/6d/26/ott-10-1561.PMC5359138.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6d/26/ott-10-1561.PMC5359138.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/26/ott-10-1561.PMC5359138.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/51/ndt-13-803.PMC5359139.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 803–813Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  803OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12840 7 Daily activity level improvement with  antidepressant medications predicts long-term  clinical outcomes in outpatients with major  depressive disorder Manish K Jha1 raymond B T eer2 abu Minhajuddin3 Tracy l greer1 a John rush4 Madhukar h Trivedi1 1center for Depression research  and clinical care, University of  T exas southwestern Medical center,   Dallas, 2University of T exas, austin,   3Department of clinical sciences,   University of Texas southwestern  Medical center, Dallas, TX, Usa;   4Duke-NUs, singapore, singaporeBackground:  Major depressive disorder (MDD) significantly impacts performance of both  work- and nonwork-related routine daily activities.",Non-OADS,/arxiv_data1/oa_pdf/ae/51/ndt-13-803.PMC5359139.pdf
edu Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Jha et al Running head recto: Improved activity impairment with antidepressant treatment DOI: http://dx.doi.org/10.2147/NDT.S128407,Non-OADS,/arxiv_data1/oa_pdf/ae/51/ndt-13-803.PMC5359139.pdf
"Available  from: http://www.reillyassociates.net/WPAI_Scoring.htm l. Accessed  May 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/51/ndt-13-803.PMC5359139.pdf
"Available from: http://www2.sas.com/proceedings/sugi29/198-29.pd f.  Accessed November 11, 2016.",OADS,/arxiv_data1/oa_pdf/ae/51/ndt-13-803.PMC5359139.pdf
